| Year | Company name | Health Consumer Organisation | Description and/or Purpose of Support | Nature of Support | Financial Support |
|---|---|---|---|---|---|
| 2013 | A. Menarini | Impotence Australia | Unrestricted grant to support 1800 hotline for sexual dysfunction, endorsment of controlpe website, and update of IA website (PE section) | 20000 | 20000 |
| 2014 | A. Menarini | Impotence Australia | Unrestricted grant to support 1800 hotline for sexual dysfunction, endorsment of controlpe website, and update of IA website (PE section) | 20000 | 20000 |
| 2014 | A. Menarini | Impotence Australia | Unrestricted grant to support 1800 hotline for sexual dysfunction, endorsment of controlpe website, and update of IA website (PE section) | 20000 | 20000 |
| 2015 | A. Menarini | Arthritis Foundation of Australia | Sponsorship for development and printing of patient gout booklet | 9295 | 9295 |
| 2015 | A. Menarini | Metabolic Dietary Disorders Association | Sponsorship to assist MDDA with educational initiatives to support patients diagnosed with hereditary tyrosinaemia type 1 (including family retreat, newsletters, attendance at Newborn Screening Working Group) | 18700 | 18700 |
| 2015 | A. Menarini | Rare Voices Australia | Sponsorship to assist Rare Voices Australia (RVA) with their aims of presenting a unified voice for Australians living with a rare disease ( RVA Summit Feb 2015 Sponsorship and Industry Round table annual membership). | 15000 | 15000 |
| 2016 | A. Menarini | Arthritis Foundation of Australia | Sponsorship for development of Arthritis Australia Information sheets on Healthshare for 12 months (Jan-Dec16) - Medical Director, Best Practice, Genie (if available), Dispensing Software (if available). | 20700 | 20700 |
| 2016 | A. Menarini | Metabolic Dietary Disorders Association | Sponsorship to assist MDDA with educational initiatives to support patients diagnosed with hereditary tyrosinaemia type 1 (including family retreat, virtual roundtable, IEM Awareness and registry working group) | 25500 | 25500 |
| 2016 | A. Menarini | Rare Voices Australia | Sponsorship to assist RVA with their aims of presenting a unified voice for Australians living with a rare disease ( Mentorship Programme and Industry Round table annual membership). | 20000 | 20000 |
| 2017 | A. Menarini | Metabolic Dietary Disorders Association | Sponsorship to assist MDDA with educational initiatives to support patients diagnosed with hereditary tyrosinaemia type 1 (including family retreat, newsletters, web conferencing and parlimentary friends sponsorship). | 19500 | 19500 |
| 2017 | A. Menarini | Rare Voices Australia | Sponsorship to assist RVA with their aims of presenting a unified voice for Australians living with a rare disease (Mentorship & Education Project and Industry Round table annual membership). | 25000 | 25000 |
| 2018 | A. Menarini | Metabolic Dietary Disorders Association | Sponsorship to assist MDDA with educational initiatives to support patients diagnosed with hereditary tyrosinaemia type 1 (including family retreat, IEM Dietary Management App) | 24000 | 24000 |
| 2018 | A. Menarini | Rare Voices Australia | Sponsorship to assist RVA with their aims of presenting a unified voice for Australians living with a rare disease (Patient Advocacy Workshop at National Rare Disease Summit and Industry Round table annual membership). | 20000 | 20000 |
| 2019 | A. Menarini | Arthritis Foundation of Australia | Sponsorship to update and reprint 5,000 copies of the Arthritis Australia Gout Booklet, 'Taking Control of Your Gout'. 3,000 copies copies sent to Arthritis affliate offices, with the remaining 2,000 copies sent to A. Menarini. | 9820 | 9820 |
| 2019 | A. Menarini | Metabolic Dietary Disorders Association | Sponsorship to assist MDDA with educational initiatives that support patients diagnosed with hereditary tyrosinaemia type 1. As per HCO agreement, this sponsorship supported the 'Time To Shine' Family Retreat and the development of the IEM (HT1) Dietary Management Application. MDDA National Inborn Errors of Metabolism (IEM) 'Time To Shine' Family Retreat: Dates: 4th - 6th October 2019 Venue: Tamar Valley Resort, Grindelwald Tasmania The program included presentations by healthcare professionals to attendees on the following topics: 1. Latest IEM research initiatives, emerging treatments and trials, and national care guidelines 2. IEM Formula Overview and supplementary nutritional considerations 3. Advocacy for access to emerging therapies and treatments 4. Clinical panel discussions 5.'Building Resilience' workshops for mental wellbeing and fitness 6. Patient Pathway Programs and IEM Transitional Workshops 7. Low Protein cooking demonstrations, recipe development and sharing of strategies IEM Dietary Managment Application: A tool for day to day IEM management. This application aims to assist patients and their families with diet/menu planning, nutritional monitoring, protein counting, milestone recording, and wellbeing goal setting and tracking. | Family Retreat Conference Sponsorship: $14, 500 Application Development: $4,500 | 19000 |
| 2019 | A. Menarini | Rare Voices Australia | Sponsorship to assist Rare Voices Australia (RVA) with their aims of presenting a unified voice for Australians living with a rare disease. Membership for Industry Round Table, and partial sponsorship of the Mentorship & Education Project which consisted of workshops, webinars and customised advocacy mentorship programmes. | Industry Round Table Membership: $10, 000 Mentorship Programme Partial Sponsorship: $5,000 | 15000 |
| 2020 | A. Menarini | Arthritis Foundation of Australia | To reprint 10,000 copies of the Arthritis Australia Gout Booklet, 'Taking Control of Your Gout'. | Sponsorship to reprint Arthritis Australia book: $8978 | 8978 |
| 2020 | A. Menarini | Metabolic Dietary Disorders Association | Sponsorship to assist MDDA with educational initiatives that support patients diagnosed with hereditary tyrosinaemia type 1. This sponsorship supported the 'MDDA @Home Retreat Virtual Conference' and the development of the IEM (HT1) Dietary Management Application. MDDA @Home Retreat Virtual Conference: Dates: 10th – 11th October 2020 Venue: Virtual conference The program included presentations by healthcare professionals to attendees on the following topics: • Latest research initiatives, emerging treatments and trials, and national care guidelines • IEM Formula Overview and supplementary nutritional considerations • Advocacy for access to emerging therapies and treatments • Clinical panel discussions • Workshops for mental wellbeing and fitness • Patient Pathway Programs and IEM Transitional Workshops • Low Protein cooking demonstrations, recipe development and sharing of strategies IEM Dietary Managment Application: A tool for day to day IEM management. This application aims to assist patients and their families with diet/menu planning, nutritional monitoring, protein counting, milestone recording, and wellbeing goal setting and tracking. | Industry Membership: $5,000 MDDA @Home Retreat Virtual Conference Sponsorship: $6,000 Application Development (2020 ongoing contributor): $4,500 | 15500 |
| 2020 | A. Menarini | Rare Voices Australia | Sponsorship to assist Rare Voices Australia with their aims of presenting a unified voice for Australians living with a rare disease. Membership for Industry Round Table, and partial sponsorship of the Mentorship & Education Project which consisted of workshops, webinars and customised advocacy mentorship programmes. | Industry Round Table Membership: $10,000 Mentorship Programme Partial Sponsorship: $5,000 | 15000 |
| 2013 | Abbott Australasia | Cystic Fibrosis Australia | To assist with development of the Australian Cystic Fibrosis data registry and development of the dieticians guidelines | 37500 | 37500 |
| 2013 | Abbott Australasia | Pancare Foundation | To assist with cancer awareness, research and education programs | 5000 | 5000 |
| 2013 | AbbVie | Arthritis Foundation of Australia | An educational grant to support scale-up of a pilot, AS patient education program to a two-centre study | 7500 | 7500 |
| 2013 | AbbVie | Arthritis Foundation of Australia | Sponsorship for an Arthritis Australia representative to attend EULAR 2013 and to attend an AbbVie run launch event of the RA global patient survey the day before EULAR commences | 13974.06 | 13974.06 |
| 2013 | AbbVie | Arthritis Foundation of Australia | An educational grant to Arthritis Australia to host a 4th Steering Group meeting for the "Time to Move" project and completion of a resultant White Paper publication. | 14300 | 14300 |
| 2013 | AbbVie | Arthritis Foundation of Australia | An educational Grant to enable Arthritis Australia to update and reprint a series of four patient booklets, encompasssing "10 Steps" and three versions of the Arthritis Australia "Taking Control" patient educational booklet series (AS, RA, PsA) | 23000 | 23000 |
| 2013 | AbbVie | Arthritis Queensland (QLD) | A grant to support a 7 hour patient education symposium at Translational Research Institute, Princess Alexandra Hospital, on Ankylosing Sponsylosis patient and carer education | 500 | 500 |
| 2013 | AbbVie | Australian Crohn's and Colitis Association | An educational grant to support the production of a series of IBD patient story videos for feature on CCA's website & You Tube channel. | 20000 | 20000 |
| 2013 | AbbVie | Australian Crohn's and Colitis Association | An educational grant to fund the services of a professional media relations company to support CCA in their media outreach activities during May 2013 'IBD awareness month'. | 20000 | 20000 |
| 2013 | AbbVie | Ibd Support Australia | An educational grant to support 3 representatives of IBD Support Australia to attend Australian Gastroenterology Week Conference, held 7th - 9th October 2013, in Melbourne. | 3300 | 3300 |
| 2013 | AbbVie | National Association of People with HIV Australia | Unrestricted Educational Grant Treataware activity 2013 Newton, NSW 2042 HIV/AIDS topics | 10000 | 10000 |
| 2013 | AbbVie | Prostate Cancer Foundation of Australia (PCFA) | Prostate Cancer Foundation Australia (PCFA) Educational Grant for Specialist Nursing Development | 10000 | 10000 |
| 2013 | AbbVie | Skin & Cancer Foundation Australia | Support for Skin and Cancer Foundation Inc. and the Independent Steering Commitee to raise community awareness of the first Australian treatment goals for chronic psoriasis. | 10000 | 10000 |
| 2014 | AbbVie | Arthritis Foundation of Australia | Grant to Arthritis Australia for the printing of 750 copies of "Time to Move: Arthritis" white paper. | 3500 | 3500 |
| 2014 | AbbVie | Arthritis Foundation of Australia | Grant to Arthritis Australia to sponsor speaker to attend the Asia Pacific "IMMD SUMMIT 2014', the first Immune Mediated Inflammatory Diseases Summit in Seoul in August 2014. | 5066.36 | 5066.36 |
| 2014 | AbbVie | Arthritis Foundation of Australia | Grant to Arthritis Australia to support Model of Care White Paper - Professional editing and production. | 9200 | 9200 |
| 2014 | AbbVie | Arthritis Foundation of Australia | Grant to Arthritis Australia from the Medicines Australia Community Chest towards a key project that will support the advocacy work of Arthritis Australia. | 20000 | 20000 |
| 2014 | AbbVie | Arthritis Foundation of Australia | Grant to Arthritis Australia to support Model of Care White Paper Launch Campaign | 30500 | 30500 |
| 2014 | AbbVie | AS Victoria (VIC) | Grant to AS Victoria for a two hour lecture series on Ankylosing Spondylitis, Physiotherapy in AS and Research in AS. | 500 | 500 |
| 2014 | AbbVie | Australian Crohn's and Colitis Association | Grant to Crohn's & Colitis Australia to support a pilot 'Poster Campaign' in public conveniences to drive awareness of IBD and the support services of Chrohns & Colitis Australia. | 40000 | 40000 |
| 2014 | AbbVie | Australian Hepatology Australia | Grant to Australian Hepatology Association to distribute the HCV Quest global survey through its members' organisations. The survey explores the impact of hepatitis C on patients' lives and the ways in which living with the infection influences work, educ | 2000 | 2000 |
| 2014 | AbbVie | Hepatitis Australia | Grant to Hepatitis Australia for their 'Love Your Liver' Project which encompasses World Hepatitis Day and incorporates a program of awareness-raising and advocacy activities undertaken by Hepatitis Australia. | 50000 | 50000 |
| 2014 | AbbVie | Hepatitis New South Wales (NSW) | Grant to Hepatitis NSW to attend 16th Conference Asia Pacific Association in the Study of Liver at Brisbane Convention Centre. | 2089.74 | 2089.74 |
| 2014 | AbbVie | Hepatitis Queensland (QLD) | Grant to Hepatitis Queensland to attend the first International Indigenous Viral Hepatitis Meeting 15-17 Sept 2014, Alice Springs; followed by the 2014 Australasian Viral Hepatitis Conference 17-19 Sept. | 1952.45 | 1952.45 |
| 2014 | AbbVie | Juvenile Arthritis Foundation Australia | Sponsorship of Corporate table at the Juvenile Arthritis annual fundraising dinner | 2500 | 2500 |
| 2014 | AbbVie | LiverWELL | Grant to Hepatitis Victoria to develop short video recording and documenting the personal stories of 28 individuals affected by Hepatitis C. | 20825 | 20825 |
| 2014 | AbbVie | Parkinson's Victoria (VIC) | Donation to Parkinson's Victoria for their Walk in the Park 2014 fundraising event. | 5000 | 5000 |
| 2015 | AbbVie | Arthritis Foundation of South Australia (SA) | Sponsorship of Arthritis South Australia to support a representative of Arthritis South Australia to speak on patient case studies at the Asia Pacific Immune Mediated Inflammatory Diseases Patient Summit held 29‐30 August 2015 in Hong Kong. | 4511.05 | 4511.05 |
| 2015 | AbbVie | Arthritis Foundation of Victoria (VIC) | Grant to Arthritis Foundation of Victoria for the Annual Parents Forum webinar in August 2015 for parents/caregivers to educate on the links between chronic childhood illness, emotional and behavioural problems, and difficulties with adherence to illness | 5000 | 5000 |
| 2015 | AbbVie | Arthritis Foundation of Western Australia (WA) | Grant to Arthritis Foundation to support a manager of Arthritis & Osteoporosis Western Australia to attend the American College of Rheumatology annual meeting from 6‐11 November 2015 in San Francisco. | 8000 | 8000 |
| 2015 | AbbVie | Arthritis New South Wales (NSW) | Grant to Arthritis Foundation of New South Wales to support raising awareness of arthritis and osteoporosis to promote healthy bone and joints. | 5000 | 5000 |
| 2015 | AbbVie | Australasian Hepatology Association | Sponsorship of Australasian Hepatology Association's Annual Summit for hepatology nurses from 12‐13 June 2015. | 10000 | 10000 |
| 2015 | AbbVie | Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine | Grant to Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) to support the creation of two videos for inclusion in the program and viewing at the 4th International Symposium on Hepatitis Care in Substance Users (INHSU 2015), t | 15200 | 15200 |
| 2015 | AbbVie | Australian Crohn's and Colitis Association | Grant to Crohn's & Colitis Australia to support a patient/caregiver program and material reprint of Working with IBD guides for employees and employers. | 5000 | 5000 |
| 2015 | AbbVie | Australian Crohn's and Colitis Association | Grant to Crohn's & Colitis Australia to support IBD Awareness Month, May 2015, and World IBD Day, 19 May 2015, through awareness materials, webpage design and management, and social media. | 10000 | 10000 |
| 2015 | AbbVie | Australian Crohn's and Colitis Association | Grant to Crohn's & Colitis Australia to support a representative of Crohn's & Colitis Australia to attend an educational conference, European Crohn's and Colitis Organization Conference, from 18‐21 February 2015 in Barcelona. | 10369 | 10369 |
| 2015 | AbbVie | Australian Crohn's and Colitis Association | Grant to Crohn's & Colitis Australia to support a pilot Poster Campaign in public conveniences to drive awareness of IBD and the support services of Crohn's & Colitis Australia. | 20000 | 20000 |
| 2015 | AbbVie | Australian Crohn's and Colitis Association | Grant to Crohn's & Colitis Australia to support education, advocacy, support and counselling programs, and research to improve patient outcomes. | 20000 | 20000 |
| 2015 | AbbVie | Australian Injecting and Illicit Drug Users League (AIVL) | Grant to Australian Injection & Illicit Drug Users League (AIVL) to support the costs of holding a Community Networking Forum, hosted by AIVL, Canberra Alliance for Harm Minimisation and Advocacy (CAHMA), NSW Users and AIDS Association (NUAA) on 6 October | 10000 | 10000 |
| 2015 | AbbVie | Creaky Joints Australia | Grant to Creaky Joints Australia to support initiatives to build its capacities in online forums and social networks for patient‐to‐patient engagements, to establish links to additional resources such as locally based health organisations, and to provide | 45000 | 45000 |
| 2015 | AbbVie | Hepatitis Australia | Grant to Hepatitis Australia to support travel and accommodation for seven Hepatitis Australia officers to attend the book launch of "Together We Can: Building a Brighter Future for Australians living with Hepatitis C" at the Federal Parliament House on | 7000 | 7000 |
| 2015 | AbbVie | Hepatitis Australia | Grant to Hepatitis Australia to support travel and accommodation of two story‐contributors to attend the book launch of "Together We Can: Building a Brighter Future for Australians living with Hepatitis C" at the Federal Parliament House on 16 June 2015 a | 8024.7 | 8024.7 |
| 2015 | AbbVie | Hepatitis Australia | Grant to Hepatitis Australia to support printing of 1,500 additional copies and distribution of the "Together We Can: Building a Brighter Future for Australians living with Hepatitis C" book to Hepatitis Australia member organisations, liver clinics, hea | 14446 | 14446 |
| 2015 | AbbVie | Hepatitis Australia | Grant to Hepatitis Australia to build capacity of Hepatitis Australia, state hepatitis organisations, and territory hepatitis organisations through introductory webinars and a full day advanced workshop to educate member organisations on social media meth | 30000 | 30000 |
| 2015 | AbbVie | Hepatitis Australia | Grant to Hepatitis Australia to build the capacity of Hepatitis Australia, state hepatitis organisations, and territory hepatitis organisations through an audit of social media to identify conversations around hepatitis; evaluation of each member organisa | 46795 | 46795 |
| 2015 | AbbVie | Hepatitis Australia | Grant to Hepatitis Australia for Love Your Liver Project, an awareness and advocacy project, which encompasses World Hepatitis Day, July 28, undertaken by Hepatitis Australia and partner organisations, which includes the Take Action on Viral Hepatitis Now | 50000 | 50000 |
| 2015 | AbbVie | Hepatitis Australia | Grant to Hepatitis Australia for the development and launch of the "Together We Can: Building a Brighter Future for Australians living with Hepatitis C" book that depicts personal stories and hopes for the future of individuals affected by Hepatitis C. In | 110000 | 110000 |
| 2015 | AbbVie | Hepatitis New South Wales (NSW) | Payment to Hepatitis NSW to educate AbbVie on strategy development and challenges and issues faced by the NSW hepatitis community. | 950 | 950 |
| 2015 | AbbVie | Juvenile Arthritis Foundation Australia | Grant to Juvenile Arthritis Foundation in lieu of payment to 73 survey participants in AbbVie market research. | 1460 | 1460 |
| 2015 | AbbVie | Leukaemia Foundation Of Australia | Grant to Leukaemia Foundation to develop and evaluate a patient support application, My Haematology Diary, to better support patients to record side effects and anxiety levels, record doctor's appointments, questions to ask their doctor, and receive medic | 30000 | 30000 |
| 2015 | AbbVie | LiverWELL | Payment to Hepatitis Victoria Inc. to participate in an educational panel discussion on living with and advocating for people living with Hepatitis C on 9 February 2015. | 700 | 700 |
| 2015 | AbbVie | LiverWELL | Grant to Hepatitis Victoria Inc. to develop educational video of the experience of a person living with Hepatitis C living in Australia. | 3000 | 3000 |
| 2015 | AbbVie | Parkinson's Australia | Grant to Parkinson's Australia in lieu of payment to 106 survey participants in AbbVie market research. | 1060 | 1060 |
| 2015 | AbbVie | Parkinson's New South Wales (NSW) | Sponsorship to Parkinson's NSW to support the 8th Annual Parkinson's NSW Unity Walk and Run, on 30 August 2015, to support Parkinson's NSW mission to inform, educate, encourage, and support people living with Parkinson's, their families, and their carers | 10000 | 10000 |
| 2015 | AbbVie | Parkinson's Queensland (QLD) | Sponsorship to Parkinson's Queensland's Walk in the Park fundraiser to support better quality of life for patients on 13 September 2015. | 1500 | 1500 |
| 2015 | AbbVie | Parkinson's South Australia (SA) | Sponsorship of Parkinson's South Australia's Walk in the Park fundraiser to support better quality of life for patients on 30 August 2015. | 1000 | 1000 |
| 2015 | AbbVie | Parkinson's Victoria (VIC) | Grant to Parkinson's Victoria for an educational seminar, Innovation in Parkinson's, for speech pathologists, physiotherapists, occupational therapists, nurses, and social workers on 11 September 2015. | 1000 | 1000 |
| 2015 | AbbVie | Parkinson's Victoria (VIC) | Sponsorship to Parkinson's Victoria's Walk in the Park fundraiser to support better quality of life for patients in August 2015. | 1500 | 1500 |
| 2016 | AbbVie | Arthritis Foundation of Australia | Consultancy to support Arthritis Australia's contribution on an Advisory Board consisting of rheumatologists, dermatologists, representatives of Health Consumer Organisations and patients to review and provide feedback on the strategy and content of a pso | 400 | 400 |
| 2016 | AbbVie | Arthritis Foundation of Australia | Grant to support one scholarship through the Paediatric Rheumatology Scholarships Appeal for the successful applicant to undertake a two‐year training program, accredited by the Australasian College of Physicians. The total scholarship is $240,000.00 paid | 60000 | 60000 |
| 2016 | AbbVie | Arthritis Foundation of South Australia (SA) | Funding to support the annual Health Professional Conference that provides information on the latest developments in clinical and scientific research to improve the quality of care for patients with rheumatoid arthritis. | 1500 | 1500 |
| 2016 | AbbVie | Arthritis Foundation of Western Australia (WA) | Grant to support the completion of the Ankylosing Spondylitis Project (ASP) which includes the completion of analysis of all data up to the time point of September 2017 and development of an upgraded evaluation tool. | 10000 | 10000 |
| 2016 | AbbVie | Arthritis Queensland (QLD) | Funding to support the annual Health Professionals Seminar. This seminar provides information on the latest developments in medical research and arthritis treatment. | 600 | 600 |
| 2016 | AbbVie | Australian Crohn's and Colitis Association | Grant to support CCA programs that support patients nationally, including their confidential support and counselling program, education and advocacy, campaigns to increase awareness of Crohn's Disease and Ulcerative Colitis and support of their research p | 60000 | 60000 |
| 2016 | AbbVie | Australian Injecting and Illicit Drug Users League (AIVL) | Educational presentation to AbbVie staff on the injecting drug users experience of seeking and undergoing treatment for HCV in order to enhance understandings of the hard to reach patient experience. | 500 | 500 |
| 2016 | AbbVie | Australian Injecting and Illicit Drug Users League (AIVL) | Grant to support the National Hepatitis C and Other BBVs / STIs Programs which created a peer‐developed and peer‐provided education and training program for the community of people who use drugs, to enhance knowledge about HCV prevention and testing. | 22000 | 22000 |
| 2016 | AbbVie | Australian Mitochondrial Disease Foundation | Philanthropic donation to the Australian Mitochondrial Disease Foundation for the Long Bloody Walk. This was a dollar matched donation under the AbbVie Volunteer's Program. | 500 | 500 |
| 2016 | AbbVie | Cancer Council New South Wales (NSW) | Philanthropic donation to the Cancer Council NSW for the Heaven Can Wait Regatta. This was a dollar matched donation under the Abbvie Volunteer's Program. | 1000 | 1000 |
| 2016 | AbbVie | Global Healthy Living Foundation | Grant to support the travel for the Co‐Founder and President of Creaky Joints (Global Healthy Living Foundation) to travel to Australia from the USA to attend the Australian Rheumatology Association (ARA) 57th Annual Scientific Meeting to speak at an indu | 14000 | 14000 |
| 2016 | AbbVie | Global Healthy Living Foundation | Grant to support the Global Healthy Living Foundation, operating in Australia as Creaky Joints, patient education programs including moderated online chats and conference calls, development of patient guidelines, development of a resource guide and suppor | 22500 | 22500 |
| 2016 | AbbVie | Gut Foundation | Grant to support the Gut Foundation's program for the Australian activities on World IBD Day. These activities included development of a social media strategy and its execution, online content for patients and their families, development of an IBD/IBS fac | 10000 | 10000 |
| 2016 | AbbVie | Hepatitis Australia | Grant to support Hepatitis Australia's CEO Networking and Best Practice Sharing Forums. These two‐day forums were for the CEO's of the State and Territory affiliates to review current local and national trends, discuss community engagement and health prom | 30000 | 30000 |
| 2016 | AbbVie | Hepatitis Australia | Grant to support World Hepatitis Day to improve community awareness of viral hepatitis and the global viral hepatitis elimination movement. This includes the development of campaign materials and support of outreach activities including traditional and so | 40000 | 40000 |
| 2016 | AbbVie | Hepatitis New South Wales (NSW) | Funding to support Hepatitis NSW to work with Hepatitis QLD to adapt patient information for Aboriginal and Torres Strait Islander people with Hepatitis C accessing treatment. | 15050 | 15050 |
| 2016 | AbbVie | Hepatitis New South Wales (NSW) | Grant to support the Hepatitis C Community Mobilisation Program to work directly with hepatitis C affected communities and with healthcare professionals (predominantly pharmacists and GPs) to support people in NSW living with Hepatitis C to develop confid | 45063 | 45063 |
| 2016 | AbbVie | Hepatitis Queensland (QLD) | Funding to support Hepatitis QLD to lead the planning & liaison for a Focus Group with selected Indigenous groups to inform the adaptation of a Patient Booklet and Patient Dosing Guide Card (with Hepatitis NSW). | 3485 | 3485 |
| 2016 | AbbVie | Hepatitis South Australia (SA) | Grant to support the annual Heplink Forum which focuses on Hepatitis C treatment in South Australian prisons. The forum is targeted towards health workers, Aboriginal health workers, workers in BBV and STI sectors, correctional service staff, SA Health st | 1000 | 1000 |
| 2016 | AbbVie | Hepatitis South Australia (SA) | Grant to support a Hepatitis SA training event for GPs. The training was presented by a local Hepatologist and a Hepatitis C Community Nurse and provided GPs with the knowledge, skills and confidence to effectively prescribe appropriate Hepatitis C medica | 2200 | 2200 |
| 2016 | AbbVie | Hepatitis Western Australia (WA) | Grant to support the Remote and Rural Viral Hepatitis Symposium held at Royal Perth Hospital targeted at GPs working in remote or rural areas of Western Australia. The meeting facilitates the exchange of the latest information relevant to those involved i | 5000 | 5000 |
| 2016 | AbbVie | Juvenile Arthritis Fundraiser | Bronze Sponsorship of the Juvenile Arthritis Fundraiser Gatsby Ball organised to raise funds to support research being conducted at the University of NSW to find a cure for JAF and uveitis. | 2500 | 2500 |
| 2016 | AbbVie | Leukaemia Foundation Of Australia | Philanthropic donation to the Leukaemia Foundation for the World's Greatest Shave. This was a dollar matched donation under the AbbVie Volunteer's Program. | 1000 | 1000 |
| 2016 | AbbVie | Leukaemia Foundation Of Australia | Philanthropic donation to the Leukaemia Foundation for the Light The Night event. This was a dollar matched donation under the AbbVie Volunteer's Program. | 1500 | 1500 |
| 2016 | AbbVie | Leukaemia Foundation Of Australia | Grant to support the Leukaemia Foundation and Youth Cancer Service SA/NT combined Health Professional Education Day held in Darwin. | 2000 | 2000 |
| 2016 | AbbVie | Lymphoma Australia | Grant to support two projects by Lymphoma Australia. The first was a CLL Survivorship Program ‐ a web based program for those with CLL ($20,000). The second was a GP Care Plan for CLL Patients with the research, development and production conducted by Lym | 25000 | 25000 |
| 2016 | AbbVie | MOVE Muscle, Bone & Joint Health | Grant to support the development of downloadable resources for a website targeting adolescents with muscle, bone and joint conditions who are transiting from paediatric to adult care. The information is specifically targeted to this age group to engage th | 10000 | 10000 |
| 2016 | AbbVie | MOVE Muscle, Bone & Joint Health | Grant to support two projects. 1. National Stakeholder Summit on muscle, bone and joint health for consumers, clinicians, policy makers and researchers to facilitate collaboration and understanding and to prioritise research and programs to improve outcom | 30000 | 30000 |
| 2016 | AbbVie | MS Australia | Philanthropic donation to MS Australia for the MS Gong Ride. This was a dollar matched donation under the AbbVie Volunteer's Program. | 5409 | 5409 |
| 2016 | AbbVie | Myeloma Australia | Grant to support the setup of the inaugural Australian Myeloma Workshop. The workshop was organised under the auspices of the Medical and Scientific Advisory Group (MSAG) of Myeloma Australia. The meeting goals were to promote myeloma research in Australi | 20000 | 20000 |
| 2016 | AbbVie | Ovarian Cancer Australia | Philanthropic donation to Ovarian Cancer Australia Ltd for the Afternoon Teal event. This was a dollar matched donation under the AbbVie Volunteer's Program. | 608.95 | 608.95 |
| 2016 | AbbVie | Ovarian Cancer Australia | Grant to support the What Women Want Project, the aim of which is to identify critical support needs and provide agreed goals and guidance for Ovarian Cancer Australia's support services and resources. The project will also provide the evidence base for c | 15000 | 15000 |
| 2016 | AbbVie | Parkinson's Australia | Philanthropic donation to Parkinson's Australia for World Parkinson's Day. This was a dollar matched donation under the AbbVie Volunteer's Program. | 272 | 272 |
| 2016 | AbbVie | Parkinson's Australia | Grant to facilitate the video recording of the Parkinson's Australia Action Framework Launch at Parliament House in Canberra. | 2940 | 2940 |
| 2016 | AbbVie | Parkinson's Australia | Grant to support travel for the Parkinson's Australia Vice President to attend the Parkinson's Congress in Portland Oregon, USA. | 3027.53 | 3027.53 |
| 2016 | AbbVie | Parkinson's Australia | Grant to support the Parkinson's Australia Action Framework launch event in Parliament House Canberra in March, 2016. | 10000 | 10000 |
| 2016 | AbbVie | Parkinson's Australian Capital Territory (ACT) | Grant to support the development and printing of patient stories for Parkinson's ACT. | 2250 | 2250 |
| 2016 | AbbVie | Parkinson's New South Wales (NSW) | Grant to support an education and training program for nurses working in aged care on Parkinson's and related conditions. | 300 | 300 |
| 2016 | AbbVie | Parkinson's New South Wales (NSW) | Sponsorship to support the annual Unity Walk & Run which raises awareness and funds for Parkinson's which is used towards their support services including free counselling, InfoLine and Parkinson's research. | 1000 | 1000 |
| 2016 | AbbVie | Parkinson's New South Wales (NSW) | Grant to support a rural Patient Education Forum hosted by Parkinson's NSW in Orange. | 1000 | 1000 |
| 2016 | AbbVie | Parkinson's New South Wales (NSW) | Grant to support a Parkinson's Disease educational seminar titled "Let's Make It Real" conducted by the Newcastle Parkinson's Support Group. | 2000 | 2000 |
| 2016 | AbbVie | Parkinson's New South Wales (NSW) | Grant to support a Parkinson's Awareness Campaign at State Parliament House to provide education on Parkinson's Disease and to develop educational resources including video and printed materials. | 10000 | 10000 |
| 2016 | AbbVie | Parkinson's New South Wales (NSW) | Grant to support the continuation of the Central Western NSW Parkinson's Education and Support Program. The program was established in 2011 and has provided vital ongoing support to patient and their families. | 15000 | 15000 |
| 2016 | AbbVie | Parkinson's South Australia (SA) | Sponsorship to support the Walk in the Park event in South Australia. The event raises awareness and significant funds to help in the fight against Parkinson's disease and is the largest event in South Australia for people with Parkinson's, their families | 1000 | 1000 |
| 2016 | AbbVie | Parkinson's Victoria (VIC) | Sponsorship to support the Walk in the Park event in Victoria. The event raises awareness and funding to help in the fight against and raising awareness of Parkinson's disease. | 1000 | 1000 |
| 2016 | AbbVie | Parkinson's Victoria (VIC) | Grant to support the Living Well with Parkinson's Disease Seminar. The seminar targeted two groups: 1. People living with Parkinson's focusing on the needs of people who have had Parkinson's for five or more years, empowering them with helpful informatio | 1500 | 1500 |
| 2016 | AbbVie | Parkinson's Victoria (VIC) | Grant to support the Infusion Peer Support Group conducted by Parkinson's Victoria to raise awareness of the therapy choices and connect people who are receiving an infused therapy. The Group, requested by the community, connects patients and their famili | 10000 | 10000 |
| 2016 | AbbVie | Parkinson's Western Australia (WA) | Sponsorship to support the Walk in the Park event in Western Australia. The event raises awareness and funding to help in the fight against and raising awareness of Parkinson's disease. | 500 | 500 |
| 2016 | AbbVie | Prostate Cancer Foundation of Australia (PCFA) | Sponsorship of the Prostate Cancer Foundation of Australia's Biggest Ever Blokes Lunch held to raise awareness of prostate cancer. | 1200 | 1200 |
| 2016 | AbbVie | Psoriasis Australia | Consultancy to support Psoriasis Australia's contribution on an Advisory Board consisting of rheumatologists, dermatologists, representatives of Health Consumer Organisations and patients to review and provide feedback on the strategy and content of a pso | 400 | 400 |
| 2016 | AbbVie | Rare Cancers Australia | Sponsorship of the pre‐event dinner to the Patient Voice Initiative Conference held in Canberra. The dinner preceded the conference focusing on incorporating input from patients and consumers into health decision making in the Australian health technology | 5000 | 5000 |
| 2016 | AbbVie | Shake It Up Australia Foundation | Philanthropic donation to the Shake It Up Australia Foundation for the Pause 4 Parkinson's Morning Tea. This was a dollar matched donation under the AbbVie Volunteer's Program. | 271.55 | 271.55 |
| 2016 | AbbVie | Shake It Up Australia Foundation | Sponsorship of the Pause 4 Parkinson's events to raise awareness of Parkinson's disease and its impact nationally. | 500 | 500 |
| 2016 | AbbVie | Shake It Up Australia Foundation | Sponsorship of a free research information event for Shake It Up supporters in Brisbane. | 1000 | 1000 |
| 2017 | AbbVie | Arthritis Foundation of Australia | Donation to the Medicines Australia Community Chest program. The Community Chest supports programs that benefit patients with immunological conditions across Australia. | 20000 | 20000 |
| 2017 | AbbVie | Arthritis Foundation of South Australia (SA) | Philanthropic donation to support Kids Flix program which enables children with JIA to have a day out at the movies with their families. | 500 | 500 |
| 2017 | AbbVie | Arthritis Foundation of South Australia (SA) | Provide funding to assist in the production of patient education booklets. | 1000 | 1000 |
| 2017 | AbbVie | Arthritis Foundation of South Australia (SA) | Sponsorship of annual HCP conference on the latest information and treatment options for arthritis. | 1500 | 1500 |
| 2017 | AbbVie | Arthritis New South Wales (NSW) | Sponsorship of 6 Arthritis & Osteoporosis NSW webinars. The purpose of the webinars was to educate healthcare professionals and consumers about health literacy, osteoarthritis and chronic disease management in healthcare settings, fibromyalgia, arthritis aids and anti-inflammatory foods for arthritis. | 3000 | 3000 |
| 2017 | AbbVie | Arthritis Queensland (QLD) | Funding support of an GP education seminar to provide information on the latest developments in medical research and arthritis treatments. | 750 | 750 |
| 2017 | AbbVie | Arthritis Queensland (QLD) | Funding to support an Arthritis education seminar for healthcare professionals. This seminar provides information on the latest developments in medical research and arthritis treatment. | 1000 | 1000 |
| 2017 | AbbVie | Australian Crohn's and Colitis Association | Funding to support CCA's 2017 Patient Experience Survey. | 25000 | 25000 |
| 2017 | AbbVie | Australian Crohn's and Colitis Association | Grant provide to support CCAs Flagship program : IBS Forums - Live and Online for 10 national forums for patients diagnosed with Crohn's or ulcerative colitis which was focused on education and local community support. | 55000 | 55000 |
| 2017 | AbbVie | Australian Injecting and Illicit Drug Users League (AIVL) | Participation in AbbVie Patient Journey Day to provide input regarding the injecting drug users experience of seeking and undergoing treatment for HCV. The purpose was to enhance understandings of the hard to reach patient experience. | 450 | 450 |
| 2017 | AbbVie | Children's Cancer Institute | Philanthropic donation to support medical research dedicated to putting an end to childhood cancer. | 2600 | 2600 |
| 2017 | AbbVie | Cure Brain Cancer Foundation | Corporate Sponsorship of Cure Brain Cancer Gala Ball which raises funds towards medical research. | 5000 | 5000 |
| 2017 | AbbVie | Cure Brain Cancer Foundation | Sponsorship of Walk4 Brain Cancer Series that raises awareness and funds for brain cancer research. | 10000 | 10000 |
| 2017 | AbbVie | Gut Foundation | Educational grant - Funding support for IBD Campaign support. | 17000 | 17000 |
| 2017 | AbbVie | Hepatitis Australia | Support for World Hepatitis Day activities to promote awareness and patient mobilisation, as well as Hepatitis C Community Radio announcements. | 40000 | 40000 |
| 2017 | AbbVie | Hepatitis New South Wales (NSW) | Participation in AbbVie Patient Journey Day. This provides insights to AbbVie on living with diseases directly from patients. | 450 | 450 |
| 2017 | AbbVie | Hepatitis New South Wales (NSW) | Support for Hepatitis C-free town project in Albury-Wodonga NSW. | 15000 | 15000 |
| 2017 | AbbVie | Hepatitis Queensland (QLD) | Grants support for Hepatitis Queenslands participation at University of Queensland's event to discuss how Australia can reach the WHO target of Hepatitis C elimination by 2030. | 2727.27 | 2727.27 |
| 2017 | AbbVie | IBD Support Australia | Educational grant to refresh IBD Australian website to update information and connectivity for IBD patients and their carers. | 3116 | 3116 |
| 2017 | AbbVie | Leukaemia Foundation Of Australia | Funding to support Light the Night Fundraising Event to help raise awareness and funds for blood cancer. | 5000 | 5000 |
| 2017 | AbbVie | Leukaemia Foundation Of Australia | Support for the Blood Buddies Peer Support program that connects patients together as they navigate their blood cancer journey. | 10000 | 10000 |
| 2017 | AbbVie | LiverWELL | Grant to support education programs in different cultural community groups including Chinese, Vietnamese and Italian communities. | 20180 | 20180 |
| 2017 | AbbVie | Lymphoma Australia | Patient participation in AbbVie Patient Journey Day Workshop to promote greater understanding of what it is like living with diseases. | 500 | 500 |
| 2017 | AbbVie | Lymphoma Australia | Funding support for the production of the "Know your CLL" Patient Education Booklet. | 10000 | 10000 |
| 2017 | AbbVie | March On | Philanthropic donation to support giving people with a spinal cord injury the helping hand to get back into life. | 150 | 150 |
| 2017 | AbbVie | March On | Matched donation toward employees fundraising to support giving people with a spinal cord injury the helping hand to get back into life. | 710 | 710 |
| 2017 | AbbVie | Multiple Sclerosis | Philanthropic donation to support research into MS matching employee fundraising efforts. | 5000 | 5000 |
| 2017 | AbbVie | Myeloma Australia | Sponsorship of a Myeloma Scientific & Advisory Group Education workshop to collaborate and facilitate scientific advances and medical care in myeloma. | 10000 | 10000 |
| 2017 | AbbVie | Parkinson's Australian Capital Territory (ACT) | Funding support of the annual Walk in the Park Community Event that raises funds and awareness for Parkinson's Disease. | 1000 | 1000 |
| 2017 | AbbVie | Parkinson's New South Wales (NSW) | Support Parkinson's Disease(PD) NSW with the printing of the sailing craft Scaramouch mainsail with the PD NSW logo - raise Parkinson's Awareness via solo circumnavigation of Australia. | 700 | 700 |
| 2017 | AbbVie | Parkinson's New South Wales (NSW) | Matched Donation towards employee fundraising for Walk in the Park event. | 2000 | 2000 |
| 2017 | AbbVie | Parkinson's New South Wales (NSW) | Funding support of the annual Walk in the Park Community Event that raises funds and awareness for Parkinson's Disease. | 3000 | 3000 |
| 2017 | AbbVie | Parkinson's New South Wales (NSW) | Sponsorship to support the continuation of the Central Western NSW Parkinson's Education & Support Program. | 15000 | 15000 |
| 2017 | AbbVie | Parkinson's Queensland (QLD) | Funding support of the annual Walk in the Park Community Event that raises funds and awareness for Parkinson's Disease. | 2000 | 2000 |
| 2017 | AbbVie | Parkinson's South Australia (SA) | Honorarium to support speaker attending event. | 300 | 300 |
| 2017 | AbbVie | Parkinson's South Australia (SA) | Provide funding for a World Parkinson's Day Seminar Support - marking 200 years of Parkinson's. | 636.36 | 636.36 |
| 2017 | AbbVie | Parkinson's South Australia (SA) | Provide funding to enable Parkinson's South Australia (PDSA) to host a breakfast for Parkinson's Disease (PD) clinicians and supporters at their annual conference. | 2285 | 2285 |
| 2017 | AbbVie | Parkinson's South Australia (SA) | Donation to support Parkinson's Disease (PD) support group activity on Remembrance Day. | 3000 | 3000 |
| 2017 | AbbVie | Parkinson's Victoria (VIC) | Funding support of the Insearch Parkinson's Research Series. | 2272.73 | 2272.73 |
| 2017 | AbbVie | Parkinson's Western Australia (WA) | Funding support of the annual Walk in the Park Community Event that raises funds and awareness for Parkinson's Disease. | 909.09 | 909.09 |
| 2017 | AbbVie | Prader-Willi Syndrome Association of Victoria (VIC) | Funding support of the annual Walk in the Park Community Event that raises funds and awareness for Parkinson's Disease. | 1500 | 1500 |
| 2017 | AbbVie | Rare Cancers Australia | Speaker reimbursement for Internal Employee event. | 150 | 150 |
| 2017 | AbbVie | Rare Cancers Australia | Donation to support Rare Cancers Ball that raises funds and awareness of rare and less common cancers. | 5000 | 5000 |
| 2017 | AbbVie | Rare Cancers Australia | Provide funding support to enable RCA to host a Cancer Forum at Parliament House to engage policy makers to better understand the challenges surrounding equitable funding in rare cancers. | 10000 | 10000 |
| 2018 | AbbVie | Arthritis Foundation of Australia | Donation to the Medicines Australia Community Chest (MACC) program, which is a collaboration between AbbVie, Janssen, Eli Lilly, Pfizer, Roche, and Sanofi. The Community Chest aims to identify and address the needs of people living with arthritis. In 2018, the MACC supported the project "Assessing access to rural rheumatology services in Australia." The purpose of this project is to assess access to specialist rheumatology services for people with arthritis living in rural and regional areas of Australia, in order to identify underserviced areas and to support planning of future rural rheumatology services. | 20000 | 20000 |
| 2018 | AbbVie | Arthritis Foundation of South Australia (SA) | Support for room hire for a Rheumatologist Education event. The objective of the meeting was to enhance medical knowledge in Rheumatology and the quality use of medicines. | 109.09 | 109.09 |
| 2018 | AbbVie | Arthritis Foundation of South Australia (SA) | Support for Arthritis SA's 2018 Health Professionals conference. The objective of the meeting was to provide information on new concepts in arthritis treatment including the importance of transitioning patients from paediatric to adult services, risks and benefits of physical activity and chronic pain management. | 1500 | 1500 |
| 2018 | AbbVie | Arthritis Foundation of South Australia (SA) | Support for GP educational meeting - "Update on the management of rheumatoid arthritis'. The objective of the meeting was to provide information on new concepts in the treatment of arthritis including the risks and benefits of physical activity. | 4500 | 4500 |
| 2018 | AbbVie | Arthritis Foundation of South Australia (SA) | Funding was provided to support the delivery of a professional education meeting for up to 30 general practitioners in Adelaide - ‘An update on Ankylosing Spondylitis – identifying inflammatory from mechanical back pain.’ The objective of the meeting was to enhance medical knowledge and the quality use of medicines through the expert delivery of contemporary information by a specialist in rheumatology in South Australia. | 4545.45 | 4545.45 |
| 2018 | AbbVie | Arthritis Foundation of Western Australia (WA) | Support to develop and publish the 'Handbook for people with Ankylosing Spondylitis/Psoriatic Arthritis". This handbook is a user friendly patient reference/handbook to accompany the Ankylosing Spondylitis education and self management program. | 20000 | 20000 |
| 2018 | AbbVie | Arthritis Queensland (QLD) | Support for the 19th Annual Health Professionals Seminar. This seminar features presentations and panel discussions relevant to the treatment of arthritic conditions at a primary care level. | 750 | 750 |
| 2018 | AbbVie | Hepatitis Australia | To support the national coordination of activities in Australia for World Hepatitis Day 2018 - theme 'Why miss Out?" The objective was to engage people who may have been missing out on care for hepatitis B or C and connecting them to vaccination, testing and treatment. | 60000 | 60000 |
| 2018 | AbbVie | Hepatitis South Australia (SA) | Support for the SA Prison Health (SAPHS) Liver Health Day. This initiative aims to positively impact Hepatitis C prevalence across South Australian prisons by engaging hard to reach people in rural area prisons and assisting them to seek testing and treatment. | 5600 | 5600 |
| 2018 | AbbVie | Inflammatory Neuropathy Support Group Of Victoria (VIC) | The grant supported the costs associated with convening the Parkinson’s Victoria Infused Therapy Support Group so that Parkinson's patients, and those considering infused treatment, can share experiences, learn from each other and demystify what can be a complex treatment choice. | 3000 | 3000 |
| 2018 | AbbVie | Leukaemia Foundation Of Australia | Support for the 'Light the Night' event on 5 October 2018 . This activity brings together the blood cancer community to support patients, carers and their families living with blood cancer and to raise funding for research. | 5000 | 5000 |
| 2018 | AbbVie | Lymphoma Australia | Contribution to Lymphoma Australia's Lymphoma Nurse education program which provides a series of face-to face education events in addition to webinars for blood cancer nurses, patients and caregivers to ensure they receive current and balanced information to assist them deliver world class service. | 18000 | 18000 |
| 2018 | AbbVie | Ovarian Cancer Australia | Support the creation, delivery and promotion of a webinar to tackle patient fear of ovarian cancer reoccurring. | 9800 | 9800 |
| 2018 | AbbVie | Parkinson's New South Wales (NSW) | Provide funding support towards the provision of a Parkinson's Community nurse specialist to support residents living with Parkinson’s in the Central West. The specialist nurse works closely with practicing neurologists in the region to service patients with PD in a region servicing a rural population of approximately 300,000 people from major regional centres such as Dubbo, Orange, Bathurst, Mudgee, Parkes and Cowra. | 15000 | 15000 |
| 2018 | AbbVie | Parkinson's South Australia (SA) | Support for the Parkinson's 'Grab& Go Toiletry Bag' to assist patients when they are admitted to hospital with a resource that contains vital information about the individual including medicines, advanced treatments and basic information for hospital staff on how to care for someone with Parkinson's. | 20000 | 20000 |
| 2018 | AbbVie | Parkinson's Victoria (VIC) | Donation to support Parkinson's Victoria's 'Walk in the Park' held on Sunday 28 August, to raise awareness of Parkinson's Disease (PD) in the community to support those dealing with PD. | 2368.96 | 2368.96 |
| 2018 | AbbVie | Parkinson's Western Australia (WA) | Support for reprinting 20,000 copies of the Parkinson's patient education booklet - the 'Blue Book' which is distributed to newly diagnosed patients. | 11510 | 11510 |
| 2018 | AbbVie | Rare Cancers Australia | Donation to support Rare Cancer Australias's (RCA) Sick or Treat Fundraising event. Funds raised contribute to RCA's mission of providing direct support and advocacy to people living with rare or less common cancers. | 5000 | 5000 |
| 2018 | AbbVie | Rare Cancers Australia | Contribution to 'CanForum 2018', specifically costs associated with graphic design, printing and digital agency support to live broadcast the day. This event brings together members of the oncology community to discuss important issues. | 20000 | 20000 |
| 2019 | AbbVie | Arthritis Foundation of Australia | Support Arthritis Australia's development of a range of donwloadable Culturally and Linguistically Diverse (CALD) resources for people living with arthritic conditions and where there are no existing resources for a range of arthritic conditions. Languages include: Arabic, Cantonese, Croatian, Greek, Italian, Korean, Macedonian, Persian, Spanish, and Vietnamese. | 20000 | 20000 |
| 2019 | AbbVie | Arthritis Foundation of South Australia (SA) | Support for GP educational meeting on 1 August 2019 for approximately 30 GPs titled "An update on the management of Psoriatic Arthritis". | 5000 | 5000 |
| 2019 | AbbVie | Arthritis Queensland (QLD) | Sponsorship of GP educational seminar on 27 July 2019. The seminar fetaured presentations from leading rheumatologists, primary care physicians and academics and covered topics relevant to the treatment of arthritic conditions in primary care. | 750 | 750 |
| 2019 | AbbVie | Australian Crohn's and Colitis Association | Charitable donation to Crohns and Colitis Australia (CCA) as part of CCA's Live Fearless campaign where an AbbVie employee's fundraising efforts were matched by AbbVie. | 500 | 500 |
| 2019 | AbbVie | Australian Crohn's and Colitis Association | Silver sponsorship of CCA's Silver Linings Lunch - a fundraising event to raise awareness of Crohn's disease and ulcerative colitis. | 2500 | 2500 |
| 2019 | AbbVie | Australian Crohn's and Colitis Association | Support CCA's Kids Fun Day - a day for young children (under the age of 12) with inflammatory bowel disease (IBD) and their carers to meet with similar families across Sydney. In addition to activities for children, attendees also participated in networking and educational sessions with healthcare staff from local Sydney hospitals addressing topics related to the management of pediatric IBD. | 13500 | 13500 |
| 2019 | AbbVie | Australian Crohn's and Colitis Association | License granted to use patient educational material (AbbVie's The Bottom End podcast series) for 12 months, starting September 2019. | In kind | 0 |
| 2019 | AbbVie | Cancer Council New South Wales (NSW) | Charitable donation to Cancer Council NSW where an AbbVie employee's fundraising efforts for Cancer Council at City2Surf were matched by AbbVie. | 1626.37 | 1626.37 |
| 2019 | AbbVie | Hepatitis Australia | Contribution to support Hepatitis Australia's World Hepatitis Day (WHD) consumer awareness campaign including to update the WHD website with a range of downloadable digital posters and graphics for use on social media platforms. The development and implementation of a social media campaign and the support and promotion of a number of local community events. | 15000 | 15000 |
| 2019 | AbbVie | Hepatitis Australia | Support of Hepatitis Australia's Culturally and Linguistically Diverse (CALD) media initiative. The initiative included the development of a range of communication initiatives to support an increased awareness around hepatitis B and hepatitis C risk factors and to promote testing in CALD communities. | 30000 | 30000 |
| 2019 | AbbVie | Hepatitis New South Wales (NSW) | Support of the 'Postcards from Prison' project. This project is a hep C health promotion campaign which aims to increase awareness of hep C prevention, testing and cure among people within the criminal justice system. Funding support included the cost of A6 postcard sheets, packs of coloured pencils, plastic document pouches and brochures. | 14000 | 14000 |
| 2019 | AbbVie | Hepatitis Queensland (QLD) | Support for Hepatitis Queensland's to put on the HEAT (Hepatitis C Elimination Action Team) on Queenslanders through an innovative targeted digital messaging campaign. Funding supported this campaign and the development of collateral that has the capacity to translate nationally. | 15000 | 15000 |
| 2019 | AbbVie | Hepatitis Queensland (QLD) | Support for the Fibroscan In-Reach (FIR) Project at Woodford Correctional Center. The FIR project offers clinical fibroscan services, including the provision of a trained/accredited fibroscan operator, to assist in liver fibrosis assessment prior to HCV treatment of detainees at the Woodford Correctional Centre. Additionally, the project provides education and training to clinical and non-clinical staff at Woodford Correctional Centre including in the use and interpretation of the fibroscan and through providing targeted workforce development and best practice resources and guidelines to support onsite testing and treatment. | 24150 | 24150 |
| 2019 | AbbVie | Hepatitis South Australia (SA) | Support for Hepatitis SA's Priority Plus Project. The project aimed to enhance the HCV treatment information and education services provided to HCV priority populations in South Australia - specifically people who inject drugs; Aboriginal and Torres Strait Islanders, Vietnamese, Chinese; and people with a mental illness. | 15465 | 15465 |
| 2019 | AbbVie | Leukaemia Foundation Of Australia | Donation to support the Leukaemia Foundation's Light the Night community program. The Light the Night community program aims to provide emotional support to people across Australia who are affected by a blood cancer diagnosis, to let them know that they are not alone, and to raise funds that will provide support to them. | 5000 | 5000 |
| 2019 | AbbVie | Lymphoma Australia | Support for Lymphoma Australia's delivery of online webinars and filming sessions that focus on subtypes, treatments and survivorship education that is relevant to Lymphoma /CLL patients, as well as the updating of the "Living with CLL" book to ensure patients and health professionals are accessing the latest information. | 30000 | 30000 |
| 2019 | AbbVie | Musculoskeletal Australia | Support for Musculosketal (MSK) Australia to further distribute and print the MSK Kids Rheum Record Resource Kit, a comprehensive resource with all the information parents, teachers and coaches need in one place. The funding will allow Musculoskeletal Australia to increase its partnerships with paediatric rheumatologists, professional organisations and other key stakeholders involved in this program. | 15000 | 15000 |
| 2019 | AbbVie | Parkinson's New South Wales (NSW) | Donation to support Parkinson's NSW's Unity Walk to raise awareness of Parkinson's Disease (PD) in the community to support those dealing with PD. | 1000 | 1000 |
| 2019 | AbbVie | Parkinson's New South Wales (NSW) | Charitable donation to Parkinson's NSW as part of the Unity Walk campaign where AbbVie's employees fundraising efforts were matched by AbbVie. | 1903.09 | 1903.09 |
| 2019 | AbbVie | Parkinson's New South Wales (NSW) | Sponsorship of GP Forum on 17 August 2019 to provide education on Parkinson's disease to GPs in metropolitan Sydney. Titled "GP Education Forum:" Understanding Parkinson's - Treatments and Research", the Forum aimed to provide information and education to GPs to enable them to understand the disease, provide knowledge about medications and treatments to ultimately assist in better outcomes for patients who have Parkinson's. | 2000 | 2000 |
| 2019 | AbbVie | Parkinson's Queensland (QLD) | Donation to support Parkinson's QLD's 'Walk in the Park' held on Sunday 14 April, to raise awareness of Parkinson's Disease (PD) in the community to support those dealing with PD. | 5000 | 5000 |
| 2019 | AbbVie | Parkinson's South Australia (SA) | Support to professionally record and edit Parkinson's South Australia (SA) "Living Well" seminar series. The series which includes 16 different videos aims to provide information to regional clients on living better with Parkinson's and help them maximise choice, independence and wellbeing. Topics include: Stress, Resilience and Wellbeing. | 19905 | 19905 |
| 2019 | AbbVie | Parkinson's Victoria (VIC) | Contribution to support Parkinson's Victoria's Infused Therapy Peer Support Network program. The Infused Therapy Peer Support Network draws participants from across Victoria providing a safe supportive space with expert facilitation to support those living with Parkinson's and their families who are considering an infused therapy or who are receiving an infused therapy to meet and share information. | 2000 | 2000 |
| 2019 | AbbVie | Parkinson's Western Australia (WA) | Donation to support Parkinsons Western Australia (WA)'s 'Walk in the Park' held on Sunday 14 April, to raise awareness of Parkinson's Disease (PD) in the community to support those dealing with PD. | 1000 | 1000 |
| 2019 | AbbVie | Rare Cancers Australia | Sponsorship of Rare Cancers Australia (RCA) Gala Halloween event with proceeds raised going to help fund RCA's PatientCare Team in continuing to deliver emotional and financial support to patients and carers during their cancer diagnosis journey. | 5000 | 5000 |
| 2019 | AbbVie | Rare Cancers Australia | Charitable donation to Rare Cancers Australia as part of 2019 KOSI Challenge campaign where AbbVie employee's fundraising efforts were matched by AbbVie. | 12500 | 12500 |
| 2019 | AbbVie | Rare Cancers Australia | Contribution to support the CanForum 20 initiative, a one day seminar at Parliament House in Canberra. The CanForum provides a platform for the entire cancer community to come together and consider the developments and challenges they collectively face and highlight needs and solutions for cancer care attended by patients, industry, healthcare professionals, politicians and policy makers. AbbVie funding used for event management, materials development and AV. | 25000 | 25000 |
| 2019 | AbbVie | Rare Voices Australia | Contribution to support the resource development component of Rare Voices Mentorship & Education Program - 2019. | 5000 | 5000 |
| 2020 | AbbVie | Arthritis Foundation of Australia | Support of direct costs associated with Arthritis Australia's national Rheumatoid Arthritis Consumer Awareness Campaign. Funds assisted in covering some of the direct costs associated with the mainstream commercial radio advertising campaign, social media campaign and marketing collateral. | 15,000.00 AUD | 15000 |
| 2020 | AbbVie | Australian Crohn's and Colitis Association | Sponsorship of Crohn's and Colitis Australia's Live Fearless Campaign, a national fundraising event that encourages participants to get active in their own way. The objective of the campaign is to empower people with Crohn’s and Colitis to share their experiences with others, such as their friends, family and work colleagues, to increase the reach and understanding of these invisible illnesses beyond the patient community. | 5,745.00 AUD | 5745 |
| 2020 | AbbVie | Australian Crohn's and Colitis Association | Sponsorship of Crohn's and Colitis Australia's World Toilet Day campaign. World Toilet Day aims to inspire positive action to tackle the global sanitation crisis and raise awareness of the issues with gaining access to clean and decent public toilets across Australia, particularly for people living with chronic illnesses, like Crohn’s disease or ulcerative colitis who often have an urgent need to access clean toilet facilities when they are out and about. | 10,000.00 AUD | 10000 |
| 2020 | AbbVie | Beyond Blue | Charitable donation to Beyond Blue to assist with their work towards achieving an Australian community that understands anxiety, depression and suicide. | 1,000.00 AUD | 1000 |
| 2020 | AbbVie | Eczema Support Australia | Support to Eczema Support Australia to produce a brochure and information resources to outline services available to members to support the eczema community. | 10,000.00 AUD | 10000 |
| 2020 | AbbVie | Hepatitis New South Wales (NSW) | Support for the enhancement of Hepatitis NSW's Live Hep C Free peer program by delivering intensive peer engagements across five proposed sites in NSW to help reach anyone living with or at risk of hepatitis C and to facilitate access to hep C healthcare. | 9,000.00 AUD | 9000 |
| 2020 | AbbVie | Hepatitis New South Wales (NSW) | Support of Hepatitis NSW with the running of small peer promotion events at priority services to encourage clients to have better, longer, and more meaningful interactions with peer workers so that better health-seeking behaviour can be established by the client. | 21,600.00 AUD | 21600 |
| 2020 | AbbVie | Hepatitis Queensland (QLD) | Support of Hepatitis QLD's hepatitis elimination digital media campaign to increase awareness and influence positive change in the testing and treatment for hepatitis B and hepatitis C. | 10,000.00 AUD | 10000 |
| 2020 | AbbVie | Leukaemia Foundation Of Australia | Purchase of eleven lanterns for Leukaemia Foundation's Light the Night fundraising event. The event raises money and awareness to give hope to all those affected by blood cancer. | 1,100.00 AUD | 1100 |
| 2020 | AbbVie | Leukaemia Foundation Of Australia | Support Leukaemia Foundation’s "Access to Treatment" Patient Education Series to help deliver digital patient education and information content to people living with blood cancer throughout Blood Cancer Awareness month. | 20,000.00 AUD | 20000 |
| 2020 | AbbVie | Lymphoma Australia | Support of Lymphoma Australia's “Knowledge is Power” project that included audit of all current website content by a third party provider, interactive interviews and videos featuring international and national experts that provide patients and carers with the latest information on CLL/SLL and development of a nurse learning module for CLL/SLL. | 35,000.00 AUD | 35000 |
| 2020 | AbbVie | Musculoskeletal Australia | Sponsorship of Musculoskeletal Australia's educational webinar on the topic of 'Musculoskeletal conditions and your mental health.' | 4,545.45 AUD | 4545.45 |
| 2020 | AbbVie | Ovarian Cancer Australia | Support of Ovarian Cancer Australia with the development of a webinar, ‘Living with Ovarian Cancer,’ to help women newly diagnosed with ovarian cancer, as well as their husbands, partners, friends and families who rely on information, advice and reassurance from Ovarian Cancer Australia. | 7,850.00 AUD | 7850 |
| 2020 | AbbVie | Parkinson's Victoria (VIC) | Charitable donation to Parkinson's Victoria to support Parkinson’s Victoria in its inaugural virtual event called 27forParkinson’s. The virtual walk was held throughout October to support the 27,000 Victorians living with Parkinson’s disease. | 6,200.00 AUD | 6200 |
| 2020 | AbbVie | Parkinson's Western Australia (WA) | Support of Parkinson's WA's development of an educational resource, Parkinson's Best Practice Management in Nutrition, to help patients living with Parkinson's better understand the nutritional advice specific to their needs. | 11,900.00 AUD | 11900 |
| 2020 | AbbVie | Prostate Cancer Foundation of Australia (PCFA) | Donation to Prostate Cancer Foundation of Australia for the Long Run. The Long Run is a fundraising initiative that encourages Australians to conquer 72kms each to raise funds and awareness for Australian men and families fighting prostate cancer. | 5,000.00 AUD | 5000 |
| 2020 | AbbVie | Psoriasis Australia | Support of Psoriasis Australia's World Psoriasis Day 2020 disease awareness and social media campaign ‘Be Informed’ - World Psoriasis Day 2020. Funding support included design and creation of a series of social media tiles and / or infographics, distribution of infographics and / or tiles on Psoriasis Australia’s owned social channels, translation of social media tiles to up to 5 languages and distribution of translated social media tiles on Psoriasis Australia’s owned social channels. | 10,000.00 AUD | 10000 |
| 2020 | AbbVie | Rare Cancers Australia | Support of Rare Cancers Australia with greater patient engagement and digital awareness through two initiatives including amplification and development of content for season 2 podcasts and development of patient-centric support services to enhance the Patient Record Management tool. | 25,000.00 AUD | 25000 |
| 2013 | Actelion | Heart Kids Australia | Donation for Annual Education Day | 10000 | 10000 |
| 2013 | Actelion | Heart Kids New South Wales (NSW) | Donation for Tiny Tickers Ball | 2000 | 2000 |
| 2013 | Actelion | Pulmonary Hypertension Association Australia | Unrestricted Educational Grant for Pulmonary Hypertension awareness event | 6000 | 6000 |
| 2014 | Actelion | Arthritis Foundation of South Australia (SA) | Unrestricted Educational Grant to support Seminar on Scleroderma run jointly by Arthritis South Australia and Scleroderma Australia Inc | 600 | 600 |
| 2014 | Actelion | Scleroderma Association Of New South Wales (NSW) | Unrestricted Educational Grant to support World Scleroderma Event organised and run by the Scleroderma Association | 2000 | 2000 |
| 2014 | Actelion | Scleroderma Australia | Unrestricted Educational Grant to support an Information Seminar organised and hosted by Scleroderma Australia Inc | 1430 | 1430 |
| 2014 | Actelion | Scleroderma Australia | Unrestricted Educational Grant to support undertaking a Strategic Review of Scleroderma Australia by the Executive | 2500 | 2500 |
| 2014 | Actelion | Scleroderma Australia | Unrestricted Educational Grant to sponsor the President of the Scleroderma Australia in attending the Third World Systemic Sclerosis Congress in Rome | 5000 | 5000 |
| 2015 | Actelion | Arthritis Queensland (QLD) | Sponsorship for GP Rheumatology update | 682 | 682 |
| 2015 | Actelion | Heart Kids Australia | Donation towards CHD Registry | 15000 | 15000 |
| 2015 | Actelion | Heartkids New South Wales (NSW) | Gold Sponsorship ‐ Tiny Tickers Ball | 5000 | 5000 |
| 2015 | Actelion | Pulmonary Hypertension Association Australia | Sponsorship of 2 Pulmonary Hypertension Association Australia (PHAA) Management Board members to attend interstate Pulmonary Hypertension Society of Australia and New Zealand Scientific Meeting, Sydney | 2500 | 2500 |
| 2015 | Actelion | Scleroderma Australia | Sponsorship for President of Scleroderma Australia to attend Fourth World Systemic Sclerosis Congress for Patients, Lisbon Portugal | 2500 | 2500 |
| 2016 | Actelion | Pulmonary Hypertension Association Australia | Donation to support Pulmonary Hypertension Association Australia (PHAA)Website maintenance | 3000 | 3000 |
| 2016 | Actelion | Pulmonary Hypertension Association Australia | Donation to support Pulmonary Hypertension Association Australia (PHAA)Website maintenance | 4080 | 4080 |
| 2016 | Actelion | Pulmonary Hypertension Association Australia | Donation to support Pulmonary Hypertension Association Australia (PHAA) | 10000 | 10000 |
| 2017 | Actelion | Autoimmune Resource and Research Centre | Donation to support printing of Educational Information brochures, Newsletters and Factsheets | 7500 | 7500 |
| 2017 | Actelion | Heart Kids Australia | Donation to support production of eduactional materials on the causes, diagnosis, treatment and management of congenital heart disorders | 20000 | 20000 |
| 2017 | Actelion | Pulmonary Hypertension Association Australia | Donation to support production of Education and awareness material | 8500 | 8500 |
| 2017 | Actelion | Pulmonary Hypertension Association Australia | Donation to support Members and Carers Education and Information Day | 10000 | 10000 |
| 2017 | Actelion | Pulmonary Hypertension Network Australia | Donation to support development and production of "Living Better with PAH/PH" information series. | 12000 | 12000 |
| 2018 | Actelion | Arthritis Foundation of Australia | Develop a best-practice Rheumatoid Arthritis Support Program (RASP): Part 1 | 75000 | 75000 |
| 2018 | Actelion | Heart of Australia | Heart of Australia mobile specialist medical investigation and treatment clinics to regional, rural, and remote area communities across Queensland | 50000 | 50000 |
| 2018 | Actelion | HeartKids | Production of educational materials on the causes, diagnosis, treatment and management of congenital heart disorders | 20000 | 20000 |
| 2018 | Actelion | Pulmonary Hypertension Association Australia | Website construction and IT services | 4080 | 4080 |
| 2018 | Actelion | Pulmonary Hypertension Association Australia | Facilitate the attendance of a member or members at the International Pulmonary Hypertension Conference and Scientific Sessions held in Orlando, Florida, USA | 10000 | 10000 |
| 2013 | Alcon | Glaucoma Australia | Educational Grant | 1000 | 1000 |
| 2013 | Alcon | Glaucoma Australia | Sponsorship of Glaucoma Australia's Commercial Glaucoma Adherence Program. This program provides aids for pharmacists and other HCPs to increase awareness and improve the adherence rate or glaucoma medications for patients. | 25000 | 25000 |
| 2013 | Alcon | Sight for All | Educational Grant | 5000 | 5000 |
| 2014 | Alcon | Glaucoma Australia | Funding to support development of a patient education brochure in eight languages | 12000 | 12000 |
| 2015 | Alcon | Glaucoma Australia | Funding to support the development and implementation of community awareness campaigns for people affected by glaucoma, including patients, relatives and friends. | 25000 | 25000 |
| 2013 | Allergan | Benign Essential Blepharospasm (BEB) | Financial support towards the running costs | 1000 | 1000 |
| 2013 | Amgen | Carers Australia | Sponsorship towards Pollie Pedal (a fundraising bike ride from Adelaide to Geelong) to raise awareness of Australia's carers. Carers Australia represents 2.6 million carers in Australia who provide care to family or friends who have a disability, illness | 80000 | 80000 |
| 2013 | Amgen | Kidney Health Australia | Monetary support has been pivotal in allowing the KCAT program to deliver many achievements including written materials educating general practitioners about CKD (the latest booklet has now had 35,000 copies printed), online learning materials and the del | 50000 | 50000 |
| 2013 | Amgen | Kidney Health Australia | Monetary support towards the KHA-CARI guidelines program which provides for the support of guideline development and revision processes, peer and consumer review of new and revised guidelines, identification of relevant trials, maintenance of the website | 100000 | 100000 |
| 2013 | Amgen | Rare Cancers Australia | Sponsorship of rare cancer evidence discovery and collation project. During RCA recent investigations it has become increasingly apparent that progress on improved treatment in Australia is being hampered by the absence of comprehensive and easily accessi | 10000 | 10000 |
| 2014 | Amgen | CanSpeak | Funding towards a two day educational workshop focused on facilitating linkages and capacity building between small health consumer organisations. | 15000 | 15000 |
| 2014 | Amgen | CanTeen | The recipient of this donation was selected by a winning group in the company who won a teambuilding activity. CanTeen supports 12-24 year olds at every stage of their cancer journey, whether they're dealing with having cancer themselves, a parent, brothe | 7000 | 7000 |
| 2014 | Amgen | Carers Australia | Sponsorship towards Pollie Pedal (a fundraising bike ride from Moree to Penrith) to raise awareness of Australia's carers. Carers Australia represents 2.6 million carers in Australia who provide care to family or friends who have a disability, illness or | 80000 | 80000 |
| 2014 | Amgen | Heart Support-Australia | Heart Support-Australia sought donation to broaden their reach of the Support, Information and Encouragement project to enable all Branches to attend their AGM and for them to conscript the support of their HS-A trained Heart Health Support Service volunt | 5000 | 5000 |
| 2014 | Amgen | Kidney Health Australia | Monetary support towards the KHA-CARI guidelines program which provides for the support of guideline development and revision processes, peer and consumer review of new and revised guidelines, identification of relevant trials, maintenance of the website | 75000 | 75000 |
| 2014 | Amgen | Melanoma Patients Australia | Funds to assist in holding a National Advocacy Training Workshop for the benefit of volunteer national facilitators to learn more about advocacy and return to the local network equipped with a greater skill set and broader knowledge for melanoma patients | 5000 | 5000 |
| 2014 | Amgen | Rare Cancers Australia | Financial support (Bronze sponsorship) towards Rare Cancers Australia's "Maintaining the Momentum project. | 5000 | 5000 |
| 2014 | Amgen | Rare Voices Australia | Rare Voices Australia is a not for profit organisation and a national alliance advocating for those who live with a rare disease. Funding will support their advocacy work on behalf of Australians affected by rare diseases. | 5000 | 5000 |
| 2015 | Amgen | Australian & New Zealand Bone and Mineral Society (ANZBMS) | Donation towards Australian & New Zealand Bone & Mineral Society (ANZBMS)'s secondary fracture prevention website development. | 20000 | 20000 |
| 2015 | Amgen | Australian Atherosclerosis Society | Donation towards the AAS National Familial Hypercholesterolaemia (FH) registry to support the running costs for their registry launch meeting. The launch of the registry is to raise awareness of the FH National Registry, encouraging patients to enrol in t | 5000 | 5000 |
| 2015 | Amgen | Australian Atherosclerosis Society | Donation towards the AAS PCSK9 stakeholder meeting to support the running costs for their clinical meeting. The rationale of the meeting was to discuss the likely clinical scenarios for the integration of PCSK9 agents into clinical practice and to underst | 8635 | 8635 |
| 2015 | Amgen | Carers Australia | Sponsorship towards Pollie Pedal (a fundraising bike ride in Tasmania) to raise awareness of Australia's carers. Carers Australia represents 2.6 million carers in Australia who provide care to family or friends who have a disability, illness or who need | 80000 | 80000 |
| 2015 | Amgen | FH (Familial hypercholesterolemia) Australasia Network | Donation towards FH Australasia for the Network to establish a website for patients and healthcare professionals across Australia & New Zealand. The website will assist users to access information on FH, including screening diagnosis, management and trea | 15000 | 15000 |
| 2015 | Amgen | Kidney Health Australia | Donation towards Kidney Health Australia (KHA). The financial support was chanelled by KHA towards delivering the project "Progressing Kidney Policy in the area of chronic kidney disease involving Aboriginal and Torres Strait Islander people". | 18181 | 18181 |
| 2015 | Amgen | Kidney Health Australia | Donation towards the KHA-KCAT national education program for 2015. The program aims to raise the profile of chronic kidney disease in the community via educational meetings to GPs and practice nurses. This sponsorship goes towards funding of the program | 80000 | 80000 |
| 2015 | Amgen | Kidney Health Australia | Monetary support towards the KHA-CARI guidelines program which provides for the support of guideline development and revision processes, peer and consumer review of new and revised guidelines, identification of relevant trials, maintenance of the website | 100000 | 100000 |
| 2015 | Amgen | Leukaemia Foundation Of Australia | Donation towards Leukaemia Foundation's cancer drug access workshop and patient advocate training. | 15000 | 15000 |
| 2015 | Amgen | Myeloma Australia | The Myeloma Foundation is the only “myeloma specific” organisation in Australia dedicated to providing support, education, information and research to those affected by multiple myeloma. The Foundation receives no government funding and relies on the supp | 4000 | 4000 |
| 2015 | Amgen | Osteoporosis Australia | Donation towards Osteoporosis Australia (OA). The financial support was chanelled by OA towards a range of their core projects for 2015 which included general practitioner education and awareness, seminars, OA website, consumer awareness and data analysi | 80000 | 80000 |
| 2015 | Amgen | Osteoporosis Australia | Financial support (grant) towards the Osteoporosis Australia (OA) national Allied Health Professional educational initiative. The program aims to raise awareness and improve education about managing bone health. The grant will contributed to project dev | 100000 | 100000 |
| 2015 | Amgen | Osteoporosis Australia | Financial support (grant) towards the Osteoporosis Australia (OA) direct-to- consumer 'bone tracker' national project. The grant will contribute to project development, management, launch, promotion and tracking which will be fully managed by OA. The pro | 250000 | 250000 |
| 2015 | Amgen | Rare Cancers Australia | Rare Cancers Australia Ltd (RCA) is a charity whose purpose is to improve awareness, support and treatment of Australians with rare and less common (RLC) cancers. Every year there are over 44,000 diagnoses of RLC Cancers and around 24,000 deaths. Amgen's | 10000 | 10000 |
| 2016 | Amgen | Heart Support-Australia | Financial support towards Heart Support Australia's Community Heart Healthcare Education Project to create awareness for the prevention and rehabilitation of heart conditions in the community. | 3000 | 3000 |
| 2016 | Amgen | Kidney Health Australia | Financial support towards Kidney Health Australia's new collaboration with the Renal Resource Centre for the review and ongoing supply and distribution of patient educational literature for people with chronic kidney disease. The objective of this project | 10000 | 10000 |
| 2016 | Amgen | Kidney Health Australia | Financial support towards the Primary Care Awards for Excellence in Early Detection of Kidney Disease. The new awards program is designed to recognise excellence in early detection of kidney disease in primary care settings. | 20000 | 20000 |
| 2016 | Amgen | Kidney Health Australia | Financial support towards the Kidney Health Australia (KHA)'s Kidney Check Australia Taskforce (KCAT) Clinical Education program of 2016. A program focused on clinical education for the management of Chronic Kidney Disease in primary care. | 60000 | 60000 |
| 2016 | Amgen | Kidney Health Australia | Financial support towards the development of the KHA-CARI Guidelines (Kidney Health Australia – Caring for Australasians with Renal Impairment). These guidelines have been developed and promoted to the Australian and New Zealand nephrology sector for almo | 100000 | 100000 |
| 2016 | Amgen | Lymphoma Australia | Financial support towards Lymphoma Australia's education activities including patient and carer education days, developing and distribution of educational booklets, upskilling and website maintenance. | 27272.8 | 27272.8 |
| 2016 | Amgen | Melanoma Patients Australia | Financial support towards the redevelopment of Melanoma Patients Australia's website. The redevelopment focussed on updating the website to create an effective website that will allow patients to easily access critical pieces of information relevant to t | 10000 | 10000 |
| 2016 | Amgen | Melanoma Patients Australia | Financial support towards developing patient support materials. The objective of the materials was to inform patients of the latest news as it relates to melanoma and of Melanoma Patients Australia's services such as counselling and support. | 10000 | 10000 |
| 2016 | Amgen | Myeloma Australia | Financial support towards Myeloma Australia's Medical and Scientific Advisory Group (MSAG) to further patient education and advocacy, facilitate investigator collaboration and research, hold scientific meetings and to be the peak body, in association with | 10000 | 10000 |
| 2016 | Amgen | Myeloma Australia | Financial support towards ground transfers and flights for three Myeloma Australia representatives to attend meetings around the American Society of Haematology (ASH) 2016 conference including the Global Myeloma Advocacy Network meeting and International | 10000 | 10000 |
| 2016 | Amgen | Myeloma Australia | Financial support towards Myeloma Australia in aid of patients suffering from Multiple Myeloma or Myeloma. The grant funded their information packs and updates of the 2015 Myeloma Foundation of Australia's publications with 2016 version updates. The fundi | 15000 | 15000 |
| 2016 | Amgen | Myeloma Australia | Financial support towards Myeloma Australia's Medical and Scientific Advisory Group (MSAG). The MSAG is comprised of 21 independent haematologists and scientists representing each State and Territory in Australia and is considered the peak myeloma body in | 20000 | 20000 |
| 2016 | Amgen | Myeloma Australia | Financial support towards Myeloma Australia's Myeloma Medical & Scientific Group (MSAG)'s inaugural Australian Myeloma Workshop. | 30000 | 30000 |
| 2016 | Amgen | National Heart Foundation Of Australia | Financial support towards the National Heart Foundation of Australia (NSW Division)'s Women & Heart Disease Campaign: Women with Heart Luncheon to support the Foundation's awareness and educational initiatives in 2016. | 10000 | 10000 |
| 2016 | Amgen | Osteoporosis Australia | Financial support towards Osteoporosis Australia's (OA) Roundtable projects in support of national General Practitioner (GP) education and awareness. In 2016, OA's projects would include GP education seminars, education booths and a GP survey to improve a | 65000 | 65000 |
| 2016 | Amgen | Osteoporosis Australia | Financial support towards the joint Osteoporosis Australia & Australia New Zealand Bone & Mineral Society's Clinical Grant Program 2016. The grant program is channelled towards the support of Australian bone researchers and their research in relation to t | 75000 | 75000 |
| 2016 | Amgen | Rare Cancers Australia | Attendance of 10 Amgen staff at the Rare Cancers Sick or Treat ball to raise awareness and funds for people suffering from rare and less common cancers. | 2200 | 2200 |
| 2016 | Amgen | Rare Cancers Australia | Financial support towards Rare Cancers Australia's Patient Voice Initiative conference. The conference objective was focused on a framework to formally acknowledge, facilitate and incorporate input from patients and consumers into health decision-making i | 7500 | 7500 |
| 2016 | Amgen | Rare Cancers Australia | Financial support towards Rare Cancer's "Just A Little More Time" report which raises awareness of the lack of improvement in outcomes for Australians with rare and less common cancers and communicates the current state of funding and treatment. | 10000 | 10000 |
| 2016 | Amgen | Rare Cancers Australia | Financial support towards Rare Cancer Australia's endeavours in building awareness of the plight of rare cancer patients including the establishment of a 'patient hub' providing information and gateways on the many issues patients face. | 50000 | 50000 |
| 2017 | Amgen | Heart Support-Australia | "A Second Chance" patient video resource, raising awareness of the importance of heart health. | 10000 | 10000 |
| 2017 | Amgen | Kidney Health Australia | Registration fee and accommodation for a Kidney Health Australia representative to attend the American Society of Nephrology's annual conference. | 2679.58 | 2679.58 |
| 2017 | Amgen | Kidney Health Australia | Kidney Health Australia and Royal North Shore Hospital's patient education booklets for kidney disease, haemodialysis, peritoneal dialysis and transplantation. | 10000 | 10000 |
| 2017 | Amgen | Kidney Health Australia | Publication, printing and distribution of kidney health related booklets for Supportive Care and Living Kidney Donors. | 14400 | 14400 |
| 2017 | Amgen | Kidney Health Australia | Online education component of KHA's Primary Care Education program. | 50000 | 50000 |
| 2017 | Amgen | Kidney Health Australia | Primary Care Education Program for Australian healthcare professionals about the management of chronic kidney disease in primary care. | 80000 | 80000 |
| 2017 | Amgen | Myeloma Australia | Myeloma Australia's Myeloma Medical and Scientific Advisory Group (MSAG) meeting support. | 10000 | 10000 |
| 2017 | Amgen | Myeloma Australia | Travel support for two Myeloma Australia representatives to attend the American Society of Haematology meeting. | 10000 | 10000 |
| 2017 | Amgen | Myeloma Australia | Myeloma Australia Publications and Information Packs for patients, carers and medical professionals. | 15000 | 15000 |
| 2017 | Amgen | Myeloma Australia | Financial contribution towards Myeloma Australia's Medical and Scientific Advisory Group's (MSAG) administrative and organisational co-ordinator. | 20000 | 20000 |
| 2017 | Amgen | Myeloma Australia | Administrative requirements to run Myeloma Foundation of Australia's Medical & Scientific Advisory Group (MSAG) for 2018. | 20000 | 20000 |
| 2017 | Amgen | Myeloma Australia | Pilot program for direct support services for Myeloma patients in rural, remote and regional areas. | 125000 | 125000 |
| 2017 | Amgen | Osteoporosis Australia | Roundtable projects for 2017 to raise awareness and provide HCP education about managing bone health through seminars, educational booths and GP surveys. | 65000 | 65000 |
| 2017 | Amgen | Osteoporosis Australia | Clinical Grant Program for 2017 supporting Australian bone research in fracture prevention. | 75000 | 75000 |
| 2017 | Amgen | Osteoporosis Australia | Stage two of Osteoporosis Australia's National Allied Health Professional Educational Initiative. | 100000 | 100000 |
| 2017 | Amgen | Osteoporosis Australia | World Osteoporosis Day disease awareness activities. | 115000 | 115000 |
| 2017 | Amgen | Osteoporosis Australia | Fracture Prevention Audit program which tests the parameters of existing protocol and its effectiveness via assessment of various criteria. | 120000 | 120000 |
| 2017 | Amgen | Osteoporosis Australia | Support of the 'Know Your Bones' bone health self-assessment initiative. | 150000 | 150000 |
| 2017 | Amgen | Osteoporosis Australia | Know Your Bones 'In-Pharmacy' education project. | 217000 | 217000 |
| 2017 | Amgen | Rare Cancers Australia | Updates to the CAN.Recall app including multi-lingual support, improvements to the question decks and upgrades to other functionality. | 2000 | 2000 |
| 2017 | Amgen | Rare Cancers Australia | Attendance of 10 Amgen employees at the 'Sick or Treat' fundraising dinner. | 5000 | 5000 |
| 2017 | Amgen | Rare Cancers Australia | Rare Cancers 2017 Advocacy Projects including a research / issues paper, Canberra Forum and media program. | 50000 | 50000 |
| 2018 | Amgen | ITP Australia | ITP Australia's purpose is to build awareness and assist carers, patients and medical professionals about Immune Thrombocytopenia (ITP). The donation supported the legal and accounting costs associated with setting up the charity and associated fees for the first 12 months of operation. It also included engaging in a website developer to build Phase 1 of the website including purchasing two URLs, engaging a professional copywriter and purchasing photographs for the website in a bid to provide Australian based information about the autoimmune disease. | 20002 | 20002 |
| 2018 | Amgen | Kidney Health Australia | Funding towards the publication of Kidney Health Australia patient education booklets which provide information for patients on topics such as haemodialysis, treatment options, home dialysis, symptom management and supportive care. The funds were allocated towards ongoing printing and distribution of the booklets. | 10000 | 10000 |
| 2018 | Amgen | Kidney Health Australia | Kidney Health Australia is a not–for-profit organisation dedicated to helping people with kidney disease, with a view to improving their health outcomes and quality of life, and that of their families and carers. Their mission is to promote good kidney health through education, advocacy, research and support. The funds will be used by KHA for 2019 activies such as; administration, training days for guideline groups, assisting guideline writers, organise peer review and revision of guidelines, creating summary versions for publication in the journal Nephrology and disseminating the final version of clinical and consumer guidelines. | 50000 | 50000 |
| 2018 | Amgen | Kidney Health Australia | Funding to support Kidney Health Australia's clinical practice and treatment guidelines (KHA-CARI Guidelines) for 2018 work plan. The KHA-CARI guidelines are essential for providing patient care, providing health professionals with resources for the prevention, early detection and management of people with end stage kidney disease. | 50000 | 50000 |
| 2018 | Amgen | Kidney Health Australia | Kidney Health Australia's (KHA) Chronic Kidney Disease (CKD) Management Book, 'CKD-Go!' and workshop program activities which provided primary care health professionals up to date and evidence based resources and tools that support them to detect and manage CKD in their clinical practice. | 72188 | 72188 |
| 2018 | Amgen | Kidney Health Australia | Kidney Health Australia's (KHA) Chronic Kidney Disease (CKD) Ambassador Program; a new KHA initiative that provided health professionals working in a primary care setting an opportunity to implement best practice detection and management of CKD for the benefit of patients, which includes face to face and online learning modules, patient risk identification tools and a patient information kit. | 78211 | 78211 |
| 2018 | Amgen | Leukaemia Foundation Of Australia | Funding towards the Leukaemia Foundation's Clinical Trials Symposium to discuss clinical trials and how they work, the difference between clinician-led clinical trials and company-led clinical trials in Australia, and how to find and access information about current clinical trials. | 10000 | 10000 |
| 2018 | Amgen | Leukaemia Foundation Of Australia | Leukaemia Foundation's Transport Program; an initiative serving patients with blood cancer and related blood disorders by providing a car driven by volunteer drivers that takes patients to their hospital appointments. The sponsorship is for a period of 12 months. | 14400 | 14400 |
| 2018 | Amgen | Myeloma Australia | The funding assisted Myeloma Australia's outreach to people in Australia suffering from multiple myeloma and included updates to Myeloma Australia's (MA) publications. This included MA's MyeNews magazine as well as fact sheets and information sheets in addition to a new publication on stem cell transplants. Other resources included treatment guides and overviews as well as patient wellness programs. | 25000 | 25000 |
| 2018 | Amgen | Myeloma Australia | Funding to support services for myeloma patients from rural, remote and regional areas for 2019. The funding covers patient education seminars (including an additional 10 regional areas), supply and dissemination of ''Myeloma: A comprehensive Guide'' and other booklets and fact sheets on myeloma to rural, remote and regional clinics and hospitals. The funding also covers myeloma specific education for nurses and GP's in regional areas as well as visits to regional haematology / oncology centres to meet specialists and patients to assess requirements and provide support as needed. | 110000 | 110000 |
| 2018 | Amgen | Myeloma Australia | Myeloma Australia's costs to print and update their Myeloma Patient Guide, upgrade their online delivery platforms and education and training program which equip local support group leaders with the skills and resources to provide peer support to patients. | 110000 | 110000 |
| 2018 | Amgen | National Heart Foundation Of Australia | Development of materials and consumer resources for healthcare professionals to assist patients increase their knowledge and understanding of risks and effectively manage their risk of heart disease. | 130000 | 130000 |
| 2018 | Amgen | Obesity Australia | The mission of Obesity Australia is to drive change in the public perceptions of obesity, its prevention and its treatment. The funds contributed to the support a highly skilled person to drive coordination, mobilisation, communications, alignment and continuous growth and iteration of the Engine Room Team. The initial estimated cost for the Engine Room Team is $250,000 for the first year, Amgen provided support to the value of $20,000 towards this. | 20000 | 20000 |
| 2018 | Amgen | Osteoporosis Australia | Osteoporosis Australia's (OA) 2018 Allied Health Professional Education Program. The funds assisted OA in development the educational content, liaising with key stakeholder groups, engagement with expert consultants and project management to improve understanding of osteoporosis and its impact in the community. | 45000 | 45000 |
| 2018 | Amgen | Osteoporosis Australia | Osteoporosis Australia 2018 Roundtable for General Practitioners. The roundtable activity addressed the importance of bone health and chronic disease management of patients. | 65000 | 65000 |
| 2018 | Amgen | Osteoporosis Australia | Osteoporosis Australia's (OA) 2018 Clinical Grant Program to support bone research. The funds assisted OA promoting and managing the program to organisations. In addition it included development of a flyer creation of a special section within the OA website about the grants. | 75000 | 75000 |
| 2018 | Amgen | Osteoporosis Australia | Funding towards Osteoporosis Australia that assisted the development of a key educational platform for Allied Health Professionals. This technology will be used to educate about bone health and assist with the identification of patients who are at risk. | 135000 | 135000 |
| 2018 | Amgen | Osteoporosis Australia | Osteoporosis Australia Stakeholder Engagement Campaign, promoting the health and economic benefits of a proposed National Fracture Liaison Service through a series of events including a State Government Ministerial Roundtable, participation in the International Osteoporosis Foundation regional meeting and a Council of Australian Governments (COAG) advocacy campaign. | 195800 | 195800 |
| 2018 | Amgen | Osteoporosis Australia | Funding towards Osteoporosis Australia that supported their "Know Your Bones'' initiative. The sponsorship support was used to expand the project nationally and included project management, national promotional activity to healthcare professionals, select allied professional groups and the general public. It also included website maintenance and management of responses to consumer queries received via the website as well as a consumer and healthcare professional survey to assess the program. | 210000 | 210000 |
| 2018 | Amgen | Rare Cancers Australia | Funding towards Rare Cancers Australia's 2018 projects specifically the Canberra Forum, a disease awareness event with MPs based on an update to the "Just a Little More time Report" 2:0. | 15000 | 15000 |
| 2018 | Amgen | Rare Cancers Australia | Funds provided to Rare Cancers Australia to support the 2018 Cancer Drugs Access Committee (CDAC), which focused on proposing new and innovative ways to provide the best treatment to Australians living with cancer. The CDAC 2018 project included extensive consultation with and participation from many stakeholders including clinicians, patients, patient groups, government and the pharmaceutical industry. The project also involved the composition of a detailed issues paper that drew on RCA's experience in dealing with patients, clinicians and government in a bid to highlight barriers with the current regulatory framework. Presentations on the outcomes of the working group were made to Government and key stakeholders. | 40000 | 40000 |
| 2018 | Amgen | Rare Cancers Australia | Funding towards Rare Cancers Australia (RCA) to assist with 2019 projects including: (a) The Canberra Forum, a one day event staged at Parliament House in Canberra. (b) "Just a little more time" Report 3.0 to raise awareness about rare and less common cancers. (c) National media campaign including support for an International Expert to be part of the launch to share the report findings and raise awareness of the need for innovation and reform to improve treatment for rare cancer patients. (d) Website redevelopment to improve patient access to information contained on the RCA website through innovative technology and interface. | 50000 | 50000 |
| 2019 | Amgen | Jean Hailes Foundation | Sponsorship of a women's health symposium that brought together health professionals to chart new paths through the current landscape of women's health in Australia. | 40000 | 40000 |
| 2019 | Amgen | Kidney Health Australia | Sponsorship of two healthcare professional education programs designed to promote best practice in the detection and management of chronic kidney disease (CKD). The first supported workshops for primary care professionals and the production of the CKD Management Handbook while the second supported the development of digital education, tools and resources. | 101496 | 101496 |
| 2019 | Amgen | Myeloma Australia | Sponsorship of information packs designed to provide patients, carers and medical professionals with relevant publications about the disease. | 20000 | 20000 |
| 2019 | Amgen | Myeloma Australia | Sponsorship of a program to support nursing services in regional and remote areas, including both physical and virtual patient education seminars and support groups. The Foundation seeks to provide support for patients across Australia, especially those with limited access to treatment centres. | 105000 | 105000 |
| 2019 | Amgen | National Heart Foundation Of Australia | Continuing sponsorship of resources for healthcare professionals to help patients increase their knowledge and understanding of cardiovascular risks and manage their risks effectively. | 96500 | 96500 |
| 2019 | Amgen | Obesity Australia | Sponsorship of a Project Manager to help drive the coordination, mobilisation, communications, alignment and continuous growth of the 'Engine Room Team' that supports the Obesity Collective's actions. | 20000 | 20000 |
| 2019 | Amgen | Osteoporosis Australia | Sponsorship of an independent expert forum with leading clinicians to discuss the treatment of minimal trauma fracture; therapy duration; what is the next step; what constitutes treatment failure and options for GPs. | 25000 | 25000 |
| 2019 | Amgen | Osteoporosis Australia | Sponsorship of an event at Parliament House to raise awareness of osteoporosis and highlight reaching the milestone of 50,000 people completing the 'Know Your Bones' online assessment. | 35000 | 35000 |
| 2019 | Amgen | Osteoporosis Australia | Grant to support the organisation's programs focussing on awareness, education, prevention and better management of osteoporosis in Australia. In 2019 the contribution was used to fund seminars, education booths, dissemination of clinical guidelines and a national GP survey to improve understanding of risk factors and management options for osteoporosis patients in primary care. | 65000 | 65000 |
| 2019 | Amgen | Osteoporosis Australia | Contribution to the organisation's 2019 clinical grants program for Australian researchers. As part of the program, grant requests are assessed by an independent review committee before the recipients are announced at a national conference. | 75000 | 75000 |
| 2019 | Amgen | Osteoporosis Australia | Sponsorship of the organisation's public and medical awareness campaigns on osteoporosis (including the 'Know Your Bones' campaign widely covered in electronic media and consumer magazines like Prevention ), and support for disease awareness activity associated with the National Strategic Action Plan for Osteoporosis. | 107000 | 107000 |
| 2019 | Amgen | Rare Cancers Australia | Sponsorship of the National Oncology Alliance (NOA) formed by Rare Cancers Australia as a mechanism for engaging the broader cancer community and developing consensus and understanding around the needs of those impacted by cancer. This funding helped support a foundation project that will form the basis of an Australian National Cancer Plan developed by the NOA. | 25000 | 25000 |
| 2019 | Amgen | Starlight Children's Foundation Australia | Grant to support the Starlight Express Room (SER) at the Queensland Children's Hospital. The SER is a medical-free space for hospitalised children and their families to access a range of facilities and activities, socialise and enjoy time away from the stress of the wards | 15000 | 15000 |
| 2019 | Amgen | Walter And Eliza Hall Institute Of Medical Research | Sponsorship of the expanded use of the organisation's BioGrid model (a model for setting up national/multi-site level registries in solid tumours) to include lung cancer patients. The funding supported ethics approval, appointment of a dedicated research fellow and a project manager, and payments for clinicians updating patient data. | 69000 | 69000 |
| 2020 | Amgen | Kidney Health Australia | Sponsorship of education programs designed to promote best practice in the detection and management of chronic kidney disease (CKD). This included the development and implementation of 50 primary care workshops to support the launch of the CKD Management Handbook (4th edition) as well as digital tools and resources for general practitioners, nurses and other healthcare professionals. | $100,000 | 100000 |
| 2020 | Amgen | Leukaemia Foundation Of Australia | Sponsorship to support the development of educational patient information booklets for people living with acute lymphoblastic leukaemia (ALL) to assist with their understanding of minimal residual disease (MRD). | $25,000 | 25000 |
| 2020 | Amgen | Lung Foundation Australia | Sponsorship to develop a suite of resources to support people diagnosed with lung cancer. These resources will also support families and carers to better understand the condition and genetic testing. | $25,000 | 25000 |
| 2020 | Amgen | Lung Foundation Australia | Sponsorship of a lung cancer support nurse - a highly experienced oncology nurse who can provide evidence-based information regarding diagnosis, treatment, symptom management and well-being. Available for patients, family and carers, the telephone-based nurse service recognises the symptom and side-effect burden experienced by people living with lung cancer and seeks to address unmet need by offering assistance across the five supportive care domains. | $70,000 | 70000 |
| 2020 | Amgen | Myeloma Australia | Sponsorship of the Medical and Scientific Advisory Group's 3rd National Myeloma Workshop that brought together researchers from basic science, translational and clinical medicine and nursing to look at the future of myeloma therapy and how to improve patient outcomes. | $5,000 | 5000 |
| 2020 | Amgen | Myeloma Australia | Sponsorship of a program to provide nursing services in regional and remote areas, including both physical and virtual patient education seminars and support groups. The funding supported ongoing work to support patients across Australia, especially those with limited access to treatment centres. | $50,000 | 50000 |
| 2020 | Amgen | Osteoporosis Australia | Sponsorship to support an online risk assessment tool for osteoporosis and awareness of its availability. "Know Your Bones" is an evidence-based risk assessment tool where consumers receive an individualised report on the quality of their bone health. This assessment tool can be used to initiate a discussion with their doctor. | $75,000 | 75000 |
| 2020 | Amgen | Osteoporosis Australia | Sponsorship to support the implementation and full realisation of the National Strategic Action Plan for Osteoporosis, launched in 2019, and COAG's commitment to nationally fund fracture liaison services (FLS). FLS are models of care that assist in the identification of patients at risk of osteoporosis following fractures. The funding supports work to communicate the benefits of scaling FLS services across the country. | $110,000 | 110000 |
| 2020 | Amgen | Osteoporosis Australia | Sponsorship to support the development of a pilot osteoporosis risk identification program for people aged over 70 years. The pilot focused on conducting screening in primary care practices to assess the bone health of patients over 70 years of age. | $115,000 | 115000 |
| 2020 | Amgen | Prostate Cancer Foundation of Australia (PCFA) | Sponsorship to support a specialist telenursing service program and facilitate a roundtable discussion with Amgen on effective patient-clinician communication. | $15,000 | 15000 |
| 2020 | Amgen | Prostate Cancer Foundation of Australia (PCFA) | Sponsorship of the virtual launch of the STARGATE project, which aims to raise community awareness of regional variations in prostate cancer incidence, mortality, and survival in Australia. Regional variations are differences in the incidence and outcomes of Australian men with prostate cancer. | $25,000 | 25000 |
| 2020 | Amgen | Rare Cancers Australia | Sponsorship to support the development of the Vision 20-30 Report and the Genomic Testing Blueprint. Both these projects are intended to bring together relevant stakeholders to encourage Australian governments to ensure Australians can access optimum cancer diagnosis, treatment and management. | $25,000 | 25000 |
| 2013 | Astellas | Transplant Australia | Opportunity for attendance at an international meeting "Association for Multi-Cultural Affairs in Transplantation Conference" and attendance at a meeting with the "Black, Asian, Minority and Ethnic Alliance for Organ and Tissue Donation". | $5000 as a travel grant towards participation and attendance | 5000 |
| 2014 | Astellas | Australian Transplant Games | Opportunity for attendance at an international meeting "Association for Multi-Cultural Affairs in Transplantation Conference" and attendance at a meeting with the "Black, Asian, Minority and Ethnic Alliance for Organ and Tissue Donation". | $5,500.00 for "Bronze Partner" Sponsorship alongside staff participantion and attendance | 5500 |
| 2014 | Astellas | Variety - the Children's Charity | Sponsorship and attendance at NSW fundraising event for Variety, the children's charity. | $10,000.00 as a grant alongside staff participation and attendance | 10000 |
| 2015 | Astellas | Transplant Australia | Grant to support the following programs and activities: 1. Quality of Life Transplant Health Program, including the Exercise for Life Kids Program; 2. Organ Donor Registration Challenges; 3. Online launch of the "Tranplant Voices" book; and 4. Supporting | 50000 | 50000 |
| 2016 | Astellas | Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) | Support of the Below the Belt Pedalthon activity raising awareness of testicular, prostate, kidney and bladder cancers. | 1. Entering a team of riders ($2,200) 2. A corporate donation to support the riders ($8,000) 3. Partial support of event costs ($2,500) | 12700 |
| 2016 | Astellas | Man Up! | Funding to support the following programs and activities: 1. Regional and Rural education campaign in Queensland to raise awareness for prostate cancer ($10,000); 2.Printing of Man Up's information brochures (5,000) supplied for two weeks in December thro | 10492 | 10492 |
| 2016 | Astellas | Prostate Cancer Foundation of Australia (PCFA) | Funding to support the following programs and activities: 1. "#Pass4Prostate" - global social media campaign to raise awareness of prostate cancer through Spetember 2016 ($10,000) 2. Advanced Prostate cancer patient forum on September 22 2016 ($26,470) | 37970 | 37970 |
| 2016 | Astellas | Transplant Australia | Funding to support attendance of Transplant Australia selected recipient (s) at the Fit for Life Ambassador Launch in Chicago, November 2-6 2016 | $12,000.00 (for travel and accommodation) | 12000 |
| 2017 | Astellas | Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) | Support of the Below the Belt Pedalthon activity raising awareness of testicular, prostate, kidney and bladder cancers. Funds provided supported: 1. Entering a team of riders ($4,400) 2. A corporate donation to support the riders ($6,000) 3. Support of the BBQ lunch for event attendees ($3,000) 4. Development of consumer programs through 2017 including website and app development, workshops and symposiums ($20,000) | 33400 | 33400 |
| 2017 | Astellas | Australian New Zealand Society of Nephrology (ANZSN) | Funding to support an "Indigenous Patient Voices Symposium". Funding supported travel, accommodation and hospitality for patient/carer attendees and event costs | 15000 | 15000 |
| 2017 | Astellas | Heart And Lung Transplant Trust Victoria (VIC) | Donation to HLTTV to support a patient project survey for patient information booklets | 1000 | 1000 |
| 2017 | Astellas | Prostate Cancer Foundation of Australia (PCFA) | Funding to support the following programs and activities: 1. The PCFA Parliamentary event on advanced prostate cancer - "Not too old for life: Giving Aussie men of all ages a fair go" ($54,300) 2. Donation to PCFA as part of participation in the Big Aussie BBQ campaign to raise awareness of prostate cancer during Prostate Cancer Awareness Month ($1500) 3. A series of digital patient education forums across 2017 and 2018 "Ask the Expert Webcast" for the prostate cancer community including prostate cancer patients, carers and family/friends ($75,000) | 130800 | 130800 |
| 2017 | Astellas | Transplant Australia | Funding to support the Fit for Life! program across Australia. Financial support went towards the promotion of the program in transplant units across Australia, awareness of the program in the community, appointment of ambassadors in each state and educational workshops throughout 2017 | 25000 | 25000 |
| 2018 | Astellas | Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) | Support of the Below the Belt Pedalthon activity raising awareness of testicular, prostate, kidney and bladder cancers. Funds provided supported: 1. Entering 2 x teams of riders ($4,000) 2. A corporate donation to support the riders ($5,000) Development and enhancement of consumer programs through 2018 including app development, newsletter publication, consumer interaction website areas, workshops and symposiums ($20,000) | 29000 | 29000 |
| 2018 | Astellas | Bladder and Bowel Health Australia | Support of the "Let's Talk About Prostate Health" public information forum 2018. | 500 | 500 |
| 2018 | Astellas | Prostate Cancer Foundation of Australia (PCFA) | Funding to support the following programs and activities: 1. Co-sponsorship of Parliamentary 'Big Aussie BBQ' lunch to raise awareness of Prostate Cancer during Prostate Cancer Awareness Month ($17,500) 2. Donation to PCFA as part of participation in the Big Aussie BBQ campaign to raise awareness of prostate cancer during Prostate Cancer Awareness Month ($1500) | 19000 | 19000 |
| 2018 | Astellas | Transplant Australia | Support of the Australian Transplant Games ($20,000), including: 1. Provision of volunteers 2. Funding towards the Games 3. Funding towards aspects of the development of the "Living with a Transplant" program which were coordinated at the Games | 20000 | 20000 |
| 2019 | Astellas | Australia & New Zealand Urological Nurses Society | Support for the continued running of the ANZUNS Prostate Cancer Nurses Communication Forum Funding to support a virtual community that provides a forum for peer to peer communications amongst Urology & PCFA nurses working in the field of prostate cancer in hospital wards, outpatient departments and community settings across metropolitan, rural and remote areas of Australia | 25000 | 25000 |
| 2019 | Astellas | Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) | 1. Corporate Supporter for 2019 Sponsorship ($20,000) Improving the way ANZUP engages with members and key stake holders through: Continue to revamp ANZUP website, publish quarterly clinical newsletters, fund face to face Scientific Advisory Committee meetings, preceptorships and symposiums 2. Support of the Below the Belt Pedalthon activity raising awareness of testicular, prostate, kidney and bladder cancers. Funds provided supported: - Entry Fee for 2 teams to enter ANZUP Pedalthon ($4,000) - Corporate donation to support the riders - $500 per rider ($5,000) | 29000 | 29000 |
| 2019 | Astellas | Transplant Australia | Funding for the Living with a Transplant Program to make it available for more patients, and materials for transplant hospitals to use. Funding for 'Living with a Transparency Program' includes: - 5 Videos - 3 Podcasts - Educational materials for hospitals - Pull-up banners | 57000 | 57000 |
| 2020 | Astellas | Anzup Cancer Trials Group | Below the Belt Pedalthon #Your Way cancer research | 3000 | 3000 |
| 2020 | Astellas | Anzup Cancer Trials Group | Gold Sponsorship of ANZUP #Your Way 2020 | 8800 | 8800 |
| 2020 | Astellas | Anzup Cancer Trials Group | ANZUP Corporate Sponsorship 2020 | 22000 | 22000 |
| 2020 | Astellas | Australia & New Zealand Urological Nurses Society | Sponsorship of the Forum to cover the SOSIDO contract and the Prostate Forum Manager activities for a 12 month period | 13725 | 13725 |
| 2020 | Astellas | Monash Health | Pump the Pedals for Prostate Cancer Gold Sponsorship | 11000 | 11000 |
| 2013 | AstraZeneca | Asthma Australia | Funding to raise awareness and engage asthma patients and encourage them to connect with their GP or pharmacist; and general patient awareness through World Asthma Day Events | 50000 | 50000 |
| 2013 | AstraZeneca | Heart Support-Australia | Charitable donation to support the work of HeartKids who focus soley on children's heart disease | 3150 | 3150 |
| 2013 | AstraZeneca | Mental Health Australia | Funding for patient awareness programmes on Mental Health issues in Australia | 28000 | 28000 |
| 2013 | AstraZeneca | Rare Cancers Australia | Funds to produce a report on the progress and state of treatment of rare and less common cancers in Australia | 10000 | 10000 |
| 2013 | AstraZeneca | Sunflower Foundation Australia | Funding to support the Wellness Walk to raise awareness of Mental Health illnes in the community | 9091 | 9091 |
| 2014 | AstraZeneca | Arthritis Foundation of Australia | Funds to support the development and production of a Patient education booklet on Gout. | 17538 | 17538 |
| 2014 | AstraZeneca | Arthritis Foundation of Australia | Funds to support Arthritis Australia and Medicines Australia Community Chest (MACC) Collaboration project "Cost of Arthritis - Economic Impact Stucy" under the Time to Move: Arthritis strategy. | 20000 | 20000 |
| 2014 | AstraZeneca | Asthma Australia | Funding to support the cost of printing and installing the Asthma Australia "Live, Love, Play" outdoor Adshel Advertising Campaign 2014 to enhance the management of Asthma in Australia | 5500 | 5500 |
| 2014 | AstraZeneca | Heart Kids Of South Australia (SA) | Charitable donation to support a charity event to raise funds for research into childhood heart disease. | 4200 | 4200 |
| 2014 | AstraZeneca | Rare Cancers Australia | Funds to support 2 projects of Rare Cancers Australia: Cancer Community Wide Surveys and the Consumer/ Patient Group Conference to benefit Australians with rare and less common cancers. | 10000 | 10000 |
| 2015 | AstraZeneca | Breast Cancer Network Australia | Donation for AZ staff to attend fundraising luncheon in Canberra on 13/10/15 | 1600 | 1600 |
| 2015 | AstraZeneca | Cancer Council New South Wales (NSW) | Charitable donation with AZ matching the $ value of funds personally raised by AZ employees. | 2218.3 | 2218.3 |
| 2015 | AstraZeneca | CanToo Organisation | Donation of $200. Member of Can Too Organisation guest speaking at AZ Manufacturing site. | 200 | 200 |
| 2015 | AstraZeneca | Centre for Community - Driven Research | Sponsorship funds for research into the value that ovarian cancer patients and their families place on progression-free survival as a clinical outcome, as well as community engagement and education relating to the research and health policy environment | 104050 | 104050 |
| 2015 | AstraZeneca | Lung Foundation Australia | Donation for AZ staff to attend attend Charity Gala Dinner on 17/10/15 | 3080 | 3080 |
| 2015 | AstraZeneca | Lung Foundation Australia | Sponsorship for the COPD National Program. AZ partnership to develop patient materials for the Winter Warning Consumer and HCP Campaign | 90750 | 90750 |
| 2015 | AstraZeneca | National Heart Foundation Of Australia New South Wales (NSW) | Sponsorship funding for Heart Foundation Research Awards night | 10000 | 10000 |
| 2015 | AstraZeneca | Ovarian Cancer Australia | Charitable donation with AZ matching the $ value of funds raised by AZ employees for Ovarian Cancer Morning Tea. | 473.8 | 473.8 |
| 2015 | AstraZeneca | Prostate Cancer Foundation of Australia (PCFA) | Sponsorship funds for the printing and distribution of Prostate Cancer Resource Packs for Patients | 27500 | 27500 |
| 2015 | AstraZeneca | Prostate Cancer Foundation of Australia (PCFA) and Ovarian Cancer Australia | Sponsorship for a one day meeting for patients with a focus on updating women living with ovarian cancer, men living with prostate cancer and their families as well as the community at large on outcomes of cancer research. | 11000 | 11000 |
| 2015 | AstraZeneca | Rare Cancers Australia | Sponsorship for AZ staff to attend the Sick or Treat Charity Ball at Sydney University on Saturday 17th October 2015 | 11000 | 11000 |
| 2016 | AstraZeneca | Asthma Australia | Partnership funds to develop patient education materials including Asthma Coaching app & Asthma Patient Education app and social media campaign aimed at people with poorly controlled asthma. | 100000 | 100000 |
| 2016 | AstraZeneca | Diabetes Australia | Partnership funding to support the development and implementation of Diabetes Education in General Practice Program; and funding to update current online consumer information of type 2 diabetes treatments and medicines | 75000 | 75000 |
| 2016 | AstraZeneca | Movember Foundation | Donation to purchase fundraising gear during the November Program. Donations support the Foundation in its work to address men's health issues | 3500 | 3500 |
| 2016 | AstraZeneca | Movember Foundation | Funding to support the TrueNTH Program to help men, their carers and famility navigate their prostate cancer journey. Support will provide outreach care services by nurses, exercise physiologist, psychology support and other counselling services . | 50000 | 50000 |
| 2016 | AstraZeneca | Ovarian Cancer Australia | Funding to support a National Advocacy Forum for World Ovarian Cancer Day The aim of the forum: to bring together trained advocates, consumers, researchers and clinicians to tackle the major questions in the field regarding ovarian cancer. | 25000 | 25000 |
| 2016 | AstraZeneca | Ovarian Cancer Australia | Funds to support the redevelopment of the Ovarian Cancer Australia Resillience kits for patients with ovarian cancer | 60000 | 60000 |
| 2016 | AstraZeneca | Ovarian Cancer Australia | Funding to support the development, delivery of the National Ovarian Cancer Symposium being held in Sydney. Funds will support OCA resourcing to develop and convene the event and Event Company management of the event. | 120000 | 120000 |
| 2016 | AstraZeneca | Pink Hope Community | Funding to support the Launch of National Genetic Testing Program Initiative that will enable Australian families greater access to genetic testing. | 49368 | 49368 |
| 2016 | AstraZeneca | Prostate Cancer Foundation of Australia (PCFA) | Corporate sponsorship funding of the Community Conversations on Prostate Cancer in Australia Event held in Adelaide 12 Aug 2016. The event is for members of the community impacted by prostate cancer to be informed and connected | 50000 | 50000 |
| 2016 | AstraZeneca | Rare Cancers Australia | Funds to support the Sick or Treat Program including patient sessions in Canberra - to include advertising, promotion and event staging costs; and the redesign of the Sick or Treat website to provide a resource to the community for information on the issu | 25000 | 25000 |
| 2017 | AstraZeneca | Asthma Australia | Funding to support the development of a Severe Asthma Patient Engagement Strategy incorporating a severe asthma website, patient brochures and the asthma patient hospital discharge resource. | 50555 | 50555 |
| 2017 | AstraZeneca | Asthma Australia | Funds used to support World Asthma Day HCP and Asthma week promotions; GP Masterclass 2017,Asthma Patient Education App Android Development; and Better use of medication campaign. | 90000 | 90000 |
| 2017 | AstraZeneca | Breast Cancer Network Australia | Funds provided for AZ staff to attend the Pink Lady Luncheon in Sydney. | 1590.91 | 1590.91 |
| 2017 | AstraZeneca | Centre for Community - Driven Research | Funds support used to conduct patient experience studies (PEEK) for patients being treated for Bladder Cancer to understand how they navigate the healthcare system and their perspectives on diagnosis and treatment. | 59400 | 59400 |
| 2017 | AstraZeneca | Centre for Community - Driven Research | Funding support used to conduct patient experience studies (PEEK) for patients being treated for Lung Cancer to understand how they navigate the healthcare system and their perspectives on diagnosis and treatment. | 102800 | 102800 |
| 2017 | AstraZeneca | Centre for Community - Driven Research | Funding support used to conduct patient experience studies (PEEK) for patients being treated for Breast Cancer to understand how they navigate the healthcare system and their perspectives on diagnosis and treatment. | 138200 | 138200 |
| 2017 | AstraZeneca | Lupus Association Of New South Wales (NSW) | Funds used to support Lupus Association of NSW in raising awareness of Lupus during World Lupus Day 2017 programs. | 5500 | 5500 |
| 2017 | AstraZeneca | Ovarian Cancer Australia | Funds to support the BCRA Survey Program 2017. To support better health and patient outcomes in ovarian cancer through understanding and awareness of genetic testing. | 40000 | 40000 |
| 2017 | AstraZeneca | Ovarian Cancer Australia | Funds used to produce Resilience Kits for Patients with Ovarian Cancer. | 60000 | 60000 |
| 2017 | AstraZeneca | Pink Hope Community | Funding to support Pink Hope planning of 2018 patient programs such as health and wellness days and patient awareness campaigns relating to breast and ovarian cancer risks. | 30000 | 30000 |
| 2017 | AstraZeneca | Pink Hope Community | Funds used to support the National Consumer Education Program of Education and Health Days during 2017. | 124675 | 124675 |
| 2017 | AstraZeneca | Prostate Cancer Foundation of Australia (PCFA) | Funds used to support the hosting of a series of PCFA Community Conversations Events on Prostate Cancer in Australia. | 50000 | 50000 |
| 2017 | AstraZeneca | Prostate Cancer Foundation of Australia (PCFA) | Funding to support the development and provision of a programme of professionally prescribed exercise for men with prostate cancer. | 93100 | 93100 |
| 2017 | AstraZeneca | Rare Cancers Australia | Funds for advertising and promotion costs associated with producing the Rare Cancers "Unfair for Rare" Report. | 25000 | 25000 |
| 2018 | AstraZeneca | Asthma Australia | Funding provided to support Asthma Australia develop and deliver Patient Asthma Management Tools, Asthma Coaching Program and Campaigns to engage asthma patients in managing their asthma. | 110000 | 110000 |
| 2018 | AstraZeneca | Australian Prostate Centre | Sponsorship of Non-Meeting Activity Exercise Physiology Program Support 2018 | 18181.810000000001 | 18181.81 |
| 2018 | AstraZeneca | Breast Cancer Network Australia | Donation to support AZ attendance at the Pink Lady Luncheon in Sydney. | 1800 | 1800 |
| 2018 | AstraZeneca | Cystic Fibrosis Australia | Donation provided to support the association in research and development of Cystic Fibrosis. Donation initiated after the passing of AZ employee from this disease. | 5000 | 5000 |
| 2018 | AstraZeneca | Lupus Association Of New South Wales (NSW) | Funds used to support Lupus Association of NSW in raising awareness of Lupus during World Lupus Day 2018 program. | 10000 | 10000 |
| 2018 | AstraZeneca | Pink Hope Community | Funding provided to support Pink Hope in planning 2018 patient educational programs on breast and ovarian cancer. | 120340 | 120340 |
| 2018 | AstraZeneca | Prostate Cancer Foundation of Australia (PCFA) | Funding provided for 'In-kind' production and distribution of PCFA Information Guide for patients on "Understanding Hormone Therapy for Prostate Cancer" | 10560 | 10560 |
| 2018 | AstraZeneca | Rare Cancers Australia | Donation provided to support the fundraising appeal for Rare Cancers Australia at their 2018 Mount Kosciuszko Challenge. | 5000 | 5000 |
| 2018 | AstraZeneca | Rare Cancers Australia | Funding provided to travel and accommodation support for 2 Rare Cancer Australia advocates to attend the 2018 Global Cancer Therapy Research, Development and Accessibility Workshop in Maryland USA. | 25000 | 25000 |
| 2018 | AstraZeneca | Rare Cancers Australia | Funding provided to support Cancer Drugs Access Committee funding for 2018 research and community engagement | 44000 | 44000 |
| 2019 | AstraZeneca | Asthma Australia | Funding to support project Asthma Zero, which will be bringing together person-centered approaches, with design thinking methodologies, to develop new approaches to reduce SABA over reliance, and support people in achieving good asthma control, thus reduce their risk of worsening symptoms and asthma attacks. The funding will be used to support the development of the project plan and to facilitate the National Steering Committee travel costs where the project plan will be discussed. | 14510 | 14510 |
| 2019 | AstraZeneca | Australian Diabetes Educators' Association | Australian Diabetes Educators Association (ADEA) is the leading organisation in the development and provision of quality, evidence-based diabetes education and standards. This support is for an educational event for Credentialed Diabetes Educators, to support education in managing patients with Diabetes including Type 2 Diabetes (T2D). Funding to be used for food and beverage at the educational event. | 400 | 400 |
| 2019 | AstraZeneca | Australian Diabetes Educators' Association | Australian Diabetes Educators Association (ADEA) is the leading organisation in the development and provision of quality, evidence-based diabetes education and standards. This support is for an Education dinner presentation to ADEA members (Credentialed Diabetes Educators) and allied HCPs In the improvement of care for patients with Diabetes. | 400 | 400 |
| 2019 | AstraZeneca | Australian Diabetes Educators' Association | Australian Diabetes Educators Association (ADEA) is the leading organisation in the development and provision of quality, evidence-based diabetes education and standards. This funding will support the education of Credentialled Diabetes Educators (CDE) and those working towards becoming a CDE to educate in diabetes education and management. The funds will be used for catering and beverage, venue, AV hire and speaker honorariums. This is the first of two meetings. | 3636.36 | 3636.36 |
| 2019 | AstraZeneca | Australian Diabetes Educators' Association | Australian Diabetes Educators Association (ADEA) is the leading organisation in the development and provision of quality, evidence-based diabetes education and standards. This funding will support the education of Credentialled Diabetes Educators (CDE) and those working towards becoming a CDE to educate in diabetes education and management. The funds will be used for catering and beverage, venue, AV hire and speaker honorariums. This is the second of two meetings. | 5454.55 | 5454.55 |
| 2019 | AstraZeneca | Australian Diabetes Educators' Association | Australian Diabetes Educators Association (ADEA) is the leading organisation in the development and provision of quality, evidence-based diabetes education and standards. Funding will support program development for the scientific conference as well as funding for the breakfast on day two of the event. The meeting is an opportunity to brainstorm with colleagues, share recent developments in clinical and basic research, and offer new insights into clinical practice. | 64155 | 64155 |
| 2019 | AstraZeneca | BEAT Bladder Cancer Australia | BEAT is a patient-driven bladder cancer charity that wishes to increase community and Practitioner's awareness and education, provide support services to the bladder cancer community and steer and advance bladder cancer research, diagnosis and treatment options. Funding will support a new patient support model, including an enhanced website, Facebook community support group, tele-nurse support line, online forum for practitioners, both face to face and virtual support group for caregivers, and one-on-one patient matching support. These services will be phased in throughout 2019-2020 | 28000 | 28000 |
| 2019 | AstraZeneca | Diabetes Australia | Support to collaborate with Diabetes Education Self-Management for Ongoing and Newly Diagnosed (DESMOND) to promote a patient support offering focused on diabetes education and self-management, enabling clinicians and their patients to connect with experts in the field. The objective of the funding is to provide assistance to educate practitioners about the DESMOND Program in order to provide better health outcomes to patients. DESMOND is a 1-day structured diabetes self-management education program for people diagnosed with type 2 diabetes. The DESMOND program is the gold standard patient education program in type 2 diabetes and has achieved national adoption in Australia as a recognised and preferred service intervention. | 25632 | 25632 |
| 2019 | AstraZeneca | Diabetes Australia | Support for Diabetes Australia to: 1) raise awareness of early intervention, optimum treatment and the holistic care of people with type 2 diabetes (T2D) through Diabetes Australia's campaign to promote informed discussions between people with diabetes and their health care professionals, and delivery powerful consumer stories and messages; 2) support evidence based, best practice information and guidance about management of T2D in the general practice setting through supporting Diabetes Australia's work with the RACGP and publication of the next edition of the General Practice Management of T2D handbook; and 3) promote the importance of early detection of T2D through the 'It's About Time' campaign, which is aimed to reach the 500,000 Australians with silent, undiagnosed T2D, explaining why early detection/treatment is critical to reduce life threatening diabetes-related complications, since many people live with T2D for up to seven years before being diagnosed. | 132000 | 132000 |
| 2019 | AstraZeneca | Leukaemia Foundation Of Australia | The Leukaemia Foundation supports medical research that delivers advancements in treatments, encourages the careers of promising scientists, discovers new diagnostics and novel therapies, and gives Australians access to global clinical trials. The Support is intended to be used for re-development and implementation of the Leukaemia Foundation website that will host refreshed content that will transform the delivery of patient information and education. | 20000 | 20000 |
| 2019 | AstraZeneca | National Heart Foundation Of Australia | The National Heart Foundation funds life-saving heart research and work to improve heart disease prevention and care for all Australians. This support will be used to develop and operate a project that supports individuals who recently had a heart attack, their caregivers and families, as well as generate data to assess the national impact of the program and demonstrate health outcomes. | 80000 | 80000 |
| 2019 | AstraZeneca | Ovarian Cancer Australia | Support to the Ovarian Cancer Australia for their Symposium. The symposium will bring together researchers, clinicians and health professionals, providing an opportunity for discussion of new, innovative and specialist ovarian cancer treatments in Australia and internationally as well as providing a valuable networking opportunity. This specific support will be used for resourcing, which includes: Project administration, Project officer time, Develop Advisory Group, Convene Advisory Group, and Communication strategy. | 30000 | 30000 |
| 2019 | AstraZeneca | Ovarian Cancer Australia | Ovarian Cancer Australia will bring together researchers, clinicians and health professionals, providing an opportunity for discussion of new, innovative and specialist ovarian cancer treatments in Australia and internationally as well as providing a networking opportunity. This funding will allow two face-to-face ovarian cancer information forums in Sydney and Perth for women with ovarian cancer, their friends/families, as well as live stream and upload to their website. The support will be used for operating expenses, which include event catering, venue hire, website development and photography. It will also cover admin and overheads, which include insurance, office building expenses, internet costs, office equipment, IT infrastructure and support and courier fees. | 49000 | 49000 |
| 2019 | AstraZeneca | Pink Hope Community | Pink Hope is a breast and ovarian preventative health hub, working to ensure every individual can assess, manage and reduce their risk of breast and ovarian cancer, while providing personalised support to at-risk women. Support will be used to develop a workshop, the aim being for participants to gain an understanding of the challenges in NZ around access, to brainstorm new and engaging ways to drive media, communications and advocacy, to discuss potential funding opportunities and to understand and make clear the resources needed to achieve tangible results. Brainstorming sessions will discuss issues and roadblocks to care, resources, advocates and organizations needs, and to gain consensus for a plan moving forward. Funding will also be used to support hospitality and fees for Pink Hope's CEO to facilitate the workshop. | 5454.55 | 5454.55 |
| 2019 | AstraZeneca | Pink Hope Community | Pink Hope is a breast and ovarian preventative health hub, working to ensure every individual can assess, manage and reduce their risk of breast and ovarian cancer, while providing personalised support to at-risk women. The support is intended to be used to fund educational and health related events 'Information and Support Days', the 'She Shares Events', and the 'EDU Evenings' throughout Australia. These events allow patients to hear from experts in their field and empower and motivate them to better manage their health. | 80000 | 80000 |
| 2019 | AstraZeneca | Prostate Cancer Foundation of Australia (PCFA) | The Prostate Cancer Specialist Nurse (PCSN) program's goal is to provide coordinated support throughout the entire prostate cancer journey; taking into account physical, emotional, psychological and social needs of men and their families. The goal of this educational event is to promote and fund world leading, innovative research into prostate cancer, and create awareness and advocacy campaigns for the Australian community, health professionals and Government and to support men and their families affected by prostate cancer, through evidence-based information and resources, Support Groups and Prostate Cancer Specialist Nurses. The ability for all PCSNs nationwide to access prostate cancer data in clinical research is a critical component of this goal. | 30000 | 30000 |
| 2019 | AstraZeneca | Rare Cancers Australia | Rare Cancers Australia Ltd is a charity whose purpose is to improve awareness, support and treatment of Australians with rare and less common cancers. Support was given for the 2019 Halloween Charity Ball. All proceeds raised from the Charity Ball will help fund the Patient Care Team in continuing to deliver emotional and financial support to patients and carers during their cancer diagnosis journey. | 4000 | 4000 |
| 2019 | AstraZeneca | Rare Cancers Australia | Rare Cancers Australia Ltd (RCA) is a charity whose purpose is to improve awareness, support and treatment of Australians with rare and less common (RLC) cancers. Support for RCA was for the Canberra forum featuring speakers from the cancer community to discuss the evolution of precision medicine, personalised health care and targeted therapies. The intent of funding is to support one or more international speakers that are expert in innovation funding models in a single payer system. RCA's goal is to improve awareness of the issues facing Australians living with RLC to federal politicians, members of the medical profession and the general public. The forum will provide an evidence base that can be shared with health care professionals so they develop a more refined understanding of the current registration and reimbursement systems. Specifically, funding will be used to update "Just a Little More Time" Reports, staging of the Canberra Forum, a major media campaign and website update. | 20000 | 20000 |
| 2020 | AstraZeneca | Asthma Australia | Asthma Awareness Campaigns – educating consumers about good asthma management and World Asthma Day and Asthma Week series partner. Silver Support to be used for Project HCP – engaging and upskilling GPs and other HCPs across Australia, 2020 Asthma Conference – shifting the dial on asthma, and 2020. | 98,000.00 | 98000 |
| 2020 | AstraZeneca | Asthma Foundation of Western Australia (WA) | The Support is intended to be used for the following: Preventable harm remains common for people with asthma. One contributory factor is the relative lack of training about asthma among clinicians who do not have a subspecialty interest in the condition. This is manifest in doctors and nurses reporting they would like more subspecialty education in asthma, and the poor performance of health professionals (HPs)dealing with asthma in both chronic and acute settings. We are aware that AstraZeneca is patient outcome focussed and your objective of partnering with us on one of our HP education videos is to increase the correct diagnosis and treatment of asthma patients across WA.We intend to develop a short HP education video for Health Professionals and promote through our networks and the RACGP.The topic will be Asthma Diagnosis. The 5 min video featuring Dr John Blakey (tbc), Asthma WA slides with text, infographic, illustration, and photography. | 5,000.00 | 5000 |
| 2020 | AstraZeneca | Australian Diabetes Educators' Association | Sponsorship of Education to CDEs in the management of patients with T2DM, in particulate Diabetes and eye health. ADEA-SA Branch Meeting to be held on Wednesday 4 March 2020 at Martini Restaurant. The Support is intended to be used for educational purposes for approx. 35 healthcare professionals. The Bronze Sponsorship Package includes: Bronze Sponsor branding on ADEA website announcing the event with direct link to sponsor’s website ADEA Branch Event Sponsorship Prospectus. | 500.00 | 500 |
| 2020 | AstraZeneca | Australian Diabetes Educators' Association | The Support is intended to be used to Sponsor the ADEA State Branch Conferences at a Silver Sponsorship Package level. ADEA branch events are an opportunity for health professionals from multiple disciplines to come together, network and exchange their knowledge of the latest clinical practices and research in diabetes. These ADEA branch events provide a program of interesting, challenging and informative sessions that feature thought leaders in diabetes, diabetes management and diabetes care. They cover a range of clinical, practical and research topics identified by members and local organising committees. The events attract delegates from both the public and private health care sectors across Australia who are key players in diabetes education and management. They include: Diabetes Educators, Psychologists, Nurses, Physiotherapists, Dietitians, General Practitioners, Podiatrists, Practice Nurses, Managers, Pharmacists, Health Care Workers, Researchers, Midwives. | 6,000.00 | 6000 |
| 2020 | AstraZeneca | Centre for Community - Driven Research | PEEK study is to conduct patient experience studies across a number of disease streams using a protocol that will allow for comparisons over time (both quantitative and qualitative components). Through PEEK, we are able to gain insights into the experience of patient communities and their expectations of future treatment, care and information provision - in a more equitable and systematic way - particularly in the context of Health Technology Assessment. | 60,000.00 | 60000 |
| 2020 | AstraZeneca | Kaden Centre | The Virtual remote exercise Program to support a total of 70 patients with prostate, lung and ovarian cancers. The deliverables on this grant program include: Each patient shall receive the same professional, evidence based service as those attending the clinic, A Zoom based initial assessment, 10 weeks of individualised, targeted exercise programs, 15 minute Zoom contact with the clinician to support and practice technique assistance, Telephone access to the clinician at any time, A Zoom based subsequent assessment at week 12, 2 reports to the referring Doctor - 1 following the initial assessment and 1 following the final assessment and Reports shall be sent to the Astra Zeneca contact(s) bimonthly, outlining the number of patients attending by cancer type. | 40,600.00 | 40600 |
| 2020 | AstraZeneca | Kidney Health Australia | National Launch of the CKD Management in Primary Care handbook. The Support is intended to be used to support the delivery of digital and face to face activity to support the launch of the 4th edition of ‘CKD Management in Primary Care’ handbook. Digital promotion of handbook via Kidney Health Australia networks. Launch events will provide an opportunity for key stakeholders to come together, will raise awareness around the new CKD handbook and also provide education to GPs, nurses and other health professionals on the content of the new handbook with a focus of the early detection of CKD in primary care. Education component to be delivered by a senior Nephrologist. | 30,182.00 | 30182 |
| 2020 | AstraZeneca | Kidney Health Australia | Kidney Health Australia’s new Big Red Kidney Bus Mobile dialysis – NSW. Kidney Health Australia operates an award-winning mobile dialysis bus in NSW in partnership with our clinical partner, the Royal North Shore Hospital. The bus provides a vital service for dialysis patients allowing them to have a holiday whilst still receiving haemodialysis treatment. The Organisation will use the Support to contribute towards the cost of refurbishment of the new Big Red Kidney Bus which is scheduled for completion by September 2021. To support continuing Medical Education and the quality use of medicines in Australia. | 198,500.00 | 198500 |
| 2020 | AstraZeneca | Leukaemia Foundation Of Australia | Leukaemia Foundation Light the Night Grant 2020. Grant from AstraZeneca for the provision of 30 Lanterns for the Leukaemia Foundation's Light the Night at Home fundraising event. | 3,000.00 | 3000 |
| 2020 | AstraZeneca | McGrath Foundation | National Metastatic Breast Cancer (mBC) Nurse Training Program. Funding for National metastatic breast cancer nurse training program in collaboration with Monash Health (MH), Monash University and Southern Melbourne Integrated Cancer Services (SMICS). Funding is for the successful development, implementation and evaluation of this important program. This will include the design and build of a best practice online training program, as well as the delivery of the three-day practical component of the training program and ongoing clinical supervision to ensure the practices are embedded in health services around the country. | 72,900.00 | 72900 |
| 2020 | AstraZeneca | National Asthma Council Australia | The Support is intended to be used for the following: The International Primary Care Respiratory Group (IPRCG) has created an international pilot, Asthma Right Care (ARC) to explore how to use social movement approaches to create a desire for change in the management of asthma. The priority, in the first phase in each country, is to create conversations on the over-reliance on short acting beta2 agonists (SABAs). The priority groups are those with asthma in the community (consumers), pharmacists, general practitioners (GPs) and nurses. Event format used will be Web/Virtual (ex. Online Broadcast, etc.) | 5,000.00 | 5000 |
| 2020 | AstraZeneca | National Asthma Council Australia | National Asthma Council Australia (NAC). The Support is intended to be used for the following: The NAC video library will be updated to include a series of NAC-produced instructional videos on how patients should correctly use the self-administration devices. Each proposed device video will be a clip of approximately 2–4 minutes duration showing the correct technique for the device. | 22,000.00 | 22000 |
| 2020 | AstraZeneca | Osteoporosis Australia | Healthy Bones Australia expansion project includes: Assessment of patients with Prostate cancer for osteoporosis. Expansion of the program to include: The General Rheumatology Clinic at Westmead Hospital and Blacktown Hospital (Sydney, NSW) and The Fracture Prevention Clinic at St Vincent's Hospital (Sydney, NSW). | 98,000.00 | 98000 |
| 2020 | AstraZeneca | Ovarian Cancer Australia | National Ovarian Cancer Sponsorship 2020. Sponsorship for the Ovarian Cancer Australia Core Services Impacted by COVID-19. Partner with OCA to update resources and ensure quality online and telephone support can be provided to ovarian cancer patients during the COVID 19 pandemic. The Support is intended to be used to for the following: (1) Resilience Kit– urgently reprint 1,000 copies - $21,000 (2) Telephone and Online Support – meeting increased demand - $79,000. During this time, in order to keep pace with demands placed on our Helpline and OCA Connect, we ask for $79,000 to cover these costs. | 100,000.00 | 100000 |
| 2020 | AstraZeneca | Ovarian Cancer Australia | Pilot project - Ovarian Cancer: Sexuality, Body Image, Self-esteem and Relationships. This project will tackle a significant unmet need for our consumers - the challenge of changed body image and self-esteem as a result of ovarian cancer diagnosis and treatment and how that affects sex, sexuality and intimacy. The project can be divided into two phases: Phase 1: November 2020 includes: Convene Project Advisory Group comprising experts in sexual medicine, psycho-oncology and ovarian cancer, and women impacted by the disease, Create an information resource (hard copy booklet + online interactive pdf), Create web pages for OCA website including video vignettes of women (and their partners) discussing experiences, Incorporate advice/information for partners, and For a sense of what this information might look like, see our online Younger Women's Network resources. Phase 2 - November/December 2020 includes: A 12-month pilot project which explores the efficacy of offering women (and their partners) access to a sexual medicine counsellor and/or and a sexual recovery counsellor, both specialising in oncology and sexuality issues. This service would offer direct 1:1 support for more complex issues around sexuality, body image and relationships. The program would be piloted with approximately 100 women (depending on the number of sessions each women requires). | 120,864.00 | 120864 |
| 2020 | AstraZeneca | Patient Voice Initiative | Patient Voice Initiative 2020-2021 Activities Sponsorship. Silver Sponsorship for Patient Voice Initiative (PVI) 2020-2021 Financial Year activities to work to progress the recommendations to im prove the patient voice in health technology assessment in Australia through the following programs: Consumer Online Toolkit, Supporting Patient Engagement And Knowledge through Efficient Resource Search (SPEAKERS), Consumer Comment support, Patient Voice training, Consumer Conversations, Promote the use of Patient Based Evidence, Industry training and Ongoing collaboration. | 7,500.00 | 7500 |
| 2020 | AstraZeneca | Prostate Cancer Foundation of Australia (PCFA) | The Support is intended to be used for sponsorship of the Prostate Cancer Foundation of Australia Online Induction program. Prostate Cancer Specialist Nurses who have recently joined the program will undergo the induction sessions online. PCSNs will participate remotely, from around the country, integrating their learning within their working week. AstraZeneca was not responsible for selecting the venue, inviting attendees or organising the educational content. | 25,000.00 | 25000 |
| 2020 | AstraZeneca | Prostate Cancer Foundation of Australia (PCFA) | Prostate Cancer Specialist Nurses Online Induction (November 2020). The Sponsorship of Electronic Induction for 25 Prostate Cancer Specialist Nurses. To be held from 10 November 2020 until 26 November 2020 for 4 hours per week and conducted online via a closed platform. The workshop will comprise didactic clinical content relevant to prostate cancer nursing includes Familiarisation with PCFA program reporting and support tools, Clinical presentations from key clinicians (urologists, radiation oncologist, medical oncologist, specialist nurses etc) and Mentored group discussion to encourage the nurses to reflect and examine how best to implement their role. | 25,000.00 | 25000 |
| 2020 | AstraZeneca | Prostate Cancer Foundation of Australia (PCFA) | The Support is intended to be used to fund the E-Learning Module: Psychosocial Care in Prostate Cancer. The E-Learning Module will enable Prostate Cancer Specialist Nurses to understand psychological care in prostate cancer including: Helping with difficult conversations with clinicians or where men are receiving bad news, Supporting men in a practical way with difficult choices like treatment decisions, and Supporting men and partners to manage mild to moderate distress. | 50,000.00 | 50000 |
| 2020 | AstraZeneca | Rare Cancers Australia | The Support is intended to be used to be used to fund sponsorship of the patient engagement platform: Rare Cancer Patient Portal, Peer-to-peer support communities, online and hosted live discussions, Bulletin board, Patient Navigator, centralised index to enable patients to access financial services in times of hardship, Enhancement of patient engagement capabilities within RCA, Launch of redeveloped website, and Improved patient management system. | 25,000.00 | 25000 |
| 2013 | Bayer | Australian Diabetes Council | Tickets for 2 staff to attend their annual fundraising event. | 500 | 500 |
| 2013 | Bayer | Australian Thyroid Foundation | Sponsored the Australian Thyroid Foundation’s website upgrade, enabling them to improve the way they communicate with patients and the general public. | 10000 | 10000 |
| 2013 | Bayer | Bowel Cancer Australia | Sponsored the Bowel Cancer Survey, “My Cancer, My Voice” to improve knowledge and understanding of the specific experiences of people with bowel cancer. | 70000 | 70000 |
| 2013 | Bayer | Camp Quality | Sponsorship of a table at their fundraising event | 5000 | 5000 |
| 2013 | Bayer | Cancer Council New South Wales (NSW) | Sponsored the Inaugural Supportive Care Leadership Conference- Leaders in Supportive Care: Linking us Together. | 15000 | 15000 |
| 2013 | Bayer | GI Cancer Institute | Sponsored the “Engage Community Forums” to provide information to patients and their families about Gastro Intestinal (GI) cancers, research and a chance to discuss the impacts of GI Cancer. | 10000 | 10000 |
| 2013 | Bayer | Heamophelia Foundation Australia | Corporate sponsorship to support their advocacy, education and research programs which provide support to patients with bleeding disorders and their families | 50000 | 50000 |
| 2013 | Bayer | Kidney Health Australia | Sponsored the ‘Kidney Cancer Initiative’. The initiative aims to support the needs of kidney cancer patients and their families through increasing awareness of the disease, advocacy and the provision of networking opportunities for patients. | 15000 | 15000 |
| 2013 | Bayer | Kids' Cancer Project | Corporate sponsorship to support funding research programs dedicated to finding cures for childhood cancers. | 20000 | 20000 |
| 2013 | Bayer | Macular Disease Foundation | Sponsored a range of projects to support Macular Disease patients. These included the provision of patient services and resources, the development of a new website, a Medicare Locals Pilot Program, a disease awareness campaign, research and policy projec | 500000 | 500000 |
| 2013 | Bayer | MS Austraia | Sponsored MS Societies by funding them to provide support services for people with MS . This included programs such as the National nursing services, national peer support program, MS Ambassador program, telephone and online advisory and support services | 200000 | 200000 |
| 2013 | Bayer | MS Research Australia | Supported the Kiss Goodbye to MS campaign which aims to raise awareness of MS and raise funds for MS research. | 20000 | 20000 |
| 2013 | Bayer | MS Research Australia | Funded a program of research into MS including the Australian MS Longitudinal Study, The MSRA Brain Bank and the MSRA Clinical Trials Network | 80000 | 80000 |
| 2013 | Bayer | National Stroke Foundation | Sponsored a table at their annual fundraising dinner | 5000 | 5000 |
| 2013 | Bayer | National Stroke Foundation | Sponsored the “National Stroke Foundation Forums”. The three Forums brought together a range of experts including consumers, researchers, academics and technical advisers, to progress new solutions to meet the needs of the thousands of stroke survivors an | 79000 | 79000 |
| 2013 | Bayer | Northcott Disability Services | Sponsored a table at their annual fundraising lunch | 2500 | 2500 |
| 2013 | Bayer | Northcott Disability Services | Sponsored their “Walk with Me” event which raises awareness and funds for the charity that support children with disabilities and their families. | 2500 | 2500 |
| 2013 | Bayer | Prostate Cancer Foundation of Australia (PCFA) | Sponsored the 2013 Prostate Cancer Foundation of Australia Community Attitudes Survey. The survey examined community awareness of prostate cancer, attitudes and behaviours around testing, and attitudes towards available support services. | 20000 | 20000 |
| 2013 | Bayer | Pulmonary Hypertension Association Australia | Provided travel to support their attendance at the 2013 PH Society ANZ meeting in Melbourne | 2000 | 2000 |
| 2013 | Bayer | Pulmonary Hypertension Association Australia | Sponsored Pulmonary Hypertension Association (PHA) Australia website maintenance which is an integral communication tool for the charity | 2000 | 2000 |
| 2013 | Bayer | Rare Cancers Australia | Sponsored the launch of the Rare Cancers Report “Just a Little More time”, to provide understanding of the current state of research, diagnosis and treatment into rare and less common cancers in Australia | 5000 | 5000 |
| 2013 | Bayer | Rare Voices Australia | Sponsored the RVA Report: Experiences of Living with Rare Diseases i n Australia, to further understand patient needs in relation to diagnosis, access to care and treatment | 3000 | 3000 |
| 2014 | Bayer | Bowel Cancer Australia | Support to attend and participate in the Roundtable Forum. | 2000 | 2000 |
| 2014 | Bayer | Bowel Cancer Australia | Sponsorship of bowel cancer awareness month 2014. | 32000 | 32000 |
| 2014 | Bayer | Camp Quality | Sponsorship of a table at their fundraising event supporting children with cancer and their families. | 4000 | 4000 |
| 2014 | Bayer | Cancer Community Network Australia | Sponsorship of an educational workshop ‘Health Consumer Advocacy’ to facilitate linkages between small health consumer organisations. consumer organisations, focused on capacity building and knowledge sharing. This was a co funded event. | 15000 | 15000 |
| 2014 | Bayer | Haemophilia Foundation Australia | Corporate sponsorship to support their advocacy, education and research programs which provide support to patients with bleeding disorders and their families. | 50000 | 50000 |
| 2014 | Bayer | John Logan Foundation | Sponsorship of Community Service Announcement to assist in raising funds for the foundation. | 5000 | 5000 |
| 2014 | Bayer | Kids' Cancer Project | Corporate sponsorship to support funding research programs dedicated to finding cures for childhood cancers. | 20000 | 20000 |
| 2014 | Bayer | Macular Disease Foundation | Sponsored a range of projects to support macular disease patients. These included the the provision of patient services such as the national helpline telephonse service, print and electronic patient resources, the maintenance and improvment of the website | 488000 | 488000 |
| 2014 | Bayer | Macular Disease Foundation | Sponsored MDFA's national awarness campaign to increase awareness of macular degeneration. | 849000 | 849000 |
| 2014 | Bayer | MS Austraia | Sponsored MS Societies by funding them to provide support services for people with MS . This included programs such as the National nursing services, national peer support program, MS Ambassador program, telephone and online advisory and support services | 66000 | 66000 |
| 2014 | Bayer | MS Research Australia | Supported the Kiss Goodbye to MS campaign which aims to raise awareness of MS and raise funds for MS research. | 20000 | 20000 |
| 2014 | Bayer | MS Research Australia | Funded a program of research into MS including the Australian MS Longitudinal Study, The MSRA Brain Bank and the MSRA Clinical Trials Network. | 33000 | 33000 |
| 2014 | Bayer | National Stroke Foundation | Sponsored a table at their annual fundraising dinner. | 5000 | 5000 |
| 2014 | Bayer | Northcott Disability Services | Sponsored a table at their annual fundraising lunch that support children with disabilities and their families. | 2500 | 2500 |
| 2014 | Bayer | Northcott Disability Services | Sponsored their “Walk with Me” event which raises awareness and funds for the charity that support children with disabilities and their families. | 2500 | 2500 |
| 2014 | Bayer | Prostate Cancer Foundation of Australia (PCFA) | Sponsorship of economics model of prostate cancer project. The project aims to increase knowldege and understanding of the economic impact of prostate cancer in Australia. | 50000 | 50000 |
| 2014 | Bayer | Pulmonary Hypertension Association Australia | Sponsored Pulmonary Hypertension Association (PHA) Australia website maintenance which is an integral communication tool for the charity. | 2000 | 2000 |
| 2014 | Bayer | Pulmonary Hypertension Association Australia | Provided travel to support their attendance at the 2014 PH Society ANZ meeting. | 2000 | 2000 |
| 2014 | Bayer | Rare Cancers Australia | Sponsorship of a table at their fundraising event. | 5000 | 5000 |
| 2014 | Bayer | Rare Cancers Australia | Gold sponsorship program supporting a range of activities for patients with rare cancers. | 10000 | 10000 |
| 2015 | Bayer | Australian Thyroid Foundation | Sponsorship of a table at the Foundation's 20 years of service ball | 1250 | 1250 |
| 2015 | Bayer | Bowel Cancer Australia | Sponsorship of Bowel Cancer Australia's release of "Lifting the Lid on Advanced Bowel Cancer" report during Bowel Cancer Awareness Month | 10000 | 10000 |
| 2015 | Bayer | Diabetes Australia | Silver Sponsorship of Diabetes Australia Parliamentary Dinner | 5000 | 5000 |
| 2015 | Bayer | Diabetes Australia | 2014/2015 National Partnership to raise awareness about diabetes related eye complications | 25000 | 25000 |
| 2015 | Bayer | Kids' Cancer Project | Sponsorship of Parliamentary Friends Event during Kids Cancer Awareness Month | 6000 | 6000 |
| 2015 | Bayer | Kids' Cancer Project | Corporate sponsorship to support funding research programs dedicated to finding cures for childhood cancers. | 20000 | 20000 |
| 2015 | Bayer | Macular Disease Foundation | Sponsorship of of diabetic eye disease audio visual production for consumers | 28000 | 28000 |
| 2015 | Bayer | Macular Disease Foundation | Sponsorship of Macular Degeneration CPD program for healthcare professionals | 70000 | 70000 |
| 2015 | Bayer | Macular Disease Foundation | Sponsored a range of projects to support macular disease patients. These included the the provision of patient services such as the national helpline telephonse service, print and electronic patient resources, the maintenance and improvment of the website | 200000 | 200000 |
| 2015 | Bayer | MS Research Australia | Silver sponsorship of 'Progress in MS Research Conferenc'e held on 29 & 30 October 2015 | 5000 | 5000 |
| 2015 | Bayer | MS Research Australia | Sponsorship of 2015 "Kiss Goodbye to MS" media launch | 6675 | 6675 |
| 2015 | Bayer | MS Research Australia | Partnership with MS Research in supporting their ongoing research towards better outcomes for pati | 25000 | 25000 |
| 2015 | Bayer | National Stroke Foundation | Major sponsor of "My Stroke Journey" patient resource | 100000 | 100000 |
| 2015 | Bayer | Nexus Australiasia | Sponsorship of an educational workshop ‘Health Consumer Advocacy’ to facilitate linkages between small health consumer organisations.This was a co funded event. | 5000 | 5000 |
| 2015 | Bayer | Northcott Disability Services | Sponsored a table at their annual fundraising lunch that support children with disabilities and their families | 2500 | 2500 |
| 2015 | Bayer | Northcott Disability Services | Sponsored their “Walk with Me” event which raises awareness and funds for the charity that support children with disabilities and their families. | 2500 | 2500 |
| 2015 | Bayer | Pulmonary Hypertension Association Australia | Sponsored PHA Australia website maintenance which is an integral communication tool for the charity | 2000 | 2000 |
| 2015 | Bayer | Pulmonary Hypertension Association Australia | Provided travel to support their attendance at the 2015 Pulmonary Hypertension (PH) Society ANZ meeting and 'Get Breathless for PH event' | 3000 | 3000 |
| 2015 | Bayer | Rare Cancers Australia | Sponsorship of a table at their fundraising event 'Sick or treat' in October 2015 | 7500 | 7500 |
| 2015 | Bayer | Rare Cancers Australia | Gold sponsorship program supporting a range of activities for patients with rare cancers. | 10000 | 10000 |
| 2016 | Bayer | Cancer Council Australia | Fundraising dinner to Support Cancer Council NSW (Hills Relay for Life) | 2500 | 2500 |
| 2016 | Bayer | Diabetes Australia | Sponsorship of 'Diabetes Blindness Prevention Dinner' at Parliament House, Canberra | 25000 | 25000 |
| 2016 | Bayer | Diabetes New South Wales (NSW) | Sponsorship of annual fundraising event 'Live your life Ball' | 2500 | 2500 |
| 2016 | Bayer | Kids' Cancer Project | Support for Parliamentary event to raise awareness of childhood cancers | 7000 | 7000 |
| 2016 | Bayer | Kids' Cancer Project | Sponsorship to support a guest speaker presentation at Bayer annual conference | 10000 | 10000 |
| 2016 | Bayer | Kids' Cancer Project | Corporate sponsorship to support reasearch into childhood cancers | 20000 | 20000 |
| 2016 | Bayer | Macular Disease Foundation | 2016 Macular Degeneration Awareness Week | 105000 | 105000 |
| 2016 | Bayer | Macular Disease Foundation | Sponsorship of clients services including national telephone helpline, patient publications and website development | 115300 | 115300 |
| 2016 | Bayer | National Stroke Foundation | Sponsorship of 'My Stroke Journey' patient resouce | 55000 | 55000 |
| 2016 | Bayer | Pulmonary Hypertension Association Australia | Sponsorship of 'Patient information and education afternoon session' during Pulmonary Hypertension Association ANZ Annual Congress. | 3000 | 3000 |
| 2016 | Bayer | Rare Cancers Australia | Sponsorship of 'Sick or Treat' annual fundraising dinner | 5000 | 5000 |
| 2016 | Bayer | Rare Cancers Australia | Sponsorship of "The Patient Voice Innitiavite" which aims to increase patient engagement in Health Techology Assessment (HTA) in Australia | 7500 | 7500 |
| 2016 | Bayer | Rare Cancers Australia | Sponsorship of Rare Cancers Research Report Launch at Parliament House, Canberra | 15000 | 15000 |
| 2016 | Bayer | Trish Multiple Sclerosis Research Foundation | Sponsorship of annual fundraising dinner for MS Reseach | 4300 | 4300 |
| 2017 | Bayer | Kids' Cancer Project | Corporate sponsorship to support research into childhood cancers | 15000 | 15000 |
| 2017 | Bayer | Macular Disease Foundation | Sponsorship of 'The Journey to See' Report | 92000 | 92000 |
| 2017 | Bayer | Macular Disease Foundation | Sponsorship of 'Macular Disease Awareness Month' | 108000 | 108000 |
| 2017 | Bayer | National Stroke Foundation | Sponsorship of "My Stroke Journey" Patient Resource | 55000 | 55000 |
| 2017 | Bayer | Prostate Cancer Foundation of Australia (PCFA) | Sponsorship to attend 3 regional community events to raise awareness of prostate cancer | 6000 | 6000 |
| 2017 | Bayer | Prostate Cancer Foundation of Australia (PCFA) | Sponsorship of "Big Aussie BBQ" launch event at Parliament House | 17500 | 17500 |
| 2017 | Bayer | Prostate Cancer Foundation of Australia (PCFA) | Sponsorship to develop "Metastatic Prostate Cancer" patient video | 20000 | 20000 |
| 2017 | Bayer | Rare Cancers Australia | Purchased two tables to support the annual 'Sick or Treat' Charity Dinner | 5000 | 5000 |
| 2017 | Bayer | Rare Cancers Australia | Sponsorship to enable Rare Cancers Australia to develop a national consumer committee to guide their work | 15000 | 15000 |
| 2017 | Bayer | Vision 2020 Australia | Sponsorship of "Rising Stars in Eye Health and Vision Care" event at Parliament House | 2500 | 2500 |
| 2018 | Bayer | Diabetes Australia | Sponsorship of "Keepsight" - National Diabetes Blindness Prevention Innitiative. This Program is designed to fight against diabetes-related blindness to enable early detection & treatment to protect the sight of over 1.2 million Australians living with Diabetes. | 100000 | 100000 |
| 2018 | Bayer | Hearts4Heart | Sponsorship of "Feel the Beat" Atrial Fibrillation Awaeness Week campiagn. This program is designed to raise awareness of atrial fibrillation and to prevent AF related strokes in the community | 20000 | 20000 |
| 2018 | Bayer | Macular Disease Foundation | Sponsorship of "Macular Disease Awareness Month". This campiagn aims to raise awareness of macular diseases to enable early detection to prevent blindness. Sponsorship of Patient support programs including phone service and education materials. | 200000 | 200000 |
| 2018 | Bayer | National Stroke Foundation | Sponsorship of "MY Stroke Journey" patient resource | 55000 | 55000 |
| 2018 | Bayer | Pulmonary Hypertension Association Australia | Sponsorship of the "Pulmonary Hypertension Association Patient Day". Enabling patients to come together to share their experiences living with this rare disease. | 2000 | 2000 |
| 2018 | Bayer | Rare Cancers Australia | Sponsorship of annual fundraising dinner "Sick or Treat" | 10000 | 10000 |
| 2019 | Bayer | Diabetes Australia | Sponsorship of "Keepsight" - National Diabetes Blindness Prevention Innitiative. This Program is designed to fight against diabetes-related blindness to enable early detection & treatment to protect the sight of over 1.2 million Australians living with Diabetes. | 50000 | 50000 |
| 2019 | Bayer | Hearts4Heart | Sponsorship of "Feel the Beat" Atrial Fibrillation Awaeness Week campiagn. This program is designed to raise awareness of atrial fibrillation and to prevent AF related strokes in the community | 20000 | 20000 |
| 2019 | Bayer | Macular Disease Foundation | Sponsorship of "Macular Disease Awareness Month". This campiagn aims to raise awareness of macular diseases to enable early detection to prevent blindness. Sponsorship of Patient support programs including phone service and education materials. | 150000 | 150000 |
| 2019 | Bayer | Rare Cancers Australia | Sponsorship of "Sick or Treat" annual fundraising dinner | 7500 | 7500 |
| 2019 | Bayer | Rare Cancers Australia | Sponsorship of the "little more time 3.0" report on rare cancers | 25000 | 25000 |
| 2020 | Bayer | Hearts4Heart | Sponsorship of Atrial Awareness Week to raise awareness of Atrial Fibrillation and heart health to eliminate strokes and preventable deaths. | 20000 | 20000 |
| 2020 | Bayer | Kids' Cancer Project | Grants for eight researchers around Australia. Intended funds will be used to support basic scientific research. | 10000 | 10000 |
| 2020 | Bayer | Macular Disease Foundation | Sponsorship of the MDFA Macular Month — a community awareness program which encourages older Australians to get their vision tested regularly to help lower the incidence of preventable blindness | 150000 | 150000 |
| 2020 | Bayer | Prostate Cancer Foundation of Australia (PCFA) | The Big Aussie Barbie is a community-based event that invites all Australians to fire up the barbie to raise awareness and funds for men and families impacted by prostate cancer. Over the years it has been one of our most engaging events, bringing together workplaces, community groups, sporting teams, neighbours, families, and friends to throw on the snags for prostate cancer. | 25000 | 25000 |
| 2020 | Bayer | Rare Cancers Australia | Sponsorship of patient engagement platform development. | 25000 | 25000 |
| 2013 | bioCSL | Australian Pain Management Association | Contribution for attendance at national pain conference for educational purposes | 2000 | 2000 |
| 2013 | bioCSL | Chronic Pain Association of Australia | An unrestricted grant of fixed value to support pain education and awareness activities during National Pain Week. | 10000 | 10000 |
| 2013 | bioCSL | Lung Foundation Australia | An unrestricted grant of fixed value to raise awareness of lung disease, promote lung health and to provide advocacy, education and support services to those impacted by lung disease. | 25000 | 25000 |
| 2013 | bioCSL | MS Australia | A restricted contribution of fixed value to support education and training programs undertaken by Multiple Sclerosis Australia | 284000 | 284000 |
| 2013 | bioCSL | MS Queensland (QLD) | A restricted contribution of fixed value to support education and training programs undertaken by Multiple Sclerosis Queensland | 2165.94 | 2165.94 |
| 2013 | bioCSL | MS Research Australia | An unrestricted donation of fixed value to support research activities through Multiple Sclerosis Research Australia | 20000 | 20000 |
| 2013 | bioCSL | MS Research Australia | An unrestricted donation of fixed value to support research and fundraising activities through Multiple Sclerosis Research Australia | 60000 | 60000 |
| 2013 | bioCSL | MSWA | A restricted contribution of fixed value to support education and training programs undertaken by Multiple Sclerosis Society Western Australia | 3500 | 3500 |
| 2013 | bioCSL | Painaustralia | An unrestricted grant to support pain education, awareness and advocacy activities relating to Pain Australia's objectives. | 62500 | 62500 |
| 2014 | bioCSL | Australian Herpes Management Forum | An educational grant was provided to assist with development of clinical guidelines to up skill general practitioners, clinicians and specialists and allied health professionals | 5000 | 5000 |
| 2014 | bioCSL | Australian Pain Management Association | Grant to support the promotion of shingles resources to members. | 450 | 450 |
| 2014 | bioCSL | Chronic Pain Association of Australia | Unrestricted educational grant to support public relation activities to raise the awareness of Chronic Pain during Chronic Pain week | 9090.91 | 9090.91 |
| 2014 | bioCSL | MS Australia | A charitable donation following the presentation by an MS Ambassador to bioCSL employees. | 250 | 250 |
| 2014 | bioCSL | MS Research Australia | Educational grant to MS Australia to: A) assist with educational and training services provided to patients with MS, their carers and their families; B) support the research, campaigns and other activities of MS Research Australia. | 180000 | 180000 |
| 2014 | bioCSL | Painaustralia | An unrestricted grant to support pain educaion, awareness and advocacy activities relating to Pain Australia's objectives. | 62500 | 62500 |
| 2013 | Biogen | Haemophilia Foundation Australia | Support for patient education program | 25000 | 25000 |
| 2013 | Biogen | Multiple Sclerosis | Funding support for research, awareness campaigns, conferences and services provided by the State Societies | 360000 | 360000 |
| 2014 | Biogen | Australian Haemophilia Centre Directors Organisation | Funding support for the organisation to send two Registrars to the World Haemophilia Federation World Congress. Funding to cover registration and travel costs | 5500 | 5500 |
| 2014 | Biogen | Motor Neurone Disease Australia | Funding support for the Annual National MND Research Meeting | 6000 | 6000 |
| 2014 | Biogen | Motor Neurone Disease Australia | Donation for ALS Challenge | 6500 | 6500 |
| 2014 | Biogen | MS Australia | Funding support for state societies in relation to patient programs, advocacy, communications, branding and building collaborative relationships | 125000 | 125000 |
| 2014 | Biogen | MS Research Australia | Funding support for research and patient awareness campaigns | 110000 | 110000 |
| 2015 | Biogen | Motor Neurone Disease Australia | Funding support for the 2015 National MND Research Meeting held at the Brain & Mind Research Institute | 3800 | 3800 |
| 2015 | Biogen | MS Australia | Funding to support the presence of national advocates for Oceans of Hope and World MS Day | 12000 | 12000 |
| 2015 | Biogen | MS Research Australia | Funding to support the Australian MS Longitudinal Study and MSBase Data Linkage Program | 15000 | 15000 |
| 2015 | Biogen | MS Research Australia | Funding to support MS Research Australia with the development of two online platforms: MS Research Australia Clinical Trials Network and MS research Australia Grant Protocol. | 19000 | 19000 |
| 2015 | Biogen | MS Research Australia | Funding to support operational costs of managing the ANZGene research platform that brings together Geneticists from Australia and New Zealand to investigate the role of genes in MS. | 50000 | 50000 |
| 2015 | Biogen | MS Society South Australia (SA) & Northern Territory (NT) | Funding support for various patient education and support programs including: Wellness Retreat, Member MS Awareness Forums, Fatigue Self-Management Course, Patient Resource Folders and Mindfulness Program. | 18000 | 18000 |
| 2015 | Biogen | MSWA | Funding support for various patient education and support programs including: Wellness Retreat, MS research Update Forum, Member MS Awareness Forums and Fatigue Self- Management Course. | 17000 | 17000 |
| 2015 | Biogen | Multiple Sclerosis | Funding support for the launch of the "Seeing MS" campaign. | 10000 | 10000 |
| 2015 | Biogen | Multiple Sclerosis | Funding support for MS education series of webinars and teleconferences that serve to educate patients on the disease as well as educate on other MS programs, services and support. | 30000 | 30000 |
| 2017 | Biogen | Motor Neurone Disease Australia | Funding support for The National Motor Neurone Disease research Meeting 2017 | 12000 | 12000 |
| 2017 | Biogen | MS Society South Australia (SA) & Northern Territory (NT) | Funding support for the "World MS day Activities" | 1480 | 1480 |
| 2017 | Biogen | MSWA | Funding support for the "World MS day Campaign" | 1000 | 1000 |
| 2017 | Biogen | Muscular Dystrophy Foundation Australia | Funding support for 2017 Muscular Dystrophy NSW Medical and Research Seminar | 3000 | 3000 |
| 2017 | Biogen | Spinal Muscular Atrophy Association of Australia | Funding support for the Government Awareness Event at Parliament House Canberra 2017 | 6522 | 6522 |
| 2017 | Biogen | Spinal Muscular Atrophy Association of Australia | Funding support for Wellbeing Program for Families with Spinal Muscular Atrophy | 30000 | 30000 |
| 2018 | Biogen | Motor Neurone Disease Australia | Funding Support for MND Australia Research Conference 2018 | 15000 | 15000 |
| 2018 | Biogen | MSWA | Funding support for the "World MS Day Activities" 30 May 2018 | 1500 | 1500 |
| 2018 | Biogen | Multiple Sclerosis | Funding for general activities, for The Wellness Lunches - Albury Oct 2018 & Launceston Nov 2018 | 10526 | 10526 |
| 2018 | Biogen | Rare Voices Australia | Funding support for the Rare Voices Australia Round Table of Companies 19 Feb 2018, 4 May 2018, 17 July 2018, 14 Sep 2018 | 13636 | 13636 |
| 2018 | Biogen | Rare Voices Australia | Funding support for the Rare Voices Australia National Rare Disease Summit 16 -17 November 2018 | 18182 | 18182 |
| 2018 | Biogen | Spinal Muscular Atrophy Association of Australia | Funding Support of two SMAA Representatives to attend CURE SMA 2018 in Dallas, USA | 8689 | 8689 |
| 2019 | Biogen | Centre for Community - Driven Research | Nervous System Disease Network Meeting - Australian Patient Organisation Network Conference 2018 2-3 May, 2019, SMC Conference Centre, Sydney 11619-SP-EC | 10000 | 10000 |
| 2019 | Biogen | MS Society South Australia (SA) & Northern Territory (NT) | Funding support for the "World MS day Activities" 30 May 2018 9078-SP-EC | 1000 | 1000 |
| 2019 | Biogen | Multiple Sclerosis | GRANT Funding for general activities, for The Wellness Lunches - Delivery of "Exploring Wellness Workshops" in Ballarat and Sunbury during 2020 12423-G-EP | 9999 | 9999 |
| 2019 | Biogen | Muscular Dystrophy New South Wales (NSW) | GRANT MND Australia Research Conference 2018 12180-G-PE | 3810 | 3810 |
| 2019 | Biogen | Rare Voices Australia | Funding support for the Rare Voices Australia Parliamentary Events Meeting 1 - 20 Feb 2019 Meeting 2- 17 Oct 2019 11493-SP-EC | 15000 | 15000 |
| 2019 | Biogen | Rare Voices Australia | Funding support for the Rare Voices Australia Round Table of Companies 20 Feb, 7 May, 15 Aug & 12 Nov 2019 11494-SP-EC | 15000 | 15000 |
| 2019 | Biogen | Trish Multiple Sclerosis Research Foundation | Trish Foundation "winter Wonderland" Fundraising Ball, 31 August 2019 13669-SP-GEN | 2250 | 2250 |
| 2020 | Biogen | Muscular Dystrophy Western Australia (WA) | Funding support for Muscular Dystrophy 2019 Meeting, 8-9 November, 2019 13787-SP-GEN | $2,000 | 2000 |
| 2020 | Biogen | Patient Voice Initiative | Funding support for HTA Workshop Activity, 2 Workshops Q1 & Q2 2020 13759-SP-GEN | $7,500 | 7500 |
| 2020 | Biogen | Rare Voices Australia | Funding support for Rare Voices Australia (RVA) Parliamentary Event, Supporting the launch of the National Strategic Action Plan For Rare Diseases, 26 Feb 2020 11493-SP-GEN | $8,000 | 8000 |
| 2020 | Biogen | Rare Voices Australia | Funding support for Rare Voices Round Table of Companies, 13-FEB, 5-MAY, 20-AUG, 10-NOV-2020 14932-SP-EC | $15,000 | 15000 |
| 2013 | Boehringer Ingelheim | Cancer Council of Australia | Boehringer Ingelheim proudly supported staff to host Australia's Biggest Morning Tea's across Australia - the national fundraising initiative of the Cancer Council of Australia. | 20000 | 20000 |
| 2013 | Boehringer Ingelheim | Hope For Cambodian Children Foundation | HOPE for Cambodian Children is a not-for- profit organisation that has built a centre in Battambang Cambodia to care for up to 120 children who have been abandoned by their families or community because they have or are suspected to have HIV. Boehringer I | Boehringer Ingelheim provided practical support in producing printed material for distribution for fund raising drives such as a newsletter production. | 0 |
| 2013 | Boehringer Ingelheim | Kidney Health Australia | Kidney Health Australia is a national health care charity with a vision ‘to save and improve the lives of Australians affected by kidney disease’. As the national peak body, Kidney Health Australia promotes good kidney health through delivery of programs | Boehringer Ingelheim committed to an unrestricted educational grant in 2012 to support the “Two of a KinD” Report. The Report was published in 2013 and the company contributed $40,000. | 40000 |
| 2013 | Boehringer Ingelheim | Living Positive Hiv | Living Positive Victoria is a not for profit community based organisation representing all people with HIV living in Victoria. | 6000 | 6000 |
| 2013 | Boehringer Ingelheim | Lung Foundation Australia | The company provided sponsorship for Deloitte Access Economics to provide support to the stakeholder meeting and assist the Lung Foundation Australia in developing an economic impact statement to quantify the benefits of lung cancer nurses in the Australi | 11835 | 11835 |
| 2013 | Boehringer Ingelheim | Lung Foundation Australia | Boehringer Ingelheim is a proud sponsor of the Idiopathic Pulmonary Fibrosis Registry. The company contributed funds of $15,000 via an unrestricted donation to allow the Lung Foundation to carry out their Idiopathic Pulmonary Fibrosis patient registry and | 15000 | 15000 |
| 2013 | Boehringer Ingelheim | Lung Foundation Australia | The Lung Foundation and the Australian and New Zealand Lung Cancer Nurses Forum identified the need to conduct a scoping exercise to start discussions in developing an Economic Impact Statement to quantify the benefits of a Lung Cancer Nurse Specialist p | 22303 | 22303 |
| 2013 | Boehringer Ingelheim | Lung Foundation Australia | Sponsorship of the Lung Cancer National Program. This multidisciplinary group of lung cancer specialists, nurses, health professionals and consumers each year develops a strategic plan to advance research, professional development, public awareness and ed | 55500 | 55500 |
| 2013 | Boehringer Ingelheim | Lung Foundation Australia | Boehringer Ingelheim is a Foundation Sponsor and contributed an unrestricted donation to allow the Lung Foundation to carry out their COPD program which includes patient advocacy, disease awareness and HCP guidance and educational materials. | 140000 | 140000 |
| 2013 | Boehringer Ingelheim | Lung Foundation Australia | Boehringer Ingelheim provided an unrestricted sponsorship of a 2 year COPD Research Fellowship Award, awarded annually to a researcher in COPD who fulfils criteria set out and judged by the Lung Foundation Australia. | $160,000 p.a. (which is made up of 2 x $80,000 awards, one for the 2nd year of the fellowship (awarded in 2012) and one for the 1st year of newly awarded fellowship). | 160000 |
| 2013 | Boehringer Ingelheim | National Association of People with HIV Australia | Boehringer Ingelheim is proud to be a foundation member of the CHPNG which was formed in 2003 to help our Papua New Guinea (PNG) neighbours in the fight against HIV. Funds are provided to NAPWA for programs to assist in the management of HIV in PNG. The c | 15000 | 15000 |
| 2013 | Boehringer Ingelheim | National Association of People with HIV Australia | Boehringer Ingelheim is proud to be a supporter of the National Association of People Living with HIV/AIDS (NAPWA) which is the national peak organisation representing people living with HIV/AIDS in Australia through leadership in advocacy, policy, educat | 20000 | 20000 |
| 2013 | Boehringer Ingelheim | National Heart Foundation Of Australia | Boehringer Ingelheim is proud to be a member of the National Heart Foundation. The Heart Foundation Pharmaceutical Roundtable brings together members of leading pharmaceutical companies and the Heart Foundation with the aim of improving cardiovascular hea | The company contributed 20,000.00 for annual membership. | 20000 |
| 2013 | Boehringer Ingelheim | Parkinson's Australia | The Parkinson's Unity Walk is a national fundraising initiative which aims to raise vital funds for Parkinson's Australia as well as increase awareness about Parkinson's disease in our community. Boehringer Ingelheim is proud to be a sponsor of this event | Boehringer Ingelheim is proud to be a sponsor of this event for the sixth year. In 2013, the company contributed funds of $10,000 to support the ongoing maintenance and publishing of the event and fundraising website in Australia. | 10000 |
| 2014 | Boehringer Ingelheim | Arrhthymia Alliance-Australia | Boehringer Ingelheim was proud to contribute $25, 0000 to support Arrhthymia Allaince achieve their goals for improving awareness of the organisation, awareness of arrhythmia and providing education on the condition, treatments and outcomes. | 25000 | 25000 |
| 2014 | Boehringer Ingelheim | Baker Heart and Diabetes Institute | Boehringer Ingelheim were proud to be a supporter of the event ‘On Your Feet Australia’. The event raised funds for ongoing research as well as raised awareness with individuals and workplaces about how much we sit each day and that this behaviour is a ri | The company contributed $15,000. | 15000 |
| 2014 | Boehringer Ingelheim | Bobby Goldsmith Foundation | Boehringer Ingelheim was proud to contribute funds of $10, 000 to the Bobby Goldsmith Foundation to support their outreach programme which aimed to increase levels of engagement with people living with HIV, through the extension of the “Take Control of Yo | The company contributed $10,000. | 10000 |
| 2014 | Boehringer Ingelheim | Cancer Council of Australia | Australia’s Biggest Morning Tea is the national fundraising initiative of the Cancer Council of Australia. Each year our company supports our staff to hold fundraising events across Australia to help raise money. In 2014, the company proudly donated $21 | 21503 | 21503 |
| 2014 | Boehringer Ingelheim | Living Positive Hiv | Boehringer Ingelheim provides ongoing support for the development, production and distribution of their quarterly newsletter. In 2014, the company contributed $6,000. | 6000 | 6000 |
| 2014 | Boehringer Ingelheim | National Association of People with HIV Australia | The company also supports the education of Treatment Officers by sponsoring regular national meetings to allow training and discussion of the latest care and treatment issues. This knowledge is used to support HIV positive people in their own states and r | 10000 | 10000 |
| 2014 | Boehringer Ingelheim | National Association of People with HIV Australia | In 2014, the company contributed $20,000 to the following initiatives: Project Chin Wag takes the form of a 'chat show' style forum which allows HIV positive people and their friends to access information from a panel of HIV healthcare workers and provide | 10000 | 10000 |
| 2015 | Boehringer Ingelheim | Aids Council of New South Wales (NSW) | In 2015, Boehringer Ingelheim proudly supported the Aids Council of NSW (ACON) – Northern Rivers Branch information day for HIV infected patients to learn about the management of their disease and discuss with their peers. ACON is a health promotion organ | 1500 | 1500 |
| 2015 | Boehringer Ingelheim | Cancer Council of Australia | Australia’s Biggest Morning Tea is the national fundraising initiative of the Cancer Council of Australia. Each year our company is proud to support our staff to hold fundraising events across Australia to help raise money. In 2015, the company proudly | $21,270.49. | 21270.49 |
| 2015 | Boehringer Ingelheim | Hearts4Heart | In 2015, Boehringer Ingelheim proudly provided $10,000 to support the goals of Hearts4Hearts, a non-profit organisation who support, educate and advocate for Australians living with heart disease. | 10000 | 10000 |
| 2015 | Boehringer Ingelheim | Hope For Cambodian Children Foundation | HOPE for Cambodian Children is a not-for-profit organisation that has built a centre in Battambang Cambodia to care for up to 120 children who have been abandoned by their families or community because they have or are suspected to have HIV. Boehringer In | Boehringer Ingelheim staff produce printed newsletter material for distribution. | 0 |
| 2015 | Boehringer Ingelheim | Lung Foundation Australia | Over 2015 the company supported a range of initiatives including: Sponsorship of the Lung Cancer National Program. This multidisciplinary group of lung cancer specialists, nurses, health professionals and consumers each year develops a strategic plan to | 490500 | 490500 |
| 2015 | Boehringer Ingelheim | National Heart Foundation Of Australia | Boehringer Ingelheim is proud to be a member of the National Heart Foundation. The Heart Foundation Pharmaceutical Roundtable brings together members of leading pharmaceutical companies and the Heart foundation with the aim of improving cardiovascular hea | 10000 | 10000 |
| 2015 | Boehringer Ingelheim | Paceline | In 2015, Boehringer Ingelheim proudly supported Paceline a not-for-profit association in its annual bicycle ride to raise both awareness of heart arrhythmias and funds for medical research. The company provided $10,000 plus GST to Ethical Strategies to pr | 10000 | 10000 |
| 2016 | Boehringer Ingelheim | Australian Pituitary Foundation | Boehringer Ingelheim is proud to provide sponsorship towards the development of the new Australian Pituitary Foundation website. | 4545 | 4545 |
| 2016 | Boehringer Ingelheim | Cancer Council Australia | Through the Boehringer Ingelheim Australia 'Charity Partnership' program staff are encouraged to fundraise and volunteer for community organisations they are passionate about. The company commits to matching amounts raised through staff fundraising effort | 6087 | 6087 |
| 2016 | Boehringer Ingelheim | Children's Cancer Council | Through the Boehringer Ingelheim Australia 'Charity Partnership' program staff are encouraged to fundraise and volunteer for community organisations they are passionate about. The company commits to matching amounts raised through staff fundraising effort | 918 | 918 |
| 2016 | Boehringer Ingelheim | Kidney Health Australia | Boehringer Ingelheim is proud to provide sponsorship to support the delivery of independent, high quality ongoing face-face and digital medical education programs on chronic kidney disease and diabetes that will be rolled-out in 2017. | 40000 | 40000 |
| 2016 | Boehringer Ingelheim | Lung Foundation Australia | Boehringer Ingelheim is proud to provide sponsorship for the Bridging Regional Gaps – Lung Cancer Workshop held in Tasmania. This one day Lung Cancer Workshop was for all lung cancer health professionals to further understand the disease and reduce the im | 2500 | 2500 |
| 2016 | Boehringer Ingelheim | Lung Foundation Australia | Boehringer Ingelheim was proud to be a major sponsor of the Lung Foundation Gala Dinner. This fundraising event raised funds to provide essential services and resources for patients, families, health professionals and everyone affected by lung disease. Th | 20000 | 20000 |
| 2016 | Boehringer Ingelheim | Lung Foundation Australia | Boehringer Ingelheim provided funds for the development of a video about the COPD Research Fellowship Award and the past participants to help attract future applicants. | 31000 | 31000 |
| 2016 | Boehringer Ingelheim | Lung Foundation Australia | Boehringer Ingelheim is a proud sponsor of the Idiopathic Pulmonary Fibrosis Registry. The company contributed funds of $75,000 via an unrestricted donation to allow the Lung Foundation to carry out their Idiopathic Pulmonary Fibrosis patient registry and | 75000 | 75000 |
| 2016 | Boehringer Ingelheim | Lung Foundation Australia | Boehringer Ingelheim is a Foundation Sponsor and contributed an unrestricted donation of $140,000 to allow the Lung Foundation to carry out their COPD program which includes patient advocacy, disease awareness and HCP guidance and educational materials. | 140000 | 140000 |
| 2016 | Boehringer Ingelheim | Lung Foundation Australia | Boehringer Ingelheim proudly provides an unrestricted sponsorship for a 2 year COPD Research Fellowship Award, awarded annually to a researcher in COPD who fulfills criteria set out and judged by the Lung Foundation Australia.in 2016, the company provided | 160000 | 160000 |
| 2016 | Boehringer Ingelheim | National Asthma Council Australia | Sponsorship for the review of the educational asthma content for the Australian healthcare professionals’ area of the website www.lunglearning.com.au | 2900 | 2900 |
| 2016 | Boehringer Ingelheim | National Asthma Council Australia | Sponsorship for the production of an instructional video on how to correctly use the Respimat inhaler, published on the National Asthma Council website in the existing ‘How-to’ video library. | 6800 | 6800 |
| 2016 | Boehringer Ingelheim | National Asthma Council Australia | Sponsorship of the revision and updating of the 2016 Asthma & COPD Medications Chart for Australian healthcare professionals | 17000 | 17000 |
| 2016 | Boehringer Ingelheim | National Stroke Foundation | Through the Boehringer Ingelheim Australia 'Charity Partnership' program staff are encouraged to fundraise and volunteer for community organisations they are passionate about. The company commits to matching amounts raised through staff fundraising effort | 1182 | 1182 |
| 2016 | Boehringer Ingelheim | National Stroke Foundation | Boehringer Ingelheim proudly provided part sponsorship towards the update The Deloitte Access Economics Report - Impact of Stroke Across Australia | 42000 | 42000 |
| 2017 | Boehringer Ingelheim | Asthma Australia | Boehringer Ingelheim is proud to be a sponsor of the Australiasian Asthma Conference.This conference supports the delivery of independent, high quality medical education on asthma disease. | The company contributed $7,900. | 7900 |
| 2017 | Boehringer Ingelheim | Cancer Council Australia | Through the Boehringer Ingelheim Australia 'Charity Partnership' program staff are encouraged to fundraise and volunteer for community organisations they are passionate about. The company commits to matching amounts raised through staff fundraising efforts. Boehringer Ingelheim was proud to support Cancer Council through this program. | The company donated $6071. | 6071 |
| 2017 | Boehringer Ingelheim | Kidney Health Australia | Boehringer Ingelheim is proud to provide sponsorship to support the delivery of independent, high quality ongoing face-face and digital medical education programs on chronic kidney disease and diabetes. | The company contributed $40,000. | 40000 |
| 2017 | Boehringer Ingelheim | MS Australia | Through the Boehringer Ingelheim Australia 'Charity Partnership' program staff are encouraged to fundraise and volunteer for community organisations they are passionate about. The company commits to matching amounts raised through staff fundraising efforts. Boehringer Ingelheim was proud to support MS Australia through this program. | The company donated $2000. | 2000 |
| 2017 | Boehringer Ingelheim | National Asthma Council Australia | Boehringer Ingelheim is a proud sponsor of two conferences for the General Practice Conference and Exhibition series. These conference support the delivery of independent, high quality medical education on asthma disease. | The company contributed $ 20, 500. | 20500 |
| 2017 | Boehringer Ingelheim | National Asthma Council Australia | Sponsorship for the production of the Australian Asthma Handbook. The Handbook is Australia's national guidelines for asthma management. It provides independent evidence- based, practical guidance for health professionals diagnosing and managing asthma in adults and children in primary care. | The company contributed $30, 000. | 30000 |
| 2018 | Boehringer Ingelheim | Breast Cancer Network Australia | Through the Boehringer Ingelheim Australia 'Charity Partnership' program staff are encouraged to fundraise and volunteer for community organisations they are passionate about. The company commits to matching amounts raised through staff fundraising efforts. Boehringer Ingelheim was proud to support Breast Cancer network of Australia through this program. | The company donated $1,015. | 1015 |
| 2018 | Boehringer Ingelheim | Cancer Council Australia | Through the Boehringer Ingelheim Australia 'Charity Partnership' program staff are encouraged to fundraise and volunteer for community organisations they are passionate about. The company commits to matching amounts raised through staff fundraising efforts. Boehringer Ingelheim was proud to support Cancer Council through this program. | The company donated $5,100. | 5100 |
| 2018 | Boehringer Ingelheim | Diabetes Australia | Boehringer Ingelheim is proud to be a partner of Diabetes Australia. In 2018 the company sponsored an independent, evidence-based education program for patients and Healthcare Professionals to increase awareness and understanding about the link between Type 2 Diabetes and cardiovascular disease. | The company contributed $150,000. | 150000 |
| 2018 | Boehringer Ingelheim | Hearts4Heart | Boehringer Ingelheim provided an unrestricted grant to Hearts4Hearts. Hearts4Hearts used this grant to facilitate a patient focus group to inform the development of an independent, evidence-based patient resource for people living with an irregular heartbeat. | The company contributed $10,000. | 10000 |
| 2018 | Boehringer Ingelheim | Kidney Health Australia | Boehringer Ingelheim is proud to be a partner of Kidney Health Australia. The sponsorship in 2018 supported the delivery of independent, evidence-based face-face and digital medical education programs on chronic kidney disease and diabetes. | The company contributed $40,000. | 40000 |
| 2018 | Boehringer Ingelheim | Lung Foundation Australia | Boehringer Ingelheim provided the Lung Foundation Australia “Peer Connect” patient support program with non financial support to distribute printed brochures to promote the program. The Peer Connect service aims to facilitate peer support for people with Pulmonary Fibrosis wherever they are located in Australia. | In kind | 0 |
| 2018 | Boehringer Ingelheim | Lung Foundation Australia | Boehringer Ingelheim was proud to be a major sponsor of the annual Lung Foundation Gala Dinner. This fundraising event raised funds to provide essential services and resources for patients, families, health professionals and everyone affected by lung disease. The Company provided $20, 000 for the sponsorship. | The company contributed $20,000. | 20000 |
| 2018 | Boehringer Ingelheim | Lung Foundation Australia | As a Foundation Sponsor, the company contributed an unrestricted donation of $140,000. This sponsorship was used by the Lung Foundation Australia to deliver their independent COPD National program, which includes patient advocacy, disease awareness and HCP guidance and educational materials. | The company contributed $140,000. | 140000 |
| 2018 | Boehringer Ingelheim | Mito Foundation | Through the Boehringer Ingelheim Australia 'Charity Partnership' program staff are encouraged to fundraise and volunteer for community organisations they are passionate about. The company commits to matching amounts raised through staff fundraising efforts. Boehringer Ingelheim was proud to support Mito Foundation through this program. | The company donated $1,163. | 1163 |
| 2018 | Boehringer Ingelheim | MS Australia | Through the Boehringer Ingelheim Australia 'Charity Partnership' program staff are encouraged to fundraise and volunteer for community organisations they are passionate about. The company commits to matching amounts raised through staff fundraising efforts. Boehringer Ingelheim was proud to support MS Australia through this program. | The company donated $2,000. | 2000 |
| 2018 | Boehringer Ingelheim | National Asthma Council Australia | Sponsorship for the production of the National Asthma Council Asthma & COPD Medications Chart 2018. This chart is an education resource for a range of health care professionals including Respiratory physicians, Allergists, General Practitioners and Pharmacists to help with identification and explanation of different treatments. | The company contributed $ 20,000. | 20000 |
| 2018 | Boehringer Ingelheim | National Asthma Council Australia | Sponsorship for the production of the National Asthma Council Australian Asthma Handbook. The Handbook is Australia's national guidelines for asthma management. It provides independent evidence-based, practical guidance for health professionals diagnosing and managing asthma in adults and children in primary care. | The company contributed $30,000. | 30000 |
| 2018 | Boehringer Ingelheim | National Stroke Foundation | Boehringer Ingelheim is a proud partner of the Stroke Foundation. In 2018, the company funded a workshop, which included multiple stakeholders across the health industry that aimed to develop new creative content for the F.A.S.T Campaign, which helps to teach Australians the most common signs of stroke. | The company contributed $1,855. | 1855 |
| 2018 | Boehringer Ingelheim | Ovarian Cancer Australia | Through the Boehringer Ingelheim Australia 'Charity Partnership' program staff are encouraged to fundraise and volunteer for community organisations they are passionate about. The company commits to matching amounts raised through staff fundraising efforts. Boehringer Ingelheim was proud to support Ovarian Cancer Australia through this program. | The company donated $1,569. | 1569 |
| 2019 | Boehringer Ingelheim | Cancer Council Australia | Through the Boehringer Ingelheim Australia 'Charity Partnership' program staff are encouraged to fundraise and volunteer for community organisations they are passionate about. The company commits to matching amounts raised through staff fundraising efforts. Boehringer Ingelheim was proud to support Cancer Council through this program. | The company donated $6 948.00. | 6948 |
| 2019 | Boehringer Ingelheim | Hearts4Heart | Boehringer Ingelheim is proud to be a partner of hearts4heart Australia. In 2019 the company provided a donation to hearts4heart to support their initiatives in atrial fibrillation patient advocacy and education | The company donated $5 000. | 5000 |
| 2019 | Boehringer Ingelheim | Hearts4Heart | Boehringer Ingelheim is proud to be a partner of hearts4heart Australia. In 2019 the company provided an independent sponsorship for the development of a patient information booklet for atrial fibrillation (AF Explained) and also a AF patient checklist for questions to ask their HCP. | The company contributed $50 000. | 50000 |
| 2019 | Boehringer Ingelheim | Lung Foundation Australia | Boehringer Ingelheim provided support of $20, 000 to help the Lung Foundation Australia deliver their independent COPD National Program activiites which includes patient advocacy, disease awareness and Health Care Professional guidance and educational materials. | The company contributed $20 000. | 20000 |
| 2019 | Boehringer Ingelheim | Lung Foundation Australia | Boehringer Ingelheim was proud to be a major sponsor of the annual Lung Foundation Gala Dinner. This fundraising event raised funds to provide essential services and resources for patients, families, health professionals and everyone affected by lung disease. The Company provided $20, 000 for the sponsorship. | The company contributed $20 000. | 20000 |
| 2019 | Boehringer Ingelheim | Lung Foundation Australia | As a Foundation Sponsor, the company contributed $81,000 to the Lung Foundation Australia to independently develop and deliver lung health training and education framework. | The company contributed $81 000. | 81000 |
| 2019 | Boehringer Ingelheim | Lung Foundation Australia | Boehringer Ingelheim provided the Lung Foundation Australia a supply of 2000 placebo devices for educational workshops. | In kind | 0 |
| 2019 | Boehringer Ingelheim | MS Australia | Through the Boehringer Ingelheim Australia 'Charity Partnership' program staff are encouraged to fundraise and volunteer for community organisations they are passionate about. The company commits to matching amounts raised through staff fundraising efforts. Boehringer Ingelheim was proud to support MS Australia through this program. | The company donated $1 750. | 1750 |
| 2019 | Boehringer Ingelheim | National Asthma Council Australia | Boehringer Ingelheim supported the purchase and distribution of 5 000 Fact Sheets about Inhaler Techniques to Health Care Professionals for patients. | The company contributed $4 225. | 4225 |
| 2019 | Boehringer Ingelheim | National Stroke Foundation | The development and provision of 'My Stroke Journey' booklet to stroke survivors in the acute setting, ensuring they understand their stroke, are provided a discharge plan and receive information on the support and services available to them. | The company contributed $30 000. | 30000 |
| 2019 | Boehringer Ingelheim | National Stroke Foundation | Boehringer Ingelheim provided support to assist with the cost of producing both the "Cost of Stroke Report" and "No Postcode Untouched Report". These reports will be the cornerstone of stroke advocacy efforts moving towards federal and state budgets, upcoming federal and state elections. They will also be utilised in ongoing Stroke Foundation advocacy, media and campaign activities. | The company contributed $35 000. | 35000 |
| 2020 | Boehringer Ingelheim | Cancer Council Australia | Through the Boehringer Ingelheim Australia 'Charity Partnership' program employees can participate in fundraising activities. Employees around Australia participated in a virtual Morning Tea event and Boehringer Ingelheim was proud to support Cancer Council through this initiative. | The company donated $2500. | 2500 |
| 2020 | Boehringer Ingelheim | Diabetes Australia | Boehringer Ingelheim is proud to be a partner of Diabetes Australia. In 2020 the company sponsored an independent, evidence-based education program for patients and their carers to increase awareness and understanding about the link between Type 2 Diabetes and cardiovascular disease. | The company contributed $160000 | 160000 |
| 2020 | Boehringer Ingelheim | MS Australia | Through the Boehringer Ingelheim Australia 'Charity Partnership' program staff are encouraged to fundraise and volunteer for community organisations they are passionate about. The company commits to matching amounts raised through staff fundraising efforts. Boehringer Ingelheim was proud to support MS Australia through this program. | The company donated $2500. | 2500 |
| 2020 | Boehringer Ingelheim | National Asthma Council Australia | Boehringer Ingelheim supported the reprint, purchase and distribution of 5000 Fact Sheets about Inhaler Techniques to Health Care Professionals for patients. | The company contributed $4225. | 4225 |
| 2020 | Boehringer Ingelheim | National Stroke Foundation | Boehringer Ingelheim provided support to assist with the cost of producing both the “Cost of Stroke Report” and “No Postcode Untouched Report”. These reports will be the cornerstone of stroke advocacy efforts moving towards federal and state budgets, upcoming federal and state elections. They will also be utilised in ongoing Stroke Foundation advocacy, media and campaign activities. | The company contributed $37500. | 37500 |
| 2020 | Boehringer Ingelheim | White Coats Foundation | Boehringer Ingelheim was proud to sponsor a video series to enhance community awareness of clinical trials and patient participation. | The company contributed $5000.00 | 5000 |
| 2013 | Bristol-Myers Squibb | Hepatitis Australia | Hepatitis Australia is the national community organisation for viral hepatitis. In 2013, Bristol-Myers Squibb educational grants supported the 2013 "Love your Liver" campaign and development of the hepatitis B positive speaker program and resources. (The | 110000 | 110000 |
| 2013 | Bristol-Myers Squibb | Hepatitis Queensland (QLD) | Hepatitis Queensland is a community based, consumer focused organisation which represents the interests of people affected by, or at risk of viral hepatitis. In 2013, Bristol-Myers Squibb provided funding to support a media program in community language n | 3000 | 3000 |
| 2013 | Bristol-Myers Squibb | Living Positive Hiv | Living Positive Victoria is the peak body for people living with HIV, providing education, information and representation for all people living with HIV in the State of Victoria. In 2013, Bristol-Myers Squibb provided educational grants to support the Pos | $11,000 Licensing agreement to use photography, patient stories and videos in disease awareness activities | 11000 |
| 2013 | Bristol-Myers Squibb | Melanoma Institute Australia | MIA is a not for profit organisation dedicated to preventing and curing melanoma through research, treatment and education programs. In 2013, Bristol-Myers Squibb provided funding to support an event at Parliament House in Canberra to raise awareness abou | 5000 | 5000 |
| 2013 | Bristol-Myers Squibb | Melanoma Patients Australia | MPA is a patient driven organisation dedicated to meeting the needs of melanoma patients and their communities through a national network of support, information, advocacy and awareness programs. In 2013, Bristol-Myers Squibb provided an educational gra | 36577 | 36577 |
| 2013 | Bristol-Myers Squibb | National Association of People with HIV Australia | The National Association of People with HIV Australia is the peak organisation representing people living with HIV in Australia. Bristol-Myers Squibb is a member of the Collaboration in Health in Papua New Guinea (CHPNG), a philanthropic initiative invo | 15000 | 15000 |
| 2013 | Bristol-Myers Squibb | National Stroke Foundation | The National Stroke Foundation works with stroke survivors, carers, health professionals, government and the public to reduce the impact of stroke on the Australian community. Its mission is to stop stroke, save lives and end suffering. In 2013, Bristol-M | 50000 | 50000 |
| 2014 | Bristol-Myers Squibb | Brain Tumour Alliance Australia | Brain Tumour Alliance Australia (BTAA) is a national brain tumour patient and caregiver organisation. In 2014, Bristol-Myers Squibb provided sponsorship (accommodation and travel) for a representative to attend the World Cancer Congress in Melbourne. | 694 | 694 |
| 2014 | Bristol-Myers Squibb | Hepatitis Australia | Hepatitis Australia is the national community organisation for viral hepatitis. In 2014, Bristol-Myers Squibb provided funding to support the 2014 "Love your Liver" campaign and travel to attend international and local meetings. | 34511 | 34511 |
| 2014 | Bristol-Myers Squibb | Kidney Health Australia | Kidney Health Australia is a not for profit organization whose focus is to improve kidney health outcomes for people with kidney and urinary tract diseases, their families and carers, and initiatives that reduce the incidence of kidney disease in the Aust | 1527 | 1527 |
| 2014 | Bristol-Myers Squibb | Leukaemia Foundation Of Australia | The Leukaemia Foundation funds research and provides free services to support people with leukaemia, lymphoma, myeloma and related blood disorders and their families. In 2014, Bristol-Myers Squibb provided an educational grant to develop a DVD and booklet | 30000 | 30000 |
| 2014 | Bristol-Myers Squibb | Living Positive Hiv | Living Positive Victoria is the peak body for people living with HIV, providing education, information and representation for all people living with HIV in the State of Victoria. In 2014, Bristol-Myers Squibb provided educational grants to support the Pos | 11000 | 11000 |
| 2014 | Bristol-Myers Squibb | Lymphoma Australia | Lymphoma Australia aims to support Australians touched by lymphoma, raise awareness and help fund research that may lead to a cure. In 2014, Bristol- Myers Squibb provided sponsorship (registration, travel and accommodation) for a representative to attend | 2483.68 | 2483.68 |
| 2014 | Bristol-Myers Squibb | Melanoma Institute Australia | Melanoma Institute Australia is a not for profit organisation dedicated to preventing and curing melanoma through research, treatment and education programs. In 2014, Bristol-Myers Squibb provided funding to record a Melanoma Information Day for patients. | 7500 | 7500 |
| 2014 | Bristol-Myers Squibb | Melanoma Patients Australia | Melanoma Patients Australia (MPA) is a patient driven organisation dedicated to meeting the needs of melanoma patients and their communities through a national network of support, information, advocacy and awareness programs. In 2014, Bristol-Myers Squibb | 38686 | 38686 |
| 2014 | Bristol-Myers Squibb | Melanoma Western Australia (WA) | MelanomaWA aims to minimise the impact of melanoma in Western Australia by providing support for patients and families living with melanoma and raising skin cancer awareness in the WA community. In 2014, Bristol-Myers Squibb provided funding to support a | 9550 | 9550 |
| 2014 | Bristol-Myers Squibb | National Association of People with HIV Australia | The National Association of People with HIV Australia is the peak organisation representing people living with HIV in Australia. In 2014, Bristol- Myers Squibb provided a grant to support activities at the 2014 International AIDS conference (Melbourne) in | 10000 | 10000 |
| 2014 | Bristol-Myers Squibb | Rare Cancers Australia | Rare Cancers Australia is a charity whose purpose is to improve awareness, support and treatment of Australians with rare and less common cancers. In 2014, Bristol-Myers Squibb provided a grant to support the launch of a research report (paid in late 2013 | 12381 | 12381 |
| 2015 | Bristol-Myers Squibb | Asbestosis & Mesothelioma Association Australia | The Asbestosis and Mesothelioma Association of Australia offers assistance, information and guidance to people affected by and/or concerned about asbestos. In 2015, Bristol-Myers Squibb subsidised travel for a representative to attend a cancer forum in Sy | 489 | 489 |
| 2015 | Bristol-Myers Squibb | Australian Injecting and Illicit Drug Users League (AIVL) | The Australian Injecting and Illicit Drug Users League (AIVL) is the peak body for peer-based drug user organisations in Australia. A large proportion of its work focuses on preventing blood borne viruses, such as hepatitis C and HIV, for people who injec | 14250 | 14250 |
| 2015 | Bristol-Myers Squibb | Brain Tumour Alliance Australia | Brain Tumour Alliance Australia is a national brain tumour patient and caregiver organisation. In 2015, Bristol-Myers Squibb subsidised travel for a representative to attend a cancer forum in Sydney. | 553 | 553 |
| 2015 | Bristol-Myers Squibb | CanSpeak | CanSpeak is a prominent consumer advocacy body representing the interests of all Queenslanders whose lives have been affected by cancer. In 2015, Bristol-Myers Squibb subsidised travel for a representative to attend a cancer forum in Sydney. | 23 | 23 |
| 2015 | Bristol-Myers Squibb | Hearts4Heart | Hearts4Heart aims to raise awareness of heart disease and give patients equal access to advice, support, education and treatment. In 2015, Bristol-Myers Squibb contributed towards patient meetings, support groups and educational resources. | 15000 | 15000 |
| 2015 | Bristol-Myers Squibb | Hepatitis Australia | Hepatitis Australia is a not-for-profit organisation that provides leadership and advocacy on viral hepatitis, as well as supporting partnerships to ensure the needs of Australians affected by, or at risk of, viral hepatitis are met. In 2015, Bristol-Myer | 75000 | 75000 |
| 2015 | Bristol-Myers Squibb | Hepatitis New South Wales (NSW) | Hepatitis NSW is an independent, community-based, not-for-profit organisation. It provides information, support, referral and advocacy for people affected by viral hepatitis in NSW. In 2015, BMS supported the "C Me Project" which has successfully run for | 44452 | 44452 |
| 2015 | Bristol-Myers Squibb | Kidney Health Australia | Kidney Health Australia is a not-for-profit organisation that focuses on improving kidney health for people with kidney and urinary tract diseases and their families and carers. Its initiatives aim to reduce the incidence of kidney disease in the Australi | 18755 | 18755 |
| 2015 | Bristol-Myers Squibb | Leukaemia Foundation Of Australia | The Leukaemia Foundation funds research and provides free services to support people with leukaemia, lymphoma, myeloma and related blood disorders and their families. In 2015, Bristol-Myers Squibb subsidised travel for a representative to attend a cancer | 704 | 704 |
| 2015 | Bristol-Myers Squibb | LiverWELL | Hepatitis Victoria is a not-for-profit, community-based organisation and the peak body for people affected by, or at risk of, viral hepatitis in Victoria. In 2015, Bristol-Myers Squibb supported the development of an online training program for healthcare | 39022 | 39022 |
| 2015 | Bristol-Myers Squibb | Living Positive Hiv | Living Positive Victoria is the peak body for people living with HIV and provides education, information and representation for Victorians living with HIV. In 2015, Bristol-Myers Squibb provided a $6,000 grant to support 3 events to raise awareness of HIV | 11000 | 11000 |
| 2015 | Bristol-Myers Squibb | Lymphoma Australia | Lymphoma Australia is a not-for-profit organisation that supports Australians touched by lymphoma. It also raises awareness of lymphoma and supports research for a cure. In 2015, Bristol-Myers Squibb provided funding to support the development of an onlin | 25556 | 25556 |
| 2015 | Bristol-Myers Squibb | Melanoma Patients Australia | Melanoma Patients Australia (MPA) is an independent, not-for-profit organisation dedicated to supporting and representing those affected by melanoma. It provides counselling services, support groups and comprehensive patient information and undertakes adv | 13237 | 13237 |
| 2015 | Bristol-Myers Squibb | Melanoma Tasmania (TAS) | Melanoma Tasmania is a not-for-profit organisation that provides support, awareness and advocacy to melanoma patients in Tasmania. In 2015, Bristol-Myers Squibb provided financial support for Melanoma Tasmania to plan, organise and run a Forum for melanom | 6500 | 6500 |
| 2015 | Bristol-Myers Squibb | Myeloma Australia | Myeloma Australia aims to support Australians touched by myeloma, raise disease awareness and help fund research. In 2015, Bristol-Myers Squibb provided support ($42,000) for the Myeloma Australia Patient/Family Seminars throughout Australia. Bristol-Myer | 72000 | 72000 |
| 2015 | Bristol-Myers Squibb | National Stroke Foundation | The National Stroke Foundation (NSF) is the only national, not-for- profit organisation that works with stroke survivors, carers, health professionals, government and the public to reduce the impact of stroke in the Australian community. In 2015, Bristol- | 29100 | 29100 |
| 2015 | Bristol-Myers Squibb | Rare Cancers Australia | Rare Cancers Australia (RCA) aims to improve awareness, support and treatment of Australians with rare and less common (RLC) cancers. In 2015, BMS supported RCA with $20,000 for a major educational event to engage the cancer community and general public w | 45045 | 45045 |
| 2016 | Bristol-Myers Squibb | Asbestosis & Mesothelioma Association Australia | The Asbestosis and Mesothelioma Association of Australia (AMAA) offers assistance, information and guidance to people affected by and/or concerned about asbestos. In 2016, support was provided for a representative to attend a workshop on cancer survivorsh | Total Support: $1,057 | 1057 |
| 2016 | Bristol-Myers Squibb | Brain Tumour Alliance Australia | Brain Tumour Alliance Australia (BTAA) is a national brain tumour patient and caregiver organisation. In 2016, support was provided for a representative to attend a workshop on cancer survivorship in Melbourne to the value of $958 covering flights and ac | Total Support: $958 | 958 |
| 2016 | Bristol-Myers Squibb | Hearts4Heart | Hearts4Heart aims to raise awareness of heart disease and give patients equal access to advice, support, education and treatment. In 2016, support was provided that contributed towards patient meetings, support groups and educational resources. It inclu | Total Support: $30,400 | 30400 |
| 2016 | Bristol-Myers Squibb | Hepatitis Australia | Hepatitis Australia is a not-for-profit organisation that provides leadership and advocacy on viral hepatitis, as well as supporting partnerships to ensure the needs of Australians affected by, or at risk of, viral hepatitis are met. In 2016, support was | Total Support: $85,000 | 85000 |
| 2016 | Bristol-Myers Squibb | Kidney Health Australia | Kidney Health Australia is a not for profit organisation that focuses on improving kidney health for people with kidney and urinary tract diseases, their families and carers. In 2016, support was provided for the following: (1) a representative to attend | Total Support: $29,770 | 29770 |
| 2016 | Bristol-Myers Squibb | Leukaemia Foundation Of Australia | The Leukaemia Foundation funds research and provides free services to support people with leukaemia, lymphoma, myeloma and related blood disorders and their families. In 2016, support was provided for a representative to attend a workshop on cancer surv | Total Support: $980 | 980 |
| 2016 | Bristol-Myers Squibb | LiverWELL | Hepatitis Victoria is a not-for-profit, community-based organisation and the peak body for people affected by, or at risk of, viral hepatitis in Victoria. In 2016, support was provided that contributed to the development and distribution of a series of vi | Total Support: $22,000 | 22000 |
| 2016 | Bristol-Myers Squibb | Lymphoma Australia | Lymphoma Australia is a not-for-profit organisation that supports Australians touched by lymphoma. It also raises awareness of lymphoma and supports research for a cure. In 2016, support was provided that contributed to the funding to support the organis | Total Support: $27,500 | 27500 |
| 2016 | Bristol-Myers Squibb | Melanoma Patients Australia | Melanoma Patients Australia is a patient driven organisation dedicated to meeting the needs of melanoma patients and their communities through a national network of support, information, advocacy and awareness programs. In 2016, support was provided for | Total Support: $41,075 | 41075 |
| 2016 | Bristol-Myers Squibb | Rare Cancers Australia | Rare Cancers Australia (RCA) is a charity whose purpose is to improve awareness, support and treatment of Australians with rare and less common cancers. In 2016, support was provided for the following: (1) Grants to the value of $23,250 to support their e | Total Support: $48,765 | 48765 |
| 2017 | Bristol-Myers Squibb | Carers Couch | Carers Couch, is an online community providing information, education, advice and assistance for Carers. The organisation aspires to bring together in one place relevant information for carers anywhere in Australia, including rural areas and aboriginal communities. Through acknowledgement, education and awareness Carers Couch continues to normalize and validate the carers experience and its impact on physical and mental health. Carers Couch is there to assist with the unique needs that can come with caring for a loved one diagnosed with cancer. In 2017, Bristol-Myers Squibb provided funding to support the organisation in their patient, carers and health professional education days, the development of online education material and forum, the development of a Peer Support Program for Carers in conjunction with the Peter MacCallum Cancer Center and a research based program to explore the experiences and psychological priorities of young lung cancer patients and their carers. The value of this support was $45,000 | Total Support: $45,000 | 45000 |
| 2017 | Bristol-Myers Squibb | Hearts4Heart | Hearts4Heart aims to raise awareness of heart disease and give patients equal access to advice, support, education and treatment. In 2017, Bristol-Myers Squibb contributed towards the organisation's disease awareness and screening activities including the development of a white paper detailing the economic and societal costs of atrial fibrillation in Australia with the aim of improving early diagnosis. As part of the disease awareness and screening program run by Hearts4Hearts, the BMS supported the efforts by the organisation in promoting Atrial Fibrillation Awareness Week. Support for these activities valued $55,000. | Total Support: $55,000 | 55000 |
| 2017 | Bristol-Myers Squibb | Lymphoma Australia | Lymphoma Australia is a not-for-profit organisation that supports Australians touched by lymphoma. It also raises awareness of lymphoma and supports research for a cure. In 2017, Bristol-Myers Squibb provided funding to support the organisation in their patient, carers and healt professional education days, the development of online education material and webinars. The funds were also used for the a Nurse Hotline to help patients and carers understand all aspects of the Lymphoma journey. The value of this support was $50,000 | Total Support: $50,000 | 50000 |
| 2017 | Bristol-Myers Squibb | Melanoma Patients Australia | Melanoma Patients Australia is a patient driven organisation dedicated to meeting the needs of melanoma patients and their communities through a national network of support, information, advocacy and awareness programs. In 2017, Bristol-Myers Squibb provided the following support: (1) Support for the organisation's educational and advocacy programs. The initiative includes these initiatives includes Patient Information Forums, Interactive Patient Education Resource, Patient Reflection videos, and a training program for the organization's volunteers. The value of this support was $80,000 (2) Support for the Organisation to have members of their organisation attend the Australian Melanoma Consumer Alliance (AMCA) meeting coinciding with the 9th World Congress of Melanoma in October 2017. The organization was in full control of the selection of the individuals. BMS will have no input to the selection process. The Value of this support was $4,200. | Total Support: $84,200 | 84200 |
| 2017 | Bristol-Myers Squibb | National Stroke Foundation | The Stroke Foundation is dedicated in creating two-way conversations with the community, health professionals and governments to advocate for better health outcomes for all Australians affected by stroke. They ensure people understand how stroke can be prevented and work to ensure all people who have strokes are treated on specialised stroke units and discharged from hospital with appropriate care plans and support. In 2017 BMS provided the following support: (1) A donation of $10,000 to help the Stroke Foundation implement a Mobile Stroke Unit to provide a rapid response ambulance for stroke patients. The ambulance would be able to deliver high quality and expert stroke care to the patient, to increase their chances of survival and long-term health outcomes. (2) Support for the organisation's educational program. The initiative includes an update of the patient education material (Transient Ischaemic Attack Pack) and the printing and nation-wide distribution of the material. The value of this support was $30,129 | Total Support: $40,129 | 40129 |
| 2017 | Bristol-Myers Squibb | Rare Cancers Australia | Rare Cancers Australia (RCA) is a charity whose purpose is to improve awareness, support and treatment of Australians with rare and less common cancers. They do this through advocacy, awareness, community and financial support. In 2017 BMS provided the following support: (1) Grant to the value of $20,000 to support their staging of the Canberra Forum. The Forum was a one-day event held in Canberra involving speakers from inside and outside the cancer community discussing the major issues of concern around cancer treatment; including the need for improved access and funding for clinical trials, improved access to aggregated health data and faster access to medicines for rare cancer patients in Australia. (2) Grant to the value of $20,000 to develop a report detailing research/issues that draws on the organisation's experience in dealing with patients, clinicians and government to highlight the barriers within the current regulatory framework to providing access to treatment. (3) Grant to the value of $15,000 for 3 Boardroom Dinners at Parliament House bringing together Members of Parliament and Senators to explore and understand issues such as Genomics, Clinical Trial Developments and Challenges for Rare Cancers. (4) A grant of $20,000 to support the development of an "App" that will allow cancer patients to access a range of "Decks" of questions that the cancer patient may wish to ask their clinician. (5) A grant to the value of $10,000 to support their educational events and disease awareness Campaign titled "Sick or Treat" including a telephone support service and a web facility providing clinically better information on over 200 rare cancers. | Total Support: $85,000 | 85000 |
| 2018 | Bristol-Myers Squibb | CanTeen | CanTeen is an organisation that aims to optimise the health and wellbeing of young people living with cancer. Through CanTeen, young people living with cancer learn to explore and deal with their feelings about cancer, connect with other young people going through the same experiences, and where relevant, provide specialist, youth-specific treatment teams. In 2018, BMS provided a $5,000 sponsorship towards the 3rd Global Adolescent and Young Adult (AYA) Cancer Congress that supports the organisation's patient education and advocacy program. The Congress had around 400 delegates designed to develop and strengthen vital partnerships to advance global research in the diagnosis, treatment and support of young cancer patients. | Total Support: $5,000 | 5000 |
| 2018 | Bristol-Myers Squibb | Global Healthy Living Foundation | Global Healthy Living Australia (GHLA) is a non-profit organization with the mission to improve the quality of life for people living with chronic illness. In 2018 BMS provided $25,000 to enable GHLA to develop and operationalise activities that have been designed to address unmet needs of the Australian patient community. These activities included the engagement of a National Patient Council, the implementation of a patient educational and editorial calendar, including blogs that provide positive first-hand patient perspectives, the development of a monthly-e-Newsletter and advocacy programs involving workshops on dealing with TGA and PBAC. | Total Support: $25,000 | 25000 |
| 2018 | Bristol-Myers Squibb | Hearts4Heart | Hearts4Heart aims to raise awareness of heart disease and give patients equal access to advice, support, education and treatment. In 2018, Bristol-Myers Squibb contributed towards the organisation's disease awareness and screening activities including the development of a white paper detailing the need for government funding for Atrial Fibrillation screening. As part of the disease awareness and screening program run by Hearts4Hearts, the BMS supported the efforts by the organisation in promoting Atrial Fibrillation Awareness Week. Support for these activities value $75,000. | Total Support: $75,000 | 75000 |
| 2018 | Bristol-Myers Squibb | Lymphoma Australia | Lymphoma Australia is a not-for-profit organisation that supports Australians touched by lymphoma. It also raises awareness of lymphoma and supports research for a cure. In 2018, Bristol-Myers Squibb provided funding to support the organisation in their patient, carers and health professional education days, the development of online education material and webinars. The value of this support was $30,000 | Total Support: $30,000 | 30000 |
| 2018 | Bristol-Myers Squibb | Melanoma Patients Australia | Melanoma Patients Australia (MPA) is a patient driven organisation dedicated to meeting the needs of melanoma patients and their communities through a national network of support, information, advocacy and awareness programs. In 2018, Bristol-Myers Squibb provided the following support: (1) Support for the MPA's Patient Information Forums. The forums include presentations from key opinion leaders including leading clinicians, researchers and professionals to address the treatment paths for patients and the psychosocial elements of a melanoma diagnosis. The value of this support was $15,000. (2) Support for the MPA's Patient and Stakeholder Data Management Project. This allows the MPA to invest in a new data management platform, to transfer all existing data sources into the new system and improve and enhance the targeting of vital information ensuring that we can communicate the right information to the right people at the right time. The Value of this support was $20,000. (3) Support for the MPA's Advocacy and Medical Education Support. This includes the generation of a small Advisory group to provide advice and consumer feedback on a range of issues important to those affected with melanoma. It also allows the MPA to seek expressions of interest from a wide group of consumers affected with melanoma. The Value of this support was $20,000. (4) Support for the development of the MPA Website. The Value of this support was $5,000. (5) A donation of $5,000 was provided to the MPA to support the organisation's continued endeavours to reduce the burden of melanoma on all Australians. (6) A grant of $3,000 for four members of MPA to attend a Skin Check event held at Parliament house in June 2018. Total support for 2018 was $68,000 | Total Support: $68,000 | 68000 |
| 2018 | Bristol-Myers Squibb | Rare Cancers Australia | Rare Cancers Australia (RCA) is a charity whose purpose is to improve awareness, support and treatment of Australians with rare and less common cancers. They do this through advocacy, awareness, community and financial support. In 2018 BMS provided the following support: (1) Grant to the value of $50,000 to support their staging of the Canberra Forum, preparation of a 'report card' detailing the progress to parity for rare cancer patients, the redesign of the RCA website taking advantage of new technologies including "Chat bots". With respect to the Forum, it was a one-day event held in Canberra involving speakers from inside and outside the cancer community discussing the major issues of concern around cancer treatment; including the need for improved access and funding for clinical trials, improved access to aggregated health data and faster access to medicines for rare cancer patients in Australia. | Total Support: $50,000 | 50000 |
| 2018 | Bristol-Myers Squibb | Ronald McDonald House Charities | Ronald McDonald House Charities (RMHC) is an independent charity that helps families of seriously ill children. They help keep families together and close to the care their child needs. The cornerstone program of RMHC, the Ronald McDonald House®, provides a ‘home away from home’ for families of seriously ill children being treated at nearby hospitals. (1) A donation of $600 was provided to RMHC and BMS employees participated in a working bee across two sites (Monash and Adelaide) for one day. | Total Support: $600 | 600 |
| 2019 | Bristol-Myers Squibb | Australian Patients Association | The Australian Patients Association is an independent not-for-profit organisation established to promote and protect the rights and interests of patients, and improve overall patient outcomes. They address important health issues impacting on patient care in the public and private healthcare system. They are also actively involved in educating patients about their rights and choices, as well as supporting patients in need. In 2019, BMS supported the organisation in updating their web site, which contains information on patient rights and resources in Australia, and updating their comprehensive patients handbook, which is a self-help guide for patients. The value of this support was $5,000 | Total Support: $5,000 | 5000 |
| 2019 | Bristol-Myers Squibb | Head and Neck Cancer Australia | Beyond Five's mission is to improve the quality of life for head & neck cancer patients, their families and carers, through education, awarenes and access to support. In 2019, Bristol-Myers Squibb provided the following support: (1) Beyond Five's Boardroom Dinner bring together Members of Parliament and Senators to raise awareness of head and neck cancer (HNC) with key government stakeholders and explore and understand issues such as Updates in HNC Treatment, Importance of Early Diagnosis and Challenges for Head and Neck Cancer Survivors. The value of this support was $5,000 (2) Beyond Five's Website development converting over 60 existing head and neck cancer information PDFs covering topics from diagnosis, treatment to life after cancer into user friendly webpages on the Beyond Five website and associated social media campaign to raise awareness of the comprehensive information available on to support people affected by HNC. The value of this support was $11,500. (3) Printing and nation-wide distribution of Beyond Five patient educational materials including patient cards, posters, leaflets to hospitals, cancer centres, specialist consulting rooms and patient support groups. The value of this support was $6,000. (4) World Head and Neck Cancer Day 2019 Activities including the development and promotion of the New Face of Head and Neck Cancer video and associated social media campaign to raise awareness of HPV related head and neck cancer, the importance of early diagnosis and health checks with a focus on men. The value of this support was $5,000. | Total Support: $27,500 | 27500 |
| 2019 | Bristol-Myers Squibb | Hearts4Heart | hearts4heart aims to raise awareness of heart disease and give patients equal access to advice, support, education and treatment. In 2019, Bristol-Myers Squibb provided the following support: (1) BMS supported hearts4heart's Atrial Fibrillation (AF) Awareness week in September 2019 in collaboration with the Asia Pacific Heart Rhythm Society (APHRS). The key message to the public and primary care was to raise awareness of the underutilisation of anticoagulants to prevent stroke: "Preventing stroke in atrial fibrillation - It's a no-brainer". To this goal, BMS provided financial support to develop a screening APP, the development of a database and the development of an information pack. AF Awareness week was also associated with a large media campaign to ensure public awareness was maximised. The value of this support was $50,000. (2) As part of the hearts4heart's program for AF Awareness week, the organisation sought funding for the development of a poster to highligh the importance of anticoagulation and the underutilisation of anticoagulants to reduce the risk of stroke. The poster was disseminated to GP clinics, pharmacies and hospitals. The value of this support was $20,000 | Total Support: $70,000 | 70000 |
| 2019 | Bristol-Myers Squibb | Melanoma Patients Australia | The Melanoma Patients Association (MPA) is an independent, not for profit organisation dedicated to supporting and representing those affected by melanoma. Their vision is to reduce the impact of melanoma on all Australians by providing a range of comprehensive support services to patients affected by melanoma including emotional support, information and connections. In 2019, Bristol-Myers Squibb provided the following support: (1) Patient Information Forums (x3) involving between 80-100 attendees. The Forums allowed patients and those affected by melanoma to come together to learn about the disease, treatments and strategies for coping. Patients were provided access to experts in melanoma with the opportunity for question time. The value of this support was $10,000 (2) Volunteer Development & Training Project whereby MPA will be able to update and enhance MPA's existing Volunteer Policies and Procedures to ensure compliance with all legislative requirements to ensure the wellbeing and safety of our volunteers. It also enables the MPA to increase organizational capacity to recruit, train and manage volunteers nationally. The value of this support was $15,000. (3) The development of new patient information resources that are available both electronically and by hard copy. The MPA provides this information to patients across Australia free of charge. The value of this support was $5,000 (4) Donation of $10,000 for the organisation to represent melanoma patients on important issues including patient care and access to treatments and to attend key events with stakeholders such as Government, research and industry. | Total Support: $40,000 | 40000 |
| 2019 | Bristol-Myers Squibb | Rare Cancers Australia | Rare Cancers Australia (RCA) is a charity whose purpose is to improve awareness, support and treatment of Australians with rare and less common cancers. They do this through advocacy, awareness, community and financial support. In 2019, Bristol-Myers Squibb provided the following support: (1) Grant to the value of $50,000 to support their staging of the Canberra Forum, preparation of a 'report card' detailing the progress to parity for rare cancer patients and the redesign of the RCA website. With respect to the Forum, it was a one-day event held in Canberra involving speakers from inside and outside the cancer community discussing the major issues of concern around cancer treatment; including the need for improved access and funding for clinical trials, improved access to aggregated health data and faster access to medicines for rare cancer patients in Australia. The value of this support was $60,000. (2) Support of RCA's media campaign involving support for an international expert to be part of RCA's launch of their position paper. RCA endeavoured to launch a media campaign across all platforms highlighting the findings of the report drawing public attention to the need for innovation and reform to improve treatment for rare cancer patients. The value of this support was $20,000. (3) Support for the Rare Cancers Australia Charity Ball; an annual event hosted by RCA. 100 per cent of proceeds raised help fund the organisation in continuing to deliver emotional and financial support to patients and carers during their cancer diagnosis journey. BMS was able to obtain a table for 10 employees. The value of this support was $5,000. (4) Support for the Rare Cancers Australia Mount Kosi Challenge; an annual event hosted by RCA. 100 per cent of proceeds raised help fund the organisation in continuing to deliver emotional and financial support to patients and carers during their cancer diagnosis journey. BMS wa able to have a number of employees participate in the event. The value of this support was $5,000. | Total Support: $90,000 | 90000 |
| 2020 | Bristol-Myers Squibb | Aftershock Group | The Aftershock is a not-for-profit organisation raising funds and awareness for high mortality rate cancers. BMS supported the creation of the organisation's Series 1 Podcasts, which were based on discussions with people that have experienced the effect of a cancer diagnosis, those that have lost loved ones and also those with experience of surviving the disease. | Total Support: $10,000 | 10000 |
| 2020 | Bristol-Myers Squibb | Australian Crohn's and Colitis Association | The Australian Crohn's and Colitis Association (ACCA) is a charity whose primary purpose is to provide support services, advice and encouragement to people suffering from inflammatory bowel disease. It aims at raising awareness of Crohn’s and colitis and promoting gut health within the community. In 2020, BMS supported the production of the organisation's Inflammatory Bowel Disease Research videos, aiming at providing members with the opportunity to hear new research findings directly from the researchers. | Total Support: $20,000 | 20000 |
| 2020 | Bristol-Myers Squibb | Australian Patients Association | The Australian Patients Association is an independent not-for-profit organisation established to promote and protect the rights and interests of patients, and improve overall patient outcomes. They address important health issues impacting on patient care in the public and private healthcare system. They are also actively involved in educating patients about their rights and choices, as well as supporting patients in need. The financial donation provided by BMS was to support the organisation's overall mission and objectives for the year. | Total Support: $5,000 | 5000 |
| 2020 | Bristol-Myers Squibb | Global Healthy Living Foundation | Global Healthy Living Australia (GHLA) is a non-profit organization with the mission to improve the quality of life for people living with chronic illness. BMS supported the following activities in 2020: 1) the organisation's overall activities of educating and creating awareness through social media and related framework about the importance of early diagnosis for patients suffering of chronic pain such as arthritis, osteoporosis, diabetes, and psoriasis. Amount donated was $15,000. 2) the advocacy and research activities related to people living with chronic illness and COVID-19 impact, with the aim of developing patient education programme and providing support to those targeted patients during the COVID-19 period. Amount donated was $15,000. | Total Support: $30,000 | 30000 |
| 2020 | Bristol-Myers Squibb | Head and Neck Cancer Australia | Beyond Five's mission is to improve the quality of life for head & neck cancer patients, their families and carers, through education, awareness and access to support. In 2020, BMS supported the organisation's activities for the year which include: - running of the World Head and Neck Cancer Day 2020, - development of an app to cater for digital needs of Head & Neck cancer patients, - maintaining online content, printing of educational materials, - organising industry events & fund raising events, and - participating in the State of the Nation Head & Neck Cancer report compilation. | Total Support: $20,000 | 20000 |
| 2020 | Bristol-Myers Squibb | Hearts4Heart | Hearts4Heart aims to raise awareness of heart disease and give patients equal access to advice, support, education and treatment. BMS supported the organisation's Atrial Fibrillation (AF) Awareness Week on 21-27 of September 2020. The purpose of the event is to continue the education for the general public on heart health and to encourage people to get their heart checked. | Total Support: $25,000 | 25000 |
| 2020 | Bristol-Myers Squibb | Leukaemia Foundation Of Australia | The Leukaemia Foundation funds research and provides free services to support people with leukaemia, lymphoma, myeloma and related blood disorders and their families. BMS sponsored the organisation virtual patient conference in 2020. The purpose of the conference is to educate patients on a range of topics including Disease information, Living well and survivorship, Research and advocacy, and Navigating the health system. | Total Support: $25,000 | 25000 |
| 2020 | Bristol-Myers Squibb | Lung Foundation Australia | Lung Foundation Australia is a charity working to improve lung health and reduce the impact of lung disease for all Australians. Its main activities are promoting lung health and early diagnosis, advocating for policy change and research investment, raising awareness about the symptoms and disease, and championing equitable access to treatment and care. In 2020, BMS supporting the following projects: 1) the organisation's Patient Education Webinar series, aiming at providing scientific updates and facilitating discussion on Lung Cancer. Amount for this support was $10,000. 2) the organisation's overall mission and objectives through a donation of $15,000 3) the ALTG Cancer Preceptorship and ATLG consumer workshop; two main organisation's events for 2020. Amount for this support was $40,000. | Total Support: $65,000 | 65000 |
| 2020 | Bristol-Myers Squibb | Lymphoma Australia | Lymphoma Australia is a not-for-profit organisation that supports Australians touched by lymphoma. It also raises awareness of lymphoma and supports research for a cure. In 2020, BMS supported financially the following projects: 1) improving the quality and accessibility of information to people with lymphoma by hosting Patient Webinars and providing educational resources including hard copy booklets and fact sheets for hospitals and patients. Amount funded was $25,000. 2) the organisation's digital related projects including a new data driven website, online support groups, Facebook lives and online educational sessions for patients and healthcare professionals. Amount provided was $40,000. | Total Support: $65,000 | 65000 |
| 2020 | Bristol-Myers Squibb | Melanoma & Skin Cancer Advocacy Network | The Melanoma & Skin Cancer Advocacy Network (MSCAN) is a charity whose purpose is to listen to, represent and inform the melanoma and skin cancer community with a focus on innovation in care & research, advocacy & policy, and resources & information. In 2020, BMS provided support for: 1) the development of patient support materials including update of its website and the Adjuvant Decision Tree, which includes treatment options that are available to Australian patients. Amount provided was $15,000. 2) the organisation's overall mission and objectives aiming at representing and informing the melanoma/skin cancer community. Amount donated was $10,000. | Total Support: $25,000 | 25000 |
| 2020 | Bristol-Myers Squibb | Melanoma Patients Australia | The Melanoma Patients Association (MPA) is an independent, not for profit organisation dedicated to supporting and representing those affected by melanoma. Their vision is to reduce the impact of melanoma on all Australians by providing a range of comprehensive support services to patients affected by melanoma including emotional support, information and connections. BMS provided the following support in 2020: 1) a $5,000 donation in support of the organisation's overall mission and objectives for the year 2) $25,000 in support of the organisation's Patient Information Webinars, Health Professional Patient Resources and the Website & Digital Infrastructure Improvements | Total Support: $30,000 | 30000 |
| 2020 | Bristol-Myers Squibb | Patient Voice Initiative | The Patient Voice Initiative is a collaboration between patients, researchers and industry working towards improving the patient voice in the Australian health system. BMS supported the 2020 organisation's activities consisting of: - improvement of the Consumer Online Toolkit - SPEAKERS program (Supporting Patient Engagement and Knowledge through Efficient Resource Search) - undertaking direct outreach to patient and carer groups to raise awareness of online resources & social media shareables - providing training to patients/consumers on the reimbursement decision-making in Australia - promoting Consumer Conversations programme by providing opportunities for dialogues led by patient advocates | Total Support: $12,000 | 12000 |
| 2020 | Bristol-Myers Squibb | Rare Cancers Australia | Rare Cancers Australia (RCA) is a charity whose purpose is to improve awareness, support and treatment of Australians with rare and less common cancers. They do this through advocacy, awareness, community and financial support. In 2020, BMS supported the following activities: 1) the organisation's Pinnacle program, which includes updates to the Pinnacle-Asia website for Australian patient groups, individual mentoring for those patients wishing to engage in one-to-one sessions, workshops in Sydney, Melbourne and Brisbane. BMS provided $20,00 for this project. 2) the Mount Kosi Challenge 2020, which an annual fund raising event hosted by RCA. A number of BMS employees participated in the event, and the company support was towards the registration and cocktail reception for the participants. Value of BMS support was $5,125. | Total Support: $25,125 | 25125 |
| 2013 | Celgene | Joint venture between the Leukaemia Foundation of Australia and the Myeloma Foundation of Australia | Sponsorship for the 2014 Ride for Recovery Charity event | 25000 | 25000 |
| 2013 | Celgene | Leukaemia Foundation Of Australia | Printing of a Myelodysplastic Syndromes Patient Booklet | 7000 | 7000 |
| 2013 | Celgene | Leukaemia Foundation Of Australia | Financial support for partial funding of the Myelodysplastic Coordinator position at Leukaemia Foundation. The Coordinator supports MDS patients by running patient forums, preparing patient information and materials, and the organisation of an MDS day. | 30000 | 30000 |
| 2013 | Celgene | Myeloma Australia | Unrestricted educational grants to support the Myeloma Foundation of Australia National Nurse Program, the Myeloma Medical and Scientific Research Group (MSAG), and the Myeloma Foundation of Australia quarterly newsletters | 61000 | 61000 |
| 2014 | Celgene | Joint venture between the Leukaemia Foundation of Australia and the Myeloma Foundation of Australia | Sponsorship for the 2014 Ride for Recovery Charity event. | 25000 | 25000 |
| 2014 | Celgene | Leukaemia Foundation Of Australia | Sponsorship of two staff to attend UICC World Cancer Congress Melbourne. | 1960 | 1960 |
| 2014 | Celgene | Leukaemia Foundation Of Australia | Sponsorship of National MDS Day (catering and venue costs). | 2000 | 2000 |
| 2014 | Celgene | Leukaemia Foundation Of Australia | Unrestricted grant for educational and support activities including national patient seminars and materials. | 10000 | 10000 |
| 2014 | Celgene | Leukaemia Foundation Of Australia | Unrestricted grant to assist the patient education and patient support activities of the Foundation. | 20000 | 20000 |
| 2014 | Celgene | Myeloma Australia | Unrestricted grant to reprint patient booklets. | 3806 | 3806 |
| 2014 | Celgene | Myeloma Australia | Unrestricted grant to help with development of a new website. | 5000 | 5000 |
| 2014 | Celgene | Myeloma Australia | Grant to support the Foundation in providing opportunities for staff to learn about new myeloma research, and to meet with the International Myeloma Foundation to share best practice information, by attending significant scientific meetings such as ASH (A | 5000 | 5000 |
| 2014 | Celgene | Myeloma Australia | Unrestricted educational grant to support the Myeloma Australia quarterly newsletters. | 20000 | 20000 |
| 2014 | Celgene | Myeloma Australia | Unrestricted grant to support the Myeloma Medical and Scientific Research Group (MSAG). | 20000 | 20000 |
| 2014 | Celgene | Myeloma Australia | Unrestricted grant to support the research activities of the Foundation. | 25000 | 25000 |
| 2014 | Celgene | Myeloma Australia | Unrestricted educational grant to support the Myeloma Australia National Nurse Program. | 36000 | 36000 |
| 2014 | Celgene | Myeloma Australia | Unrestricted grant for development and implementation of educational and support activities (new database, ongoing patient activities, seminars, support programs and patient materials). | 135000 | 135000 |
| 2015 | Celgene | Leukaemia Foundation Of Australia | Sponsor the registration of two Leukaemia Foundation staff members to attend HAA in Adelaide | 1680 (2 registrations at $840 each) | 1680 |
| 2015 | Celgene | Leukaemia Foundation Of Australia | Support for Foundation funding of cancer care coordinator (Wesley Hospital) to attend MDS Symposium in Washington DC USA | 2000 | 2000 |
| 2015 | Celgene | Leukaemia Foundation Of Australia | Sponsorship of the "Ride as One" fundraising activity | 5000 | 5000 |
| 2015 | Celgene | Leukaemia Foundation Of Australia | Support for Foundation patient activities and educational materials (MDS booklet, MDS patient support meeting with webinar of Q&A session with leading international MDS experts) Partial funding of MDS coordinator to attend MDS Symposium in Washington DC U | 17600 | 17600 |
| 2015 | Celgene | Leukaemia Foundation Of Australia | Sponsorship of the "Light the Night" fundraising activity | 55000 | 55000 |
| 2015 | Celgene | Leukaemia Foundation Of Australia | Support for education activities of the Foundation including patient education materials (Myeloma booklets, Myeloma newsletter and Myeloma DVD) and patient meetings | 60000 | 60000 |
| 2016 | Celgene | Leukaemia Foundation Of Australia | Travel support sponsorship for healthcare professionals selected by the Leukaemia Foundation to attend health professional education day in Darwin | 1500 | 1500 |
| 2016 | Celgene | Leukaemia Foundation Of Australia | Ride as one cycling event fundraiser sponsorship. | 10000 | 10000 |
| 2016 | Celgene | Leukaemia Foundation Of Australia | Advocate training for 100 patients | 20000 | 20000 |
| 2016 | Celgene | Leukaemia Foundation Of Australia | Blood access app (My haematology diary app) conversion of existing haematology diary booklet into a web-based app. | 30000 | 30000 |
| 2016 | Celgene | Leukaemia Foundation Of Australia | Light the night fundraiser sponsorship | 50000 | 50000 |
| 2016 | Celgene | Myeloma Australia | 2016 Support for Medical and Scientific Advisory Group (MSAG) programs, patient programs, and publishing Mynews magazine | 50000 | 50000 |
| 2016 | Celgene | Myeloma Australia | 2016 Support for Medical and Scientific Advisory Group (MSAG) programs, patient programs, and publishing Mynews magazine | 50000 | 50000 |
| 2017 | Celgene | Leukaemia Foundation Of Australia | Sponsorship of the Melbourne Light the Night 2017 | 50000 | 50000 |
| 2017 | Celgene | Leukaemia Foundation Of Australia | 2017 support for Myeloma Patient newsletter, annual Patient Blood Cancer conference, and the Ride as One fundraiser event | 60000 | 60000 |
| 2017 | Celgene | Myeloma Australia | 2017 support for Medical and Scientific Advisory Group (MSAG), patient seminars and workshops and patient newsletter, support for the 2017 Inaugural Myeloma Clinical Education Workshop | 50000 | 50000 |
| 2017 | Celgene | Rare Cancers Australia | Support for 3 Boardroom Dinners for MPs and Senators with disease experts hosted in Parliament House | 15000 | 15000 |
| 2017 | Celgene | Rare Cancers Australia | Support for the development of a Rare Cancer's Research Report | 20000 | 20000 |
| 2017 | Celgene | Snowdome Foundation | Purchase of a corporate table at a fundraising dinner (Bloody Good Dinner June 2017) | 5000 | 5000 |
| 2018 | Celgene | Leukaemia Foundation Of Australia | 2018 support for Myeloma Patient newsletter, Support for Clinical Trial Symposium and annual Patient Blood Cancer conference | 30000 | 30000 |
| 2018 | Celgene | Leukaemia Foundation Of Australia | Sponsorship of the Melbourne Light the Night 2018 | 50000 | 50000 |
| 2018 | Celgene | Myeloma Australia | Support in Major Workshops and Seminars program in 2018 | 20000 | 20000 |
| 2018 | Celgene | Myeloma Australia | 2018 Support of training & awarness programs in stem cell transplants | 20000 | 20000 |
| 2018 | Celgene | Myeloma Australia | 2018 support for Medical and Scientific Advisory Group (MSAG) | 30000 | 30000 |
| 2018 | Celgene | Myeloma Australia | 2018 Support for Publishing patient Magazine(Mynews)- Quarterly | 30000 | 30000 |
| 2018 | Celgene | Rare Cancers Australia | Support of three Boardroom Dinners for MPs and Senators with relevant experts hosted in Parliament House | 15000 | 15000 |
| 2018 | Celgene | Rare Cancers Australia | Support for the Rare Soultions Updated Report with Inforgraphic | 20000 | 20000 |
| 2018 | Celgene | Rare Cancers Australia | Support of a one day event examing key issues pertinent to Australians receiving best quality Cancer Carehosted in Parliamant House | 20000 | 20000 |
| 2013 | CSL Behring | Cancer Council Victoria (VIC) | A donation equivalent to employee contributions made to the Cancer Council through CSL's workplace giving program, to support the Cancer Council Victoria. | 15298.09 | 15298.09 |
| 2013 | CSL Behring | HAE Australasia | An unrestricted educational grant to support the 2013 HAE Australasia patient meeting | 10000 | 10000 |
| 2013 | CSL Behring | Haemophilia Foundation Australia | A donation equivalent to employee contributions made to the HFA through a workplace giving fundraising event during Haemophilia Awareness Week 2013 | 250 | 250 |
| 2013 | CSL Behring | Haemophilia Foundation Australia | An educational grant to support Haemophilia Foundation Australia members attend the World Federation of Hemophilia Congress | 9090 | 9090 |
| 2013 | CSL Behring | Haemophilia Foundation Australia | An unrestricted donation to support education, advocacy and research activities undertaken by HFA according to HFA objectives | 40000 | 40000 |
| 2013 | CSL Behring | Immune Deficiency Foundation Australia | A donation equivalent to employee contributions made to the IDFA through a workplace giving fundraising event during International Plasma Awareness Week 2013 | 523.9 | 523.9 |
| 2013 | CSL Behring | Immune Deficiency Foundation Australia | An unrestricted educational grant of fixed value to support the production of education materials for people with primary immune deficiency | 10000 | 10000 |
| 2013 | CSL Behring | Immune Deficiency Foundation Australia | An unrestricted educational grant of fixed value to support the activities of the Foundation | 18899.17 | 18899.17 |
| 2013 | CSL Behring | National Heart Foundation Of Australia | An unrestricted donation equivalent to employee contributions received by the Heart Foundation through CSL's workplace giving program. | 9494 | 9494 |
| 2013 | CSL Behring | People living with HIV/AIDS (Victoria/VIC) | An unrestricted educational grant of fixed value to support the continued registration and maintenance of an Inflammatory Neuropathy Support Group website to enhance access to patient support materials. | 285.46 | 285.46 |
| 2014 | CSL Behring | HAE Australasia | HAE Australasia is a not-for-profit patient advocacy organisation dedicated to serving persons with hereditary angioedema, in Australia and New Zealand. A Contribution was provided to assist with HAE Australasia Annual Patient Conference to facilitate pa | 5000 | 5000 |
| 2014 | CSL Behring | HAE Australasia | HAE Australasia is a not-for-profit patient advocacy organisation dedicated to serving persons with hereditary angioedema, in Australia and New Zealand. An unrestricted contribution to support education and research activities undertaken by HAE Australia | 10000 | 10000 |
| 2014 | CSL Behring | Haemophilia Foundation Australia | The HFA represents the Australian bleeding disorders community and are committed to improving treatment and care through representation and advocacy, education and the promotion of research. An unrestricted contribution was provided to support education a | 40909.09 | 40909.09 |
| 2014 | CSL Behring | Immune Deficiency Foundation Australia | The IDFA is a not-for-profit organisation and registered charity caring for people who have Primary Immune Deficiencies (PID). Purchase of table tickets at the annual IDFA fundraising ball. The tickets were donated to the IDFA for use by IDFA members at I | 1272.73 | 1272.73 |
| 2014 | CSL Behring | Immune Deficiency Foundation Australia | The IDFA is a not-for-profit organisation and registered charity caring for people who have PID. An educational grant for the ongoing maintenance of content on the IDFA website and the production of Primary Immune Deficiency educational materials for pati | 20000 | 20000 |
| 2014 | CSL Behring | Immune Deficiency Foundation Australia | The IDFA is a not-for-profit organisation and registered charity caring for people who have PID. Sponsorship was provided for the printing of 3,000 copies of the PID handbook for patients. All content was developed exclusively by the IDFA. | 40000 | 40000 |
| 2014 | CSL Behring | Myositis Association Australia | The Myositis Association-Australia Incorporated (Myositis Association Australia) provides a support network, assists myositis patients to manage their condition, supporting research, promote awareness of myositis and strive to improve the quality of life | 5000 | 5000 |
| 2015 | CSL Behring | Alpha-1 Association of Australia | Support for Alpha-1 Association of Australia to develop an Australian registry for patients with Alpha-1 deficiency | 10000 | 10000 |
| 2015 | CSL Behring | HAE Australasia | Support HAE Australia raise awareness of HAE within the community | 15900 | 15900 |
| 2015 | CSL Behring | Haemophilia Foundation Australia | A donation equivalent to employee contributions made to the HFA via an employee workplace fundraising event. | 150 | 150 |
| 2015 | CSL Behring | Haemophilia Foundation Australia | An educational grant to the HFA to support a travel grant program for Australian Haemophilia Nurses Group | 5000 | 5000 |
| 2015 | CSL Behring | Haemophilia Foundation Australia | Contribution in support of Haemophilia Foundation Australia (HFA) Patient Conference | 17000 | 17000 |
| 2015 | CSL Behring | Haemophilia Foundation Australia | An educational grant to develop and implement a program for youth with haemophilia to teach them how to lead and mentor other youth patients with haemophilia | 50000 (30/06/2015 = 20K) (15/07/2015 = 30K) | 50000 |
| 2015 | CSL Behring | Immune Deficiency Foundation Australia | An Educational grant for the printing of 2,000 Primary Immmune Deficiency (PID) Fatigue pamphlets for patients | 1192 | 1192 |
| 2015 | CSL Behring | Immune Deficiency Foundation Australia | Sponsorship of the IDFA's 2016 National Patients Conference | 40000 | 40000 |
| 2016 | CSL Behring | AusPIPS | Educational grant to support primary immunodeficiency awareness with the development of patient materials and website and an advocacy program. | 10000 | 10000 |
| 2016 | CSL Behring | HAE Australasia | Sponsorship of a series of psychology workshops to help patients who may be experiencing depression and anxiety due to hereditary angioedema | 7000 | 7000 |
| 2016 | CSL Behring | Immune Deficiency Foundation Australia | Educational grant for development to produce a total of 6000 reprints of 6 different patient educational resource booklets | 5456 | 5456 |
| 2016 | CSL Behring | Myositis Association Australia | Sponsorship of the Myositis Association Australia 2016 patient conference | 4000 | 4000 |
| 2017 | CSL Behring | AusPIPS | The Australian Primary Immunodeficiency Patient Support (AusPIPS) group is an organisation that supports patients with Primary Immune Deficiency (PID) and associated chronic illnesses in Australia. Support was provided to AusPIPs to allow representation of the group at the Australasian Society for Clinical Immunology and Allergy (ASCIA) 28th Annual Conference to raise awareness of PID amongst healthcare professionals. | 2430.59 | 2430.59 |
| 2017 | CSL Behring | AusPIPS | The Australian Primary Immunodeficiency Patient Support (AusPIPS) group is an organisation that supports patients with Primary Immune Deficiency (PID) and associated chronic illnesses in Australia. Funding was provided to support the AusPIP's educational patient meetings regarding their disease, improve patient advocacy and facilitate patient outcomes through educational meetings with health care professionals. | 14100 | 14100 |
| 2017 | CSL Behring | HAE Australasia | HAE Australasia is a not for profit patient advocacy organisation, dedicated to providing support to Australian and New Zealand hereditary angioedema (HAE) patients and their families, as well as raising awareness of HAE resulting from C1-inhibitor deficiency. Support was provided for the HAE Australasia 2017 National Patient and Carers Conference to assist patient education with medical specialists from Australia. | 10000 | 10000 |
| 2017 | CSL Behring | HAE Australasia | HAE Australasia is a not for profit patient advocacy organisation, dedicated to providing support to Australian and New Zealand hereditary angioedema (HAE) patients and their families, as well as raising awareness of HAE resulting from C1-inhibitor deficiency. Support was provided for the HAE Australasia's State Patient Meetings and Psychology Workshops to help patients living with HAE and who may be experiencing depression and anxiety due to their disease. | 13000 | 13000 |
| 2017 | CSL Behring | HAE Australasia | HAE Australasia is a not for profit patient advocacy organisation, dedicated to providing support to Australian and New Zealand hereditary angioedema (HAE) patients and their families, as well as raising awareness of HAE resulting from C1-inhibitor deficiency. Support was provided to assist with HAE Australasia's patient database project. | 20000 | 20000 |
| 2017 | CSL Behring | HAE Australasia | HAE Australasia is a not for profit patient advocacy organisation, dedicated to providing support to Australian and New Zealand hereditary angioedema (HAE) patients and their families, as well as raising awareness of HAE resulting from C1-inhibitor deficiency. Support was provided to HAE Australasia to help increase Australian and New Zealand community awareness and understanding of hereditary angioedema through their awareness program. | 20000 | 20000 |
| 2017 | CSL Behring | Haemophilia Foundation Australia | The Haemophilia Foundation of Australia (HFA) is an organisation that represents people with haemophilia, von Willebrand disorder and other inherited bleeding disorders. Support was provided to assist the HFA raise community awareness of haemophilia by developing educational video stories of patients with haemophilia. | 20000 | 20000 |
| 2017 | CSL Behring | Haemophilia Foundation Australia | The Haemophilia Foundation of Australia (HFA) is an organisation that represents people with haemophilia, von Willebrand disorder and other inherited bleeding disorders. Support of the 18th Australian and New Zealand bi-annual Conference on Haemophilia and Rare Bleeding Disorders in 2017 was provided to assist with patient and carer education with medical specialists and allied health. | 30000 | 30000 |
| 2017 | CSL Behring | Immune Deficiency Foundation Australia | The Immune Deficiencies Foundation Australia (IDFA) is a not-for-profit organisation raising awareness and caring for people who have Primary (Genetic) and Secondary (due to chemotherapy and other treatments/ or autoimmune illness). Support was provided to assist the IDFA's educational meetings to help patients and their carers manage their disease and move from hospital to home treatment and care. | 31590.91 | 31590.91 |
| 2017 | CSL Behring | Inflammatory Neuropathy Support Group Of Victoria (VIC) | The Inflammatory Neuropathy Support Group of Victoria Inc (InGroup) is a non profit organisation that supports patients with Guillain-Barré Syndrome (GBS) or Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) or other Inflammatory Neuropathies. Support was provided to assist the InGroup's educational website platform that helps to educate patients and their carers around their disease. | 200 | 200 |
| 2017 | CSL Behring | Myasthenia Alliance Australia | The Myasthenia Alliance Australia (MAA) is an organisation that supports patients with myasthenic syndrome and represents the needs of myasthenics from all states in Australia. Support was provided for the MAA 2017 patient conference to assist with patient education with medical specialists. | $3,719.86. Includes provision of food and beverages | 3719.86 |
| 2017 | CSL Behring | Myositis Association Australia | The Myositis Association Australia is an organisation dedicated to supporting myositis patients and their families. Support of the Myositis Association Australia 2016 patient conference was provided to assist patient education with medical specialists from Australia and the USA as well as allied health practitioners, carers and lifestyle experts. | 4000 | 4000 |
| 2018 | CSL Behring | Alpha-1 Association of Australia | The Alpha-1 Association of Australia (AAA) is a not for profit organisation representing patients with Alpha-1 Antitrypsin Deficiency (Alpha-1) and their carers throughout Australia. The AAA focuses on increasing Alpha-1 awareness and education, diagnosis, improving patient access to therapy and encouraging research. Support was provided to sponsor attendance to the Annual Scientific Meeting of The Australia and New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (TSANZSRS) 2018 conference. | 5000 | 5000 |
| 2018 | CSL Behring | AusPIPS | The Australian Primary Immunodeficiency Patient Support (AusPIPS) group is an organisation that supports patients with Primary Immune Deficiency (PID) and associated chronic illnesses in Australia. Support was provided to help increase Australian community awareness and understanding of PID through their disease awareness program including development of a website and patient support materials. | 36363.64 | 36363.64 |
| 2018 | CSL Behring | HAE Australasia | HAE Australasia is a not for profit patient advocacy organisation, dedicated to providing support to Australian and New Zealand hereditary angioedema (HAE) patients and their families, as well as raising awareness of HAE resulting from C1-inhibitor deficiency. Support was provided for the HAE Australasia's State Patient Meetings and Psychology Workshops to help patients living with HAE and who may be experiencing depression and anxiety due to their disease. | 10000 | 10000 |
| 2018 | CSL Behring | HAE Australasia | HAE Australasia is a not for profit patient advocacy organisation, dedicated to providing support to Australian and New Zealand hereditary angioedema (HAE) patients and their families, as well as raising awareness of HAE resulting from C1-inhibitor deficiency. Support was provided to assist with HAE Australasia's Global Multicentre Registry. | 10000 | 10000 |
| 2018 | CSL Behring | HAE Australasia | HAE Australasia is a not for profit patient advocacy organisation, dedicated to providing support to Australian and New Zealand hereditary angioedema (HAE) patients and their families, as well as raising awareness of HAE resulting from C1-inhibitor deficiency. Support was provided to HAE Australasia to help increase Australian and New Zealand community awareness and understanding of hereditary angioedema through their disease awareness program. | 20000 | 20000 |
| 2018 | CSL Behring | Haemophilia Foundation Australia | The Haemophilia Foundation of Australia (HFA) is an organisation that represents people with haemophilia, von Willebrand disorder and other inherited bleeding disorders. Support was provided to assist a continuing education plan to enable members of the Australia and New Zealand Physiotherapy Haemophilia Group (ANZPHG) to develop and enhance the national standard of physiotherapy care. | 1335 | 1335 |
| 2018 | CSL Behring | Haemophilia Foundation Australia | The Haemophilia Foundation of Australia (HFA) is an organisation that represents people with haemophilia, von Willebrand disorder and other inherited bleeding disorders. Support was provided to assist in the development of personal video stories of people living with bleeding disorders to raise awareness of bleeding disorders. | 20000 | 20000 |
| 2018 | CSL Behring | Haemophilia Foundation Australia | The Haemophilia Foundation of Australia (HFA) is an organisation that represents people with haemophilia, von Willebrand disorder and other inherited bleeding disorders. Support was provided to assist the HFA's 2018 Youth Lead Connect (YLC) program to build education and life skills for young people in the bleeding disorders community. | 25000 | 25000 |
| 2018 | CSL Behring | Immune Deficiency Foundation Australia | The Immune Deficiencies Foundation Australia (IDFA) is a not-for-profit organisation raising awareness and caring for people who have Primary (Genetic) and Secondary (due to chemotherapy and other treatments/ or autoimmune illness). Support was provided for sponsorship of the 2018 Young Adult Support conference for patients living with Primary Immune Deficiencies and patient education through the printing of the Secondary Immune Deficiency Patient booklet. | 40000 | 40000 |
| 2015 | Eisai | Breast Cancer Network Australia | Donation to BCNA in lieu of Company Christmas Cards 2014 | $100 Donation | 100 |
| 2015 | Eisai | Breast Cancer Network Australia | Donation to BCNA in lieu of Company Christmas Cards 2015 | $200 Donation | 200 |
| 2015 | Eisai | Epilepsy Action Australia | Donation to EAA in lieu of Company Christmas Cards 2014 | $100 Donation | 100 |
| 2015 | Eisai | Epilepsy Action Australia | Donation to EAA in lieu of Company Christmas Cards 2015 | $200 Donation | 200 |
| 2015 | Eisai | Epilepsy Foundation | Packing of boxes, items etc for Purple Day to support annual fundraiser. Make thankyou phone calls on behalf of the organisation to regular donors. Volunteering of Staff time | Volunteering of Staff time | 0 |
| 2015 | Eisai | Epilepsy Foundation | Part of a team building activity to build 2 bikes for donation to 2 children with Epilepsy. Volunteering of Staff time & Donation of 2 Childrens bikes ($200) | Volunteering of Staff time & Donation of 2 Childrens bikes ($200) | 200 |
| 2015 | Eisai | Epilepsy Queensland (QLD) | Opportunity to support QLD Epilepsy Symposium Volunteering of Staff time to support patient event | Volunteering of Staff time to support patient event | 0 |
| 2015 | Eisai | Think Pink Foundation | Opportunity to support monthly wellness activities. Volunteering of Staff time to support patient event | Volunteering of Staff time to support patient event | 0 |
| 2016 | Eisai | Epilepsy Foundation | Sorting and organising merchandise items for upcoming Purple Day sale | Volunteering of staff time | 0 |
| 2016 | Eisai | Epilepsy Foundation | Packing of boxes and items for Purple Day to support annual fundraiser | Volunteering of staff time | 0 |
| 2016 | Eisai | Think Pink Foundation | Volunteering of staff time to support their general office administration tasks, including processing of donations, sorting brochures, & cleaning the patient stay apartment | Volunteering of staff time | 0 |
| 2017 | Eisai | Think Pink Foundation | Staff volunteering at Open Day at the Think Pink Centre. Included help with the set-up of the Open Day, assisting with catering throughout the day, & fundraising collection. | Volunteer of staff time | 0 |
| 2017 | Eisai | Think Pink Foundation | Staff volunteering at one of the Advanced Breast Cancer patient days. Included set-up of Art Therapy, assisting with catering, and also facilitated some transport logistics to ensure patients arrived & departed safely. | Volunteer of staff time | 0 |
| 2017 | Eisai | Very Special Kids | Staff volunteering at Very Special Kids - Sibling day and Bereavement day to care for a group of Children, with siblings whom have life threatening illnesses. | Volunteer of staff time | 0 |
| 2018 | Eisai | Gastroenterology Australia Research & Education | Support the Gastroenterology Society of Australia towards the development of a national Consensus Statement on the management of Hepatocellular Carcinoma | 15,000.00 AUD in Cash | 15000 |
| 2018 | Eisai | McGrath Foundation | Charitable contribution to McGrath Foundation | 200.00 AUD in Cash | 200 |
| 2019 | Eisai | Think Pink Foundation | Support for the Think Pink Education Forum 2019. This Educational Forum featured presentations on metastatic breast cancer. | 450 | 450 |
| 2013 | Eli Lilly | Alzheimer’s Australia | Grant for Dementia Awareness speaking tour (scheduled for 2014) - including speaker fees and tour promotion | 12200 | 12200 |
| 2013 | Eli Lilly | Alzheimer’s Australia | Grant to support Love Loss and Laughter Exhibition – costs for exhibition development and display | 60000 | 60000 |
| 2013 | Eli Lilly | Cure Our Kids | Grant to support 2014 Oncology diaries – printing and distribution | 2750 | 2750 |
| 2013 | Eli Lilly | Diabetes Australia | Grant to support formation of Diabetes Australia Youth Ambassador Program – registration at IDF World Diabetes Congress | 15000 | 15000 |
| 2013 | Eli Lilly | Diabetes Australia | Grant to support printing and production of Diabetes Management in General Practice Guidelines 2014 | 25000 | 25000 |
| 2013 | Eli Lilly | JDRF Australia | Peer Support Program Partnership to support roll out of services coordinated by JDRF, with Lilly communicating to HCPs | 50000 | 50000 |
| 2013 | Eli Lilly | Lung Foundation Australia | Grant to support National Shine a Light on Lung Cancer Awareness Events – development of collateral, kits & resources | 12500 | 12500 |
| 2013 | Eli Lilly | Lung Foundation Australia | Grant to support Lung Cancer Telephone Support Groups including facilitator training, group set up and facilitator fees, and set up costs | 15000 | 15000 |
| 2013 | Eli Lilly | Mental Illness Fellowship of Australia | Grant to support Schizophrenia Awareness Week 2013 | 22000 | 22000 |
| 2013 | Eli Lilly | National Heart Foundation Of Australia | Roundtable membership and Sponsorship of Research Award | 25000 | 25000 |
| 2013 | Eli Lilly | Rare Cancers Australia | Grant to support preparation of Rare Cancers Evidence Report - printing, distribution and launch costs | 4500 | 4500 |
| 2013 | Eli Lilly | Rare Cancers Australia | Grant to support Parliamentary Launch Event – Rare Cancers Baseline Report | 10000 | 10000 |
| 2013 | Eli Lilly | Rare Voices Australia | Grant to support Rare Disease Day Event at Parliament | 8000 | 8000 |
| 2013 | Eli Lilly | Skin & Cancer Foundation Australia | Grant in Support of the Australasian Psoriasis Registry | 30000 | 30000 |
| 2014 | Eli Lilly | Alzheimer's Australia | Grant for Improving Assessment and Management of Dementia in General Practice. This grant supported the delivery of educational modules for GPs with an interest in dementia assessment and management during the Brisbane and Perth GPCE conferences. Lilly wa | 25000 | 25000 |
| 2014 | Eli Lilly | Alzheimer's Australia New South Wales (NSW) | Grant to purchase four corporate dinner tickets for 'A Night with Parky', Alzheimer's Australia NSW awareness evening. | 780 | 780 |
| 2014 | Eli Lilly | Alzheimer's Australia New South Wales (NSW) | Grant for Memory Walk & Jog 2014. Grant supported education and engagement activities and printing of booklets for the event. Lilly was not involved with the development of any content. | 12000 | 12000 |
| 2014 | Eli Lilly | Australasian Paediatric Endocrine Group | Grant to fund APEG Research Grants. The APEG research grants support research in Australia and New Zealand into any aspect of paediatric endocrinology or diabetes. Grant provided to APEG which then disseminates to awardees. Specific research projects chos | 15000 | 15000 |
| 2014 | Eli Lilly | Australian Diabetes Educators' Association | ADEA/Lilly Credentialed Diabetes Educator of the Year Awards (CDE) - Phase 1. Funding provided support for education and awareness activities associated with promotion of the award and role of Credentialed Diabetes Educators. | 19000 | 19000 |
| 2014 | Eli Lilly | Cure Our Kids | Grant to support printing of 2015 Oncology Diaries. Diaries provided to newly diagnosed families and those currently in treatment either in hospital or via Oncology clinics. All content developed by Cure Our Kids Limited. | 3000 | 3000 |
| 2014 | Eli Lilly | Diabetes Australia | Grant for printing and mailing of Diabetes Management in General Practice (DMiGP) Guidelines. Lilly was not involved in the development of any content. | 18000 | 18000 |
| 2014 | Eli Lilly | JDRF Australia | Grant to purchase dinner tickets for JDRF Gala Ball 2014. Funds: silver sponsorship of corporate table at annual JDRF Ball. Funds raised go towards T1 diabetes research. | 3500 | 3500 |
| 2014 | Eli Lilly | JDRF Australia | Peer Support Program Partnership to support roll out of services coordinated by JDRF, with Lilly communicating program to HCPs. | 60000 | 60000 |
| 2014 | Eli Lilly | Mental Illness Fellowship of Australia | Grant towards support for development of PR campaign and collateral to promote Schizophrenia Awareness Week 2014. All content developed by Mental Illness Fellowship of Australia Inc. | 5000 | 5000 |
| 2014 | Eli Lilly | Rare Cancers Australia | Grant for Parliamentary Launch Event of Rare Cancers Australia Limited Baseline Report. Grant funding supported the event which aimed to promote the report into the state of rare and less common cancers. | 10000 | 10000 |
| 2014 | Eli Lilly | Rare Cancers Australia | Purchase of dinner tickets for 'Sick or Treat' Charity Ball, Rare Cancers Australia annual charity event. | 10000 | 10000 |
| 2015 | Eli Lilly | Alzheimer’s Australia New South Wales (NSW) | Funding used to support the education and engagement component associated with the 'Memory Van' for the 2016 Memory Walk & Jog event. | 15000 | 15000 |
| 2015 | Eli Lilly | Arthritis Foundation of Australia | Printing costs associated with Health consumer booklets: Arthritis Australia's 10 Steps and Rheumatoid Arthritis Consumer Information booklets. Lilly had no control or involvement with the development of the content of these booklets. | 6592 | 6592 |
| 2015 | Eli Lilly | Arthritis Foundation of Australia | Support for Arthritis Australia via the Medicines Australia Community Chest Program. All funds provided to Arthritis Australia through the program were directed towards a study into the economic cost of arthritis. | 20000 | 20000 |
| 2015 | Eli Lilly | Arthritis New South Wales (NSW) | Sponsorship to support "Our Joint - The largest gathering of Skeletons", a public event aimed to raise awareness of arthritis and osteoporosis within the community. | 5000 | 5000 |
| 2015 | Eli Lilly | Diabetes Australia - Victoria (VIC) | Funding to support the Diabetes in Schools Project : web and hardcopy resources for staff, parents and children. Lilly was not involved in the content or development of any materials associated with this activity. | 15000 | 15000 |
| 2015 | Eli Lilly | National Heart Foundation Of Australia | Bronze membership of Pharmaceutical Roundtable | 20000 | 20000 |
| 2015 | Eli Lilly | Redkite | Grant to support printing of 2016 Oncology Diaries. Diaries provided to newly diagnosed families and those currently in treatment either in hospital or via Oncology clinics. Lilly was not involved in the development of any content for these resources. | 4000 | 4000 |
| 2016 | Eli Lilly | Alzheimer's Australia New South Wales (NSW) | Support for Living Well with Dementia Conference | 5000 | 5000 |
| 2016 | Eli Lilly | Alzheimer's Australia New South Wales (NSW) | Support for Memory, Walk & Jog event | 25000 | 25000 |
| 2016 | Eli Lilly | Arthritis Foundation of Australia | Support for printing and distribution costs associated with the “10 Steps for living well with Arthritis” and “Taking control of your Rheumatoid Arthritis” Consumer Booklets. Lilly was not involved in the content or development of any content for these r | 7393 | 7393 |
| 2016 | Eli Lilly | Arthritis Foundation of Australia | Support for the Community Chest program | 20000 | 20000 |
| 2016 | Eli Lilly | Arthritis Queensland (QLD) | Support for Arthritis Week | 5000 | 5000 |
| 2016 | Eli Lilly | Diabetes Australia | Support for printing costs associated with the Diabetes Education in General Practice books. Lilly was not involved in the content or development of any content for these resources. | 10000 | 10000 |
| 2017 | Eli Lilly | Alzheimer's Australia New South Wales (NSW) | Support for Memory, Walk and Jog event | 10000 | 10000 |
| 2017 | Eli Lilly | Arthritis Foundation of Australia | Support for Arthritis Australia Community Chest | 20000 | 20000 |
| 2017 | Eli Lilly | Arthritis Foundation of Australia | A National Summit for a proposed Rheumatoid Arthritis Support Program | 46350 | 46350 |
| 2017 | Eli Lilly | Arthritis Queensland (QLD) | Sponsorship for GP seminar, "Rheumatology in Primary Care" | 750 | 750 |
| 2017 | Eli Lilly | Rare Cancers Australia | Sponsorship of the Rare Solutions Report | 20000 | 20000 |
| 2017 | Eli Lilly | Rare Cancers Australia | Sponsorship of the continuation of the Cancer Drugs Access Committee | 30000 | 30000 |
| 2018 | Eli Lilly | Australian Diabetes Educators' Association | Credentialed Diabetes Educator (CDE) Awards | 40000 | 40000 |
| 2018 | Eli Lilly | Brain Foundation | Sponsorship of Headache and Migraine Awareness Week | 15000 | 15000 |
| 2018 | Eli Lilly | Global Healthy Living Foundation | Sponsorship of the Creaky Joints Australia Patient Guidelines in RA | 50000 | 50000 |
| 2018 | Eli Lilly | Rare Cancers Australia | Sponsorship of the Rare Solutions Report and the Canberra Forum | 20000 | 20000 |
| 2019 | Eli Lilly | Arthritis Foundation of Australia | Sponsorship of the Rheumatoid Arthritis Support Program | 150000 | 150000 |
| 2019 | Eli Lilly | Australian Diabetes Educators' Association | Credentialed Diabetes Educator (CDE) Awards | 40000 | 40000 |
| 2019 | Eli Lilly | Brain Foundation | Sponsorship Headache and Migraine Awareness Week | 15000 | 15000 |
| 2019 | Eli Lilly | Patient Voice initiative | Sponsorship of 2019 activities including the Consumer Input Toolkit and the SPEAKERS (Supporting Patient Engagement And Knowledge through Efficient Resource Search) trial | 12000 | 12000 |
| 2019 | Eli Lilly | Rare Cancers Australia | Sponsorship of Halloween Ball | 5000 | 5000 |
| 2019 | Eli Lilly | Rare Cancers Australia | Sponsorship of the National Oncology Alliance | 25000 | 25000 |
| 2020 | Eli Lilly | Brain Foundation | Sponsorship Headache and Migraine Awareness Week | 12000 | 12000 |
| 2020 | Eli Lilly | Eczema Support Australia | Sponsorship of the Get Connected education initiative | 10000 | 10000 |
| 2020 | Eli Lilly | Patient Voice initiative | Sponsorship of 2020 activities including the Consumer Input Toolkit and the SPEAKERS (Supporting Patient Engagement And Knowledge through Efficient Resource Search) trial | 12000 | 12000 |
| 2020 | Eli Lilly | Rare Cancers Australia | Sponsorship of the Pinnacle Asia Digital Workshop Project | 20000 | 20000 |
| 2020 | Eli Lilly | Rare Cancers Australia | Sponsorship of the National Oncology Alliance | 25000 | 25000 |
| 2013 | Gilead | Hepatitis Australia | Support for World Hepatitis Day | 25000 | 25000 |
| 2013 | Gilead | National Association of People with HIV Australia | Projects in Papua New Guinea through the Collaboration for Health in Papua New Guinea | 15000 | 15000 |
| 2013 | Gilead | National Association of People with HIV Australia | HIV Treatment Officers Education Conference | 15000 | 15000 |
| 2013 | Gilead | National Association of People with HIV Australia | Co Sponsor Monthly Treatments publication in gay press | 30000 | 30000 |
| 2013 | Gilead | National Association of People with HIV Australia | HIV Awareness Campaign | 250000 | 250000 |
| 2013 | Gilead | People living with HIV/AIDS (Victoria) | Treatments Publication and education | 6600 | 6600 |
| 2013 | Gilead | Western Australia (WA) AIDS Council | Treatment Forum | 1300 | 1300 |
| 2014 | Gilead | AS Victoria (VIC) | HIV Positive Speakers Bureau | 5000 | 5000 |
| 2014 | Gilead | Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine | Early Treatment Education programmes | 20000 | 20000 |
| 2014 | Gilead | Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine | Hep B GP and Nurse education programmes | 27000 | 27000 |
| 2014 | Gilead | Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine | Projects in Papua New Guinea (PNG) through the Collaboration for Health in PNG | 30000 | 30000 |
| 2014 | Gilead | Hepatitis Australia | World Hepatitis Day | 40000 | 40000 |
| 2014 | Gilead | Hepatitis Australia | HCV Stakeholder support meetings ( 3 meetings) | 57000 | 57000 |
| 2014 | Gilead | Hepatitis New South Wales (NSW) | Community Advocacy Project | 55000 | 55000 |
| 2014 | Gilead | National Association of People with HIV Australia | Co sponsor Monthly treatments publication in gay press | 15000 | 15000 |
| 2014 | Gilead | National Association of People with HIV Australia | HIV Treatments Seminars | 50000 | 50000 |
| 2014 | Gilead | People living with HIV/AIDS (Victoria) | Treatments Newsletter | 6000 | 6000 |
| 2014 | Gilead | Youth Empowerment Against HIV/AIDS | Event partnership with AIDS 2014 Melbourne Youth Force meeting | 3000 | 3000 |
| 2015 | Gilead | Hepatitis Australia | Hepatitis Australia Sponsorship funding | 60000 | 60000 |
| 2015 | Gilead | Hepatitis Queensland (QLD) | Brisbane Indigenous Media Association Campaign as part of World Hepatitis Day activities | 3160 | 3160 |
| 2015 | Gilead | National Association of People with HIV Australia | To Support Positive Living Publication for period Jan‐Jun 2015 | 15000 | 15000 |
| 2015 | Gilead | National Association of People with HIV Australia | Sponsorship Positive Living Publication July‐Dec 2014 | 15000 | 15000 |
| 2015 | Gilead | People living with HIV/AIDS (Victoria) | Living Positive Victoria – Educational Sponsorship Speakers Bureau | 5000 | 5000 |
| 2015 | Gilead | People living with HIV/AIDS (Victoria) | Living Positive Victoria ‐ Educational Sponsorship Poslink Newsletter | 6000 | 6000 |
| 2015 | Gilead | Queensland Positive People | Gilead Fellowship 2016 Grant | 10000 | 10000 |
| 2015 | Gilead | Rare Cancers Australia | Rare Cancers Australia Grant ‐ increase awareness of impact of rare cancers in patients | 25000 | 25000 |
| 2016 | Gilead | Cancer Drugs Alliance | Grant provided to the organisation to support the Cancer Drugs Alliance 2016 who are a non for profit multi stakeholder organisation committed to achieving the best outcomes for cancer patients. This grant donation will assist their committee in conductin | 30000 | 30000 |
| 2016 | Gilead | Hepatitis Australia | Grant provided to Hepatitis Australia for the organisation to support communication and consumer information. Their objective is to utlitise world hepatitis day to focus community awareness on easier access to treatments which cure hepatitis C and manage | 59090.91 | 59090.91 |
| 2016 | Gilead | National Association of People with HIV Australia | Grant provided to the organisation to support the publication of Positive Living Magazine- their publication is a flagship of the organisation and the Positive Living HIV membership nationally. It has become a valuable information and education resource f | 15000 | 15000 |
| 2016 | Gilead | Positive Life New South Wales (NSW) | Grant & Service Fees provided to the organisation to support speakers for their February Internal Conference & Fair Day Exhibition stand costs- Fair day has been held annually since the first spring out pride festival in 1999. Spring out pride festival is | 1120 | 1120 |
| 2016 | Gilead | Queensland Positive People | Grant provided to the organisation with their objective to increase the number of people testing for HIV and syphilis in Toowoomba, the Community HIV Education and Prevention (CHEP) Program project. Program propose to implement a 12-month rapid testing ou | 20000 | 20000 |
| 2016 | Gilead | Western Australia (WA) AIDS Council | Grant provided to the organisation WAAC (Western Australia Aids Council Inc.) in the form of Co-Support for the Treatment Forum . Purpose to engage and educate people living with HIV in Australia via web based content detailing scientific developments & r | 1181.82 | 1181.82 |
| 2017 | Gilead | Hepatitis Australia | Grant provided to support World Hepatitis Day 2017. Hepatitis Australia is a central partner in the national response to viral hepatitis working in close partnership with eight state and territory hepatitis organisations as well as other organisations and individuals who share the same vision to end to hepatitis B and hepatitis C in Australia. Key components of their work are their national policy and advocacy, provision of community information and education and support for hepatitis service delivery. Their objective is to utlitise world hepatitis day to focus community awareness on easier access to treatments which cure hepatitis C and manage hepatitis B. The grant was utilised to produce stakeholder comunication, key messages, merchandising, media releases, online assets and graphics | 30000 | 30000 |
| 2017 | Gilead | National Association of People with HIV Australia | Grant provided to the organisation to support the publication of Positive Living Magazine- their publication is a flagship of the organisation and the Positive Living HIV membership nationally. It has become a valuable information and education resource for the HIV positive community. This grant aids in the production costs of the magazine. | 30000 | 30000 |
| 2017 | Gilead | Rare Cancers Australia | Grant provided to the organisation to support 2017 projects to lead conversations about cancer within the community that will result in a better understanding of the entrenched bias of the current systems against rare cancers and what might be done to address it. Patients with rare cancers face significant hurdles surrounding access to treatment. In order to improve awareness of the issues facing Australians living with rare cancers, RCA will undertake a number of initiatives in 2017. The intent is to directly communicate with federal politicians, members of the medical profession and the general public in a manner that promotes understanding of the issues and challenges surrounding rare cancers in Australia. The grant will assist in the following deliverables Composition of a detailed research/issues paper that draws on RCA's experience in dealing with patients, clinicians and government to highlight the barriers within the current regulatory framework that prevent fair and equitable access to treatment. - Video Community Service Announcement promoting fairer treatment for rare - Co-ordinated and extensive traditional and social media campaign. - MP Dinners staged in Parliament House and featuring high profile speakers discussing the issues and solutions surrounding rare cancers treatment. - Staging of the Canberra Forum - Two one-day events to be held separately in Canberra; scheduled for August and will feature speakers from inside and outside the cancer community discussing the major issues of concern around cancer treatment. | 10000 | 10000 |
| 2017 | Gilead | Western Australia (WA) AIDS Council | Co-Sponsored grant provided to support the WA AIDS Council Treatment Forum which is an annual event that attracts approximately 50 clients and a number of professionals working in the HIV sector. The treatment Forum engages and educates people living with HIV in Australia. The grant contributes to the venue hire, audiovisual & hospitality costs. | 1080 | 1080 |
| 2018 | Gilead | Hepatitis Australia | Hepatitis Australia is a central partner in the national response to viral hepatitis working in close partnership with eight state and territory hepatitis organisations as well as other organisations and individuals who share the same vision to end to hepatitis B and hepatitis C in Australia. Key components of their work are their national policy and advocacy, provision of community information and education and support for hepatitis service delivery. The Grant provided support in the co-ordination of World Hepatitis Day 2018 The objective of WHD 2018 was to engage people who may be missing out on care for hepatitis B and hepatitis C and to connect them to vaccination, testing, treatment and support to achieve improved health outcomes. Funding was utilised in consultant costs, design costs, meeting costs, non-print materials, print materials & bulk mail, WHD website costs, WHD community grants, management. | 30000 | 30000 |
| 2018 | Gilead | National Association of People with HIV Australia | The National Association of People with HIV Australia (NAPWHA) is Australia’s peak non-government organisation representing community- based groups of people living with HIV (PLHIV) The Grant provided support to produce an edition of Positive Living Magazine. Positive Living is an e-magazine for people living with and affected by HIV, published quarterly, Positive Living is the positive voice for PLHIV in Australia with content devised and created by a collective of HIV positive experts. | 10000 | 10000 |
| 2018 | Gilead | Rare Cancers Australia | Rare Cancers Australia Ltd (RCA) is a charity whose purpose is to improve the lives and health outcomes of Australians living with rare and less common (RLC) cancers. The Grant provided to the organisation supports 2018 Rare Cancer Projects. The purpose to lead a conversation about cancer within the community that will result in a better understanding of the entrenched bias of current systems against rare cancers and what might be done to address it. It is also to provide an evidence base that can be shared with health care professionals so they develop a more refined understanding of the registration and reimbursement systems currently operating in Australia and what is needed to ensure broader and fairer access. | 10000 | 10000 |
| 2018 | Gilead | Rare Cancers Australia | Rare Cancers Australia Ltd (RCA) is a charity whose purpose is to improve the lives and health outcomes of Australians living with rare and less common (RLC) cancers. The Grant provided to the organisation supports Rare Cancers Australia funding for the CDAC 2018 projects which aim to lead conversation about cancer within the community that will result in a better understanding of the issues within the current systems and the reforms needed to take advantage of recent scientific breakthroughs. | 30000 | 30000 |
| 2018 | Gilead | Western Australia (WA) AIDS Council | The WA AIDS Council is a non-government organisation committed to the HIV response in Western Australia. Established in 1985, the Council leads the Western Australian community in the provision of a wide range of services in the prevention of HIV, sexually transmitted infections and blood borne viruses, and the treatment and care of people living with HIV and AIDS. The Council provides counseling, wellness, referral, general and financial assistance to people living with HIV; needle and syringe exchange programs; professional training and development for health sector workers and a range of support and prevention education services to target audiences at risk of HIV, sexually transmitted infections and blood borne virus transmissions. The Co-Sponsored Grant provides support towards the Treatment Forum which is an annual event that attracts approximately 120 clients and a number of professionals working in the HIV sector. Although the epidemic has changed over the years HIV research and medication, promoting a healthy lifestyle and challenging stigma are still at the forefront.The Treatment Forum is an important occasion in the PLHIV calendar as it is the main event in WA where HIV concerns are discussed by leading experts. The support provided assists with the program, hospitality, & organisational newsletter that will provide information and key outcomes from the night to members, people with HIV and stakeholders in the WA community. | 2600 | 2600 |
| 2019 | Gilead | Hepatitis Australia | Hepatitis Australia is a central partner in the national response to viral hepatitis working in close partnership with eight state and territory hepatitis organisations as well as other organisations and individuals who share the same vision to end to hepatitis B and hepatitis C in Australia. Key components of their work are their national policy and advocacy, provision of community information and education and support for hepatitis service delivery. The purpose of the grant was in supporting the development of collateral, media and communications associated with Hepatitis Australia's role as national coordinator of World Hepatitis Day (WHD) 2019. Hepatitis Australia manage www.worldhepatitisday.org.au and use their social media accounts & strategic advertising to promulgate messages.They also develop and provide collateral & other assistance to members, partners and individuals to promote WHD viral hepatitis messages at a local level across the country. | 30000 | 30000 |
| 2019 | Gilead | Hepatitis Western Australia (WA) | HepatitisWA (Inc) is a non-profit community-based organisation providing free services to the community. HepatitisWA aims to assist in obtaining the best possible care and support for people affected by hepatitis, reducing discrimination and stigma directed at people living with viral hepatitis and raising community awareness in relation to hepatitis. The Grant provided in support to fund partnering with pharmacy teams in data identified hepatitis hotspots across the state, HepatitisWA aims to put information in the form of an education flyer on risk and testing for hep C directly into the hands of community members in priority populations when they access their local pharmacy for an unrelated health issues. The flyer will act as a resource that lists risk factor of exposure to Hep C that the general community may not be aware of - to prompt them to ask the health practitioner for testing. | 1000 | 1000 |
| 2019 | Gilead | LiverWELL | LiverWeLL trading as Hepatitis Victoria is the peak not-for-profit community organisation working across the state for people affected by or at risk of viral hepatitis and liver disease. Their vision at Hepatitis Victoria is a Victorian community where there are no new infections of viral hepatitis, and where those who have the virus are able to maximise their health and wellbeing. The Grant provided support to increase understanding of liver disease and NASH for liver patients and the general population; increase ability of the target group through appropriate channels to access testing and treatment for NASH; reduce misunderstanding and stigma around NASH; increase culture of health improvement and awareness of liver health through the output of research, consumer engagement and focus testing, resource production, online and print distribution of resources, Hepatitis Infoline, digital platforms such as website & social media accounts, and | 8125 | 8125 |
| 2019 | Gilead | National Association of People with HIV Australia | The National Association of People with HIV Australia (NAPWHA) is Australia's peak non-government organisation representing community- based groups of people living with HIV (PLHIV) The Grant provided support to fund the NAPWHA HIV Criminalisation symposium which is a breakfast event running alongside the Australasian HIV Conference held in Perth. The symposium aims to bring together experts in HIV and criminalisation from multi-disciplinary professions from Australia and the region. The format offers topic based presentations and an opportunity to discuss the impact laws have on HIV transmission and HIV stigma and their impact on people living with HIV (PLHIV). Evidence shows criminalisation does not reduce HIV transmission, and the resulting stigma and discrimination. | 20000 | 20000 |
| 2019 | Gilead | Rare Cancers Australia | Rare Cancers Australia Ltd (RCA) is a registered Australian Charity, DGR Status 1, that was formed in 2012 with the mission to improve the lives and health outcomes of Australians living with a rare or less common cancer. RCA is committed to bringing affordable and equitable access to cancer medicines to all Australians regardless of the commonality of their disease. The Grant provided to the organisation supports the National Cancer Plan Vision 2030. RCA reached out to companies to assist in funding the foundation project that will form the basis of a much-needed Australian National Cancer Plan. The Project engages external consultants to engage in widespread stakeholder consultation and at the conclusion of which the project team will produce a report capturing the vision of cancer treatment in 2030. | 20000 | 20000 |
| 2019 | Gilead | Rare Cancers Australia | Rare Cancers Australia Ltd (RCA) is a charity whose purpose is to improve the lives and health outcomes of Australians living with rare and less common (RLC) cancers. The Grant provided to the organisation supports funding following on from the highly successful "Just a Little More Time" Reports (JLMT) in 2014 and 2016. RCA intends to prepare and publish an updated version in 2019 that will contain expanded definitions of rare and rare subtypes and examine current treatment access. The report was launched in November in conjunction with the RCA CanForum and forms the centre-piece of an extended social and traditional media campaign. RCA undertook a major media campaign around the release of the report. | 25000 | 25000 |
| 2020 | Gilead | ACON Health | Pride in Diversity Membership Fees | 2675 | 2675 |
| 2020 | Gilead | ACON Health | Funding provided from the Gilead COVID-19 Acute Relief and Emergency Support Fund (CARES) to support the purchase of digital equipment that will enable ACON Health to deliver online health promotion, peer support, counselling and other services for our communities. | 38599 | 38599 |
| 2020 | Gilead | Arthritis Foundation of Australia | Funding provided to support MyRA – Arthritis Australia’s Rheumatoid Arthritis Patient Support Program. This is in support of the development of an innovative website and support program to provide tailored information, tools and support for people living with RA, as well as their carers and family. It will also become a quality resource for Rheumatologists, GPs and allied health professionals. | 150000 | 150000 |
| 2020 | Gilead | Australian Crohn's and Colitis Association | Sponsorship of Crohn's & Colitis Australia's (CCA) World Toilet Day Campaign, which aims to inspire positive action to tackle the global sanitation crisis by driving the conversation on accessibility to toilets for people with inflammatory bowel disease, and engaging with the community on social media to find the best go-to toilet spots across Australia. | 5000 | 5000 |
| 2020 | Gilead | Australian Crohn's and Colitis Association | Sponsorship of Crohn's and Colitis Australia's (CCA) National IBD Helpline, which aims to provide a resource for individual help, information and guidance to patients on living with Crohn’s disease or ulcerative colitis. | 25000 | 25000 |
| 2020 | Gilead | Australian Federation of AIDS Organisations | Grant provided to support the development, implementation and promotion of a core HIV education resource, designed in partnership with community and partner organisations, to drive demand for testing, treatment and prevention tools and services. The resource will be developed with a whole of community approach that delivers positive and community informed messages to influence behavioural change and produce informed communities. | 16250 | 16250 |
| 2020 | Gilead | Global Healthy Living Foundation | Grant provided to Global Healthy Living Foundation (GHLF) PTY, and its patient community CreakyJoints Australia, to support Coronavirus patient education, support and outreach. The financial contribution will allow the organisation to continue its efforts developing and implementing vital patient-centred education, support and advocacy for the Australian patient and caregiver community impacted by the ongoing public health crisis. | 15000 | 15000 |
| 2020 | Gilead | Global Healthy Living Foundation | Grant provided to Global Healthy Living Foundation (GHLF) PTY, and its patient community CreakyJoints Australia, to support the expansion of the Rheumatoid Arthritis patient educational resources and patient engagement activities. | 22000 | 22000 |
| 2020 | Gilead | Hepatitis Australia | Grant provided to support the 2020 World Hepatitis Day campaign in Australia, ‘Let’s Talk Hep!’, which aims to provide information that supports people at risk of or living with hepatitis B or hepatitis C to access the best care to maintain or improve their health. Dependent on budget availability (not known during initial planning), the funding may go towards; - New World Hepatitis Day website - Posters (digital and printed) - Creatives for use on social media platforms - Infographics highlighting key facts about hepatitis B and C - World Hepatitis Day video - Public media advertising - Media alert and media Release - Online hepatitis knowledge survey and/or quiz | 10000 | 10000 |
| 2020 | Gilead | Hepatitis Queensland (QLD) | Grant provided to support the state wide elimination hepatitis media campaign, in the month of July, on selected print platforms. The proposed campaign theme, “Find the Hero Inside You”, aims to educate the general population about the liver and drawing attention to the issue of prevention (vaccination for hepatitis B), early detection (testing and cure for hepatitis C) particularly those living with viral hepatitis and therefore those at most risk of severe liver disease including liver cancer. | 4566.3100000000004 | 4566.31 |
| 2020 | Gilead | Hepatitis Queensland (QLD) | Grant provided to support education to prisoners about the importance of early detection, testing and cure for hepatitis, and to upskill the correctional officers workforce in the benefits of hepatitis C treatment for prisoners | 7500 | 7500 |
| 2020 | Gilead | LiverWELL | Funding provided from the Gilead COVID-19 Acute Relief and Emergency Support Fund (CARES) to support the leadership and coordination of the community response to liver disease within the COVID-19 context by: - Reorientate school and community education to digital platforms - Reorientate workforce training initiatives - Expand content and reach of Living Well lifestyle guides - Develop and license associated electronic tools and software - Develop supportive communication and engagement plan to build awareness - Resourcing of additional specialist advice to assist in navigating program of adaption | 45000 | 45000 |
| 2020 | Gilead | National Association of People with HIV Australia | Donation to the NAPWHA COVID-19 National Relief Fund. | 10000 | 10000 |
| 2020 | Gilead | Positive Life New South Wales (NSW) | Funding provided to support #Ending HIV, Now What...? workshops, which involve community engagement/consultations to inform NSW HIV Strategy 2021-2025. The educational objective of the three workshops is to build health literacy, capacity development and empowerment of all people living with HIV in NSW | 24545.45 | 24545.45 |
| 2020 | Gilead | Rare Cancers Australia | Grant provided to support the Societal Impact of Cancer Study, which aims to demonstrate the societal and economic value of therapeutic intervention, that prolongs the lives of parents of young children.The project will involve external consultants to engage in widespreadstakeholder consultation, and at the conclusion of which the project team will produce a report capturing the return to the community of increased investment in cancer care. The project outcomes to include an economic model and report, federal and state government engagement, and public and media engagement. | 15000 | 15000 |
| 2020 | Gilead | Rare Cancers Australia | Funding provided from the Gilead COVID-19 Acute Relief and Emergency Support Fund (CARES) to support Rare Cancers Australia Ltd who has been seriously impacted by the COVID-19 Pandemic. Several major fundraising events have been cancelled which has caused considerable financial stress on the organisation. | 45457.120000000003 | 45457.12 |
| 2020 | Gilead | Rare Cancers Australia | Donation to Rare Cancer Australia's “Facemasks4Firies” fundraising campaign in support of Australian bushfire relief. | 50000 | 50000 |
| 2020 | Gilead | Snowdome Foundation | Funding provided to support the Australasian Lymphoma Alliance (ALA) research programs further development of the website, including the “Members” area - a secure, member-only area, for project sharing, educational updates and publications. | 3500 | 3500 |
| 2013 | GlaxoSmithKline | Asthma Foundation of Victoria (VIC) | Purchase of tickets ($195 for tickets to attend the 50th anniversary celebrations for the asthma federation) | $195 for tickets to attend the 50th anniversary celebrations for the asthma federation | 195 |
| 2013 | GlaxoSmithKline | Kidney Health Australia | Kidney Health Australia Sponsorship ($5000 for Patient Information Project) | $5000 for Patient Information Project | 5000 |
| 2013 | GlaxoSmithKline | Lung Foundation Australia | Support for activities listed in the agreement. ($65000 for activities including training, community awareness, website development, material development, patient rehabilition support.) | $65000 for activities including training, community awareness, website development, material development, patient rehabilition support. | 65000 |
| 2013 | GlaxoSmithKline | Melanoma Patients Australia | Attendance at the melanoma consumer forum held in conjunction with the 2013 Global Controversies and Advances in Skin Cancer Congress, Brisbane Convention Centre. ($25,000 includes meals, accomodation and travel for 2 staff and patients.) | $25,000 includes meals, accomodation and travel for 2 staff and patients. | 25000 |
| 2013 | GlaxoSmithKline | National Asthma Council Australia | Funding to support the translation of written asthma action plans into 9 languages, the printing of 26,500 additional asthma action plan wallets and the printing of 10000 copies of the NAC asthma action plan z-cards. | 61750 | 61750 |
| 2013 | GlaxoSmithKline | Polio Australia | Polio Australia Sponsorship ($8000 for Polio Retreat) | $8000 for Polio Retreat | 8000 |
| 2013 | GlaxoSmithKline | Pulmonary Hypertension Association Australia | Non monetary donation. Resources in kind. (Non monetary support to assist in filming and video development.) | Non monetary support to assist in filming and video development. | 0 |
| 2013 | GlaxoSmithKline | Rare Cancers Australia | Support for the development and printing of Rare Cancer Evidence Report | 10000 | 10000 |
| 2013 | GlaxoSmithKline | Rare Voices Australia | Support for Rare Voices Australia ($10,000 for running educational workshops for patients and their carers on the lifesaving drugs program.) | $10,000 for running educational workshops for patients and their carers on the lifesaving drugs program. | 10000 |
| 2014 | GlaxoSmithKline | AS Victoria (VIC) | Product Donation (1,000 x mouthpeices to ensure appropriate use of placebo devices during training) | 1,000 x mouthpeices to ensure appropriate use of placebo devices during training | 0 |
| 2014 | GlaxoSmithKline | Asthma Australia | Product Donation (Donation of 1,545 x Breo Ellipta placebo devices and 2170 x MDI placebo devices for use at State based foundations) | Donation of 1,545 x Breo Ellipta placebo devices and 2170 x MDI placebo devices for use at State based foundations | 0 |
| 2014 | GlaxoSmithKline | Asthma Australia | Financial Support ($40,000 as per 2014 agreement: magnets, support for patient information kits) | $40,000 as per 2014 agreement: magnets, support for patient information kits | 40000 |
| 2014 | GlaxoSmithKline | Asthma Foundation of Victoria (VIC) | Product Donation (768 x Ventolin donation to Morwell community in response to Hazelwood mine fire) | 768 x Ventolin donation to Morwell community in response to Hazelwood mine fire | 0 |
| 2014 | GlaxoSmithKline | Asthma Foundation of Victoria (VIC) | Product Donation (1, 080 x Ventolin donation to Morwell community in response to Hazelwood mine fire) | 1, 080 x Ventolin donation to Morwell community in response to Hazelwood mine fire | 0 |
| 2014 | GlaxoSmithKline | Asthma Foundation of Victoria (VIC) | Product Donation (Donation of 1000 MDI mouthpieces for use in Asthma Victoria training) | Donation of 1000 MDI mouthpieces for use in Asthma Victoria training | 0 |
| 2014 | GlaxoSmithKline | Asthma Foundation of Victoria (VIC) | Financial Support ($5,500 for filiming of symposium at Royal Melbourne Hospital for accessibility of larger audience) | $5,500 for filiming of symposium at Royal Melbourne Hospital for accessibility of larger audience | 5500 |
| 2014 | GlaxoSmithKline | Australian Cervical Cancer Foundation | Financial Support ($10,000 for the support of a community awareness campaign, aimed at generating awareness on the importance of regular pap tests) | $10,000 for the support of a community awareness campaign, aimed at generating awareness on the importance of regular pap tests | 10000 |
| 2014 | GlaxoSmithKline | Brain Tumour Alliance Australia | Financial Support ($15,000 support for the development and maintenance of digital channels) | $15,000 support for the development and maintenance of digital channels | 15000 |
| 2014 | GlaxoSmithKline | Foundation 49: Men's Health | Financial Support ($18,800 support for the development, printing and distribution of the Men's Health Toolkit booklet) | $18,800 support for the development, printing and distribution of the Men's Health Toolkit booklet | 18800 |
| 2014 | GlaxoSmithKline | Melanoma Patients Australia | Financial Support ($660 for the Melanoma Patients Australia gala dinner) | $660 for the Melanoma Patients Australia gala dinner | 660 |
| 2014 | GlaxoSmithKline | Melanoma Patients Australia | Financial Support ($25,250 for attendance of Melanoma Patients Australia staff and support at group facilitator at Melanoma Patients Australia workshop) | $25,250 for attendance of Melanoma Patients Australia staff and support at group facilitator at Melanoma Patients Australia workshop | 25250 |
| 2014 | GlaxoSmithKline | Polio Australia | Financial Support ($8,000 for the 2014 Polio Retreat) | $8,000 for the 2014 Polio Retreat | 8000 |
| 2014 | GlaxoSmithKline | Rare Cancers Australia | Financial Support ($10,000 for the development and maintenance of the 'Sick or Treat' website) | $10,000 for the development and maintenance of the 'Sick or Treat' website | 10000 |
| 2014 | GlaxoSmithKline | Rare Cancers Australia | Financial Support ($15,000 for the Rare Cancers Australia position paper and budget submission) | $15,000 for the Rare Cancers Australia position paper and budget submission | 15000 |
| 2014 | GlaxoSmithKline | Rare Cancers Australia | Financial Support ($25,000 for the Rare Cancers Roadshow ($12,500), development support for the Rare Cancers Australia website ($10,000), administrative support ($2,500)) | $25,000 for the Rare Cancers Roadshow ($12,500), development support for the Rare Cancers Australia website ($10,000), administrative support ($2,500) | 25000 |
| 2014 | GlaxoSmithKline | Rare Voices Australia | Financial Support ($20,000 for the production of 'Australian Experience': a video highlighting Australians living with a rare disease) | $20,000 for the production of 'Australian Experience': a video highlighting Australians living with a rare disease | 20000 |
| 2015 | GlaxoSmithKline | Asthma Australia | Partnership in a GSK led disease awareness campaign 'Asthma; Know Your Options' | Non monetary support | 0 |
| 2015 | GlaxoSmithKline | Asthma Australia | Donation of 1,000 Asthma Control Test (Asthma Score) note pads which were used as part of the organisation's disease awareness activities during the National Asthma Week | Non-monetary support - Donation value of $500 | 500 |
| 2015 | GlaxoSmithKline | Asthma Australia | Independent restricted grant to support the development of a digital patient tool designed to provide key information and messages to patients | 54000 | 54000 |
| 2015 | GlaxoSmithKline | Asthma Foundation of Victoria (VIC) | Donation of 4,000 MDI placebo inhalers, 500 Accuhaler placebo devices and 500 Ellipta placebo devices for training purposes | Non-monetary support - Donation value of products $15,000 | 15000 |
| 2015 | GlaxoSmithKline | Australian Cervical Cancer Foundation | Independent grant to support the development of a mobile app aimed to improve cervical cancer prevention awareness and adherence to cervical screening | 20000 | 20000 |
| 2015 | GlaxoSmithKline | Brain Tumour Alliance Australia | Independent grant to support BTAA build additional funcationality to their existing website which will allow the organisation to be more effective in managing their online membership subscription | 6000 | 6000 |
| 2015 | GlaxoSmithKline | Fabry Australia | Independent grant to support costs associated with a strategic planning day as well as a Fabry patient conference | 15000 | 15000 |
| 2015 | GlaxoSmithKline | Foundation 49 Men's Health | Independent grant to enable Foundation 49 to support 15 local community groups, each being allocated $2,000 to facilitate a men's health event/activity | 30000 | 30000 |
| 2015 | GlaxoSmithKline | Foundation 49: Mens Health | Partnership with BPH awareness campaign | Non monetary support | 0 |
| 2015 | GlaxoSmithKline | Foundation 49: Mens Health | Partnership with men's health campaign | Non-monetary support | 0 |
| 2015 | GlaxoSmithKline | Lung Foundation Australia | Product donation - 135 Accuhaler, 125 MDI and 460 Ellipta | Non-monetary support - Donation value of products $2040 | 2040 |
| 2015 | GlaxoSmithKline | Lung Foundation Australia | Independent grant to support the Lungs in Action program. Support was also provided to local patient advocacy and support groups associated with the Lung Foundation | 50000 | 50000 |
| 2015 | GlaxoSmithKline | Meningococcal Australia | Travel and accomodation assistance to enable the organisation to participate in media activities related to the public campaign 'Know, Check, Act' | 1540 | 1540 |
| 2015 | GlaxoSmithKline | National Asthma Council Australia | Partnership with a disease awareness campaign 'Asthma; Know Your Options' | Non monetary support | 0 |
| 2015 | GlaxoSmithKline | National Asthma Council Australia | Donation of 250 Accuhaler placebo devices, 250 Ellipta placebo devices and 200 MDI placebo devices for the purpose of community health worker training | Non-monetary support - Donation value of products $2,100 | 2100 |
| 2015 | GlaxoSmithKline | National Asthma Council Australia | Independent grant to support the printing of Asthma Action Plans | 8900 | 8900 |
| 2015 | GlaxoSmithKline | National Asthma Council Australia | Independent grant to support the development of a digital social hub for parents and children with asthma | 29800 | 29800 |
| 2015 | GlaxoSmithKline | Polio Australia | Independent restricted grant to support with the costs associated with the annual Polio Australia Retreat in Victoria | 10000 | 10000 |
| 2015 | GlaxoSmithKline | Pulmonary Hypertension Association Australia | Travel and accomodation assistance for two staff members of the association to attend the annual conference of the Pulmonary Hypertension Society of Australia and New Zealand. In their capacity as invited guests at the conference, PHAA sought to strengthe | 3000 | 3000 |
| 2015 | GlaxoSmithKline | Rare Cancers Australia | Independent restricted grant to sponsor the organisation's annual Sick or Treat fundraising gala and supplementary communications campaign | 20000 | 20000 |
| 2015 | GlaxoSmithKline | Rare Voices Australia | Grant to support the development of an implementation strategy for a national plan for rare diseases | 15000 | 15000 |
| 2015 | GlaxoSmithKline | Rare Voices Australia | Financial support for the Forgotten Ones photography project which is an exhibition dedicated to showcasing the stories of patients and carers | 15000 | 15000 |
| 2016 | GlaxoSmithKline | Allergy & Anaphylaxis Australia | The Kid's 'Food Allergies for Dummies' resource - the development of a special edition for parents of newly diagnosed children with food allergy. Review, print and distribution of Be a M.A.T.E bookmark Print and disseminate posters and flyers to schools, | 45000 | 45000 |
| 2016 | GlaxoSmithKline | Asthma Australia | Placebo donation for training purposes to support Asthma Foundation in their training sessions in each state. Total placebo donations of 3130 devices | 9390 | 9390 |
| 2016 | GlaxoSmithKline | Asthma Australia | Support of the COACH patient support program | 65000 | 65000 |
| 2016 | GlaxoSmithKline | Australian Scleroderma Interest Group | The Fellowship provides support for rheumatologist or physician-in-training to gain further education in the study of patients with systemic sclerosis and its complications such as pulmonary hypertension. The financial support provided will be used to un | 20000 | 20000 |
| 2016 | GlaxoSmithKline | Foundation 49: Men's Health | Attendance for two staff members at F49's Men's Health business breakfast 2016 | 200 | 200 |
| 2016 | GlaxoSmithKline | Foundation 49: Men's Health | Funding for Web Based Health & Educational Tool 'Man Test' Only (digital distribution) | 66000 | 66000 |
| 2016 | GlaxoSmithKline | Lung Foundation Australia | Placebo donation for training purposes to support LFA in their training sessions. Total placebo donations of 4720 devices | 14280 | 14280 |
| 2016 | GlaxoSmithKline | Lung Foundation Australia | Support for the Lungs in Action program and support for the re-design and re-printing of LFA patient handbook. | 58300 | 58300 |
| 2016 | GlaxoSmithKline | Meningitis Centre | Support to cover costs of re-printing their patient advocacy materials ;pamphlets, media collaterals etc…Ϳ | 11000 | 11000 |
| 2016 | GlaxoSmithKline | Meningococcal Australia | Attendance and exhibit at Parent, Child & Baby exposition in four states | 17988 | 17988 |
| 2016 | GlaxoSmithKline | National Asthma Council Australia | Updating of inhaler posters in doctor's surgeries and creation of video to show proper technique to use inhalers | 23800 | 23800 |
| 2016 | GlaxoSmithKline | Pancreatic Cancer Support Australia | Financial support to the Pancreatic Cancer Nurse Network for the Annual Nurse Network Retreat and the Nurse Network Program Site Visits | 30000 | 30000 |
| 2016 | GlaxoSmithKline | Polio Australia | Support for a conference bringing patients and doctors together to share new therapies, for doctors to have first hand accounts of patients living with post polio syndrome | 9000 | 9000 |
| 2016 | GlaxoSmithKline | Pulmonary Hypertension Association Australia | Support travel and accommodation costs of conduting Pulmonary Hypertension Association Australia (PHAA)'s first Patient Education and Information day and to assist in bringing their management team for the first time to attend the ASM on October 6 to 8 | 4000 | 4000 |
| 2016 | GlaxoSmithKline | Pulmonary Hypertension Society of Australia and New Zealand | Financial support for the maintenance of the Pulmonary Hypertension Society of Australia and New Zealand (PHSANZ) national Pulmonary Hypertension (PHT) registry | 48000 | 48000 |
| 2016 | GlaxoSmithKline | Rare Cancers Australia | Support for the development and launch of the Just in Time V2 report including parliamentary event | 25000 | 25000 |
| 2017 | GlaxoSmithKline | Asthma Australia | Support of the COACH patient support program (Part 2). Funding was provided over a two year period to assist in the development and implementation of the COACH program which is a goal setting program for people with poorly controlled asthma. This program is a standardised coaching program delivered by telephone and mail-out for people with high risk of chronic respiratory diseases like asthma. The program is intended to facilitate the improved uptake of evidence based asthma management, such as the asthma cycle of care and asthma action plans and offers great potential to optimise management and thus reduce negative health impacts. | 65000 | 65000 |
| 2017 | GlaxoSmithKline | Foundation 49 Men's Health | Purchase of 10 tickets for GSK staff to attend the Foundation 49 Men's Health business breakfast, which is an annual fundraising event with the aim to raise awareness of the importance of Men's Health and encourage men to have regular health checks. This specific business breakfast was an opportunity for Foundation 49 to launch a new initiative 'The Man Test' which is a quick 15 question quiz designed to start the 'health conversation' with men. | 1100 | 1100 |
| 2017 | GlaxoSmithKline | Meningitis Centre | Financial support to cover costs of flight and accommodation for two people to attend and operate stands at the Pregnancy and Baby Exposition in Perth, Melbourne and Sydney with the aim of raising awareness about meningococcal disease to th general public and specifically targetting pregnant women. | 7365 | 7365 |
| 2017 | GlaxoSmithKline | National Asthma Council Australia | Placebo device donation for training purposes; total of 150 devices | 450 | 450 |
| 2017 | GlaxoSmithKline | National Asthma Council Australia | To support the development of the Asthma Buddy mobile website that will enable users to create individual asthma action plans that can be accessed online or via their mobile phone. The objectives of the project is to provide a comprehensive summary of asthma diagnosis and management for people with asthma and their families. Funding was also requested for the printing and distribution of My Asthma Guide handbook. | 52400 | 52400 |
| 2017 | GlaxoSmithKline | Polio Australia | Support for The Late Effects of Polio (LEoP) Self-Management Residential Program, which is an annual 4 day health and patient support activity with objectives of the project to elevate the level of knowledge and management of the LEoP across the patient, health and community sectors, improve the quality of life for people living with the LEoP and to provide carers of people living with the LEoP with the opportunity to discuss their own issues, share strategies and receive peer support. | 10000 | 10000 |
| 2018 | GlaxoSmithKline | Allergy & Anaphylaxis Australia | Financial support provided to Allergy and Anaphylaxis Australia (A&AA) to update parent resources. The update includes converting exisiting Camp Booklets for parents, schools and camp facilities into an online e-book (available in both Apple and Android). Having an e-book specific to camp preparation and management of severe allergy allows improved understanding and knowledge of practices that increases safety at camps. In addition, recent changes to the ASCIA Action Plans requires existing resources to be updated and free online training made available. Funding is also to be used to employ a Social Media and Communications Coordinator who will assist in the promotion of this e-book and other educational resources | 25000 | 25000 |
| 2018 | GlaxoSmithKline | Asthma Australia | Donation of 1,182 Ellipta, 1,096 Accuhaler, 2,156 MDI, 426 Haleraid 120 and 411 Haleraid 200 placebo inhaler devices Asthma Australia use GSK placebo devices alongside other companies’ devices in their inhaler technique sessions. In 2018 GSK donated placebo devices to Asthma Australia for use across state-run training programs. This is not an exclusive arrangement between GSK and AA and GSK does not have any input in the development or delivery of these training programs. | 20306 | 20306 |
| 2018 | GlaxoSmithKline | Lung Foundation Australia | Financial support to provide up-to-date information and education to people impacted by Pulmonary Arterial Hypertension (PAH) and increase awareness of PAH in the community to support early diagnosis. The support covers the cost of the webinar platform, creation of a web page and online booking form for registrations, development of a promotional flyer and a promotional campaign. In addition, the planning and delivery of two PAH specific presentations at the Lung Foundation Australia Education Seminar in Perth & Melbourne (includes flight and accommodation costs). | 15000 | 15000 |
| 2018 | GlaxoSmithKline | Lung Foundation Australia | Donation of 3,000 Ellipta, 3,000 Accuhaler and 3,000 MDI placebo inhaler devices for LFA’s education and training. This training provides clinicians with an interactive session to familiarise themselves with the various inhaler devices for COPD. When a placebo is in a training event it is utilised in a demonstration capacity with a 1:1 attendee:placebo ratio. GSK’s placebo devices are included in a pack containing all available COPD inhalers; training demonstrates correct inhaler technique for all devices from all companies. GSK does not have any input in the development or delivery of these training programs. In 2018 the Lung Foundation reached over 2000 GPs, Nurses, and Pharmacists and educated them in correct inhaler device technique through various COPD projects. The inhaler kits and hands-on learning is always well received and of high value to all health professionals that participate in their education. | 40350 | 40350 |
| 2018 | GlaxoSmithKline | Lung Foundation Australia | Support 'Expanding the Lungs in Action Program' for patients with chronic lung disease. The program is an evidence-based intervention of pulmonary maintenance exercise and provides people with chronic lung disease the essential tools to reduce hospital admissions. Lungs in Action classes are delivered by exercise professionals specially trained by Lung Foundation Australia and provides participants with unlimited access to a structured exercise program and connection with peers with similar symptoms and experiences. Lungs in Action also acts a vehicle for promoting disease self management, symptom awareness and control. | 59900 | 59900 |
| 2018 | GlaxoSmithKline | Meningitis Centre | Donation of Menveo and Bexsero vaccines for a family of 10. | 4100 | 4100 |
| 2018 | GlaxoSmithKline | Meningitis Centre | Financial support for costs associated with attendance and stall operations at five Pregnancy and Baby Expos across Australia (Adelaide, Sydney, Brisbane, Perth and Melbourne). The aim of the event is to inform parents of the vaccinations which are available for their children to prevent meningococcal disease. In addition, brochures and information kits on the signs, symptoms, strains, vaccinations, adverse effects and recovery from disease to be disseminated. | 20000 | 20000 |
| 2018 | GlaxoSmithKline | National Asthma Council Australia | Donation of 120 Ellipta, 170 Accuhaler and 170 MDI placebo inhaler devices. The National Asthma Council uses GSK placebo inhalers in an initative to educate pharmacists on best practice asthma care. GSK inhalers are used alongside inhalers from other companies – this is not an exclusive arrangement with NAC and GSK does not have any input in the development or delivery of these training programs | 1897 | 1897 |
| 2018 | GlaxoSmithKline | National Asthma Council Australia | Financial support to review the ‘My Asthma Guide’ booklet, translate and print 10,000 copies. Support to reprint Written Asthma Action Plans Initial phase support of ‘Rethinking Written Asthma Action Plans' project. This publication is based on the Australian Asthma Handbook and is the comprehensive summary of asthma diagnosis and management for people with asthma and their families. | 72700 | 72700 |
| 2018 | GlaxoSmithKline | Pulmonary Hypertension Association Australia | Support for the Pulmonary Hypertension Association Australia (PHAA) Board of Management with $4,000 for their travel and accommodation costs, assisting PHAA to attend a ‘meet and greet’ session and conduct the PHAA Members and Carers Day session at PHSANZ ASM with the theme of Engaging high risk population. The topics of the event were Engaging VFR travellers and migrants, Occupationally at risk groups (focus on HCW influenza vaccination) and Challenges of vaccinating the homeless in the hep A outbreaks in California | 4000 | 4000 |
| 2019 | GlaxoSmithKline | Asthma Australia | Delivery of Emergency Department Discharge Protocol (EDP) project in Victoria. (Funding agreed: $150,000 split over two years. This is the first year's payment.) The project aims to develop and implement an optimised and systematic discharge planning protocol for patients who have attended the Emergency Department for management of an acute asthma episode. | 75000 | 75000 |
| 2019 | GlaxoSmithKline | Hepatitis Australia | Grant to assist with World Hepatitis Day Campaign, which aimed to bring awareness and education to Hepatitis in Australia including treatment, testing and prevention. | 20000 | 20000 |
| 2019 | GlaxoSmithKline | Lung Foundation Australia | Pulmonary Hypertension Program 2019 Program objectives: - Provide up to date information and education to people impacted by PAH - Expand the reach of this information and education via digital platforms for people with PAH who live in rural and remote locations - Increase to awareness of PAH in the community to support early diagnosis | 20000 | 20000 |
| 2019 | GlaxoSmithKline | Lung Foundation Australia | Lungs in Action Program Evaluation A program based around the evidence-based intervention of pulmonary maintenance exercise. This provides people with chronic lung disease the essential need to maintain the gains achieved in Pulmonary Rehabilitation. GSK supported Lung Foundation Australia to undertake an impact evaluation of the Lungs in Action program model in 2019 to determine its effectiveness and the outcomes realised for participants (in line with the Lungs in Action 3 Year Strategic Plan). | 45500 | 45500 |
| 2019 | GlaxoSmithKline | Lung Foundation Australia | Donation of 1000 each of MDIs, Elliptas and Accuhalers to improve COPD patients' medicine adherence through correct inhaler device technique. through various COPD projects. The inhalers are included in kits containing placebo inhalers from all manufacturers, for healthcare professionals (pharmacists, GPs and nurses) to take part in hands-on learning. | Placebo device donation | 0 |
| 2019 | GlaxoSmithKline | Meningitis Centre Australia | Charitable donation, recipient of donation chosen by GSK staff members as part of internal GSK recognition activities. | 1800 | 1800 |
| 2019 | GlaxoSmithKline | Meningitis Centre Australia | Attendance at Baby Expos across Australia in 2019 and costs related to this activity. - To inform as many people as possible about what vaccinations are available for their children to prevent meningococcal and meningitis disease - To offer brochures and information kits on the signs, symptoms, strains, vaccinations, side effects and recovery. | 20000 | 20000 |
| 2019 | GlaxoSmithKline | National Asthma Council Australia | Support an update, print run (50,000 copies) and distribution of My Asthma Guide - My Handbook for Managing Asthma. To provide a comprehensive summary of asthma diagnosis and management for people with asthma and their families. | 58000 | 58000 |
| 2019 | GlaxoSmithKline | Rotarians Against Malaria | Charitable donation, recipient of donation chosen by GSK staff members as part of internal GSK recognition activities. | 1800 | 1800 |
| 2020 | GlaxoSmithKline | Asthma Australia | Delivery of Emergency Department Discharge Protocol (EDP) project in Victoria. The project aims to develop and implement an optimised and systematic discharge planning protocol for patients who have attended the Emergency Department for management of an acute asthma episode. Grant provided to Asthma Australia as part two of our support for their Emergency Discharge Protocol Project | 75000 | 75000 |
| 2020 | GlaxoSmithKline | Australian Patient Organisation Network | Grant provided to support the 2nd Annual Conference of the Australia Patient Organisation Network. | 10000 | 10000 |
| 2020 | GlaxoSmithKline | Hepatitis Australia | Grant provided to support World Hepatitis Day activities | 20000 | 20000 |
| 2020 | GlaxoSmithKline | LiverWELL | Grant provided to Hepatitis Victoria for their health literacy program. The grant was to help develop an online presence in order to improve reach in terms of developing and disseminating 4 different animations that were translated into multiple languages | 31862 | 31682 |
| 2020 | GlaxoSmithKline | Lung Foundation Australia | Grant provided to Lung Foundation Australia for their peer support program: a regular webinar series (10 per year) targeting a range of self-management issues | 15000 | 15000 |
| 2020 | GlaxoSmithKline | Meningitis Centre Australia | Grant provided to support participation by The Meningitis Centre Australia at national baby expos around Australia to reach parents and soon-to-be parents. | 30000 | 30000 |
| 2020 | GlaxoSmithKline | National Asthma Council Australia | Grant provided to support the development, distribution and promption of an information paper: Targeted Biological Therapies for Asthma. | 22500 | 22500 |
| 2020 | GlaxoSmithKline | Pink Hope Community | Grant provided for promotion of events for women experiencing or at risk of breast and ovarian cancer to increase education, empowerment and inspiration. | 10000 | 10000 |
| 2020 | GlaxoSmithKline | Pink Hope Community | Grant provided to Pink Hope to conduct 6 'EduEvening' events over 12 months | 21000 | 21000 |
| 2020 | GlaxoSmithKline | Pulmonary Hypertension Association Australia | Grant provided in support of the development of a patient handbook and car stickers. | 5000 | 5000 |
| 2013 | Ipsen | Australian Pituitary Foundation | To provide support for the Australian Pituitary Foundation database | 4000 | 4000 |
| 2013 | Ipsen | Australian Pituitary Foundation | To provide support for their Patient education Seminar at St Vincents Hospital | 4630 | 4630 |
| 2013 | Ipsen | Australian Pituitary Foundation | To provide sponsorship for 12 months to support their activities throughout the year. (Silver sponsorship) | 12000 | 12000 |
| 2014 | Ipsen | Australian Pituitary Foundation | Silver Sponsorship to support their patient and healthcare educational activities throughout the year and assist with fundraising and mentoring services. | Silver Sponsorship: $12,000.00 Fundraising and Mentoring Service Support: $8,000.00 Total: $20,000.00 | 20000 |
| 2015 | Ipsen | Australian Dystonia Support Group | Assisting The Australian Dystonia Support Group printing 200 patient brochures | 121.82 | 121.82 |
| 2015 | Ipsen | Australian Pituitary Foundation | Gold Sponsorship to support their patient and healthcare educational activities throughout the year and assist with fundraising and mentoring services | 18000 | 18000 |
| 2015 | Ipsen | Benign Essential Blepharospasm (BEB) | Sponsorship for the group to undertake activities such as newsletters, website update and information sessions to build awareness | 1900 | 1900 |
| 2015 | Ipsen | Unicorn Foundation (NeuroEndocrine Cancer Australia) | Providing booth space for the Unicorn Foundation to be present at COSA, November 2015 | Non-financial support only. Allowing for the Unicorn Foundation to share booth space with Ipsen at the COSA conference in November 2015 | 0 |
| 2015 | Ipsen | Unicorn Foundation (NeuroEndocrine Cancer Australia) | Flight and accommodation costs to present at Gastroenteropancreatic Neuroendocrine tumour (GEPNET) dinner meeting in Perth | Flight: $706.82 Accommodation: $285.13 Total: $991.95 | 991.95 |
| 2015 | Ipsen | Unicorn Foundation (NeuroEndocrine Cancer Australia) | Run Melbourne Charity Event - to help raise awareness about Neuroendocrine Cancer (NETs) and funds for research. T-shirts: $2,569.94 Freight for t-shirts: $25.00 Marquee hire: $888.00 Total: $3,482.94 | T-shirts: $2,569.94 Freight for t-shirts: $25.00 Marquee hire: $888.00 Total: $3,482.94 | 3482.94 |
| 2015 | Ipsen | Unicorn Foundation (NeuroEndocrine Cancer Australia) | Grant for awareness and education campaign for neuroendocrine tumours (NET) patients and neuroendocrine tumours (NET) nurses. Website NET Nurse Resource Library (part build): $5,000.00 Conference Poster Presentation: $2,000.00 Re design and printing of Nu | Website NET Nurse Resource Library (part build): $5,000.00 Conference Poster Presentation: $2,000.00 Re design and printing of Nurse materials: $7,000.00 Total: $14,000.00 | 14000 |
| 2016 | Ipsen | Australian Pituitary Foundation | Support both directors to attend the World Alliance of Pituitary Organizations (WAPO) Summit 2016 in Amsterdam and at The Pituitary Foundation's National Conference in Leeds | Flights x 2 directors to attend WAPO meeting: $13,937.88 Registration x 2 directors to attend WAPO meeting: $1,054.95 Accommodation x 2 directors to attend WAPO meeting: $690.40 Flights x 2 directors to attend The Pituitary Foundation's National Conferenc | 17375.86 |
| 2016 | Ipsen | Australian Pituitary Foundation | 2016 projects below: Patient Education : QLD: Lady Cilento Children’s Hospital (congenital paediatric – confirmed) (surgical paediatric -under negotiation) Princess Alexandra Hospital (adult – confirmed) NSW: Garvan Institute of Medical Research (adult – | 25000 | 25000 |
| 2016 | Ipsen | Unicorn Foundation (NeuroEndocrine Cancer Australia) | Grant for awareness and education campaign for neuroendocrine tumours (NET) patients and neuroendocrine tumours (NET) nurses | Series of Webinars: $15,000.00 Series of fact sheets and downloads: $10,000.00 Assistance in attending Cancer Nurses Society of Australia (CNSA) and establishing NET special interest group as part of CNSA: $10,000.00 European Neuroendocrine Tumour Society | 100000 |
| 2017 | Ipsen | Australian Pituitary Foundation | Grant to assist with costs of creation of their Newsletter for 2017. This newsletter provides a critical avenue for The Australian Pituitary Foundation to achieve their key focus in areas of: * Support * Education * Awareness * Organisational Effectiveness | 25000 | 25000 |
| 2017 | Ipsen | Unicorn Foundation (NeuroEndocrine Cancer Australia) | Grant to assist Unicorn Foundation with costs of some of their activities related to their awareness and education campaign for neuroendocrine tumours (NET) patients and neuroendocrine tumours (NET) nurses. | 100000 | 100000 |
| 2018 | Ipsen | Rare Cancers Australia | Grant to support the Cancer Drugs Access Committee (CDAC) 2018 projects. The grant will be used in the following areas: - Consulting fees to consultants to assist with research into specific projects. - Travel and accommodation Expenses associated with prosecuting the CDAC 2018 agenda. - Engagement of PR/Comms Companies to promote the outcomes of CDAC. - Development and implementation of communications campaigns to maximise coverage across electronic, print and social media. - Development of Report Material including appointment of graphic design consultant. Launch Event Costs. | 30000 | 30000 |
| 2018 | Ipsen | Unicorn Foundation (NeuroEndocrine Cancer Australia) | Chairperson at Ipsen's Cancer Registry 9 November 2018 Meeting and present patients apps. | Honorarium: $1,050.00 Total: $1,050.00 | 1050 |
| 2018 | Ipsen | Unicorn Foundation (NeuroEndocrine Cancer Australia) | Ipsen Sponsored Breakfast Session at Asia Pacific Neuroendocrine Tumour Society (APNETS) 9-11 November 2018 in Melbourne and Clinical Oncology Society of Australia (COSA) 13-15 November 2018 in Perth. Present and join a panel of speakers who will support and enrich a video entitled “NET: Connecting the last 110 Years” and allow for up to 2 hours discussions with an Ipsen representative in the lead up to the Event. | Honorarium: $1,750.00 Perth flights: $765.92 Perth 1 night accommodation: $211.91 Perth taxi: $44.53 Melbourne airport parking: $150.00 Total $2,922.36 | 2922.36 |
| 2018 | Ipsen | Unicorn Foundation (NeuroEndocrine Cancer Australia) | Attendance at Ipsen's Telotristat Advisory Board 23 August 2018 Meeting in Sydney. | Honorarium: $3,050.00 Sydney flights: $479.10 Melbourne airport parking: $85.00 Total: $3,614.10 | 3614.1 |
| 2018 | Ipsen | Unicorn Foundation (NeuroEndocrine Cancer Australia) | Grant to support increased awareness and education for neuroendocrine tumours (NET) patients and healthcare professionals carried out by the Unicorn Foundation Australia in 2018. | Webinars: $15,000.00 Upkeep and growth of Salesforce Database of patient information: $15,000.00 Assistance in attendance and booth at CNSA, RACGP, AGITG and COSA: $10,000.00 ENETs attendance for NET Nurse: $2,500.00 Production and dissemination of fact sheets including for symptom control, surgery, treatments, diagnostics: $5,000.00 World NET Cancer Awareness Day Campaign: $2,500.00 Total: $50,000.00 | 50000 |
| 2019 | Ipsen | Australian Pituitary Foundation | Sponsorship of the 2019 Sydney Pituitary Patient Information Session (Seminar), which was held at the St Vincent's Centre for Applied Medical Research in Sydney on 14th September 2019. Sponsorship covers food and beverage costs; and videotaping of the entire session for archiving on the Australian Pituitary Foundation (APF) website for those patients from interstate unable to attend seminar. The primary objective of the patient education seminar is to provide insight into aspects of the management of pituitary tumours for both patients and their carers. This seminar was free of charge to both patients and carers. | Food & Beverage: $2,500.00 Videotaping the session for archiving on the APF website: $5,500.00 Total: $8,000.00 | 8000 |
| 2019 | Ipsen | Liver Foundation | Grant to support funding of a Deloitte Access Economics Report "Social an Economic Cost of Liver Diseases in Australia". Total grant is for $40,000.00 $20,000.00 at initiation of the project (commencement date October 2019). $20,000.00 milestone payment in 2020. | 20000 | 20000 |
| 2019 | Ipsen | NeuroEndocrine Cancer Australia | Grant to support education and awareness activities relating to Neuroendocrine Tumor (NET). 2019 Education activities: - Presentation on GP Education needs at a scientific meeting and an associated working group meeting to help develop a GP education program - SA NET Patient Education Forum (Staff travel, catering and filming) - World NET Cancer Awareness Day Campaign (PR and distribution of materials support) | 25000 | 25000 |
| 2019 | Ipsen | NeuroEndocrine Cancer Australia | Grant for the establishment, support and maintenance of an Australian NET registry (PLANETs). 2019 Phase 3: - Future Management (Monitoring of systems ongoing) | 50000 | 50000 |
| 2019 | Ipsen | Rare Cancers Australia | Grant to assist with the development of a National Cancer Plan, prepared under the auspices of the National Oncology Alliance (a Rare Cancers Australia Initiative). Total project cost of $270,000 involves funding from multiple sources. Funds will be used to fund a program manager to coordinate development of the plan that will be communicated through a nationwide media campaign and via the NOA website which requires redevelopment. | 25000 | 25000 |
| 2019 | Ipsen | Rare Cancers Australia | Sponsorship of Rare Cancers Canberra Forum and "Just a little more time" report. Inclusive of preparation and publishing of report, staging of the Canberra Forum and undertaking of a major media campaign. Total sponsorship is for $40,000. 70% of the total contribution in 2019 and the remaining 30% upon completion of activity. The Canberra Forum is a one day event to held in 2020. 'Just a little more time Report 3.0' has a strong focus on Precision Oncology and legal and regulatory implications. This report highlights the emerging importance of genomics and genetics in future cancer treatment. | 28000 | 28000 |
| 2020 | Ipsen | Australian Pituitary Foundation | Sponsorship for 2020 Pituitary Patient Online Information Sessions (Seminars). Details: Video production of the 3 Seminars scheduled to be presented by APF during the year 2020. This patient education online seminar aims to provide insight into aspects of the management of pituitary tumours. | 15000 | 15000 |
| 2020 | Ipsen | Dystonia Network of Australia | Educational Grant for enhancement of Dystonia App. To develop the educational content which includes reformatting current brochures for the app as well as creating new content. | 5000 | 5000 |
| 2020 | Ipsen | Kaden Centre | Donation for upgrading the organisation’s website to facilitate online individualised exercise programs for people diagnosed with cancer and/or chronic conditions. | 2000 | 2000 |
| 2020 | Ipsen | NeuroEndocrine Cancer Australia | Grant for General Practitioner Education 2020. Improving the education and understanding of General Practitioners in Australia about Neuroendocrine Tumors through online education of General Practitioners. | 62000 | 62000 |
| 2020 | Ipsen | Rare Cancers Australia | Sponsorship of CanForum 9 November 2020 event. 2020 CanForum incorporated the launch of the Vision 20-30 Report: a united case for a National Cancer Plan. | 12000 | 12000 |
| 2020 | Ipsen | Rare Voices Australia | Sponsorship for 1 x Round Table of Companies Membership 2020. Meeting held in November 2020 via zoom. To establish and maintain relationships with commercial companies in order to enhance communication between rare disease stakeholders and collaborate where appropriate on common issues. RVA’s Round Table of Companies is the key vehicle for engaging with key stakeholders, via the Terms of Reference. | 5000 | 5000 |
| 2013 | Janssen | Arthritis Foundation of Australia | 10 Steps for Living Well With Arthritis booklet | 3000 | 3000 |
| 2013 | Janssen | Arthritis Foundation of Australia | Arthritis Disability Research Project | 35000 | 35000 |
| 2013 | Janssen | Australian Crohn's and Colitis Association | Inflammatory Bowel Disease (IBD) educational forums in Sydney and Brisbane during Crohn's & Colitis Awareness Month, May 2013 | 5000 | 5000 |
| 2013 | Janssen | Australian Crohn's and Colitis Association | Development of a Members-only section on the CCA website | 5000 | 5000 |
| 2013 | Janssen | Australian Crohn's and Colitis Association | Production of video series: personal stories of life with an Inflammatory Bowel Disease (IBD) | 10000 | 10000 |
| 2013 | Janssen | Australian Crohn's and Colitis Association | National Crohn's and Colitis Awareness Month (May) 2013 Promotion via television commercial, community service radio announcement, social media, and brochure distribution | 17000 | 17000 |
| 2013 | Janssen | Hepatitis Australia | Love Your Liver Project | 25000 | 25000 |
| 2013 | Janssen | Hepatitis Queensland (QLD) | Beyond the Bars | 91181 | 91181 |
| 2013 | Janssen | Living Positive Hiv | Positive Speakers Bureau 2013: Speaker talks (30) and speaker professional development workshops (2) | 5000 | 5000 |
| 2013 | Janssen | Living Positive Hiv | Poslink Newsletter and Treatment Interactive Events 2013: Newsletter x 4 editions and Events x 3 | 6000 | 6000 |
| 2013 | Janssen | Mental Health Australia | MHCA Pharma Collaboration (MHCA, Janssen, Eli Lilly, Astrazeneca, Lundbeck, Pfizer, Servier Laboratories): Quality Use of Medicines Project: $12,150 Indigenous Comorbidity Publication and Launch: $6,750 World Mental Health Day Parliamentary Breakfast: $4, | 27000 | 27000 |
| 2013 | Janssen | Mental Illness Fellowship of Australia | Schizophrenia Awareness Week 2013: public awareness campaign | 22000 | 22000 |
| 2013 | Janssen | Myeloma Australia | Printing: Myeloma, A Concise Patient Guide, 2012 edition - 1,500 copies | 8900 | 8900 |
| 2013 | Janssen | Myeloma Australia | Production of Medico Face to Face Program (Stage2): filming, web content, information posters | 20380 | 20380 |
| 2013 | Janssen | Myeloma Australia | MFA Myeloma Seminar and Workshop Program 2013 | 45000 | 45000 |
| 2013 | Janssen | SANE Australia | Exhibition stand at the 23rd Mental Health Services Conference 20-23 August 2013 | 597.27 | 597.27 |
| 2013 | Janssen | SANE Australia | Establish the Informal Community Care Network: Communications strategy, media interventions, printed materials, convening Alliance | 90000 | 90000 |
| 2013 | Janssen | Skin & Cancer Foundation Australia | One presentation and workshop for 40 psoriasis patients (2.5 hours) to raise the level of knowledge of psoriasis and facilitate access to greater support networks. | 5000 | 5000 |
| 2013 | Janssen | Skin & Cancer Foundation Australia | Support the provision of Biologics Masterclasses in 2013 | 5000 | 5000 |
| 2013 | Janssen | Sunflower Foundation Australia | Wellness Walk - Increase Mental Health Awareness | 10000 | 10000 |
| 2014 | Janssen | ADDults with ADHD | Annual Conference (Sponsorship) | $5,000 - Sponsorship | 5000 |
| 2014 | Janssen | Arthritis Foundation of Australia | Attendance at American Chamber of Commerce luncheon 28/5/14 (1 representative) | 137.7 | 137.7 |
| 2014 | Janssen | Arthritis Foundation of Australia | Attendance at post-Budget breakfast briefing (2 representatives) 15/5/15 | 160 | 160 |
| 2014 | Janssen | Australian Crohn's and Colitis Association | Attendance at post-Budget breakfast briefing (1 representative) 15/5/15 | 80 | 80 |
| 2014 | Janssen | Australian Crohn's and Colitis Association | Silver Lining Lunch - Sponsorship | $5,000 - Sponsorship | 5000 |
| 2014 | Janssen | Australian Crohn's and Colitis Association | Crohn's & Colitis Awareness Month - Grant | $5,000 - Grant | 5000 |
| 2014 | Janssen | Australian Crohn's and Colitis Association | Bully in the Bowel: Social media campaign, IBD awareness - Sponsorship | $15,000 - Sponsorship | 15000 |
| 2014 | Janssen | Australian Crohn's and Colitis Association | Patient Toolkit - Sponsorship | $20,000 - Sponsorship | 20000 |
| 2014 | Janssen | Australian Crohn's and Colitis Association | Improving IBD Quality of Care Program - Sponsorship; $150,000 over three years | $50,000 - Sponsorship; $150,000 over three years | 50000 |
| 2014 | Janssen | Australian Diabetes Educators' Association | Diabetes education and care management video (Grant) | $10,000 - Grant | 10000 |
| 2014 | Janssen | Australian Federation of AIDS Organisations | Attendance at post-Budget breakfast briefing (1 representative) 15/5/15 | 80 | 80 |
| 2014 | Janssen | CanSpeak | Attendance at American Chamber of Commerce luncheon 28/5/14 (2 representatives) | 275.4 | 275.4 |
| 2014 | Janssen | CanSpeak | Health consumer advocacy workshop 2014 (Sponsorship) | $15,000 - Sponsorship | 15000 |
| 2014 | Janssen | Carers Australia | Attendance at post-Budget breakfast briefing (1 representative) 15/5/15 | 80 | 80 |
| 2014 | Janssen | Carers Australia | Pollie Pedal 2014 - Sponsorship | $50,000 - Sponsorship | 50000 |
| 2014 | Janssen | Hepatitis Australia | Attendance at post-Budget breakfast briefing (1 representative) 15/5/15 | 80 | 80 |
| 2014 | Janssen | Hepatitis Australia | World Hepatitis Day: Love your Liver - Sponsorship | $25,000 - Sponsorship | 25000 |
| 2014 | Janssen | Hepatitis New South Wales (NSW) | Hep Connect Training: capacity building weekend for peer workers to support people living with HCV - Grant | $2,200 - Grant | 2200 |
| 2014 | Janssen | Leukaemia Foundation Of Australia | Patient services brochure and education sessions - Grant | $20,000 - Grant | 20000 |
| 2014 | Janssen | Leukaemia Foundation Of Australia | Myeloma Education Meetings and patient video - Grant | $35,000 - Grant | 35000 |
| 2014 | Janssen | Living Positive Hiv | Positive Speakers Bureau (May-Dec 2014) - Grant | 5000 - Grant | 5000 |
| 2014 | Janssen | Living Positive Hiv | Poslink Newsletter and Treatment Interactive Events 2014 - Grant | 6000 - Grant | 6000 |
| 2014 | Janssen | Lymphoma Australia | Attendance at post-Budget breakfast briefing (1 representative) 15/5/15 | 80 | 80 |
| 2014 | Janssen | Lymphoma Australia | Awareness Month - Grant | $15,000 - Grant | 15000 |
| 2014 | Janssen | Lymphoma Australia | National Lymphoma Education Day (Sept 2014) - Grant | $20,000 - Grant | 20000 |
| 2014 | Janssen | Mental Health Australia | Attendance at post-Budget breakfast briefing (1 representative) 15/5/15 | 80 | 80 |
| 2014 | Janssen | Mental Health Australia | Pharmaceutical Collaboration 2013-2014 - Grant | $28,000 - Grant | 28000 |
| 2014 | Janssen | Mental Illness Fellowship of Australia | Attendance at post-Budget breakfast briefing (1 representative) 15/5/15 | 80 | 80 |
| 2014 | Janssen | Mental Illness Fellowship of Australia | Parliamentary Friends of Mental Illness - Grant | $9,300 - Grant | 9300 |
| 2014 | Janssen | Mental Illness Fellowship of Australia | Schizophrenia Awareness Week 2014 - Sponsorship | $25,000 - Sponsorship | 25000 |
| 2014 | Janssen | Prostate Cancer Foundation of Australia (PCFA) | Blue September - Grant | $15,000 - Grant | 15000 |
| 2014 | Janssen | Prostate Cancer Foundation of Australia (PCFA) | Advanced Prostate Cancer Resource Packs - Grant | $50,000 - Grant | 50000 |
| 2014 | Janssen | Rare Cancers Australia | Sick or Treat Ball - Sponsorship | $10,000 - Sponsorship | 10000 |
| 2014 | Janssen | SANE Australia | Attendance at post-Budget breakfast briefing (1 representative) 15/5/15 | 80 | 80 |
| 2014 | Janssen | Schizophrenia Fellowship Of New South Wales (NSW) (One Door Mental Health) | Sunflower Foundation Wellness Walk 2014 - Sponsorship | $15,000 - Sponsorship | 15000 |
| 2015 | Janssen | ADDults with ADHD | Annual conference - Keeping up with ADHD | 4000 | 4000 |
| 2015 | Janssen | Aftercare | Australian Institute of Policy and Science Post Budget Health Briefing event at Parliament House, Canberra 14/5/15: attendee sponsorship | 80 | 80 |
| 2015 | Janssen | Arthritis Foundation of Australia | Australian Institute of Policy and Science Post Budget Health Briefing event at Parliament House, Canberra 14/5/15: attendee sponsorship x 2 | 160 | 160 |
| 2015 | Janssen | Arthritis Foundation of Australia | Review and revision of booklet: 10 Steps for Living Well with Arthritis | 5000 | 5000 |
| 2015 | Janssen | Arthritis Foundation of Australia | Empower Project: online patient resource - website development | 25000 | 25000 |
| 2015 | Janssen | Arthritis Foundation of Australia | Medicines Australia Community Chest Program: support research, publication and awareness of the Economic Impact of Arthritis study | 40000 | 40000 |
| 2015 | Janssen | Arthritis Foundation of Australia | Empower Project: online patient resource - launch | 59010 | 59010 |
| 2015 | Janssen | Australian Crohn's and Colitis Association | Australian Institute of Policy and Science Post Budget Health Briefing event at Parliament House, Canberra 14/5/15: attendee sponsorship | 80 | 80 |
| 2015 | Janssen | Australian Crohn's and Colitis Association | Inflammatory Bowel Disease Quality of Awareness Program: concept, content development, production of a television campaign to raise awareness of IBD | 5000 | 5000 |
| 2015 | Janssen | Australian Crohn's and Colitis Association | Inflammatory Bowel Disease Quality of Care Program: concept, production, launch of an online support team and helpline | 150000 | 150000 |
| 2015 | Janssen | CanSpeak Australia | Australian Institute of Policy and Science Post Budget Health Briefing event at Parliament House, Canberra 14/5/15: attendee sponsorship | 80 | 80 |
| 2015 | Janssen | Carers Australia | Australian Institute of Policy and Science Post Budget Health Briefing event at Parliament House, Canberra 14/5/15: attendee sponsorship | 80 | 80 |
| 2015 | Janssen | Carers Australia | Pollie Pedal 2015 | 50000 | 50000 |
| 2015 | Janssen | Hepatitis Australia | Australian Institute of Policy and Science Post Budget Health Briefing event at Parliament House, Canberra 14/5/15: attendee sponsorship | 80 | 80 |
| 2015 | Janssen | IBD Support Australia | Australian Gastroenterology Week 2015: attendee sponsorship | 2925 | 2925 |
| 2015 | Janssen | Leukaemia Foundation Of Australia | Australian Institute of Policy and Science Post Budget Health Briefing event at Parliament House, Canberra 14/5/15: attendee sponsorship | 80 | 80 |
| 2015 | Janssen | Leukaemia Foundation Of Australia | Light the Night Partnership 2015-2016 | 100000 | 100000 |
| 2015 | Janssen | Lymphoma Australia | Australian Institute of Policy and Science Post Budget Health Briefing event at Parliament House, Canberra 14/5/15: attendee sponsorship | 80 | 80 |
| 2015 | Janssen | Lymphoma Australia | Patient education materials: production, distribution | 30000 | 30000 |
| 2015 | Janssen | Lymphoma Australia | National Education Day and Lymphoma Survivor Platform | 50000 | 50000 |
| 2015 | Janssen | McGrath Foundation | Australian Institute of Policy and Science Post Budget Health Briefing event at Parliament House, Canberra 14/5/15: attendee sponsorship x 2 | 160 | 160 |
| 2015 | Janssen | Mental Health Australia | Australian Institute of Policy and Science Post Budget Health Briefing event at Parliament House, Canberra 14/5/15: attendee sponsorship | 80 | 80 |
| 2015 | Janssen | Mental Health Australia | Pharmacutical collaboration to make improvements in the area of mental health | 20000 | 20000 |
| 2015 | Janssen | Mental Illness Fellowship of Australia | Federal Parliamentary Friends of Mental Illness Event | 4500 | 4500 |
| 2015 | Janssen | Mental Illness Fellowship of Australia | Public Awareness and Anti-stigma Program 2015 | 47394 | 47394 |
| 2015 | Janssen | Myeloma Australia | Australian Institute of Policy and Science Post Budget Health Briefing event at Parliament House, Canberra 14/5/15: attendee sponsorship | 80 | 80 |
| 2015 | Janssen | Myeloma Australia | Myeloma Scientific Advisory Group Program - six monthly consultation on patient initiatives | 10000 | 10000 |
| 2015 | Janssen | Myeloma Australia | Haematology Society of Australia and New Zealand (HSANZ) Conference: display/information stand | 12000 | 12000 |
| 2015 | Janssen | Myeloma Australia | National Myeloma Week 2015 | 15000 | 15000 |
| 2015 | Janssen | Myeloma Australia | Myeloma Patient Seminars and Workshops Program | 54000 | 54000 |
| 2015 | Janssen | Prostate Cancer Foundation of Australia (PCFA) | Prostate Cancer Awareness Month: raise community awareness and research funding | 25000 | 25000 |
| 2015 | Janssen | Prostate Cancer Foundation of Australia (PCFA) | Aboriginal and Torres Strait Islander (ATSI) monograph and resource materials | 50000 | 50000 |
| 2015 | Janssen | Prostate Cancer Foundation of Australia (PCFA) | Prostate Cancer Regional Patient Forums (Tasmania, ACT, Queensland) | 54000 | 54000 |
| 2015 | Janssen | Rare Cancers Australia | Australian Institute of Policy and Science Post Budget Health Briefing event at Parliament House, Canberra 14/5/15: attendee sponsorship | 80 | 80 |
| 2015 | Janssen | Rare Cancers Australia | Patient Engagement Study Tour USA | 15000 | 15000 |
| 2015 | Janssen | Rare Cancers Australia | Sick or Treat Campaign | 20000 | 20000 |
| 2015 | Janssen | Rare Cancers Australia | Technical extension and integration of web-based oncology navigator | 35000 | 35000 |
| 2015 | Janssen | Rare Cancers Australia | Oncology Funding Navigator | 40000 | 40000 |
| 2015 | Janssen | Rare Voices Australia | Rare Disease Summit | 15000 | 15000 |
| 2015 | Janssen | SANE Australia | Australian Institute of Policy and Science Post Budget Health Briefing event at Parliament House, Canberra 14/5/15: attendee sponsorship x 2 | 160 | 160 |
| 2015 | Janssen | SANE Australia | Mindful Employer Programme | 91900 | 91900 |
| 2015 | Janssen | Schizophrenia Fellowship Of New South Wales (NSW) (One Door Mental Health) | Australian Institute of Policy and Science Post Budget Health Briefing event at Parliament House, Canberra 14/5/15: attendee sponsorship | 80 | 80 |
| 2015 | Janssen | Sunflower Foundation Australia | Wellness Walk 2015 | 13500 | 13500 |
| 2016 | Janssen | Arthritis Foundation of Australia | Rheumatology Nurse Project: assess the scope, activities and benefits in terms of patient experience and outcomes and health system efficiencies and costs, of rheumatology nurses in the management of people with chronic inflammatory arthritis in Australia | 20000 | 20000 |
| 2016 | Janssen | Arthritis Foundation of Australia | Patient education materials, printed and online | 61145 | 61145 |
| 2016 | Janssen | Arthritis Foundation of Australia | EMPOWERED Website 2016: enhance website content, site performance and promotion | 140000 | 140000 |
| 2016 | Janssen | Australian Crohn's and Colitis Association | Crohn's & Colitis Awareness Month: Silver Lining Lunch | 5000 | 5000 |
| 2016 | Janssen | Australian Crohn's and Colitis Association | "Students with IBD" education booklet: design, print, distribution | 10000 | 10000 |
| 2016 | Janssen | Australian Crohn's and Colitis Association | Support Group Network: training program facilitator training development and delivery, training resources/materials | 10000 | 10000 |
| 2016 | Janssen | Australian Crohn's and Colitis Association | ͞Guide to IBD͟ brochure: design, print, distribution | 10000 | 10000 |
| 2016 | Janssen | Australian Crohn's and Colitis Association | World IBD Day: promotional materials and social media development, print, distribution | 25000 | 25000 |
| 2016 | Janssen | Australian Crohn's and Colitis Association | iConnect Information Hub | 55000 | 55000 |
| 2016 | Janssen | IBD Support Australia | Australian Gastroenterology Week Conference: registration, travel, accommodation x 2 representatives | 3218 | 3218 |
| 2016 | Janssen | Leukaemia Foundation Of Australia | Representative attendance at Parliamentary meetings: travel and accommodation | 850 | 850 |
| 2016 | Janssen | Leukaemia Foundation Of Australia | National Myeloma Day Seminars 2016 (3) | 15000 | 15000 |
| 2016 | Janssen | Leukaemia Foundation Of Australia | Patient Advocate Training | 20000 | 20000 |
| 2016 | Janssen | Leukaemia Foundation Of Australia | ͞My Haematology Diary͟: convert booklet to web-based app | 40000 | 40000 |
| 2016 | Janssen | Leukaemia Foundation Of Australia | "Light the Night" fundraising and awareness program | 50000 | 50000 |
| 2016 | Janssen | Leukaemia Foundation Of Australia | Chronic Lymphocytic Leukaemia (CLL) My Way Patient Adherence Program Pilot | 100000 | 100000 |
| 2016 | Janssen | Lymphoma Australia | Produce lymphoma patient treatment diaries | 10660 | 10660 |
| 2016 | Janssen | Lymphoma Australia | Lymphoma patient education initiatives (4) and develop patient resource | 50000 | 50000 |
| 2016 | Janssen | Lymphoma Australia | Lymphoma awareness materials for electronic and print media campaign | 50000 | 50000 |
| 2016 | Janssen | Mental Illness Fellowship of Australia | Representative participation in mental health advisory board | 1424 | 1424 |
| 2016 | Janssen | Mental Illness Fellowship of Australia | Parliamentary Friends of Mental Illness: education for parliamentarians and staff | 4500 | 4500 |
| 2016 | Janssen | Mental Illness Fellowship of Australia | Parliamentary Friends of Mental Illness: awareness event at Parliament House | 5000 | 5000 |
| 2016 | Janssen | Mental Illness Fellowship of Australia | Schizophrenia Awareness Week Activities | 22394 | 22394 |
| 2016 | Janssen | Myeloma Australia | Myeloma Support Group Leadership Training | 10000 | 10000 |
| 2016 | Janssen | Myeloma Australia | Myeloma Medical and Scientific Advisory Group (MSAG) meeting support | 10000 | 10000 |
| 2016 | Janssen | Myeloma Australia | Myeloma Australia Haematology Congress Stand: delegate attendance, stand construction | 12000 | 12000 |
| 2016 | Janssen | Myeloma Australia | Myeloma Comprehensive Patient Guide: update and print | 13000 | 13000 |
| 2016 | Janssen | Myeloma Australia | National Myeloma Week Patient Education Program | 15000 | 15000 |
| 2016 | Janssen | Myeloma Australia | Myeloma Medical and Scientific Advisory Group (MSAG) medical education programs | 30000 | 30000 |
| 2016 | Janssen | Myeloma Australia | Myeloma patient education national workshop series | 54000 | 54000 |
| 2016 | Janssen | Myeloma Australia | Myeloma Direct Patient Support Pilot Program | 100000 | 100000 |
| 2016 | Janssen | Prostate Cancer Foundation of Australia (PCFA) | Prostate Cancer Awareness Month: generate public awareness, event management, delegate attendance | 25000 | 25000 |
| 2016 | Janssen | Prostate Cancer Foundation of Australia (PCFA) | Advanced Prostate Cancer: Patient Value Mapping Research & Advocacy Project | 168800 | 168800 |
| 2016 | Janssen | Rare Cancers Australia | Patient Voice Initiative: patient focus group meetings series | 7500 | 7500 |
| 2016 | Janssen | Rare Cancers Australia | International Society for Pharmacoeconomics and Outcomes Research 21st Annual International Meeting (Washington USA): delegate attendance and patient advocacy study tour | 16500 | 16500 |
| 2016 | Janssen | Rare Cancers Australia | ͞A Little More Time͟ (v2.0): report and launch | 25000 | 25000 |
| 2016 | Janssen | Rare Cancers Australia | Sick or Treat Program: develop and deliver information program; redesign website | 30000 | 30000 |
| 2016 | Janssen | SANE Australia | Thriving Communities Campaign | 74750 | 74750 |
| 2016 | Janssen | Schizophrenia Fellowship Of New South Wales (NSW) (One Door Mental Health) | Schizophrenia Fellowship Staff Conference 2016: to raise the importance of patient involvement in treatment choices, building a network of support around the patient, linking and communicating with all stakeholders in the treatment plan aligned to the rec | $2,444.38 speaker fee, travel, accommodation | 2444.38 |
| 2016 | Janssen | Sunflower Foundation Australia | Wellness Walk: media, online/social media campaign | 15000 | 15000 |
| 2017 | Janssen | Arthritis Foundation of Australia | Establishment of the Arthritis Australia Patient Support Program | 20000 | 20000 |
| 2017 | Janssen | Arthritis Foundation of Australia | Assess access to specialist rheumatology services for people with arthritis living in rural and regional areas of Australia, in order to identify under-serviced areas and assist with planning of future rural rheumatology services | 25000 | 25000 |
| 2017 | Janssen | Arthritis Foundation of Australia | Create additional content on the EMPOWERED website to provide patient advice on treatment and lifestyle options | 60000 | 60000 |
| 2017 | Janssen | Australian Crohn's and Colitis Association | National Crohn's and Colitis Awareness Month: awareness campaign, website and social media analytics, promotional materials | 25000 | 25000 |
| 2017 | Janssen | Australian Crohn's and Colitis Association | "Day in the life of" video to drive awareness of the real-world impact of Crohn’s disease and ulcerative colitis | 38024 | 38024 |
| 2017 | Janssen | Creaky Joints Australia | Broaden Creaky Joints Australia's footprint to healthcare professionals and throughout social and traditional media channels | 20000 | 20000 |
| 2017 | Janssen | Creaky Joints Australia | Develop patient and caregiver web-based education focused on non-radiographic Ankylosing Spondylitis | 20000 | 20000 |
| 2017 | Janssen | Leukaemia Foundation Of Australia | WA World Lymphoma Awareness Day Patient Seminar: education seminar on lymphoma with focus on haematology, psychology and exercise physiology | 2500 | 2500 |
| 2017 | Janssen | Leukaemia Foundation Of Australia | Ride As One:charity cycle event to raise awareness of blood cancers | 5000 | 5000 |
| 2017 | Janssen | Leukaemia Foundation Of Australia | CLL My Way Patient Adherence Program: identify the needs of CLL patients, guide service delivery and explore how best to engage patients at the point of diagnosis | 118172 | 118172 |
| 2017 | Janssen | Lupus Group Of Western Australia | Support the delivery of telephone, email, Facebook and web-based interactive support and information to patients, their families, and the wider community | 6600 | 6600 |
| 2017 | Janssen | Lymphoma Australia | Improve support services for lymphoma patients through a Lymphoma Care Nurse Program incorporating a website, e-newsletters, webinars, education sessions, a hotline, awareness activities and a patient survey | 50000 | 50000 |
| 2017 | Janssen | Mental Illness Fellowship of Australia | Parliamentary Friends of Mental Illness Dinner: event logistics | 7400 | 7400 |
| 2017 | Janssen | Myeloma Australia | Train leaders of myeloma support groups to provide local peer support and group leadership to patients | 10000 | 10000 |
| 2017 | Janssen | Myeloma Australia | Medical Scientific Advisory Group of Myeloma Australia meeting: logistics, printing | 10000 | 10000 |
| 2017 | Janssen | Myeloma Australia | Myeloma Australia to secure an exhibition space and stand at the HSANZ 2017 conference | 12500 | 12500 |
| 2017 | Janssen | Myeloma Australia | National Myeloma Week Program: event logistics | 15000 | 15000 |
| 2017 | Janssen | Myeloma Australia | Myeloma transplant education: develop educational content and resources on stem cell transplantation in myeloma for patients | 20000 | 20000 |
| 2017 | Janssen | Myeloma Australia | Inaugural Medical & Scientific Advisory Group Education Workshop: event management, materials, catering, transport | 30000 | 30000 |
| 2017 | Janssen | Myeloma Australia | Provide a comprehensive program of patient education workshops and seminars in major regional centres | 57500 | 57500 |
| 2017 | Janssen | Myeloma Australia | Myeloma Direct Patient Support Program expansion: resources to provide direct patient support for myeloma patients via Calvary Mater Hospital in Newcastle | 80000 | 80000 |
| 2017 | Janssen | Prostate Cancer Foundation of Australia (PCFA) | Create expert clinician video interviews that will be available through websites to inform patients and the broader community about developments in advanced prostate cancer: videography and post-production. | 7000 | 7000 |
| 2017 | Janssen | Prostate Cancer Foundation of Australia (PCFA) | PCFA Information Guide - Maintaining Wellbeing with Prostate Cancer: content update, printing and distribution | 8000 | 8000 |
| 2017 | Janssen | Prostate Cancer Foundation of Australia (PCFA) | Prostate cancer consumer resources: staging Q&A session, video production and distribution, travel, integration with online platforms. | 13250 | 13250 |
| 2017 | Janssen | Prostate Cancer Foundation of Australia (PCFA) | Prostate Cancer Awareness Month Activities: project management, promotion, travel/accommodation | 17500 | 17500 |
| 2017 | Janssen | Rare Cancers Australia | Sick or Treat Raven Sponsorship: fundraising and awareness event | 12500 | 12500 |
| 2017 | Janssen | Rare Cancers Australia | Sick or Treat Program: support patient story website, social media campaign | 30000 | 30000 |
| 2017 | Janssen | Rare Cancers Australia | Patient advocacy at Health Technology Assessment International Conference: delegate travel, accommodation | 30000 | 30000 |
| 2017 | Janssen | Rare Cancers Australia | Patient Voice Initiative: provide support to facilitate and incorporate input from patients and consumers into health decision-making in the Australian Health Technology Assessment (HTA) system | 30000 | 30000 |
| 2017 | Janssen | Rare Cancers Australia | Rare Cancers 2017 awareness and advocacy Projects: research paper publication, community service announcement, social media engagement, and stakeholder forum | 50000 | 50000 |
| 2017 | Janssen | SANE Australia | Lived Experience Engagement Program: review and redesign of the SANE speakers program, Phase 1 | 23000 | 23000 |
| 2018 | Janssen | Arthritis Foundation of Australia | Inclusion of non-radiographic Axial Spondyloarthritis (nr-AxSpA) patient support materials on the EMPOWERED website | 28900 | 28900 |
| 2018 | Janssen | Arthritis Foundation of Australia | Support AA partnership with the Australian Paediatric Rheumatology Group Paediatric to provide scholarships to train ten paediatric rheumatologists | 60000 | 60000 |
| 2018 | Janssen | Arthritis Foundation of Australia | Develop a best-practice Rheumatoid Arthritis Support Program (RASP): Part 1 | 75000 | 75000 |
| 2018 | Janssen | Arthritis Foundation of Western Australia (WA) | Develop an evidence-based consumer reference book for people with Ankylosing Spondylitis/Psoriatic Arthritis (AS/PsA) | 5000 | 5000 |
| 2018 | Janssen | Australian Crohn's and Colitis Association | Youth Empowerment Program (YEP!) for young people living with Crohn’s Disease or Ulcerative Colitis | 12500 | 12500 |
| 2018 | Janssen | Australian Crohn's and Colitis Association | Awareness Month 2018: support design, print and distribution of print media | 15000 | 15000 |
| 2018 | Janssen | Australian Crohn's and Colitis Association | Inflammatory Bowel Disease Quality of Care Program: The Patient Experience (Stage 2) | 50000 | 50000 |
| 2018 | Janssen | Creaky Joints Australia | 2018 National Patient Council Summit: support international presentation and workshop | 20000 | 20000 |
| 2018 | Janssen | Dragon Claw Charity | Production costs to develop a rheumatoid arthritis educational video in four Aboriginal languages for use in remote Australia | 20000 | 20000 |
| 2018 | Janssen | IBD Sydney | Australian Gastroenterology Week 2018: support Member attendance | 2900 | 2900 |
| 2018 | Janssen | Leukaemia Foundation Of Australia | Support delivery of community awareness through Light the Night 2018 lantern walk | 20000 | 20000 |
| 2018 | Janssen | Leukaemia Foundation Of Australia | Cancer Concierge for CLL: implementation of pilot project | 150000 | 150000 |
| 2018 | Janssen | Lymphoma Australia | Lymphoma Australia Patient & Carer Education Session: support international lymphoma expert webcast presentations | 4228 | 4228 |
| 2018 | Janssen | Lymphoma Australia | Putting all Lymphoma Patients First project: production and maintenance of webinars, website, fact sheets, data base | 50000 | 50000 |
| 2018 | Janssen | Mental Illness Fellowship of Australia | Parliamentary Friends of Mental Illness Dinner: Stigma Reduction - Drive for a national campaign | 8300 | 8300 |
| 2018 | Janssen | Mental Illness Fellowship of Australia | Parliamentary Friends of Mental Illness Dinner 2018: venue and audio-visual equipment hire, catering, speaker travel and accommodation | 8500 | 8500 |
| 2018 | Janssen | Mental Illness Fellowship of Australia | Mental Health Week Support 2018: traditional and social media campaign | 9000 | 9000 |
| 2018 | Janssen | Mental Illness Fellowship of Australia | Support MI Networks: maintain educational resources, information materials, website | 16667 | 16667 |
| 2018 | Janssen | Mental Illness Fellowship of Australia | MIFA Member Organisations Biannual Collaboration Meeting: venue hire, catering, Member travel and accommodation | 25000 | 25000 |
| 2018 | Janssen | Myeloma Australia | Education and Training Communication Program for Support Group Leaders: venue and equipment hire, presenter costs, training resources, catering | 9570 | 9570 |
| 2018 | Janssen | Myeloma Australia | MSAG 2018 Meetings Sponsorship: meeting and report production and publication costs | 10000 | 10000 |
| 2018 | Janssen | Myeloma Australia | MSAG Meeting Support: determine the activities of greatest benefit to myeloma patients | 10000 | 10000 |
| 2018 | Janssen | Myeloma Australia | Myeloma: A Comprehensive Patient Guide: education resource design and production | 13000 | 13000 |
| 2018 | Janssen | Myeloma Australia | 2018 National Myeloma Week: awareness program delivery costs | 15000 | 15000 |
| 2018 | Janssen | Myeloma Australia | 2018 HSANZ Annual Scientific Meeting: information display, delegate attendance and presentation | 20000 | 20000 |
| 2018 | Janssen | Myeloma Australia | Medical Professional Education Programs: logistics including venue hire, speaker costs, catering | 30000 | 30000 |
| 2018 | Janssen | Myeloma Australia | 2018 National Patient & Family Workshops and Seminars Program: guest presenters, filming, website maintenance | 42000 | 42000 |
| 2018 | Janssen | One Door Mental Health | 2018 Wellness Walk Sponsorship: event logistics and marketing | 15000 | 15000 |
| 2018 | Janssen | Prostate Cancer Foundation of Australia (PCFA) | Prostate Cancer Awareness Month Campaign Support: project management and promotion | 17500 | 17500 |
| 2018 | Janssen | Psoriasis Australia | World Psoriasis Day 2018: social media campaign | 31400 | 31400 |
| 2018 | Janssen | Rare Cancers Australia | Continuation of Cancer Drugs Access Committee: consulting, program and secretariat management, communications, travel | 40000 | 40000 |
| 2018 | Janssen | Rare Cancers Australia | 2018 Rare Cancers Projects: community and government awareness program | 40000 | 40000 |
| 2018 | Janssen | SANE Australia | Lived Experience Engagement Program: review and redesign of the SANE speakers program, Phase 2 | 37950 | 37950 |
| 2018 | Janssen | SANE Australia | Shared decision making in the management of schizophrenia: a mixed-methods study of consumers and carers | 40700 | 40700 |
| 2019 | Janssen | Arthritis Foundation of Australia | Rheumatoid Arthritis Support Program (RASP) – Phase 2: development of the myRA (Rheumatoid Arthritis) website, UAT and soft launch https://arthritisaustralia.com.au/managing-arthritis/ | 75000 | 75000 |
| 2019 | Janssen | Arthritis Queensland (QLD) | Rheumatology in Primary Care - An Update for GPs | 750 | 750 |
| 2019 | Janssen | Arthritis Queensland (QLD) | International expert-led disease education webinar for patients with Axial Spondyloarthritis | 1000 | 1000 |
| 2019 | Janssen | Australian Crohn's and Colitis Association | Sponsor Crohn’s & Colitis Awareness Month: World IBD Day 16 May 2019 | 10000 | 10000 |
| 2019 | Janssen | Australian Crohn's and Colitis Association | Sponsor Youth Empowerment Program (YEP!) for young people living with inflammatory bowel disease | 12000 | 12000 |
| 2019 | Janssen | Australian Crohn's and Colitis Association | Hand in Hand Resources Online Promotional Campaign to assist patients’ psychological health and wellbeing https://crohnsandcolitishub.com.au/psychological-wellbeing-and-ibd-go-hand-in-hand-in-2020/ | 14000 | 14000 |
| 2019 | Janssen | Australian Crohn's and Colitis Association | Sponsor 2019 IBD Information and Education Forums | 16400 | 16400 |
| 2019 | Janssen | Australian Crohn's and Colitis Association | Sponsor IBD Quality of Care Program: Partner in My IBD Care consumer information booklet and online e-book development and production | 30000 | 30000 |
| 2019 | Janssen | Creaky Joints Australia | Develop Patient Guidelines for Spondyloarthropathies to increase health literacy, understanding and patient outcomes https://creakyjoints.org.au/news-and-features/new-guide-living-with-ra-in-australia/ | 20000 | 20000 |
| 2019 | Janssen | Dragon Claw Charity | Indigenous language project promoting medication adherence for Rheumatoid Arthritis sufferers: launch and awareness raising event | 9900 | 9900 |
| 2019 | Janssen | Dragon Claw Charity | Feasibility study to extend remote area Indigenous health and disease education resources across northern Australia | 10000 | 10000 |
| 2019 | Janssen | IBD Support Australia | Representative attendance at Australian Gastroenterology Week 2019: registration, travel, accommodation | 2518 | 2518 |
| 2019 | Janssen | Leukaemia Foundation Of Australia | Patient Education Seminar: international expert presenter: – webcast, video and resource production | 7000 | 7000 |
| 2019 | Janssen | Leukaemia Foundation Of Australia | CLL and MCL Patient Stories Social/Digital Campaign: promote online engagement of people diagnosed, improve awareness of support services and treatment options | 31000 | 31000 |
| 2019 | Janssen | Leukaemia Foundation Of Australia | Redevelop Patient Education and Information Platform: creation of integrated information; digital content and education resources to increase health literacy | 100000 | 100000 |
| 2019 | Janssen | Lymphoma Australia | Patient and Carer Education: international expert seminar webcast and video production | 7050 | 7050 |
| 2019 | Janssen | Lymphoma Australia | Education and Awareness: nurse education; patient information, resources and webinars | 50000 | 50000 |
| 2019 | Janssen | Mental Illness Fellowship of Australia | Mental Health Week Campaign: traditional and social media collateral and technology development | 10000 | 10000 |
| 2019 | Janssen | Mental Illness Fellowship of Australia | Parliamentary Friends of Mental Illness Event: stakeholder education and advocacy | 10000 | 10000 |
| 2019 | Janssen | Mental Illness Fellowship of Australia | MI Networks Promotion and Media Campaign: https://mifa.org.au/en/minetwork | 12500 | 12500 |
| 2019 | Janssen | Mental Illness Fellowship of Australia | MIFA Member Organisations Biannual Collaboration Meeting: venue hire, catering, Member travel and accommodation | 17500 | 17500 |
| 2019 | Janssen | Myeloma Australia | Patient Education Seminar: venue hire, audio visual facilities, catering | 6720 | 6720 |
| 2019 | Janssen | Myeloma Australia | HSANZ BLOOD 2019 Annual Scientific Meeting: information display and delegate attendance | 10000 | 10000 |
| 2019 | Janssen | Myeloma Australia | Myeloma Scientific Advisory Group (MSAG): meeting costs, report development and publication https://myeloma.org.au/who-we-are/medical-scientific-advisory-group-msag/ | 10000 | 10000 |
| 2019 | Janssen | Myeloma Australia | Specialist Myeloma Nurse 2-Day Education and Training Program: venue hire, catering, training resource; travel, speaker fees | 15000 | 15000 |
| 2019 | Janssen | Myeloma Australia | 2019 National Myeloma Week Program: awareness activities, including project management; event management and promotion | 15000 | 15000 |
| 2019 | Janssen | Myeloma Australia | Myeloma Scientific Advisory Group (MSAG) GP and Registrar Education Workshops: develop educational resources, travel costs, venue hire, audio visual facilities, catering | 30000 | 30000 |
| 2019 | Janssen | Myeloma Australia | Patient and Family Seminars Australia-wide 2019: develop educational resources, speaker fees, venue hire, audio visual facilities, catering | 42000 | 42000 |
| 2019 | Janssen | One Door Mental Health | Wellness Walk 2019: event logistics, marketing | 15000 | 15000 |
| 2019 | Janssen | Patient Voice Initiative | Patient Voice Initiative 2019-2020: general support to enable the work of the PVI including communication activities (toolkit), research and community engagement | 7500 | 7500 |
| 2019 | Janssen | Prostate Cancer Foundation of Australia (PCFA) | Prostate Cancer Awareness Month 2019: project and event management, management and promotion | 35000 | 35000 |
| 2019 | Janssen | Pulmonary Hypertension Association Australia | Pulmonary Hypertension Society of Australia and New Zealand (PHSANZ) 2019 Scientific Meeting and Member and carer education satellite symposium: venue hire, audio visual hire, travel, accommodation | 36000 | 36000 |
| 2019 | Janssen | Pulmonary Hypertension Network Australia | Pulmonary Vascular Research Institute 2019 Drug Discovery and Development Symposium: delegate registration, travel, accommodation | 5290 | 5290 |
| 2019 | Janssen | Rare Cancers Australia | National Oncology Alliance – National Cancer Plan Project: project management, media campaign, web development | 25000 | 25000 |
| 2019 | Janssen | Rare Cancers Australia | Awareness, Education and Advocacy Projects 2019: patient, community and government awareness and education campaigns; patient support | 55000 | 55000 |
| 2019 | Janssen | SANE Australia | Peer Ambassador program 2019/2020: continued development and implementation of Lived Experience Impact Measurement Framework | 14000 | 14000 |
| 2019 | Janssen | SANE Australia | Shared Decision Making in Schizophrenia Study Dissemination: publication of a peer-reviewed journal and presentation to a relevant mental health conference | 26000 | 26000 |
| 2019 | Janssen | SANE Australia | Peer Ambassadors Program 2019: develop stakeholder engagement strategy and Program Impact Evaluation Framework, deliver induction training | 100000 | 100000 |
| 2019 | Janssen | Scleroderma Australia | National Patient Education Conference: delegate attendance travel | 1993 | 1993 |
| 2020 | Janssen | Arthritis Foundation of Australia | National Rheumatoid Arthritis Consumer Awareness Campaign. | 10000 | 10000 |
| 2020 | Janssen | Arthritis Foundation of Australia | My AS Patient Support Program website to provide tailored information, tools and support for people living with ankylosing spondylitis. | 40000 | 40000 |
| 2020 | Janssen | Arthritis Foundation of Australia | My PsA Patient Support Program website providing tailored information, tools and support for people living with Psoriatic Arthritis. | 40000 | 40000 |
| 2020 | Janssen | Arthritis Foundation of Australia | National Research Program to strengthen capacity of Aboriginal and Torres Strait Islander health researchers in the field of arthritis and musculoskeletal conditions. | 50875 | 50875 |
| 2020 | Janssen | Australian Crohn's and Colitis Association | A month-long National Awareness campaign for patients living with inflammatory bowel disease. | 25000 | 25000 |
| 2020 | Janssen | Australian Crohn's and Colitis Association | Integrated Care Project to develop a framework for an integrated model of care for patients living with Inflammatory Bowel Disease. | 37000 | 37000 |
| 2020 | Janssen | Creaky Joints Australia | Development and launch of a new patient resource "A Patient's Guide to Living with Axial Spondyloarthritis" | 20000 | 20000 |
| 2020 | Janssen | Dragon Claw Charity | Emerging Priorities - Musculoskeletal Medication Adherence Project aimed at helping close the gap in health outcomes for First Australians living with musculoskeletal conditions, including inflammatory arthritis. | 25000 | 25000 |
| 2020 | Janssen | Leukaemia Foundation Of Australia | Digitalisation of the Cancer Concierge Service: an omni-channel service offering for people living with blood cancer, comprising seamless online and offline interaction with the LF's digital health content and Blood Cancer Support Coordinators. The digital platform will bring together several priority service needs into a personalised digital experience to help people: • deal with cancer-related fatigue • transition into post-treatment life • provide financial and legal support • return to work/productivity • learn to manage their health details. | 50000 | 50000 |
| 2020 | Janssen | Lymphoma Australia | Lymphoma Australian Consumer Advisory Committee Inaugural Meeting to establish a consumer advisory committee comprising a group of patients, convening the group, and hosting an inaugural virtual meeting to inform the future work of Lymphoma Australia in meeting the needs of CLL and lymphoma patients. | 4500 | 4500 |
| 2020 | Janssen | Lymphoma Australia | CLL Virtual Education Forum: providing Australian patients with the opportunity to hear from both international and local experts on the latest developments in CLL and how best to manage their disease through a dedicated virtual patient education forum. | 5300 | 5300 |
| 2020 | Janssen | Lymphoma Australia | Lymphoma Australia’s 2020 patient and nurse education and awareness activities, including: • Raising awareness of lymphoma leading to earlier detection and better outcomes for patients. • Improving health literacy through education • Developing capabilities including digital, to better support patients and nurses. Carried out through patient and nurse webinars, website redesign/development, and development and delivery of nurse education modules. | 60000 | 60000 |
| 2020 | Janssen | MSK Australia | MSK Helpline offering information, consumer education and support for people living with musculoskeletal conditions, carers and families. | 5000 | 5000 |
| 2020 | Janssen | Myeloma Australia | Facilitate the convening of the Myeloma Scientific Advisory Group’s two annual meetings and the publication of clinical papers, including COVID-19 Guidelines, to support better health outcomes for myeloma patients. | 7500 | 7500 |
| 2020 | Janssen | Myeloma Australia | 2020 National Myeloma Month Program: raise awareness of the disease, provide education and information to patients, carers, and the wider community through the provision of four virtual myeloma awareness and education seminars during the month of May. | 12500 | 12500 |
| 2020 | Janssen | Myeloma Australia | Convene a one-day virtual meeting for clinical researchers, nurses and clinicians working in the field of myeloma across Australia/New Zealand. Organised under the auspices of the Myeloma Scientific Advisory Group of Myeloma Australia. Aims of the meeting are: • Provide a focus to promote myeloma research in ANZ • Provide a forum for early and mid-career researchers to present their work • Promote collaboration and innovation • Develop novel translational and clinical trial projects | 15000 | 15000 |
| 2020 | Janssen | Myeloma Australia | Delivery of the 2020 Major Workshops and Seminars Program: providing education, information and support to myeloma patients and their families through fact-to-face and online workshops and seminars across Australia. | 33096 | 33096 |
| 2020 | Janssen | Patient Voice Initiative | Support 2020/21 activities that: • deliver a forum for collaboration and dialogue within a public-private partnership that encourages broad participation of a variety of stakeholders including patient advocacy groups and not-for-profits, the pharmaceutical and medical device industries, healthcare professionals, academia, and government. • utilise the expertise of stakeholders through working groups to identify and prioritise key issues, and to evaluate, and propose initiatives that support the patient voice through enhanced involvement in the HTA process; • provide tools and resources for consumers, patients, industry, and government that support education and the development of new methods and approaches to delivering patient input to be used in the regulatory and HTA processes. | 12000 | 12000 |
| 2020 | Janssen | Rare Cancers Australia | Support the work of the National Oncology Alliance through Rare Cancers Australia to deliver and launch Vision 2030 - the foundation of a National Cancer Plan focussing on • Emerging therapies and technologies from treating symptoms to cure • Patient preferences and choice • Collaboration of stakeholders and integration • Understanding and measuring outcomes for future investment • Equitable and timely access to best treatment and technologies • Healthy lives generate a healthier economy | 25000 | 25000 |
| 2020 | Janssen | Rare Cancers Australia | Awareness and patient support initiatives that include: • Providing a line of direct support to those diagnosed with rare or less common cancers • Improving understanding and awareness of need for health system reform • Delivering conversations and driving debate surrounding personalised medicine and new technologies • Increasing understanding of the registration and reimbursement systems that underpin access and what needs to change Delivered through: • Digital awareness programs • Societal impact of Rare Cancers report • Cancer genetic panel testing review/analysis | 55000 | 55000 |
| 2013 | Lundbeck | Mental Health Australia | Sponsorship (general) | 28000 | 28000 |
| 2013 | Lundbeck | Movement Disorder Society of Australia | Unrestricted educational grant | 7500 | 7500 |
| 2013 | Lundbeck | Parkinson's New South Wales (NSW) | Dance classes in Rozelle for people with Parkinson's and their carers | 4200 | 4200 |
| 2013 | Lundbeck | Parkinson's New South Wales (NSW) | Unity walk sponsorship to support Parkinson's Disease patients | 6000 | 6000 |
| 2013 | Lundbeck | Parkinson's New South Wales (NSW) | Neurological nurse sponsorship. Contribution towards providing a nurse to cover the Orange-Bathurst-western NSW region | 7500 | 7500 |
| 2013 | Lundbeck | Parkinson's New South Wales (NSW) | Parkinson's passport which provides information on Parkinson's disease and helps patients to manage their appointments and care | $25, 000 and distribution to health care professionals | 25000 |
| 2013 | Lundbeck | Parkinson's other state branches | Unity walk sponsorship to support Parkinson's Disease patients | 10000 | 10000 |
| 2013 | Lundbeck | Parkinson's Queensland (QLD) | Advertising sponsorship Connections Magazine | 2000 | 2000 |
| 2013 | Lundbeck | Parkinson's Unity Walk | Lewis and the Lewy Bodies Donation to support Parkinson's Disease patients | 500 | 500 |
| 2013 | Lundbeck | SANE Australia | Roundtable discussion to discuss research outcome | 7809 | 7809 |
| 2013 | Lundbeck | SANE Australia | Workplace depression survey including sponsorship of research | 27500 | 27500 |
| 2013 | Lundbeck | Schizophrenia Fellowship Of New South Wales (NSW) (One Door Mental Health) | Sponsorship of Sydney Harbour Bridge walk for mental wellness | 1000 | 1000 |
| 2014 | Lundbeck | Parkinson's New South Wales (NSW) | Parkinson's Disease Unity walk is undertaken each year to raise money for research and support services for people living with Parkinson's Disease. Lundbeck sponsored a walking group to participate as well as sponsorship to the event of $3000 | 3482 | 3482 |
| 2014 | Lundbeck | Parkinson's New South Wales (NSW) | Dance for Parkinson’s is a weekly session held for patients living with PD and their carers to participate in dance that has been specifically developed to help patients improve movement and motivation and improve their quality of life. Lundbeck sponsored | 6909 | 6909 |
| 2014 | Lundbeck | Parkinson's Passports Reprints - Parkinson's Disease Australia | To help patients manage their Parkinson’s disease with a patient support pack produced by the NPS and endorsed by PD Australia. This sponsorship also included distribution to healthcare professionals to give to patients and carers. | Cost $20 705 Lundbeck representatives also distributed the passports to health care professionals | 20705 |
| 2014 | Lundbeck | Parkinson's Queensland (QLD) | Advertising sponsorship of Connections Magazine which aims to support patients and their carers of $2000. This sponsorship was provided to support the development of a contact list for Parkinson’s disease patients and their carers/families (doctors, carer | 2000 | 2000 |
| 2014 | Lundbeck | Parkinson's Queensland (QLD) | Parkinson's Disease Unity walk is undertaken each year to raise money for research and support services for people living with Parkinson's Disease. Lundbeck sponsored this event for $2000. | 2000 | 2000 |
| 2014 | Lundbeck | Parkinson's South Australia (SA) | Parkinson's Disease Unity walk is undertaken each year to raise money for research and support services for people living with Parkinson's Disease. Lundbeck sponsored this event for $1000 | 1000 | 1000 |
| 2014 | Lundbeck | Parkinson's Victoria (VIC) | Parkinson's Disease Unity walk is undertaken each year to raise money for research and support services for people living with Parkinson's Disease. Lundbeck sponsored a walker in this event as well as general sponsorship of $2500 | 2650 | 2650 |
| 2014 | Lundbeck | Parkinson's Western Australia (WA) | Parkinson's Disease Unity walk is undertaken each year to raise money for research and support services for people living with Parkinson's Disease. Lundbeck sponsored this event for $1500 | 1500 | 1500 |
| 2020 | Merck Healthcare | Mstranslate | Financial support towards the development and distribution of digital education resources for the general public on latest developments in multiple sclerosis research. | 6000 | 6000 |
| 2020 | Merck Healthcare | NeuroEndocrine Cancer Australia | Donation towards ongoing communication and patient education activities (national online fact sheets and webinars) in merkel cell carcinoma for the period April 2020-2021. | 21000 | 21000 |
| 2013 | Merck Serono | Access Australia (infertility) | Financial support of patient advocacy and support programs | 70000 | 70000 |
| 2013 | Merck Serono | MS Australia | Financial support to fund MS Australia nursing staff and their services | 160000 | 160000 |
| 2014 | Merck Serono | Access Australia (infertility) | Financial support of patient advocacy and support programs | 40000 | 40000 |
| 2014 | Merck Serono | Bowel Cancer Australia | Financial support of patient RAS brochure, bowel cancer atlas and Parliamentary Event. | 16000 | 16000 |
| 2015 | Merck Serono | Access Australia (infertility) | Merck provided financial support as a Diamond Visionary Partner to Access Australia - Australia's National Infertility Network which is a resource for information and support for the one in six people in Australia with infertility by supporting them throu | 30000 | 30000 |
| 2015 | Merck Serono | Bowel Cancer Australia | Merck provided a financial grant towards a market research project conducted by Bowel Cancer Australia (BCA) for research into community awareness and understanding of Bowel Cancer in people under 50 years of age. | 26400 | 26400 |
| 2015 | Merck Serono | Bowel Cancer Australia | Merck globally provided a financial grant to the International Colorectal Cancer Association (ICCA) towards their "Get Tested" campaign in various countries. Other companies also provided funds towards this campaign. ICCA provided 34,000 Euros (approx. AU | ̴̴̴50,000 (approx.) (34,000 Euro) | 50000 |
| 2015 | Merck Serono | Gut Foundation | Merck purchased a corporate table for Merck staff and partners at the 30 year celebration of The Gut Foundation | 1850 | 1850 |
| 2015 | Merck Serono | MS Research Australia | Merck provided a financial donation to MS Research Australia as a 'MS Angel' for 2016. This raises funds that is invested by MS research Australian in a research project that will make a real contribution to solving MS. | 5000 | 5000 |
| 2015 | Merck Serono | MS Research Australia | Merck provided a financial grant to MS Research Australia towards the following research and education/awareness programs - The Australian MS Longitudinal study - with a focus on employment and MS national patient needs analysis. - The "Kiss Goodbye to M | 11000 | 11000 |
| 2015 | Merck Serono | Sydney Children's Hospitals Foundation | Merck provided a financial grant to the FUTuRE Fertility Research Team (Fertility Understanding Through Registry and Evaluation) based at the Sydney Children's Hospital and Prince of Wales Hospital towards the development and ongoing establishment of the | 30000 | 30000 |
| 2016 | Merck Serono | Access Australia (infertility) | Merck provided financial support as a Diamond Visionary Partner to Access Australia - Australia's National Infertility Network which is a resource for information and support for the one in six people in Australia with infertility by supporting them thro | 30000 | 30000 |
| 2016 | Merck Serono | Australian Pituitary Foundation | Merck provided a financial grant to the Australian Pituitary Foundation Ltd in support of the development of a website to assist in the creation of awareness for patients and carers, proving them with support and education and thus increasing their engage | 5500 | 5500 |
| 2016 | Merck Serono | MS Research Australia | Merck purchased a corporate table for staff and partners at the Multiple Sclerosis Research Australia "Kiss goodbye to MS" 2016 dinner. Merck also provided funds towards fundraising lapel pins associated with the event. Funds raised will be used by MS Res | 3300 | 3300 |
| 2016 | Merck Serono | MS Research Australia | Merck provided a financial grant to MS Research Australia towards The Australian MS Longitudinal study (AMSLS). The AMSLS is a survey-based study of life issues, designed to more fully understand the impact of MS, including the individual and overall com | 15000 | 15000 |
| 2016 | Merck Serono | MS Research Australia | Support of the above Longitudinal Study. Management of the AMSLS is overseen by the Menzies Institute for Medical Research at the University of Tasmania. | 16500 | 16500 |
| 2016 | Merck Serono | MS Research Australia | Merck provided a financial grant to MS research Australia to be used towards the following activities: 1. corporate table at the "Kiss Goodbye to MS - The Red Affair' campaign dinner. This is a public awareness and fundraising event organised by MS Resear | 22500 | 22500 |
| 2016 | Merck Serono | MS Society South Australia (SA) & Northern Territory (NT) | Merck provided a financial grant to the MS society of South Australia & Northern Territory Inc. to assist in a range of special projects in support of patients with MS. | 11000 | 11000 |
| 2016 | Merck Serono | MSWA | Merck provided a financial grant to MS Western Australia (MSWA) to assist in a range of special projects in support of patients with MS. | 11000 | 11000 |
| 2016 | Merck Serono | Trish Multiple Sclerosis Research Foundation | Merck purchased a corporate table for staff and partners at the Trish Multiple Sclerosis Research Foundation Black and White Ball. Funds raised will be used by Trish Multiple Sclerosis Research Foundation for funding of various research projects. | 4300 | 4300 |
| 2017 | Merck Serono | Access Australia (infertility) | Funds provided towards supporting Access Australia's program for providing educational information resources to the public (printed and on line). | 33000 | 33000 |
| 2017 | Merck Serono | Bowel Cancer Australia | Funds provided to support Bowel Cancer awareness activities. | 5500 | 5500 |
| 2017 | Merck Serono | Cancer Drugs Alliance | Funds provided towards finding a solution that will enable more Australians to access affordable cancer medicines in a timely way. The Cancer Drugs Alliance (CDA) has established a Cancer Drugs Access Committee (CDAC) to develop and outline a cancer drugs access framework that aim to deliver better health outcomes for cancer patients and their families. | 33000 | 33000 |
| 2017 | Merck Serono | Chris O'Brien Lifehouse | Purchase of Corporate table for 10 at Fundraising Gala Dinner event for raising money for a new prosthesis service to be offered to patients. (Merck staff only) | 2000 | 2000 |
| 2017 | Merck Serono | Fertility Matters Foundation | Funds provided towards producing an education resource package about fertility health. The goal is to create a knowledgeable conversation around fertility early in life so that people can make informed and confident decisions. The educational package includes a new digital resource, take home information, videos, etc. | 5500 | 5500 |
| 2017 | Merck Serono | Multiple Sclerosis | Support provided to fund various Educational programs for patients with MS throughout Australia during 2018. Activities include: The MS Educational Program, The MS Connect Service | 22000 | 22000 |
| 2017 | Merck Serono | Rare Cancers Australia | Purchase of a corporate table of 10 (@$2,500 per table) at the Rare Cancers 4th annual Sick or Treat Charity Ball fund raiser ball raising money in support of rare and less common cancers. All proceeds raised will help Rare Cancers Australia fund vital work in research advocacy, patient support and treatment. (Merck staff only) | 2500 | 2500 |
| 2018 | Merck Serono | Bowel Cancer Australia | Donation towards ongoing communication and patient activities in 2018 to promote the vision and mission of Bowel Cancer Australia; i.e. "To have an everlasting impact on our health future – one where no Australian dies from bowel cancer and all those diagnosed receive the support they need". | 4400 | 4400 |
| 2018 | Merck Serono | Global Pediatric Endocrinology and Diabetes (GPED) | Support the publication of educational booklets by GPED in various languages on endocrine disorders for provision to patients and their carers | 10000 | 10000 |
| 2018 | Merck Serono | MS Australia | Merck donation from car wash fundraising activity organised by Merck | 756 | 756 |
| 2018 | Merck Serono | MS Research Australia | Purchase of 2 tables (2x $2,000 each) at Kiss Goodbye MS Secret Gardens fund raising event. Merck staff & partners attended | 4000 | 4000 |
| 2018 | Merck Serono | Rare Cancers Australia | Purchase a table for 10 at Rare Cancers Halloween Charity Ball 2018 fundraiser. Merck staff and partners attended. | 2500 | 2500 |
| 2018 | Merck Serono | Rare Cancers Australia | Financial support provided towards travel and accommodation for patients and carers (nominated by Rare Cancers) to attend The CanForum at Parliament House, Canberra, September 2018 | 4800 | 4800 |
| 2018 | Merck Serono | Trish Multiple Sclerosis Research Foundation | Donation towards the operation of the Trish MS Foundation. The Foundation works in association with MS Research Australia and with researchers around Australia and provides funds towards research projects that aim to find a cure or preventive strategy for multiple sclerosis. | 4000 | 4000 |
| 2019 | Merck Serono | Access Australia (infertility) | Contribution toward PR activities and updates to AA's website functionality | 8800 | 8800 |
| 2019 | Merck Serono | Bowel Cancer Australia | Donation towards ongoing communication and patient activities during National Bowel Cancer Awareness Month 2019 to promote the vision and mission of Bowel Cancer Australia; i.e. "To have an everlasting impact on our health future - one where no Australian dies from bowel cancer and all those diagnosed receive the support they need". | 4400 | 4400 |
| 2019 | Merck Serono | Fertility Matters Foundation | Financial support towards the development and distribution of digital education resources for the general public | 12800 | 12800 |
| 2019 | Merck Serono | Global Pediatric Endocrinology and Diabetes (GPED) | Support towards the publication of educational booklets by GPED in various languages on paediatric endocrine disorders for provision to patients and their carers | 5000 | 5000 |
| 2019 | Merck Serono | MS Research Australia | Contribution towards the "MSRA Remoteness Impact Study" on the impact of living in regional or remote areas of Australia for people with MS | 55000 | 55000 |
| 2019 | Merck Serono | Rare Cancers Australia | Donation towards Rare Cancer Australia Embracing Carers Program, focused on improving carers' health and wellness, while increasing awareness and support for them within the healthcare system. | 25000 | 25000 |
| 2019 | Merck Serono | Rare Cancers Australia | Foundation phase of the National Cancer Plan of initiatives that will improve all aspects of patient care for Australians living with cancer today and tomorrow | In kind | 0 |
| 2019 | Merck Serono | Trish Multiple Sclerosis Research Foundation | Purchase of 1 table (10 people) at the Winter Wonderland Ball. Merck staff & partners attended. Donated funds go towards the operation of the Trish MS Foundation, which works in association with MS Research Australia and other researchers around Australia and provides funds towards research projects that aim to find a cure or preventive strategy for multiple sclerosis. | 4300 | 4300 |
| 2019 | Merck Serono | Turner Syndrome Association Of Australia | Donation towards educational and patient support activities of the Association | 1000 | 1000 |
| 2013 | MSD | Access Australia (disability) | This funding supported ACCESS education and patient welfare initiatives in 2013. | 20000 | 20000 |
| 2013 | MSD | Diabetes Australia | This funding supported a symposium to increase awareness of the health burden of diabetes around the world as well as Diabetes Australia's national strategy for enhanced management of diabetes in Australia. The symposium was held at Parliament House Sydne | 15000 | 15000 |
| 2013 | MSD | Diabetes Australia | This funding supported a forum at the World Diabetes Congress in Melbourne focused on the 'Parliamentary Champions for Diabetes' aims and objectives. The forum also launched the initiative to an international audience of diabetes health care professionals | 45000 | 45000 |
| 2013 | MSD | Glaucoma Australia | This funding contributed to Glaucoma Australia's glaucoma awareness education program. | 1000 | 1000 |
| 2013 | MSD | Glaucoma Australia | This funding supported quality eye care programs, delivered by healthcare professionals, for glaucoma sufferers. | 15000 | 15000 |
| 2013 | MSD | Hepatitis Australia | MSD provided a grant to Hepatitis Australia towards a range of programs aimed at raising awareness and providing education about viral hepatitis, including: - World Hepatitis Day promotional materials - Development of digital tools to assist with liver h | 25000 | 25000 |
| 2013 | MSD | Hepatitis New South Wales (NSW) | This funding provided part support for Hepatitis NSW Deputy CEO to attend an International Symposium on HCV treatment in Substance Abusers held in Munich, Germany. The amount represents 50% of costs (airfare, accommodation, meals, transfers, registration | 2130 | 2130 |
| 2013 | MSD | LiverWELL | MSD provided a grant to Hepatitis Victoria to support their HEPATITIS CHAMPIONS Project, which has the following objectives: To increase awareness of hepatitis C and B as a public health issue To increase access to testing for people at risk of hepatitis | 70000 | 70000 |
| 2013 | MSD | National Heart Foundation Of Australia | MSD is a member of The National Heart Foundation Pharmaceutical Roundtable, comprising 12 member companies. The funding supports the Heart Foundation Research Fund (allocated by the NHF Research Committee) as well as a joint project – 'Improving Adherence | 30000 | 30000 |
| 2013 | MSD | National Heart Foundation Of Australia | This funding supported the development of an educational resource aimed at promoting the uptake of evidence based vascular disease prevention and management initiatives within general practice. The project aims to make a national contribution toward enh | 60000 | 60000 |
| 2014 | MSD | Access Australia (disability) | This funding supported ACCESS education and patient welfare initiatives in 2014. Access Australia was established in Sydney in 1985 and provides a range of services to improve access for people with disabilities. Services include architectural advice, ass | 10000 | 10000 |
| 2014 | MSD | CanSpeak | This funding supported an educational workshop ‘Health Consumer Advocacy’ to facilitate linkages and capacity building between small health consumer organisations. The two day workshop program, developed by a Steering Committee comprised of CEOs of four h | 15000 | 15000 |
| 2014 | MSD | Glaucoma Australia | This funding supported Glaucoma Australia, the peak glaucoma awareness/education/support association in Australia, to raise awareness about glaucoma, support glaucoma sufferers and to raise funds for research. The GLAUCOMA ADHERANCE PROJECT (GAP) aimed to | 18000 | 18000 |
| 2014 | MSD | Hepatitis Australia | This funding supported Hepatitis Australia conduct a range of programs focused on community education to improve public awareness and understanding of hepatitis across Australia. Activities included production of Project newsletters, development and distr | 25000 | 25000 |
| 2014 | MSD | Melanoma Patients Australia | This funding assisted the acting CEO of Melanoma Patients Australia who was already travelling to Zurich to attend an International Melanoma Coalition Meeting, to stay on in Zurich and attend an additional Melanoma Research Conference. The funds contribut | 2000 | 2000 |
| 2014 | MSD | Melanoma Patients Australia | This funding supported the launch of a report – ‘Advanced Melanoma, The Real Cost of Australia’s National Cancer’. The report, conducted by KPMG and commissioned by MPA, assessed and analysed the financial and non-financial burdens of melanoma in Australi | 10000 | 10000 |
| 2014 | MSD | Melanoma Patients Australia | This funding supported the logistics and media services required by Melanoma Patients Australia to launch the Report – ‘Advanced Melanoma, The Real Cost of Australia’s National Cancer’. The launch was conducted as a breakfast event at Parliament House Can | 18000 | 18000 |
| 2014 | MSD | Melanoma Patients Australia | This funding supported a workshop for MPA facilitators already in Melbourne attending the Clinical Oncology Society of Australia conference. The workshop, conducted by an expert facilitator, assisted participants in building skills to articulate the patie | 20000 | 20000 |
| 2014 | MSD | Melanoma Patients Australia | This funding supported MPA to commission a report ‘Advanced Melanoma, The Real Cost of Australia’s National Cancer’ to gain a better understanding of the impact of melanoma on all Australians. MPA was responsible for the coordination, development and mana | 50000 | 50000 |
| 2014 | MSD | National Association of People with HIV Australia | This funding supported the NAPWA program, 'Treataware', aimed at raising awareness and providing education about treatment for individuals who have been diagnosed as HIV positive. ‘Treataware’ delivered a range of information and education initiatives inc | 40000 | 40000 |
| 2014 | MSD | Parkinson's New South Wales (NSW) | This funding supported a Parkinson NSW charity walk. The project ‘Unity Walk’ is a fundraising event held in Sydney to raise awareness about Parkinson’s disease as well as raise funds for people with Parkinson’s disease. In 2013 over 2000 people participa | 3000 | 3000 |
| 2014 | MSD | Rare Cancers Australia | This funding supported an event to facilitate consumer groups already in Melbourne attending the World Cancer Congress and Clinical Oncology Society of Australia Meetings to come together to discuss the current issues facing access to cancer medicines in | 10000 | 10000 |
| 2015 | MSD | Lung Foundation Australia | This funding will support the Lung Foundation annual dinner to raise awareness of the impact of lung cancer in the community. The dinner included presentations from Lung Foundation CEO, research clinicians and patients and their carers. | 10000 | 10000 |
| 2015 | MSD | Lung Foundation Australia | National Lung Cancer Program. Lung Foundation Australia is a national organisation supporting all aspects of lung health. This funding provided partial sponsorship to the Lung Foundation National Lung Cancer Program which includes a range of information a | 62500 | 62500 |
| 2015 | MSD | Melanoma Patients Australia | Annual Dinner Event. Melanoma Patients Australia is the key health consumer organisation in Australia providing support services and information for people with melanoma and their carers. Sponsorship of the annual MPA dinner provides funds for MPA to cont | 5000 | 5000 |
| 2015 | MSD | Melanoma Patients Australia | Consumer Forums. This funding supports two consumer forums conducted by Melanoma Patients Australia. The forums were co-funded and include sponsorship form a number of other pharma companies. The events included clinicians, researchers and allied health p | 5000 | 5000 |
| 2015 | MSD | Melanoma Patients Australia | Website Project. This funding supported work toward improving The MPA website, so that patients and carers had access the information and services as efficiently as possible. | 50000 | 50000 |
| 2015 | MSD | Melanoma Western Australia (WA) | Annual Dinner Event & Consumer Workshops. This funding supported Melanoma Western Australia conduct three events. It provided partial support toward the MelanomaWA annual dinner to raise awareness as well as funds to support the range of patient services | 10000 | 10000 |
| 2015 | MSD | Multiple Heath Consumer Organisations | Annual Health Consumer Advocacy Workshop. This funding provides partial sponsorship for a 2 day Health Consumer Advocacy (HCA) workshop. HCA has hosted four 2-day workshops and undertaken a variety of additional activities aimed at building capacity, fac | 16276 | 16276 |
| 2015 | MSD | National Heart Foundation Of Australia | Pharmaceutical Roundtable. MSD has been a member of the Heart Foundation Roundtable (NHF PRT) for 11 years. The NHF PRT comprises 9 pharma member companies that each contribute an equal grant annually to the NHF, funding a joint project (agreed in liaison | 30000 | 30000 |
| 2015 | MSD | Rare Cancers Australia | Annual Dinner Event. Rare Cancers Australia is a oncology consumer organisation providing information and a range of support services to people with less common cancers and their carers. This funding supported the organisation's annual dinner which is is | 2500 | 2500 |
| 2015 | MSD | Rare Cancers Australia | Sick or Treat Sessions Sydney University. This funding supported Rare Cancers Australia (RCA) in conducting a forum “The Sick orTreat Sessions” to raise awareness about the challenges facing Australians with a rare or less common cancer. The froum was hel | 25000 | 25000 |
| 2016 | MSD | Lung Cancer Central | This funding supported an upgrade to the Lung Cancer Central website. The upgrade included improving the design and navigation of the site to maximise access to the information provided. | 2000 | 2000 |
| 2016 | MSD | Lung Foundation Australia | This funding supported the Lung Foundation’s annual dinner to raise awareness of the impact of Lung cancer in the community. The dinner included presentations from Lung Foundation CEO, research clinicians and patients and their carers. | 1818.18 | 1818.18 |
| 2016 | MSD | Lung Foundation Australia | This funding supported the Lung Foundation develop and implement a Communications Program to build national awareness of a key Lung Foundation report “Improving Outcomes for Australians with Lung Cancer – A Call to Action”. | 30000 | 30000 |
| 2016 | MSD | Lung Foundation Australia | This funding supported The Lung Foundation’s Lung Cancer National Program. The program provides information and services including: - Clinical Community, education, awareness and support - Wider Community, reaching those at risk - Patient & Carers Communi | 62500 | 62500 |
| 2016 | MSD | Melanoma Patients Australia | This funding supported the MPA patient support manager to attend the 18th International Pschyo Oncology Soceity Congress. The conference themes included eHealth Interventions, Psychosocial Care and Psychological Interventions. The funding contributed to t | 2000 | 2000 |
| 2016 | MSD | Melanoma Patients Australia | This funding supported the following MPA programs aimed at providing information and services for people with melanoma and their carers: - Training program for MPA volunteer advocates - Information forums in Townsville, Sydney, Melbourne and Adelaide - Pa | 43500 | 43500 |
| 2016 | MSD | Melanoma Western Australia (WA) | This funding supported Melanoma Western Australia conduct two consumer workshops to provide patients and their carers up to date information about services available in WA for people with melanoma. | 6000 | 6000 |
| 2016 | MSD | National Association of People with HIV Australia | This funding supported the ‘Treataware’ program to raise awareness and provide education for individuals who have been diagnosed as HIV positive. Treataware delivers a range of information and education outreach initiatives including: - Responding to phon | 10000 | 10000 |
| 2016 | MSD | National Heart Foundation Of Australia | This funding supported MSD membership of The NHF Pharmaceutical Roundtable (PRT). The PRT comprises 9 pharma member companies that each contributes an equal grant annually to the NHF, funding a joint project to improve cardiovascular outcomes for Australi | 30000 | 30000 |
| 2016 | MSD | Rare Cancers Australia | This funding supported an additional forum held in Canberra to build on the work achieved at the February ‘Room For Patient View’ event. This funding also supported two related satellite forums held in Brisbane and Melbourne to ensure optimal representati | 7500 | 7500 |
| 2016 | MSD | Rare Cancers Australia | This funding supported two RCA events to raise awareness about the challenges facing Australians with a rare or less common cancer as well as to focus attention on the burden of disease in this cancer group: - ‘Disrupting Cancer Forum’ held at Parliament | 30000 | 30000 |
| 2017 | MSD | Head and Neck Cancer Australia | This funding supported Beyond Five to develop a patient information and support pack. The pack was developed in response to the identification of a need within the community for reliable, comprehensive, yet easy to understand information for patients, their families and caregivers. | 15000 | 15000 |
| 2017 | MSD | John Logan Foundation | This funding supported enhancement of the Foundation website to assist patients accessing JLF information and assist JLF volunteers in managing requests and information. | 4000 | 4000 |
| 2017 | MSD | Lung Foundation Australia | This funding supported the Lung Foundation Australia Annual Gala dinner. Funds raised support the provision of essential services and resources for patients, families, health professionals and everyone affected by lung disease. | 3000 | 3000 |
| 2017 | MSD | Lung Foundation Australia | This funding supported the Lung Foundation Australia's Parliamentary Friends of Lung Health Event in Canberra. The event was linked to Lung Health Awareness Month aimed at increasing awareness and support for those impacted by lung cancer.MP John Alexander OAM as Co-Chair of the Parliamentary Friends group, hosted the event. | 5000 | 5000 |
| 2017 | MSD | Lung Foundation Australia | This funding supported the Lung Foundation's National Lung Cancer Program which aims to reduce the impact of lung cancer and improve outcomes for patients, their carers and families. The Program provides information and educational programs relating to the prevention, detection, treatment and management of lung cancer and Mesothelioma across Australia. | 40000 | 40000 |
| 2017 | MSD | Lymphoma Australia | As part of Lymphoma Awareness day, MSD held an awareness raising event at Macquarie Park to assist staff understand the impact Lymphoma has on individuals and their families. Staff were encouraged to make a donation with MSD matching the donations. | 110 | 110 |
| 2017 | MSD | Lymphoma Australia | This funding supported enhancements to the Lymphoma Australia website to improve accessibility of the site for patients and carers as well as to update information provided on the site. | 10000 | 10000 |
| 2017 | MSD | Melanoma Patients Australia | This funding supported Melanoma Patients Australia in providing a range of programs including counselling services and comprehensive patient information and support services for those impacted by melanoma and their carers. The funding also supported a training program for state based MPA volunteers. | 40000 | 40000 |
| 2017 | MSD | Melanoma Western Australia (WA) | This funding supported a community forum for people touched with Melanoma in Western Australia. The forum aims to increase community awareness of Melanoma with leading experts in melanoma as part of the forum speaker program. In addition, the forum highlights the support and information services provided by Melanoma WA. | 5454.45 | 5454.45 |
| 2017 | MSD | National Association of People with HIV Australia | This funding supported the National Association of People with HIV, Australia (NAPWHA) Patient Education Resource. The printed resource aimed at assisting patients in understanding their treatment program, is distributed to clinicians to provide to their HIV patients. | 3000 | 3000 |
| 2017 | MSD | National Association of People with HIV Australia | This funding supported the 'Treataware' program, an initiative delivered by the National Association of People living With HIV in Australia (NAPWHA). The Treataware program raises awareness and provides education regarding treatment for individuals who have been diagnosed HIV positive. A Meeting was held for all Treatment Officers from HIV organisations across Australia to cover issues including quality of life, HIV self-testing, HIV disclosure, peer service delivery and the 8th National HIV Strategy. | 5000 | 5000 |
| 2017 | MSD | National Heart Foundation Of Australia Queensland (QLD) | This funding supported the National Heart Foundation QLD towards 2017 Cardiac Society of Australia and New Zealand and Heart Foundation Cardiology Symposium on 28 October 2017 in Brisbane. | 1818.18 | 1818.18 |
| 2017 | MSD | Rare Cancers Australia | The Mount Kosciuszko Challenge is an annual event hosted by Rare Cancers Australia to raise awareness and much needed funds for Australians diagnosed with rare and less common cancers. The event involves a climb from Thredbo to the summit of Mount Kosciuszko . All funds raised go toward RCA programs for Australians diagnosed each year with a rare and less common cancer. This funding was contributed as 'matched' funding related to funds that were raised by staff. | 1000 | 1000 |
| 2017 | MSD | Rare Cancers Australia | This funding supported a range of projects to build awareness and equitable access for those people impacted by a rare cancer. Initiatives included public forums to review issues pertinent to Australians receiving best quality cancer care as well as reports that examined the functioning of key pillars of the health system. Funding also supported elements of the 'Sick or Treat' Campaign to build community awareness around the needs and challenges facing Australians with a rare or less common cancer. | 65000 | 65000 |
| 2018 | MSD | BEAT Bladder Cancer Australia | This funding contributed to the development of a patient-driven interactive website aimed at increasing community, GP and health professional awareness of bladder cancer. In addition, the website aimed to help increase early detection of bladder cancer in Australia by encouraging people to see their GP if exhibiting symptoms. | 20000 | 20000 |
| 2018 | MSD | Diabetes New South Wales (NSW) | This funding supported an educational 'Update Day' held by Diabetes NSW to enhance understanding of the latest information in the prevention, treatment and management of diabetes in the community. | 4950 | 4950 |
| 2018 | MSD | Hepatitis Australia | This funding supported Hepatitis Australia to increase local awareness of World Hepatitis Day 2018 and the impact of hepatitis in the community. In addition, the program focused on building primary care health community understanding about how to identify, recall and manage people who have Hep C. | 50000 | 50000 |
| 2018 | MSD | Lung Foundation Australia | This funding supported the Lung Foundation's National Lung Cancer Program which aims to reduce the impact of lung cancer and improve outcomes for patients, their carers and families. The Program provides information and educational programs relating to the prevention, detection, treatment and management of lung cancer and Mesothelioma across Australia. | 40000 | 40000 |
| 2018 | MSD | Lymphoma Australia | This funding supported the establishment of a Scientific Advisory Committee to support Lymphoma Australiain the delivery of updated information and services to people impacted by lymphoma and their carers. | 15000 | 15000 |
| 2018 | MSD | Lynch Syndrome Australia | The funding supported Lynch Syndrome Australia in conducting a consumer information forum for people impacted by Lynch Syndrome and their families. The forum provided information about the latest research as well as information about new treatments and services available to patients. The forum also provided the opportunity for health care professionals as well as people impacted by Lynch Syndrome to network and share information. | 6000 | 6000 |
| 2018 | MSD | Melanoma Patients Australia | This funding supported Melanoma Patients Australia in providing a range of programs including a patient information forum along with comprehensive support services for those impacted by melanoma and their carers. | 25000 | 25000 |
| 2018 | MSD | Ovarian Cancer Australia | The funding supported Ovarian Cancer Australia to provide support and information services to women impacted by ovarian cancer and their carers. | 1600 | 1600 |
| 2018 | MSD | Ovarian Cancer Australia | This funding supported the development and printing of a patient information leafletfor women impacted by ovarian cancer. | 3000 | 3000 |
| 2018 | MSD | Rare Cancers Australia | This funding supported a charity event held by Rare Cancers Australia to raise awareness about the impact of less common cancers in the community. | 5000 | 5000 |
| 2018 | MSD | Rare Cancers Australia | This co funding supported a public forum to build awareness about the need for equitable access for people impacted by a rare cancer. The forum, held at Parliament House Canberra, reviewed issues related to best quality cancer care for people impacted by a rare cancer. | 30000 | 30000 |
| 2019 | MSD | Leukaemia Foundation Of Australia | This funding supported the Leukaemia Foundation to re-develop their patient education and information website to update website content and enhance user access. | 15000 | 15000 |
| 2019 | MSD | Lung Foundation Australia | This funding supported the Lung Foundation in providing a national program to support Australians impacted by lung cancer. The program included activities and materials to support patients and their carers as well as information events for health care professionals including lung cancer nurses. | 40000 | 40000 |
| 2019 | MSD | Lymphoma Australia | This funding supported Lymphoma Australia's national fundraising event 'Legs Out For Lymphoma'. MSD provided matching funds for those raised by MSD staff who participated in the charity walk. | 1000 | 1000 |
| 2019 | MSD | Lymphoma Australia | This funding supported Lymphoma Australia in delivering an educational meeting for lymphoma nurses about the treatment and management of patients with lymphoma. | 2000 | 2000 |
| 2019 | MSD | Lymphoma Australia | This funding supported Lymphoma Australia in providing a webinar program about lymphoma for patients and carers as well as lymphoma nurses. | 10000 | 10000 |
| 2019 | MSD | Melanoma Patients Australia | This funding supported Melanoma Patients Australia in the development of a program to assist patients and caregivers understand how to ensure their personal experience living with melanoma is considered when health decisions are made about melanoma care and treatment. | 10000 | 10000 |
| 2019 | MSD | Melanoma Patients Australia | This funding supported Melanoma Patients Australia conduct patient information forums for people impacted by melanoma as well as refresh and re print a range of patient information resources. | 25000 | 25000 |
| 2019 | MSD | Rare Cancers Australia | This funding supported foundation work required to form the basis of a National Cancer Plan for Australia. The project aim is to present a comprehensive and united case for the funding and completion of a comprehensive National Cancer Plan. | 25000 | 25000 |
| 2019 | MSD | Rare Cancers Australia | This funding supported a range of activities by Rare Cancers Australia to build understanding in the community about issues impacting access to new oncology treatments for people impacted by rare cancers including: 1. CanForum - A conference at Parliament House Canberra 2. RCA Report - 'Just A Little More Time' 3. Scare4Rare - Annual Rare Cancers Australia Ball | 30000 | 30000 |
| 2020 | MSD | BEAT Bladder Cancer Australia | This funding supported the BEAT Bladder Cancer Australia Patient and Nurse Information and Support Project. The program included a patient information webinar as well as a series of patient and carer case study videos aimed to assist understanding of bladder cancer in the community. | 20000 | 20000 |
| 2020 | MSD | Head and Neck Cancer Australia | This funding represents additional dollar matching by MSD for staff fundraising linked to the Beyond Five Charity Event 'Soup for the Soul' where staff participated in an awareness raising event and raised funds to support Beyond Five. | 700 | 700 |
| 2020 | MSD | Head and Neck Cancer Australia | This funding supported Beyond Five in developing, printing and distributing a range of printed information and support materials for patients impacted by head and neck cancer and their families. | 10000 | 10000 |
| 2020 | MSD | Lung Foundation Australia | This funding represents additional dollar matching by MSD for staff fundraising linked to the Lung Foundation Charity Event - #Challenge30 where MSD staff participated in awareness raising activities to raise funds to support the Lung Foundation. | 800 | 800 |
| 2020 | MSD | Lung Foundation Australia | This funding supported the Lung Foundation 2020 Patient Support and Lung Health Program. The program provided a range of information and support services to patients and families impacted by lung cancer. | 40000 | 40000 |
| 2020 | MSD | Lymphoma Australia | This funding represents additional dollar matching by MSD for staff fundraising linked to the Lymphoma Australia Charity Event 'Go Lime for Lymphoma' where staff participated in an awareness raising event and raised funds to support Lymphoma Australia | 400 | 400 |
| 2020 | MSD | Lymphoma Australia | This funding supported Lymphoma Australia update their website to improve navigation by patients and families seeking information and support services provided by Lymphoma Australia. | 7500 | 7500 |
| 2020 | MSD | Melanoma & Skin Cancer Advocacy Network | This funding supported Melanoma & Skin Cancer Advocacy Network (MSCAN) develop their website to provide improved patient access to information about MSCAN as well as information and resources available to their patient community. | 15000 | 15000 |
| 2020 | MSD | Melanoma Patients Australia | This funding supported Melanoma Patients Australia enhance their website design to support easier navigation by patients and families seeking information about melanoma and the support services provided by MPA. | 15000 | 15000 |
| 2013 | Mundipharma | Asthma Australia | Internal training of Mundipharma staff and development of training materials | 13300 | 13300 |
| 2013 | Mundipharma | Australian Pain Management Association | Sponsorship to attend and have a booth at the Australian Pain Society in Canberra | 5240 | 5240 |
| 2013 | Mundipharma | Painaustralia | Presentation at internal training sessions of Mundipharma staff | 330 | 330 |
| 2013 | Mundipharma | Painaustralia | Sponsorship of Painaustralia collaboration | 62500 | 62500 |
| 2014 | Mundipharma | Asthma Foundation of Queensland (QLD) | Sponsorship of Asthma Workshop for Health Professionals (25&26 Oct 2014) | 7200 | 7200 |
| 2014 | Mundipharma | Australian Pain Management Association | Sponsorship towards the cost of an exhibitor stand, 2 passes, plus travel for 2 delegates to IASP 2014 | 2000 | 2000 |
| 2014 | Mundipharma | Painaustralia | 12 month sponsorship of Fact sheet in Medical Director | 3690 | 3690 |
| 2014 | Mundipharma | Painaustralia | Sponsorship of 2015 Australian Pain Society Consumer Symposium | 5000 | 5000 |
| 2014 | Mundipharma | Painaustralia | Contribution to Painaustralia Collaboration for 2014 | 65000 | 65000 |
| 2015 | Mundipharma | Australia and New Zealand Burn Association | National Prevention Committee Meeting – Julian Burton Burns Trust | 5000 | 5000 |
| 2015 | Mundipharma | Australian Pain Management Association | The Big Brunch (During National Pain Week) | 29220 | 29220 |
| 2015 | Mundipharma | Australian Pain Society | APS Corporate Membership for 2015 | 10000 | 10000 |
| 2015 | Mundipharma | Australian Pain Society | Exclusive sponsorship of the APS History Project | 25000 | 25000 |
| 2015 | Mundipharma | National Asthma Council Australia | Major sponsorship of the Aust Asthma Handbook 2015 | 30000 | 30000 |
| 2015 | Mundipharma | New Zealand Pain Society | New Zealand Pain Society Corporate Membership 2015 | 5000 | 5000 |
| 2015 | Mundipharma | Painaustralia | Sponsorship of 2015 Australian Pain Society Consumer Symposium | 5000 | 5000 |
| 2015 | Mundipharma | Painaustralia | Contribution to Painaustralia Collaboration for 2015 | 65000 | 65000 |
| 2014 | Mylan EPD | Cystic Fibrosis Australia | Provided support for Cystic Fibrosis data registry, Cystic Fibrosis clinic peer review, development of guideline for healthcare worker with Cystic Fibrosis and Cystic Fibrosis Australia website development. | 40000 | 40000 |
| 2014 | Mylan EPD | Macular Disease Foundation | Provided support for development of a publication to address the gap in information around diabetic eye disease and promote it to ophthalmologists, optometrists and general practitioners. | 120000 | 120000 |
| 2015 | Mylan EPD | Cystic Fibrosis Australia | Supporting the Cystic Fibrosis Data Registry in developing a high quality source of information that provides on-demand patient level reports for clinicians, delivers benchmarking reports at treatment centre level and a platform for a range of research pr | 30000 | 30000 |
| 2015 | Mylan EPD | Macular Disease Foundation | Supporting the development of a publication to address the gap in information around diabetic eye disease and promote it to ophthalmologists, optometrists and general practitioners. | 128000 | 128000 |
| 2013 | Norgine | Diabetes Australia - Tasmania (TAS) | Silver sponsorship for Pollie Pedal 2013. The annual charity bike ride was launched at Parliament House by Tony Abbott. The 1000km ride through SA to VIC has raised ove $2.5m for a range of charitable organisations. The funds are used for: activate Care A | 6600 | 6600 |
| 2014 | Norgine | ALA Chronic Liver Disease Faculty | Sponsorship support for Gastroenterological Society of Australia (GESA) - Australian Liver Association (ALA) Chronic Liver Disease Faculty. November 2014. The ALA Chronic Liver Disease Faculty has been established for the advancement of education and training | 16500 | 16500 |
| 2014 | Norgine | Diabetes Australia - Tasmania (TAS) | Sponsorship for Diabetes Tasmania Pollie Pedal 2014. February 2014. The annual charity bike ride has been operating since 2006 and has raised funds and awareness for Diabetes. The funds are used for diabetes education and community awareness activities in | 5909 | 5909 |
| 2014 | Norgine | IBD Sydney | Unrestricted education grant provided to the Inflammatory Bowel Disease Clinic supporting the IBD Sydney Consensus Working Group Statements on Managing Acute Severe Ulcerative Colitis. July 2014. Funds provided to assist the group define and publish appro | 2500 | 2500 |
| 2015 | Norgine | Diabetes Australia - Tasmania (TAS) | Donation for sponsorship for Diabetes Tasmania Pollie Pedal 2015. February 2015. The annual charity bike ride has been operating since 2006 and has raised funds and awareness for diabetes. The funds are used for diabetes education and community awareness | 6573 | 6573 |
| 2016 | Norgine | Diabetes Australia - Tasmania (TAS) | Donation for sponsorship for Diabetes Tasmania Pollie Pedal 2016. Held in February 2016. The annual charity bike ride has been operating since 2006 and has raised funds and awareness for Diabetes. The funds are used for diabetes education and community aw | $6500 donation | 6500 |
| 2017 | Norgine | Diabetes Australia - Tasmania (TAS) | Donation for sponsorship for Diabetes Tasmania Pollie Pedal 2017. Held in 3-5 March 2017. The annual charity bike ride has been operating since 2006 and has raised funds and awareness for Diabetes. The funds are used for diabetes education and community awareness activities in Tasmania. Two Norgine employees paticipated in the cycling event. | $5,500. Donation | 5500 |
| 2013 | Novartis | Australian Diabetes Council | Purchase of corporate table at World Diabetes Day fundraising dinner | 5000 | 5000 |
| 2013 | Novartis | Australian Pituitary Foundation | Funds to support creation and distribution of the APF Quarterly Newsletter, website, event signage, printed literature, educational events literature (includes recognition as Platinum sponsor on event signage).All content developed exclusively by the APF. | 35000 | 35000 |
| 2013 | Novartis | Cure Our Kids | Funds to support print and development of 'Cure our Kids' Oncology Diary for 2014.All content developed exclusively by Cure our Kids. | 2750 | 2750 |
| 2013 | Novartis | Cystic Fibrosis Australia | Funding towards: Maintenance and upkeep of the Australian Cystic Fibrosis Data Registry (ACFDR), Management of the CF Clinic Peer Review program, Conducting Cystic Fibrosis disease awareness campaigns and The Cystic Fibrosis Dircetors Meetings. | 40000 | 40000 |
| 2013 | Novartis | Hepatitis Australia | The funding will go towards supporting an initiative of Hepatitis Australia titled ‘Love your Liver’. The purpose of the campaign is to raise awareness of Australians living with hepatitis and reducing the social stigma related with the disease | 15000 | 15000 |
| 2013 | Novartis | Leukaemia Foundation Of Australia | Funds to support activities relating to three disease areas (MPN, MPS and CML) including Newsletter production and distribution; production of a CML DVD; logistics for state-based conferences; creation of an MPN Coordinator for two years. All content dev | 132000 | 132000 |
| 2013 | Novartis | Macular Disease Foundation | Funds to produce 15,000 Amsler Grids in March 2013 to help patients with the detection and progression of wAMD | 2235 | 2235 |
| 2013 | Novartis | Macular Disease Foundation | Funds to produce 30,000 Amsler Grids in October 2013 to help patients with the detection and progression of wAMD | 3965 | 3965 |
| 2013 | Novartis | Macular Disease Foundation | Funds to produce 10,000 Macular Degeneration A4 booklets in May to assist patients with their condition | 11309 | 11309 |
| 2013 | Novartis | Macular Disease Foundation | Funds to produce 20,000 Macular Degeneration A4 booklets in November to assist patients with their condition | 23927 | 23927 |
| 2013 | Novartis | Macular Disease Foundation | Macular Degeneration Awareness Week, Deloitte Acess Economics, Keep on Driving- Safety, Friends of the Foundation Program, Retirement and Lifestyle expo, Print Advertising Campaign week. | 501000 | 501000 |
| 2013 | Novartis | McGrath Foundation | Funds to support breast care nurse education at the McGrath Foundation in 2013; attendance of Novartis employees at the McGrath Foundation Ashes luncheon; provision of volunteers working for 80 hours to fundraise for the Foundation during the Ashes. | 14140 | 14140 |
| 2013 | Novartis | MS Australia | Funding of national advocacy coordination & communications programs. | 40000 | 40000 |
| 2013 | Novartis | MS Australia | Funding of state-based MS Societies to provide services for people with MS as follows: Provision of education and resource material; telephone and online advisory and support services; national nursing services including training for immunotherapy treatme | 180000 | 180000 |
| 2013 | Novartis | Multiple Heath Consumer Organisations | Novartis partnered with another pharmaceutical company to provide funding for ZEST to develop and host an education weekend for Health Consumer Advocacy Organisations. All agenda content and speakers was developed by a steering committee involving three H | 39886 | 39886 |
| 2013 | Novartis | Myeloma Australia | Funds to support development, printing and distribution of quarterly newsletter MyeNews. All content presented in MyeNews developed exclusively by the Myeloma Foundation of Australia. | 5000 | 5000 |
| 2013 | Novartis | Parkinson's Australia | Design & printing of the 'Blue Book' - an educational resource for people with parkinsons disease | 6623 | 6623 |
| 2013 | Novartis | Parkinson's New South Wales (NSW) | Funding to support a disease awareness service to the Orange area | 15000 | 15000 |
| 2013 | Novartis | Rare Cancers Australia | Funds to support preparation of Rare Cancer Evidence Report: 'Just a little more time' and attendance awareness-raising event. All content developed exclusively by RCA. | 10210 | 10210 |
| 2013 | Novartis | Rare Voices Australia | Funds to support disease awareness and launch event at Parliament House. Funds were also used to support educational activities such as educational workshops and a roundtable meeting with industry. All content developed exclusively by RVA. | 14000 | 14000 |
| 2013 | Novartis | Sight for All | Donation for Ophthalmologists to travel and provide eye procedures to 3rd world countries including Cambodia, Korea and Vietnam | 60000 | 60000 |
| 2013 | Novartis | Skin & Cancer Foundation Australia | Sponsorship of Skin & Cancer Foundation Education sessions | 4250 | 4250 |
| 2013 | Novartis | Skin & Cancer Foundation Australia | Funding will support the Australasian Psoriasis Registry by providing financial support for administration of the Registry application and data, including data quality assurance audits, data analysis and reporting, software upgrades and site visits for us | 30000 | 30000 |
| 2013 | Novartis | Thalassaemia & Sickle Cell Australia | Funds to support development, printing and distribution of quarterly newsletter; travel to attend 2013 TIF World Congress; and to secure an exhibit at GPCE in Melbourne and Sydney to educate GPs about Thalassaemia. All content developed exclusively by Tha | 24000 | 24000 |
| 2013 | Novartis | Transplant Australia | Funding of Transplant Australia’s ‘Education Multicultural Australia’ Program. The program will address information gaps, myths and misconceptions about organ donation amongst culturally and linguistically diverse communities. The program is aimed to incr | 20000 | 20000 |
| 2013 | Novartis | Tuberous Sclerosis Australia | Funds to support the ATSS Conference in Perth in 2013; for Fundraising Capability Improvement (targeted awareness campaign to grow donors and build independence and sustainability); Annual Family Conference to provide new i information to and from familie | 60000 | 60000 |
| 2013 | Novartis | Unicorn Foundation (NeuroEndocrine Cancer Australia) | Funds to print and development of written materials and website for World NET Awareness Day campaign; Funds were also used to support conference attendance and involvement in patient group activities at the Asia Pacific Neuroendocrine Tumour Society (APNE | 14855 | 14855 |
| 2014 | Novartis | ADDults with ADHD | Support for the 2014 Adult ADHD Annual Conference | 1800 | 1800 |
| 2014 | Novartis | Amanda Young Foundation (AYF) | Purchase of a corporate table at the Amanda Young Foundation Charity Ball | 2000 | 2000 |
| 2014 | Novartis | Association of Genetic Support of Australasia | Support of the Annual Genetic Disorders Awareness Week Launch. | 6000 | 6000 |
| 2014 | Novartis | Asthma Australia | Funding to support 5 World Asthma Day symposia sessions. | 10000 | 10000 |
| 2014 | Novartis | Australian Gastro‐Intestinal Cancer Institute | Support for fundraising and educational programs throughout 2014 including the GI Cancer Institute Engage Community Forums (support services and forum for patients, carers and clinicians), ‘The Gutsy Challenge’ to raise awareness and encourage healthy liv | 12500 | 12500 |
| 2014 | Novartis | Australian Pituitary Foundation | Support throughout 2014 for the following activities: GP Conference Events education; Health Psychologist Workshops; Patient education seminars; Educational support materials (newsletter and website). | 25000 | 25000 |
| 2014 | Novartis | Australian Pituitary Foundation | Support throughout 2014 for the following activities: APF Quarterly Newsletter; APF Website; APF Event Signage; APF Educational Events Literature. | 25000 | 25000 |
| 2014 | Novartis | CanSpeak | Health Consumer Advocacy Weekend Meeting This funding supported an educational workshop ‘Health Consumer Advocacy’ to facilitate linkages between small health consumer organisations. The two day workshop program, developed by a Steering Committee comprise | 15000 | 15000 |
| 2014 | Novartis | Cure Our Kids | Support to develop and distribute children's diary that support children on their treatment journey. | 3000 | 3000 |
| 2014 | Novartis | Cystic Fibrosis Australia | Funding to support the CF Centre Collaborative Meeting | 5000 | 5000 |
| 2014 | Novartis | Cystic Fibrosis Australia | Funding to support the maintenance of the Australian Cystic Fibrosis Data Registry | 15000 | 15000 |
| 2014 | Novartis | Diabetes Australia - Tasmania (TAS) | Funding towards support of the Pollie Pedal fundraising activity | 3900 | 3900 |
| 2014 | Novartis | Macular Disease Foundation | Support for printed materials such as amsler grids. | 30000 | 30000 |
| 2014 | Novartis | Macular Disease Foundation | Funds provided to the Macular diseases Foundation of Australia to support patient orientated programs run by the MDFA. These programs are Macular Degeneration awareness week, Macular disease resources and services, support services (info kits, helpline), | 450000 | 450000 |
| 2014 | Novartis | McGrath Foundation | 5 Novartis associate volunteers' to collect donations at a McGrath Foundation event. | 5 Novartis associate volunteers' to collect donations at a McGrath Foundation event. | 0 |
| 2014 | Novartis | McGrath Foundation | Support provided towards the development and running of x5 Breast Care Nurse meetings across Australia. | 100000 | 100000 |
| 2014 | Novartis | Meningococcal Australia | Financial assistance to support travel and accommodation expenses for Meningococcal Australia members to attend Protecting Our Tomorrows meningococcal disease awareness fundraising event. | 8415 | 8415 |
| 2014 | Novartis | Meningococcal Australia | Support of the Protecting Our Tomorrows meningococcal disease awareness fundraising event. | 20000 | 20000 |
| 2014 | Novartis | Meningococcal Australia | Support of activities associated with the meningococcal peak season media awareness campaign, update to/maintenance of website content and Facebook presence, and the creation and distribution of daycare centre/pre‐school educational kits. | 25000 | 25000 |
| 2014 | Novartis | MS Australia | Support of the MSA Volunteer National Advocates Conference 2014. | 5000 | 5000 |
| 2014 | Novartis | MS Queensland (QLD) | Printing of the 2013‐2014 MS Queensland Annual Report | 5500 | 5500 |
| 2014 | Novartis | MS Research Australia | Support for MS Angels Meeting | 400 | 400 |
| 2014 | Novartis | MS Society South Australia (SA) & Northern Territory (NT) | Support provided for Patient Education Forums | 5000 | 5000 |
| 2014 | Novartis | National Asthma Council Australia | Funds provided to the National Asthma Council (NAC) Australia to develop and run a total of 11 interactive workshops and 4 seminars throughout 2014, focusing on Asthma and COPD. These | 46255 | 46255 |
| 2014 | Novartis | Parkinson's New South Wales (NSW) | Funding for education and support activities based in the Orange district | 15000 | 15000 |
| 2014 | Novartis | Parkinson's Western Australia (WA) | Support for x2 patient seminars for people diagnosed with Parkinson's Disease more than six years ago. | 640 | 640 |
| 2014 | Novartis | Parkinson's Western Australia (WA) | Funding towards x2 Parkinson's Nurse Specialists to attend an International Congress on Non‐ Motor Dysfunctions in Parkinson's Disease and related Disorders | 1900 | 1900 |
| 2014 | Novartis | Rare Cancers Australia | Support for Rare Cancers Australia members to attend an Asia Pacific patient group meeting. | 1349 | 1349 |
| 2014 | Novartis | Rare Cancers Australia | Support for Patient Advocates Meeting | 1500 | 1500 |
| 2014 | Novartis | Rare Cancers Australia | Support for awareness‐building of RCA initiative for 'Sick or Treat' medicines fund. | 30000 | 30000 |
| 2014 | Novartis | Rare Voices Australia | Support for rare diseases awareness activities/projects throughout 2014 including in support of awareness campaigns via RVA website, social media and printed materials; Rare Disease National Plan Engagement Roadshow; Rare Disease Day event at Parliament H | 10000 | 10000 |
| 2014 | Novartis | Thalassaemia & Sickle Cell Australia | Support of Thalassaemia Australia education activities 2014/2015, including TA Quarterly Newsletter; support for patient material development, and GP and haematology meeting attendance and participation; development and distribution of educational materia | 49300 | 49300 |
| 2014 | Novartis | Thalassaemia Society Of New South Wales (NSW) | Purchase of tickets for Thal NSW fundraising event. | 300 | 300 |
| 2014 | Novartis | Unicorn Foundation (NeuroEndocrine Cancer Australia) | Support of the Unicorn Foundation activities throughout 2014 including: Development of videos to support NET (Neuroendocrine tumours) awareness and understanding; supported attendance at key medical conferences to promote and NET data (APNETS); Support to | 32400 | 32400 |
| 2014 | Novartis | Vision 2020 Australia | Funding support for the Eye Health Survey | 40000 | 40000 |
| 2015 | Novartis | Breast Cancer Network Australia | Purchase of tickets for the Pink Lady luncheon, a series that provides education on breast cancer and the role of BCNA | 450 | 450 |
| 2015 | Novartis | Cancer Council Australia | Purchase of a corporate table at the Emeralds and Ivy Ball, supporting the Cancer Council's work with Australian patients suffering from cancer | 7500 | 7500 |
| 2015 | Novartis | Cystic Fibrosis Australia | Australian Cystic Fibrosis Data Registry including online hosting and maintenance | 23000 | 23000 |
| 2015 | Novartis | Cystic Fibrosis Australia | Cystic Fibrosis Clinical Peer Review Program | 25504 | 25504 |
| 2015 | Novartis | Diabetes Australia | Parliamentary Event co‐hosted by Diabetes Australia | 10000 | 10000 |
| 2015 | Novartis | Diabetes Australia - Tasmania (TAS) | PolliePedal Tasmania 2015 | 5500 | 5500 |
| 2015 | Novartis | Genetic Alliance Australia | Genetic Alliance Australia's (GAA) 'Annual Genetic Disorders Awareness Week Launch' | 1000 | 1000 |
| 2015 | Novartis | Leukaemia Foundation Of Australia | Educational activities led by the Leukaemia Foundation of Australia in 2015, supporting the needs of Australians living with MPN, CML and MDS. The activities included but were not restricted to: ‐ Patient newsletter development and production (2015) ‐ MDS | 35000 | 35000 |
| 2015 | Novartis | Macular Degeneration Foundation (MDF) | Printing of booklets for Macular Degeneration and Amsler Grids (in‐kind support) | 30000 | 30000 |
| 2015 | Novartis | Macular Degeneration Foundation (MDF) | Funding provided throughout 2015 to support: ‐ Macular Degeneration Awareness Week 2015 (including in‐kind AV support $2,245) ‐ A variety of patient support activities (e.g. Info kits, helpline, website, 'Keep on Driving ‐ Safely' materials) ‐ Development | 397245 | 397245 |
| 2015 | Novartis | McGrath Foundation | McGrath Foundation's fundraising and awareness efforts at January 2015 Sydney Cricket Test through provision of x3 volunteers to collect donations from spectators for approximately 5 hours each (in‐kind support) | Volunteer Hours | 0 |
| 2015 | Novartis | Melanoma Patients Australia | Funding in support of the 2015 Journey Gala Dinner, with all proceeds going towards improvements to MPA services for those affected by melanoma based on support, information and advocacy | 1000 | 1000 |
| 2015 | Novartis | Melanoma Patients Australia | Purchase of corporate table at 2015 Journey Gala Dinner, supporting fundraising and awareness raising efforts of MPA | 1700 | 1700 |
| 2015 | Novartis | Melanoma Patients Australia | 2 x Patient Forums with the objective to support and inform patients with regard to optimal disease management | 5000 | 5000 |
| 2015 | Novartis | Melanoma Patients Australia | MPA Volunteer Training program for MPA support group facilitators. | 7500 | 7500 |
| 2015 | Novartis | MS Queensland (QLD) | Printing of the MS Queensland Annual Report | 5500 | 5500 |
| 2015 | Novartis | Multiple Heath Consumer Organisations | Health Consumer Advocacy Weekend Meeting Support for an educational workshop ‘Health Consumer Advocacy’ to facilitate linkages between small health consumer organisations. The two day workshop program, developed by a Steering Committee comprised of CEOs f | 16276 | 16276 |
| 2015 | Novartis | Multiple Sclerosis | MS Patient Seminars across VIC, NSW and ACT | 33000 | 33000 |
| 2015 | Novartis | National Asthma Council Australia | Funding to support the National Asthma Council's presence at 3 GPCE 2015 events (Sydney, Brisbane and Melbourne) | 42680 | 42680 |
| 2015 | Novartis | National Heart Foundation Of Australia | Heart Foundation Industry Roundtable Initiative 2015 which included the development of the 'My Heart My Life' app | 60000 | 60000 |
| 2015 | Novartis | Psoriasis Australia | Psoriasis Australia Community Chest | 12500 | 12500 |
| 2015 | Novartis | Rare Cancers Australia | Rare Cancers Australia (RCA) ‘Sick or Treat’ Campaign to raise awareness and support for Australians living with rare cancers. The campaign components include: ‐ Social media activity ‐ Parliamentary event attendance ‐ RCA website upgrade ‐ Annual ‘Sick o | 35000 | 35000 |
| 2015 | Novartis | Redkite | Development and printing of 2016 Oncology Diaries to support patients receiving treatment at the Children’s Westmead Hospital | 2800 | 2800 |
| 2015 | Novartis | Tuberous Sclerosis Australia | Support the TSA Annual Meeting for patients and clinicians | 45000 | 45000 |
| 2015 | Novartis | Unicorn Foundation (NeuroEndocrine Cancer Australia) | Unicorn Foundation awareness and education activities during 2015. This included but was not limited to: ‐ Attendance at national cancer conferences, MOGA, COSA, AGITG and CNSA ‐ Attendance at international NET Conferences (ENETs and APNETs) | 25000 | 25000 |
| 2015 | Novartis | Unicorn Foundation (NeuroEndocrine Cancer Australia) | Support of attendance by a Unicorn Foundation patient group representative to present at APNETs in Kochi, India. | 5000 | 5000 |
| 2016 | Novartis | Australian Pituitary Foundation | Support towards Australian Pituitary Foundation educational programs and disease‐awareness activities for 2016 | 15000 | 15000 |
| 2016 | Novartis | Beard Season | Support for skin check services | 41072 | 41072 |
| 2016 | Novartis | Cancer Drugs Alliance | Support towards development of the cancer drug alliance committee and support to development a paper to present to the government on cancer drug access for patients | 30000 | 30000 |
| 2016 | Novartis | Diabetes New South Wales (NSW) | Support towards Diabetes NSW's National Conference | 20000 | 20000 |
| 2016 | Novartis | Dragons Abreast Australia | Donation towards Dragons Abreast Australia Festival which assist patients living with a diagnosis of breast cancer | 2420 | 2420 |
| 2016 | Novartis | Glaucoma Australia | Support towards: • Glaucoma Call Support Line ($34,000) • In‐kind support of printing Patient Brochures ($5,500) | $34,000 + In‐kind provision of printing | 34000 |
| 2016 | Novartis | Kidney Health Australia | Support towards the development of an advanced kidney cancer information kit for patients | 16500 | 16500 |
| 2016 | Novartis | Kidney Health Australia | Support towards the development and role out of World Kidney Cancer Day 2017 | 22000 | 22000 |
| 2016 | Novartis | Leukaemia Foundation Of Australia | Donation towards the Leukaemia Foundation's Light the Night | 1000 | 1000 |
| 2016 | Novartis | Leukaemia Foundation Of Australia | Support for Leukaemia Foundation Educational activities 2016 | 70000 | 70000 |
| 2016 | Novartis | Macular Disease Foundation | Support towards: • Printing of a comprehensive range of publications on macular diseases and low vision ($40,000) • Distribution of the publication information kits ($15,000) • In‐kind provision of MD Booklet and Amsler grid | $55,000 + In‐kind provision of materials | 55000 |
| 2016 | Novartis | Melanoma Patients Australia | Support to Melanoma Patients Association for the Australian Melanoma Consumer Alliance meeting which discusses initiatives and activities for improving the outcomes for Australian melanoma patients | 1500 | 1500 |
| 2016 | Novartis | Melanoma Patients Australia | Support towards Melanoma Patients Association's: • Training Program • Information Forums • Patient care pack • Website redevelopment | 30000 | 30000 |
| 2016 | Novartis | MS Society South Australia (SA) & Northern Territory (NT) | A series of 4 MS Awareness Seminars, Information Sessions and Forums across 2016/2017 for people affected by MS | 5000 | 5000 |
| 2016 | Novartis | MSWA | A Series of workshops and seminars delivered by qualified counsellors tailored to support people living with MS | 5000 | 5000 |
| 2016 | Novartis | Multiple Sclerosis | Donation towards MS Sydney to the Gong Ride | 5000 | 5000 |
| 2016 | Novartis | Parkinson's New South Wales (NSW) | Donation in kind of Parkinson's patient resource | In‐kind provision of materials | 0 |
| 2016 | Novartis | Rare Cancers Australia | Donation towards 2016 Mount Kosciuszko Challenge | 2500 | 2500 |
| 2016 | Novartis | Rare Cancers Australia | Support towards report on the impact and disadvantages on patients with less common cancers | 25000 | 25000 |
| 2016 | Novartis | Rare Cancers Australia | Support towards: • Patient information website • Social media campaign • Sick or Treat Sessions at Old Parliament House | 30000 | 30000 |
| 2016 | Novartis | Thalassaemia & Sickle Cell Australia | Support awareness raising and educational activities conducted by Thalassaemia Australia | 10000 | 10000 |
| 2016 | Novartis | Tuberous Sclerosis Australia | Support towards Tuberous Sclerosis Australia's educational forum and webinar | 15000 | 15000 |
| 2016 | Novartis | Unicorn Foundation (NeuroEndocrine Cancer Australia) | Support the Unicorn Foundation in 2016 for awareness and educational activities | 25000 | 25000 |
| 2017 | Novartis | Glaucoma Australia | Support towards 2 issues of Glaucoma Now and related CME education: - Issue 1 - Functional Assessment in Glaucoma - Issue 2 - Glaucoma What is New and Where are we Going | 42534 | 42534 |
| 2017 | Novartis | Melanoma Patients Australia | Support towards: - Patient Information Forums - Interactive Patient Education Resource - Melanoma and Me (patient reflections) project | 35000 | 35000 |
| 2017 | Novartis | Rare Cancers Australia | $50,000 towards 2017 Projects Advocacy for: - Research/issues paper - Video Community Service - Co-ordinated and extensive social media campaign - MP Dinners at Parliament House, staging of Canberra Forum $10,000 towards: - Raven Sponsorship of the Annual Sick or Treat Ball - includes table of 10 on the night | 60000 | 60000 |
| 2017 | Novartis | Redkite | Support towards: Development, printing and delivery of Redkite Oncology Diaries to help families manage appointments and treatment protocols | 3000 | 3000 |
| 2018 | Novartis | Allergy & Anaphylaxis Australia | Support towards Allergy & Anaphylaxis Australia's World Urticaria Day | 4500 | 4500 |
| 2018 | Novartis | Allergy & Anaphylaxis Australia | Support towards Disease State Brochure focusing on a background of Urticaria as well as a balanced view on treatment options/management and other relevant information for a consumer | 5000 | 5000 |
| 2018 | Novartis | Brain Foundation | Support towards Headache & Migraine Awareness Week | 15000 | 15000 |
| 2018 | Novartis | Creaky Joints Australia | Support towards Creakyjoints National Patient Council Australia 2018 | 12500 | 12500 |
| 2018 | Novartis | Macular Disease Foundation | Support towards implementation of a range of projects in support of services to patients and caregivers, and the health and wellbeing of the general public. | 109000 | 109000 |
| 2018 | Novartis | Melanoma Patients Australia | Support towards: 1. Patient Information Forums ($10,000) 2. Patient and Stakeholder Data Management Project ($10,000) 3. MPA Website and Content Review ($10,000) 4. Medical Education and Advocacy support ($10,000) | 40000 | 40000 |
| 2018 | Novartis | Multiple Sclerosis | Support towards MS Sydney to the Gong Bike Ride | 7255 | 7255 |
| 2018 | Novartis | Rare Cancers Australia | Support towards the National Oncology Alliance projects | 40000 | 40000 |
| 2018 | Novartis | Rare Cancers Australia | Support towards: 1. Canberra Forum ($20,000) 2. Rare Solutions Update Report with Infographic ($20,000) 3. Sick or Treat Campaign and Ball ($10,000) | 50000 | 50000 |
| 2018 | Novartis | Redkite | Support towards Redkite's Family Wellbeing Program at The Children's Hospital at Westmead | 16120 | 16120 |
| 2018 | Novartis | Transplant Australia | Support towards Australian Transplant Games 2018 | 13300 | 13300 |
| 2018 | Novartis | Unicorn Foundation (NeuroEndocrine Cancer Australia) | Support towards 1. GP Education and focus groups ($10,000) 2. World NET Cancer Awareness Day Campaign ($10,000) and 3. PLANET Registry Maintenance ($10,000) | 30000 | 30000 |
| 2019 | Novartis | Arthritis Foundation of Australia | Support towards Arthritis Australia's RASP (Rheumatoid Arthritis Support Program) campaign and research in the disease area. RASP is a virtual space that empowers people on their journey through life with rheumatoid arthritis. It will encourage them to become active participants in their care so they can ensure that the care they receive meets their needs. | 75000 | 75000 |
| 2019 | Novartis | Asthma Australia | Support towards the 2017 Australasian Asthma Conference | 20000 | 20000 |
| 2019 | Novartis | Australian Sickle Cell Advocacy | Support towards: Quaterly patient support network meetings across three sites | 5250 | 5250 |
| 2019 | Novartis | Brain Foundation | Support towards: Headache Australia Strategy Workshop (31 July 2019) | 2500 | 2500 |
| 2019 | Novartis | ITP Australia | Support towards: ITP Patient Meeting 2019 | 10000 | 10000 |
| 2019 | Novartis | Leukaemia Foundation Of Australia | Support towards: Life Ride 2019, which is a community fundraising event that will help raise much needed funds to help achieve Leukaemia Foundation of Australia Limited's goal of zero lives lost to blood cancer by 2035. Funding from Novartis contributed to the costs of running the event, allowing for greater impact of fundraising by participants. | 10000 | 10000 |
| 2019 | Novartis | Leukaemia Foundation Of Australia | Support towards: - 2019 "Inform Me" patient education website redevelopment (AUD40,000) - Provision of lanterns for the Leukaemia Foundation Light the Night event (AUD20,000) | 60000 | 60000 |
| 2019 | Novartis | Melanoma Patients Australia | Support towards Melanoma Awareness Campaign and Patient Voice Project, including: - To work with an external Public Relations Company to develop a social media content strategy and campaign in November 2019 - To host a facilitated meeting with the Australian Melanoma Consumer Alliance (AMCA) to identify the current patient journey facing a melanoma patient and opportunities for AMCA Members to improve collaboration. | 20000 | 20000 |
| 2019 | Novartis | Multiple Sclerosis | Support towards Multiple Sclerosis Sydney to Wollongong Charity Bike Ride 2019 | 4895 | 4895 |
| 2019 | Novartis | Pink Hope Community | 2019 Content and mentorship program for New Zealand Patient Advocates, which includes: - Production Costs & Content Creation $12,000 - Travel & Accommodation for 1 week period to capture interviews and video content $4,000 - Project coordination, research and management costs $4,000 | 20000 | 20000 |
| 2019 | Novartis | Rare Cancers Australia | Support towards: Mount Kosciuszko Challenge 2019 The Mount Kosciuszko Challenge is an annual event hosted by Rare Cancers Australia (RCA) to raise awareness and much needed funds for the over 52,000 Australians diagnosed with a rare and less common cancer each year. | 10000 | 10000 |
| 2019 | Novartis | Rare Cancers Australia | Support towards: - "Just a Little More Time" Report (JLMT), to prepare and publish an updated version in 2019 that will contain expanded definitions of rare and rare subtypes and examine current treatment access - Staging of the Canberra Forum, a One-day event held in Canberra in September 2019 and featuring speakers from inside and outside the cancer community discussing the evolution of precision medicine, personalised health care and targeted therapies - "Raven" sponsorship of Scare4Rare ball | 50000 | 50000 |
| 2019 | Novartis | Redkite | Support towards 2020 Westmead Families Diaries - a diary provided to parents of children diagnosed with any form of cancer, to ensure they are able to collect results, appts and information on one handy place. | 7178 | 7178 |
| 2019 | Novartis | Spinal Muscular Atrophy Association of Australia | Support towards: SMA Parliamentary Event The event is to shine a light on the still unmet need for adults with SMA in access to treatment and highlights the need for newborn screening due to new advancements in drug treatments, and highlights the benefits of these treatements and early access. | 7852 | 7852 |
| 2019 | Novartis | Vision 2020 Australia | Corporate Member Contribution - 1 January to 31 December 2019 | 65468 | 65468 |
| 2020 | Novartis | Allergy & Anaphylaxis Australia | Support towards producing consumer education brochure ‘Do you suffer from Urticaria (Hives)? | 5000 | 5000 |
| 2020 | Novartis | Arthritis Foundation of Australia | Support towards: 1) Outbound call program from the National Arthritis Info Line, which is aimed at members, consumers, e-newsletter subscribers, and social media networks of arthritis affiliate offices, and 2) Program which supports young adults entering or re-entering the workforce with autoimmune conditions | 35000 | 35000 |
| 2020 | Novartis | Australian Sickle Cell Advocacy | Support towards adaptation of community program to an online webinar platform | 7500 | 7500 |
| 2020 | Novartis | Australian Sickle Cell Advocacy | Support towards Sickle cell community engagement via social media platform | 10000 | 10000 |
| 2020 | Novartis | Beard Season | Support towards creation of a digital platform, in light of the COVID-19 pandemic, to correctly stage people with Melanoma and prompt individuals to seek services if they have lesions (or moles) that are suspicious | 10000 | 10000 |
| 2020 | Novartis | Hearts4Heart | Support towards: 1) Generation of content as the COVID-19 pandemic evolves and the need for information changes 2) Virtual symptom awareness compaign, scheduled for September 2020, and 3) Advocacy work on cardiac remote monitoring | 20000 | 20000 |
| 2020 | Novartis | ITP Australia | Support towards launching a series of polls and building capability to collect data using online platforms to allow the organisation to observe how their community has been coping during COVID-19 and the impact it is having. | 7500 | 7500 |
| 2020 | Novartis | Leukaemia Foundation Of Australia | Support towards fundraising activity which was changed from annual disease awareness day due to COVID-19 | 3000 | 3000 |
| 2020 | Novartis | Leukaemia Foundation Of Australia | Support towards outreach program which will aim to reach out to those who have a compromised immnue system due to leukemia and provide resources and up to date information around COVID-19 | 30000 | 30000 |
| 2020 | Novartis | Lymphoma Australia | Support towards transition of face to face training for lymphoma nurses to an online platform during COVID_x0002_19 | 20000 | 20000 |
| 2020 | Novartis | Macular Disease Foundation | Support towards Consumer/ Professional Education and Webinar Development | 75000 | 75000 |
| 2020 | Novartis | Macular Disease Foundation | Support towards development of AMD Risk Checker | 75000 | 75000 |
| 2020 | Novartis | Macular Disease Foundation | Support towards Consumer Health Publications Redevelopment & Printing/ Distribution | 100000 | 100000 |
| 2020 | Novartis | McGrath Foundation | Support towards transitioning of training called 'Model of Care' program in a virtual way | 20000 | 20000 |
| 2020 | Novartis | Melanoma Institute Australia | Support towards: 1) Investigation of melanoma patient needs regarding COVID-19 including impact on current therapies 2) Implementation of changes via writers/designers into patient books 3) Re-printing of patient books with new COVID-19 information | 20000 | 20000 |
| 2020 | Novartis | Melanoma Patients Australia | Support towards development of accessible resources on COVID-19 and the impact the virus may have on patients with Melanoma | 5000 | 5000 |
| 2020 | Novartis | Melanoma Patients Australia | Support towards: 1) Patient Information Forums 2) Volunteer Development and Training Project 3) MPA Printed Resources Refresh | 20000 | 20000 |
| 2020 | Novartis | National Asthma Council Australia | Support towards development of microsite with COVID-19 related information | 20000 | 20000 |
| 2020 | Novartis | NeuroEndocrine Cancer Australia | Support towards enabling the patient group to develop and distribute information for their community during the COVID-19 pandemic | 10000 | 10000 |
| 2020 | Novartis | NeuroEndocrine Cancer Australia | Support towards: - Provision of input on materials prepared by the Unicorn Foundation to ensure information around the Patient Support Program (eSHINE) is accurately captured. - Co-ordination with Unicorn Foundation for materials prepared for the purpose of Nurse and GP education and distribute these to HCP’s. - Training new HCPs such as community GPs administering injections. | 20000 | 20000 |
| 2020 | Novartis | NeuroEndocrine Cancer Australia | Support towards accredited online NET education for GPs currently treating Australian Neuroendocrine Cancer patients | 35325 | 35325 |
| 2020 | Novartis | Pink Hope Community | Support towards weekly online newsletters on breast and ovarian cancers during the COVID-19 period | 10000 | 10000 |
| 2020 | Novartis | Pink Hope Community | Support towards production of written content and videos/interviews to raise awareness of Breast Cancer in the community for their 'If you feel something, say something' campaign | 20000 | 20000 |
| 2020 | Novartis | Pink Hope Community | Support towards development of Hope Weekly which was a weekly newsletter in the height of COVID to answer the questions most asked from the Breast Cancer community | 20000 | 20000 |
| 2020 | Novartis | Psoriasis Australia | Support towards development of webinars, a video social community, with Auslan interpreter for deaf community members, and videos of best management practices and updates on COVID-19 | 24000 | 24000 |
| 2020 | Novartis | Rare Cancers Australia | Support towards Pinnacle Report Development and Vision 2030 planning for the area of rare cancers | 20000 | 20000 |
| 2020 | Novartis | Rare Cancers Australia | Support towards the provision of information, health care and support to rare and less common cancer patients through digital platforms to the community | 20000 | 20000 |
| 2020 | Novartis | Redkite | Support towards provision of support services and increased assistance to the families of children with cancer. | 10000 | 10000 |
| 2020 | Novartis | Snowdome Foundation | Snowdome Foundation will provide monies to Australian Lymphoma Alliance for the below activities: 1) Consensus Practice Statement development • WebEx meetings amongst working groups • Writing & Preparation • Manuscript submission costs • Administration costs, website management and uploading of statements 2) Website maintenance & further development • Publication of Consensus Practice Statements • ALA Newsletters upload to share updates • Further development of website to register & track projects, and announce results | 10000 | 10000 |
| 2020 | Novartis | Spinal Muscular Atrophy Association of Australia | Support towards understanding the patient and family journey of those who are diagnosed with Spinal Muscular Atrophy (SMA) | 10000 | 10000 |
| 2020 | Novartis | Spinal Muscular Atrophy Association of Australia | Support towards transitioning those immediate face to face activities of SMA Australia across to digital channels to ensure the SMA community could continue to be supported during the COVID-19 pandemic including virtual evening masterclasses with the SMA community and allied health and medical experts , ZOOM meetings throughout the day with the SMA community and the preparartion of a national virtual conference | 10000 | 10000 |
| 2013 | Novo Nordisk | Australian Pituitary Foundation | Unrestricted Educational Grant to fund the Foundation Website and Educational Events Literature | 6000 | 6000 |
| 2013 | Novo Nordisk | Danii Meads-Barlow Foundation | Corporate Sponsorship Foundation Ball | 796 | 796 |
| 2013 | Novo Nordisk | Diabetes Australia | National Press Club Event - Launch of DA National Strategy | 15000 | 15000 |
| 2013 | Novo Nordisk | Diabetes Australia | Sponsorship of Western Pacific Morning Tea 2012-2015 | 15000 | 15000 |
| 2013 | Novo Nordisk | Diabetes Australia | IDF Parliamentary Diabetes Champions | 12060 | 12060 |
| 2013 | Novo Nordisk | Diabetes Australia - Victoria (VIC) | Sponsorship for the 60th Anniversary of Diabetes Australia – Vic Ball | 10000 | 10000 |
| 2013 | Novo Nordisk | Diabetes Australia - Western Australia (WA) | Platinum sponsorship for Corporate Long Table Lunch WA Sponsorship | 10000 | 10000 |
| 2013 | Novo Nordisk | Diabetes Queensland (QLD) | Sponsorship of the Diabetes Impact Symposium 2013 | 500 | 500 |
| 2013 | Novo Nordisk | Haemophilia Foundation Australia | Grant Contract to fund Australians attending the World Federation of Haemophilia 2014 World Congress | 20000 | 20000 |
| 2013 | Novo Nordisk | Haemophilia Foundation Australia | Corporate Sponsorship which aims to foster relationships which will enhance a greater understanding of the needs of people with bleeding disorders and their families and timely access to medicines and treatments and care | 40000 | 40000 |
| 2013 | Novo Nordisk | Haemophilia Foundation of New Zealand | Grant Contract to support the Sustaining Patrons Grant and contribution toward the Outreach Worker Australasia Meeting, World Chief Executive Officer Meeting and a Men’s Workshop | 25000 | 25000 |
| 2013 | Novo Nordisk | JDRF Australia | Sponsorship for the JDRF Jelly Baby Ball 2013 | 6500 | 6500 |
| 2013 | Novo Nordisk | JDRF Australia | Ride for Cure Diabetes Sponsorhip | 8750 | 8750 |
| 2013 | Novo Nordisk | JDRF Australia | JDRF community farewell to retiring parliamentary diabetes support group MPs | 10000 | 10000 |
| 2014 | Novo Nordisk | Australian Pituitary Foundation | Annual corporate sponsorship of HCO. Unrestricted educational grant for education and support materials for patients, carers, families and healthcare professionals. | 10000 | 10000 |
| 2014 | Novo Nordisk | Diabetes Australia - Tasmania (TAS) | Unrestricted educational grant to Diabetes Tasmania to support work with the Menzies Research Institute, University of Tasmania. Funds provided to support costs of manuscript preparation on the cost-effectiveness of The COACH Program in type 2 diabetes, w | 20000 | 20000 |
| 2014 | Novo Nordisk | Diabetes Western Australia (WA) | Donation in Kind. Use of Novo Nordisk KEEpads (IT solution) for the APEG meeting in Darwin on 29 October - 1 November 2014 for an educational session at the meeting. | 0 | 0 |
| 2014 | Novo Nordisk | Diabetes Western Australia (WA) | Cost to sponsor and participate in a trade display as part of the Nurse Study Day, organised through Diabetes WA. | 50 | 50 |
| 2014 | Novo Nordisk | Haemophilia Foundation Australia | Educational Grant sponsorship to support the launch of the Australian Buddy Awards which are to increase awareness of the challenges faced by people living with bleeding disorders. The Buddy Awards recognise the significant medical, emotional and practica | 5000 | 5000 |
| 2014 | Novo Nordisk | Haemophilia Foundation Australia | Corporate Sponsorship which aims to foster relationships which will enhance a greater understanding of the needs of people with bleeding disorders and their families and timely access to medicines and treatments and care. | 40000 | 40000 |
| 2014 | Novo Nordisk | JDRF Australia | Charitable contribution to JDRF. Corporate sponsorship of a table at the JDRF Gala Ball 2014, which is an annual fund raising event. | 6500 | 6500 |
| 2014 | Novo Nordisk | JDRF Australia | Charitable contribution to JDRF. Corporate sponsorship for the annual ‘Ride for Cure’ event. Sponsorship allowed participation of 5 Novo Nordisk employees in the charity ride, and 1 global ‘ Team Novo Nordisk’ rider. | 8977.27 | 8977.27 |
| 2015 | Novo Nordisk | Australian Pituitary Foundation | Corporate sponsorship of HCO. Unrestricted educational grant for the production of education and support materials for patients, carers, families and healthcare professionals (Bronze Sponsorship Level): (i) Supporting people through direct communication. | 10000 | 10000 |
| 2015 | Novo Nordisk | Diabetes New South Wales (NSW) | Charitable contribution to Diabetes NSW. Purchase of a sponsor table at the "Live your Life" Ball on 21 February 2015. | 5000 | 5000 |
| 2015 | Novo Nordisk | Haemophilia Foundation Australia | Corporate Sponsorship of HFA. Unrestricted educational grant for the implementation of predefined HFA programs which aim to foster relationships between patients and enhance a greater understanding of the needs of people with bleeding disorders and their | 40000 | 40000 |
| 2015 | Novo Nordisk | JDRF Australia | Charitable contribution to JDRF. Corporate sponsorship of charity run/walk. | 300 | 300 |
| 2015 | Novo Nordisk | JDRF Australia | Charitable contribution to JDRF. Corporate sponsorship for the annual ‘Ride for Cure’ event. Sponsorship allowed participation of 5 Novo Nordisk employees in the charity ride, and 1 global ‘Team Novo Nordisk’ rider. | 10200 | 10200 |
| 2016 | Novo Nordisk | Australian Pituitary Foundation | Corporate Sponsorship of APF. Unrestricted educational grant for the production of education and support materials for patients, carers, families and healthcare professionals: i) development of marketing strategy to improve presence and brand awareness am | 10000 | 10000 |
| 2016 | Novo Nordisk | Haemophilia Foundation Australia | Corporate Sponsorship of HFA. Unrestricted educational grant for the implementation of predefined HFA programs to support people with haemophilia, von Willebrand disorder and other related inherited bleeding disorders, and their families through advocacy | 30000 | 30000 |
| 2016 | Novo Nordisk | JDRF Australia | Charitable contribution to JDRF. Corporate sponsorship of a table at the JDRF Gala Ball 2016. An annual fund-raising event. | 2300 | 2300 |
| 2017 | Novo Nordisk | Danii Meads-Barlow Foundation | Charitable contribution to Danii Foundation. Corporate sponsorship of a table at the Danii Foundation 2017 Jelly Bean Ball, an annual fundraising event | 2000 | 2000 |
| 2017 | Novo Nordisk | Diabetes Australia | Charitable contribution to Diabetes Australia. Corporate sponsorship of a table at the Diabetes Australia 60th Anniversary Dinner - purchase included multiple tickets to attend the event, advertising in associated materials etc. | 15000 | 15000 |
| 2017 | Novo Nordisk | Diabetes New South Wales (NSW) | Charitable contribution to Diabetes NSW/ACT. Corporate sponsorship of 'Flying Trapeze' Package at the Diabetes NSW/ACT 2017 Gala - purchase included 10 tickets to attend the event, advertising in associated materials etc. | 5000 | 5000 |
| 2017 | Novo Nordisk | Diabetes New South Wales (NSW) | Charitable contribution to Diabetes NSW/ACT to support the creation of an animated educational tool. The educational tool consists of an animated series of short clips, which raises awareness of type 1 diabetes in children and how to treat it (As 1 Kids Project). Novo Nordisk did not have any involvement in creating the content of the animation. | 10000 | 10000 |
| 2017 | Novo Nordisk | Haemophilia Foundation Australia | Corporate Sponsorship of HFA. Unrestricted educational grant to support the HFA in improving outcomes for people with bleeding disorders and their families. The support will enable the HFA to provide patient support and education programs to the bleeding disorders community and ensure solid representation from the community's point of view. | 15000 | 15000 |
| 2017 | Novo Nordisk | JDRF Australia | Charitable contribution to JDRF. Corporate sponsorship of a table at the JDRF Gala Ball 2017. An annual fund-raising event. | 2300 | 2300 |
| 2017 | Novo Nordisk | JDRF Australia | Charitable contribution to JDRF. Corporate sponsorship for annual "Ride for Cure" event - which allowed for participation of 5 NN Employees in the charity ride. | 8750 | 8750 |
| 2017 | Novo Nordisk | Turner Syndrome Association Of Australia | Corporate Sponsorship of Turner Syndrome Association of Australia. Unrestricted educational grant to support the Association in providing medical information, support, and opportunities to connect for females living with Turner Syndrome and their support networks. | 5000 | 5000 |
| 2018 | Novo Nordisk | Diabetes New South Wales (NSW) | Charitable contribution to Diabetes NSW/ACT. Corporate sponsorship of 'Snowball 2018'. Contribution included tickets to attend the event and advertising in the programme. | 5000 | 5000 |
| 2018 | Novo Nordisk | Diabetes New South Wales (NSW) | Charitable contribution to Diabetes NSW/ACT to support the lighting of the Opera House sails during National Diabetes Week. | 10000 | 10000 |
| 2018 | Novo Nordisk | Diabetes New South Wales (NSW) | Corporate sponsorship to support the launch of the Diabetes State of the Nation Report during National Diabetes Week. Contribution included the venue hire for the event. | 10000 | 10000 |
| 2018 | Novo Nordisk | Haemophilia Foundation Australia | Corporate Sponsorship of HFA. Unrestricted educational grant to support the HFA in improving outcomes for people with bleeding disorders and their families. The support will enable the HFA to provide patient support and education programs to the bleeding disorders community and ensure solid representation from the community's point of view. | 20000 | 20000 |
| 2018 | Novo Nordisk | JDRF Australia | Charitable contribution to JDRF. Corporate sponsorship of a table at the JDRF Gala Ball 2018, an annual fund-raising event. | 3500 | 3500 |
| 2018 | Novo Nordisk | JDRF Australia | Charitable contribution to JDRF. Corporate sponsorship of a table at the Kids in the House Dinner event to raise awareness of the importance of continuing to fund research to cure Type 1 Diabetes. | 10000 | 10000 |
| 2019 | Novo Nordisk | Diabetes New South Wales (NSW) | Sponsorship of the Diabetes Update Days to educate and update Healthcare Professionals working with people living with diabetes. | 17000 | 17000 |
| 2019 | Novo Nordisk | Diabetes New South Wales (NSW) | 12 month Sponsorship of the It's Time to Act Campaign platform to improve the day-to-day lives of people living with diabetes, and informing around the prevention of diabetes-related complications. | 100000 | 100000 |
| 2019 | Novo Nordisk | Diabetes Victoria (VIC) | Sponsorship of the OzDAFNE Collaborative Meeting. OzDAFNE is a program for Adults with Type 1 diabetes. The Collaborative Meeting is held annually and provides a program of interesting, challenging and informative sessions that features thought leaders in Diabetes Education management. | 5000 | 5000 |
| 2019 | Novo Nordisk | Haemophilia Foundation Australia | Silver sponsorship of Haemophilia Foundation Australia 19th Australian Conference. This sponsorship will support the HFA in improving outcomes for people with bleeding disorders and their families. The support will enable the HFA to provide patient support and education programs to the bleeding disorders community and ensure solid representation from the community's point of view. | 25000 | 25000 |
| 2019 | Novo Nordisk | JDRF Australia | Charitable contribution to JDRF. Corporate sponsorship of a table at the JDRF Gala Ball 2019, an annual fund-raising event. | 3500 | 3500 |
| 2019 | Novo Nordisk | Turner Syndrome Association Of Australia | Corporate Sponsorship of Turner Syndrome Association of Australia. Unrestricted educational grant to support the Association in providing medical information, support, and opportunities to connect for females living with Turner Syndrome and their support networks. | 5000 | 5000 |
| 2020 | Novo Nordisk | Australian Pituitary Foundation | Corporate Sponsorship of APF. Grant to establish the education and training program for the Patient Liaison Support Co-ordinators who provide specialised support for patients living with pituitary conditions. These co-ordinators are patients living with the condition and the APF is committed to ensuring they are adequately supported in this role to benefit the pituitary patient community. | 10000 | 10000 |
| 2020 | Novo Nordisk | JDRF Australia | Support was initally provided for the JDRF annual Gala Dinner however due to COVID-19 this was cancelled and the support was repurposed to a charitable donation. | 4000 | 4000 |
| 2013 | Pfizer | Alzheimer's Australia | Alzheimer's Australia is the peak body providing support and advocacy for the 320,000 Australians with dementia and the million Australians who care for them. The organisation supplies information, support, education, counselling and helpline services and | 27273 | 27273 |
| 2013 | Pfizer | Arthritis Foundation of Australia | Nearly one in five Australians (3.85 million people) have arthritis. They are represented by Arthritis Australia, the peak arthritis organisation in Australia and supported by affiliate offices in each State and Territory, except in Victoria. Arthritis Au | 23000 | 23000 |
| 2013 | Pfizer | Arthritis Foundation of Victoria (VIC) | Arthritis and Osteoporosis Victoria is the peak body representing Victorians living with arthritis and more than 100 musculoskeletal conditions. It was established in 1968 and since 1992 has incorporated Osteoporosis Victoria. Arthritis Victoria's work is | 15000 | 15000 |
| 2013 | Pfizer | Arthritis New South Wales (NSW) | Arthritis NSW was established over 45 years ago to provide education, support and services to people in the community living with arthritis and other musculoskeletal conditions. More than 3.1 million Australians have arthritis. Arthritis NSW supports peop | 30000 | 30000 |
| 2013 | Pfizer | Australian Pain Management Association | The Australian Pain Management Association (APMA) provides pain management options and information to support people living with pain, their families and friends. They also operated the Pain Link Helpline. Pfizer Australia provided funding to support the | 10000 | 10000 |
| 2013 | Pfizer | Australian Pituitary Foundation | The Australian Pituitary Foundation Ltd (APF) was founded in Sydney in 1994 by pituitary patients and famly members, with the endorsement of Australian endocrinologists, neurosurgeons, radiation therapists and endocrine nurses, who saw the need to support | 25000 | 25000 |
| 2013 | Pfizer | Breast Cancer Network Australia | Colleague volunteers providing support as required | 24 hours | 0 |
| 2013 | Pfizer | Cancer Council Australia | Colleague volunteers selling merchandise at various locations for Daffodil Day and for Pink Ribbon Day | 328 hours | 0 |
| 2013 | Pfizer | Cancer Council New South Wales (NSW) | Colleague volunteers providing support as required | 16 hours | 0 |
| 2013 | Pfizer | Cancer Council New South Wales (NSW) | Cancer Council NSW is a community funded, community focused cancer charity dedicated to the defeat of cancer. They are a member of Cancer Council Australia, along with their State and Territory counterparts. Through the development of prevention strategie | 5500 | 5500 |
| 2013 | Pfizer | Cancer Council Victoria (VIC) | Colleague volunteers providing support as required | 8 hours | 0 |
| 2013 | Pfizer | CanTeen | Colleague volunteers providing support as required | 8 hours | 0 |
| 2013 | Pfizer | Carers Australia | Pollie Pedal is a charity bike ride started in 1998 by a number of federal and state politicians. Its purpose is to raise money for a range of charities whilst giving smaller Australian communities the opportunity to meet various Members of Parliament and | 21818 | 21818 |
| 2013 | Pfizer | Chronic Pain Association of Australia | Chronic Pain Australia's mission is to reduce the unnecessary suffering and isolation caused by chronic pain in the Australian community. Their key aims are to improve knowledge and understanding about chronic pain across Australia; promote better underst | 35000 | 35000 |
| 2013 | Pfizer | Cure Our Kids | Cure Our Kids is dedicated to helping children at the Oncology Unit of The Children's Hospital at Westmead. They raise funds to provide a range of support services to help make the challenge easier for kids with cancer and their families. Through programs | 2750 | 2750 |
| 2013 | Pfizer | Day of Difference Foundation | Colleague volunteers providing fundraising support | 8 hours | 0 |
| 2013 | Pfizer | Donate Life | Colleague volunteers supporting a patient event | 8 hours | 0 |
| 2013 | Pfizer | Glaucoma Australia | Glaucoma Australia is the peak glaucoma awareness/education/support association in Australia. It is a national, not-for-profit registered charity dedicated to providing educational services to raise awareness about the serious and common eye disease glau | 20142.5 | 20142.5 |
| 2013 | Pfizer | Haemophilia Foundation Australia | Haemophilia Foundation Australia (HFA) represents people with haemophilia, von Willebrand disorder and other related inherited bleeding disorders and their families through advocacy and representation, education and research. HFA works with a network of s | 70000 | 70000 |
| 2013 | Pfizer | Jean Hailes Foundation | Jean Hailes for Women's Health is a not-for-profit organisation providing important services for women across Australia, from adolescence to midlife and beyond. Established in Victoria in 1992, it is now regarded throughout Australia as a leader in women' | 40000 | 40000 |
| 2013 | Pfizer | Kidney Health Australia | Kidney Health Australia is a not-for-profit organisation whose focus is to improve kidney health outcomes which lead to substantial improvements to the quality of life for people with kidney and urinary tract disease, their families and carers, as well as | 15000 | 15000 |
| 2013 | Pfizer | Lung Foundation Australia | Lung Foundation Australia is a national organisation which was originally established as The Australian Lung Foundation in 1990 to provide support to patients and carers burdened by lung disease and to ensure lung health is a priority for all in Australia | 20000 | 20000 |
| 2013 | Pfizer | McGrath Foundation | Colleague volunteers selling merchandise at the Sydney Pink Test Match | 32 hours | 0 |
| 2013 | Pfizer | Meningitis Centre | The Meningitis Centre is an Australian not-for-profit organisation based in Perth, Western Australia. It was established in 1992 by a group of parents and health care professionals who recognised the need to raise public awareness of meningitis and its va | 70000 | 70000 |
| 2013 | Pfizer | Mental Health Australia | The Mental Health Council of Australia (MHCA) is the peak, national non-government organisation representing and promoting the interests of the Australian mental health sector and committed to achieving better mental health for all Australians. It was est | 28000 | 28000 |
| 2013 | Pfizer | National Heart Foundation Of Australia | The Heart Foundation Pharmaceutical Roundtable (the Roundtable) brings together members of leading pharmaceutical companies to help improve the cardiovascular health of Australians. Since its inception, the Roundtable has contributed about $4 million towa | 40000 | 40000 |
| 2013 | Pfizer | Painaustralia | Painaustralia is the national not-for-profit organisation which aims to improve the quality of life of people living with pain and their families, to minimise the burden of pain on individuals and the community by working with consumers, healthcare profes | 73750 | 73750 |
| 2013 | Pfizer | People living with HIV/AIDS (Victoria/VIC) | The Prader-Willie Syndrome Association of Victoria Inc was set up in 1978 by parents of children affected by the syndrome and is totally run by volunteers. It has a long history of providing help, support and information to its members. Pfizer Australia | 5500 | 5500 |
| 2013 | Pfizer | Rare Cancers Australia | Colleague volunteers providing support as required | 8 hours | 0 |
| 2013 | Pfizer | Rare Cancers Australia | Rare Cancers Australia Ltd (RCA) is a charity whose purpose is to improve awareness, support and treatment of Australians with rare and less common (RLC) cancers. Every year there are over 42,000 diagnoses of RLC cancers and around 22,000 deaths. As disti | 50000 | 50000 |
| 2013 | Pfizer | Rare Voices Australia | Rare Voices Australia (RVA) is the country's national organisation advocating for those who live with a rare disease. RVA provides a strong common voice to promote for health policy and a healthcare system that works for those with rare diseases. RVA work | 10000 | 10000 |
| 2013 | Pfizer | SANE Australia | SANE Australia helps all Australians affected by mental illness lead a better life through campaigning, education and research. SANE conducts innovative programs and campaigns to improve the lives of people living with mental illness, their family and fr | 30000 | 30000 |
| 2013 | Pfizer | Schizophrenia Fellowship Of New South Wales (NSW) (One Door Mental Health) | The Schizophrenia Fellowship is a non-profit, community based organisation working in the field of mental illness. It is committed to improving the circumstances and welfare of people living with a mental illness, their relatives and carers, and professio | 2000 | 2000 |
| 2013 | Pfizer | Tour de Cure | The Tour de Cure (TDC) is a cycling foundation committed to raisng awareness and funds to support world class cancer reserach, support and prevention projects. Through engaging Australian communities via their cycling tours and events, their aim is to rai | 8500 | 8500 |
| 2013 | Pfizer | Turner Syndrome Association Of Australia | The Turner Syndrome Association of Australia was started in 1983 by Glenn Fisher after the birth of her second daughter Mandy, who was diagnosed with TS just after birth. The Association provides information and support for those with Turner Syndrome and | 5000 | 5000 |
| 2013 | Pfizer | ZEST Health Strategies (Health Communication Company) | ZEST excels in developing education for patient support. Pfizer Australia partnered with Novartis to provide funding for ZEST to develop and host an education weekend for Health Consumer Advocacy Organisations. | 39886 | 39886 |
| 2014 | Pfizer | Alzheimer's Australia | Alzheimer's Australia is the peak body providing support and advocacy for Australians with dementia and the Australians who care for them. Pfizer Australia provided funding to support Dementia Awareness Month and to support the administration of the Natio | 20000 | 20000 |
| 2014 | Pfizer | Arthritis Foundation of Australia | Arthritis Foundation Australia (Arthritis Australia) is the peak arthritis organisation in Australia and provides support and information to people living with arthritis, as well as their carers, families and friends. Pfizer Australia contributed to the A | 20000 | 20000 |
| 2014 | Pfizer | Arthritis Foundation of South Australia (SA) | The Arthritis Foundation of SA (Arthritis SA) is committed to improving the quality of life of people with arthritis and related conditions. Pfizer Australia provided funding to support three GP education seminars in the area of rheumatology. | 3636 | 3636 |
| 2014 | Pfizer | Arthritis Foundation of Victoria (VIC) | The Arthritis Foundatio of VIC (Arthritis Victoria) is the peak body representing Victorians living with arthritis and more than 100 musculoskeletal conditions. Pfizer Australia provided funding to support the printing of the JIA children's book "The Wors | 12391 | 12391 |
| 2014 | Pfizer | Arthritis Foundation of Western Australia (WA) | The Arthritis Foundation of WA is committed to reducing the incidence and disabling effects of Arthritis in the people of WA. Pfizer Australia provided funding to support a GP education event on inflammatory arthritis, held during Arthritis Week 2014. | 5000 | 5000 |
| 2014 | Pfizer | Arthritis New South Wales (NSW) | The Arthritis Foundation of NSW (Arthritis NSW) provides education, support and services to people in the community living with arthritis and other musculoskeletal conditions. Pfizer Australia provided funding to support the annual Williams Walk, the prod | 30000 | 30000 |
| 2014 | Pfizer | Arthritis Queensland (QLD) | Arthritis QLD provides education, information and support services for Queensland children and adults living with arthritis or osteoporosis. Pfizer Australia provided funding to support rural community information and health professional seminars. | 409 | 409 |
| 2014 | Pfizer | Australian Pain Management Association | The Australian Pain Management Association provides pain management options and information to support people living with pain, their families and friends. Pfizer Australia provided funding to support the publication of the APMA newsletter in 2014. | 10000 | 10000 |
| 2014 | Pfizer | Australian Pituitary Foundation | The Australian Pituitary Foundation's mission is to provide support to those who have experienced pituitary gland conditions. They promote awareness and disseminate information among the medical community, the public, and pituitary patients and their fami | 12000 | 12000 |
| 2014 | Pfizer | Carers Australia | Carers Australia is the national peak body representing Australia’s carers, advocating on behalf of Australia's carers to influence polices and services at a national level. Pfizer Australia provided funding to support the 2014 Pollie Pedal, a charity bik | 50000 | 50000 |
| 2014 | Pfizer | Chronic Pain Association of Australia | Chronic Pain Australia works towards de-stigmatising chronic pain by providing high quality user-friendly research-based information and support for patients and carers. Pfizer Australia provided funding to support National Pain Week in July 2014. | 65000 | 65000 |
| 2014 | Pfizer | Diabetes Australia - Tasmania (TAS) | Diabetes Tasmania provides support services to prevent type 2 diabetes and reduce the impact of all types of diabetes for people affected by the condition. Pfizer Australia provided funding to sponsor the Diabetes Tasmania Pollie Pedal in 2014, which rais | 3000 | 3000 |
| 2014 | Pfizer | Glaucoma Australia | Glaucoma Australia is the peak glaucoma awareness/education/support association in Australia. Pfizer Australia provided funding to support Glaucoma Australia's Glaucoma Adherence Project . | 7000 | 7000 |
| 2014 | Pfizer | Haemophilia Foundation Australia | Haemophilia Foundation Australia represents people with haemophilia, von Willebrand disorder and other related inherited bleeding disorders and their families through advocacy and representation, education and research. Pfizer Australia provided funding t | 84000 | 84000 |
| 2014 | Pfizer | Lung Foundation Australia | Lung Foundation Australia supports all aspects of lung health from asthma to cancer to COPD, through research, the development of educational fact-sheets, training health professionals, and undertaking community awareness activity and advocacy around Aust | 55500 | 55500 |
| 2014 | Pfizer | McGrath Foundation | The McGrath Foundation is considered to be one of Australia’s leading breast cancer support organisations. Pfizer Australia provided funding to secure a trade display for the McGrath Foundation at a Breast Care Nurses Seminar. | 2500 | 2500 |
| 2014 | Pfizer | Multiple Heath Consumer Organisations | Pfizer Australia employees are provided with up to four days of volunteer leave per year and are encouraged to serve their community by volunteering for a registered charity of their choice. | ~ 90 days | 0 |
| 2014 | Pfizer | Osteoporosis Australia | Osteoporosis Australia provides osteoporosis information and services to the community and health professionals. Pfizer Australia provided funding to support national awareness initiatives, health professional awareness and education and raising the profi | 73000 | 73000 |
| 2014 | Pfizer | Painaustralia | Painaustralia is a national not-for-profit body established to improve the treatment and management of pain in Australia, and in particular to facilitate implementation of the National Pain Strategy. Pfizer Australia provided funding to support the formal | 65000 | 65000 |
| 2014 | Pfizer | Palliative Care Queensland (QLD) | Palliative Care QLD is the peak organisation for palliative care in Queensland, representing the interests and aspirations of all who share the ideal of quality care at the end of life for all. Pfizer Australia provided funding to support the 50 Shades of | 7573 | 7573 |
| 2014 | Pfizer | Palliative Care Western Australia (WA) | Palliative Care WA is the Western Australian peak body for palliative care – raising awareness and building capacity for the community to address life limiting conditions, death and dying, grief and loss. Pfizer Australia sponsored the WA Palliative Care | 818 | 818 |
| 2014 | Pfizer | Prader-Willi Syndrome Association of Victoria (VIC) | The Prader-Willie Syndrome Association provides help, support and information to its members. Pfizer Australia provided funding in support of the Prader-Willi Syndrome Association of Victoria's Family Information Day . | 8000 | 8000 |
| 2014 | Pfizer | Rare Cancers Australia | Rare Cancers Australia is a charity whose purpose is to improve awareness, support and treatment of Australians with rare and less common cancers. Pfizer Australia provided funding to support the Cancer Community Survey program ($10,000). Pfizer Australia | 20000 | 20000 |
| 2014 | Pfizer | Rare Voices Australia | Rare Voices Australia is Australia’s national alliance advocating for those who live with a rare disease. Pfizer Australia provided funding towards a suite of activities supporting public policy advocacy and funding for rare diseases. | 10000 | 10000 |
| 2014 | Pfizer | Skin & Cancer Foundation Australia | The Skin & Cancer Foundation Australia is dedicated to benefiting those who suffer from diseases of the skin. Pfizer Australia sponsored the following events on behalf of Skin & Cancer Foundation: the 2014 Bio Masterclass ($3,000) and the 2014 Gala ball a | 11727 | 11727 |
| 2014 | Pfizer | Turner Syndrome Association Of Australia | The Association provides information and support for those with Turner Syndrome and their families. Pfizer Australia provided funding to support the printing of the TSA newsletter. | 2300 | 2300 |
| 2014 | Pfizer | Unicorn Foundation (NeuroEndocrine Cancer Australia) | The Unicorn Foundation's mission is to improve awareness of neuroendocrine tumours within the medical profession and the general public; foster patient understanding through support groups; and raise much needed funding for Australian research in this are | 14000 | 14000 |
| 2015 | Pfizer | Arrhthymia Alliance-Australia | Arrhythmia Alliance (A-A) - Australia is a health promotion charity working to improve the diagnosis, treatment and quality of life for all those affected by arrhythmias. The aims of the charity are to promote: Awareness of causes, symptoms, diagnosis and | 20000 | 20000 |
| 2015 | Pfizer | Arthritis Foundation of Australia | The aims of the charity are to promote: Awareness of causes, symptoms, diagnosis and treatments; Better understanding and education; Improved diagnosis, treatment and quality of life; Multi-centre and multi-disciplinary assessment. Arthritis Australia i | 20000 | 20000 |
| 2015 | Pfizer | Arthritis Foundation of South Australia (SA) | The Arthritis Foundation of SA (Arthritis SA) is committed to improving the quality of life of people with arthritis and related conditions. Pfizer Australia provided funding to support GP education seminars in the area of | 1500 | 1500 |
| 2015 | Pfizer | Arthritis Foundation of Western Australia (WA) | The Arthritis Foundation of WA is committed to reducing the incidence and disabling effects of Arthritis in the people of WA. Pfizer Australia provided funding to support a GP education event on inflammatory arthritis. | 5000 | 5000 |
| 2015 | Pfizer | Arthritis New South Wales (NSW) | The Arthritis Foundation of NSW (Arthritis NSW) provides education, support and services to people in the community living with arthritis and other musculoskeletal conditions. Pfizer Australia provided funding to support the annual Williams Walk, the pr | 10000 | 10000 |
| 2015 | Pfizer | Arthritis Queensland (QLD) | Arthritis QLD provides education, information and support services for Queensland children and adults living with arthritis or osteoporosis. Pfizer Australia provided funding to support rural community information and health professional seminars. | 2500 | 2500 |
| 2015 | Pfizer | Australian Pain Management Association | The Australian Pain Management Association provides pain management options and information to support people living with pain, their families and friends. Pfizer Australia provided funding to support the publication of the APMA newsletter in 2015. | 11000 | 11000 |
| 2015 | Pfizer | Australian Pituitary Foundation | The Australian Pituitary Foundation's mission is to provide support to those who have experienced pituitary gland conditions. They promote awareness and disseminate information among the medical community, the public, and pituitary patients and their fami | 10000 | 10000 |
| 2015 | Pfizer | Carers Australia | Carers Australia is the national peak body representing Australia’s carers, advocating on behalf of Australia’s carers to influence policies and services at a national level. Pfizer Australia provided funding to support the 2015 Pollie Pedal, a charity bi | 50000 | 50000 |
| 2015 | Pfizer | Chronic Pain Association of Australia | Chronic Pain Australia works towards de-stigmatising chronic pain by providing high quality user-friendly research-based information and support for patients and carers. Pfizer Australia provided funding to support National Pain Week in July 2015. | 35000 | 35000 |
| 2015 | Pfizer | Diabetes Australia - Tasmania (TAS) | Diabetes Tasmania provides support services to prevent type 2 diabetes and reduce the impact of all types of diabetes for people affected by the condition. Pfizer Australia provided funding to sponsor the Diabetes Tasmania Pollie Pedal in 2015, which rai | 3000 | 3000 |
| 2015 | Pfizer | Glaucoma Australia | Glaucoma Australia is the peak glaucoma awareness/education/support association in Australia. It is a registered, national, not-for-profit organisation. Glaucoma Australia’s mission is “To eliminate glaucoma blindness”. Pfizer Australia provided funding t | 11600 | 11600 |
| 2015 | Pfizer | Haemophilia Foundation Australia | Haemophilia Foundation Australia (HFA) represents people with haemophilia, von Willebrand disorder and other related inherited bleeding disorders and their families through advocacy and representation, education and research. Pfizer Australia provided fun | 14000 | 14000 |
| 2015 | Pfizer | Health Consumer Advocacy (HCA) | The HCA is a collaboration of sponsors from the health care industry (Amgen, Bayer, Celgene, Janssen-Cilag, Pfizer and Roche), working with an independent steering committee of health consumer organisation representatives to support the learning needs of | 16500 | 16500 |
| 2015 | Pfizer | Jean Hailes Foundation | Jean Hailes for Women’s Health is a national not-for-profit organisation dedicated to improving the knowledge of women’s health throughout the various stages of their lives, and to provide a trusted world-class health service for women. Pfizer supported t | 14000 | 14000 |
| 2015 | Pfizer | Kidney Health Australia | Kidney Health Australia is a peak patient organisation supporting the community of patients and carers impacted by kidney disease. Pfizer provided support for the Kidney Cancer Helpline, fact sheets and web-based information and materials to support patie | 30000 | 30000 |
| 2015 | Pfizer | McGrath Foundation | The McGrath Foundation is one of Australia’s leading breast cancer support organisations and its primary remit is to provide Breast Cancer Care Nurses in the Australian health system based on metrics of greatest need. Pfizer Australia provided funding as | 300000 | 300000 |
| 2015 | Pfizer | Meningitis Centre | Meningitis Centre Australia strives to eliminate meningitis in Australia. It has successfully lobbied for vaccines and produced materials for educating the community across Australia to be aware of the signs and symptoms. It also provides support for fami | 50000 | 50000 |
| 2015 | Pfizer | Mental Health Australia | MHA is a peak body representing the interests of patients and patient support organisations in Mental Health throughout Australia. Pfizer supported the Industry Community Chest and its projects for 2014 - though this was paid in the 2015 business year. Th | 20000 | 20000 |
| 2015 | Pfizer | Multiple Heath Consumer Organisations | Pfizer Australia employees are provided with up to four days of volunteer leave per year and are encouraged to serve their community by volunteering for a registered charity of their choice. Approximately 1100 hrs volunteering was attended and an estimate | Approximately 1100 hrs volunteering was attended and an estimated$40,000 in colleague donations to charities. Pfizer Australia Donated $3,500 to The Australian Red Cross for Cyclone Pam disaster relief. | 0 |
| 2015 | Pfizer | Osteoporosis Australia | Osteoporosis Australia (OA) provides osteoporosis information and health promotion and patient support services to the community and health professionals. Pfizer Australia provided sponsorship for a Cause Related Marketing contract for our Consumer Health | 75500 | 75500 |
| 2015 | Pfizer | Painaustralia | Painaustralia is a national not-for-profit body established to improve the treatment and management of pain in Australia, and in particular to facilitate implementation of the National Pain Strategy. Pfizer Australia provided funding to support the formal | 60000 | 60000 |
| 2015 | Pfizer | Prader-Willi Syndrome Association of Victoria (VIC) | The Prader-Willie Syndrome Association provides help, support and information to its members. Pfizer Australia provided funding in support of the Prader-Willi Syndrome Association of Victoria's Family Information Day . | 10000 | 10000 |
| 2015 | Pfizer | Rare Cancers Australia | Rare Cancers Australia is a charity purposed to improve awareness, support and treatment of Australians with rare and less common cancers. Pfizer Australia provided funding to support the Just a Little More Time report ($25,000) Sick or Treat Rare Disease | 35000 | 35000 |
| 2015 | Pfizer | Rare Voices Australia | Rare Voices Australia is Australia’s national alliance advocating for those who live with a rare disease. Pfizer Australia provided funding towards a suite of activities supporting public policy advocacy and funding for rare diseases and in particular, su | 13636 | 13636 |
| 2015 | Pfizer | Skin & Cancer Foundation Australia | The Skin & Cancer Foundation Australia is dedicated to benefiting those who suffer from diseases of the skin. Pfizer Australia sponsored the following events on behalf of Skin & Cancer Foundation: Pfizer Australia provided funding to support continuing pr | 4500 | 4500 |
| 2015 | Pfizer | Unicorn Foundation (NeuroEndocrine Cancer Australia) | The Unicorn Foundation is a small consumer organisation dedicated to the support, research and health system advocacy for patients and families impacted by (NuroEndocrineTumors) NET. Pfizer sponsored the development of two education booklets on NET. One f | 14000 | 14000 |
| 2016 | Pfizer | Arthritis Foundation of Australia | Arthritis Australia is the National organisation representing and supporting state based, service oriented affiliates. Along with Janssen-Cilag, Roche, Abbvie, Lilly and Astra Zeneca, Pfizer Australia sponsored an Industry Community Chest. The main projec | 63140 | 63140 |
| 2016 | Pfizer | Australian Pain Management Association | The Australian Pain Management Association provides pain management options and information to support people living with pain, their families and friends. Pfizer Australia provided funding to support the publication of the APMA newsletter and awareness i | 26000 | 26000 |
| 2016 | Pfizer | Australian Pituitary Foundation | The Australian Pituitary Foundation's mission is to provide support to those who have experienced pituitary gland conditions. They promote awareness and disseminate information among the medical community, the public, and pituitary patients and their fami | 12000 | 12000 |
| 2016 | Pfizer | Breast Cancer Network Australia | Breast Cancer Network Australia are a peak body supporting the needs of women, men and families coping with a breast cancer diagnosis through provision of information, support groups and a support phone line. Pfizer was asked to support one of their major | 1800 | 1800 |
| 2016 | Pfizer | Carers Australia | Carers Australia is the national peak body representing Australia’s carers, advocating on behalf of Australia’s carers to influence policies and services at a national level. Pfizer Australia provided funding to support the 2015 Pollie Pedal, a charity bi | 15000 | 15000 |
| 2016 | Pfizer | Chronic Pain Association of Australia | Chronic Pain Australia works towards de-stigmatising chronic pain by providing high quality user-friendly research-based information and support for patients and carers. Pfizer Australia provided funding to support Na | 35000 | 35000 |
| 2016 | Pfizer | Congenital Adrenal Hyperplasia Support Group Australia | A volunteer organisation set up to support patients and families with Adrenal Hyperplasia. Pfizer supported a family conference day in October 2016. | 1800 | 1800 |
| 2016 | Pfizer | Diabetes Australia - Tasmania (TAS) | Diabetes Tasmania provides support services to prevent type 2 diabetes and reduce the impact of all types of diabetes for people affected by the condition. Pfizer Australia provided funding to | 3000 | 3000 |
| 2016 | Pfizer | Dragon Claw Charity | A new organisation set up to assist patients with rheumatic disease with self care navigation and peer support. Pfizer provided $10,000 seed funding to assist this organisation with version 2.0 of their website platform. | 10000 | 10000 |
| 2016 | Pfizer | Glaucoma Australia | Glaucoma Australia is the peak glaucoma awareness/education/support association in Australia. It is a registered national, not-for-profit organisation. Glaucoma Australia's mission is "To eliminate glaucoma blindness". | 7272 | 7272 |
| 2016 | Pfizer | Haemophilia Foundation Australia | Haemophilia Foundation Australia (HFA) represents people with haemophilia, von Willebrand disorder and other related inherited bleeding disorders and their families through advocacy and representation, education and research. Pfizer Australia provided fun | 10100 | 10100 |
| 2016 | Pfizer | Kidney Health Australia | Kidney Health Australia is a peak patient organisation supporting the community of patients and carers impacted by kidney disease. Pfizer provided support for the Kidney Cancer Helpline, fact sheets and web-based information and materials to support patie | 30000 | 30000 |
| 2016 | Pfizer | Meningitis Centre | Meningitis Centre Australia strives to eliminate meningitis in Australia. It has successfully lobbied for vaccines and produced materials for educating the community across Australia to be aware of the signs and symptoms. It also provides support for fami | 60000 | 60000 |
| 2016 | Pfizer | Meningococcal Australia | Development of a series of meningococcal disease and immunisation awareness videos | 20000 | 20000 |
| 2016 | Pfizer | MOVE Muscle, Bone & Joint Health | A new national organisation supporting patients experiencing joint and musculoskeletal conditions. This group used to be affiliated with Arthritis Australia as Arthritis Victoria. Pfizer supported the independent development of a basic DL introductory bro | 15000 | 15000 |
| 2016 | Pfizer | Multiple Heath Consumer Organisations | Pfizer Australia employees are provided with up to four days of volunteer leave per year and are encouraged to serve their community by volunteering for a registered charity of their choice. Approximately 1000 hrs volunteering was attended and an estimate | $55,000.00 + colleague donations | 55000 |
| 2016 | Pfizer | Osteoporosis Australia | Osteoporosis Australia (OA) provides osteoporosis information and health promotion and patient support services to the community and health professionals. Pfizer Australia provided sponsorship for a Cause Related Marketing contract for our Consumer Health | 75500 | 75500 |
| 2016 | Pfizer | Painaustralia | Painaustralia is a national not-for-profit body established to improve the treatment and management of pain in Australia, and in particular to facilitate implementation of the National Pain Strategy - advancing the national pain management agenda in Austr | 120000 | 120000 |
| 2016 | Pfizer | Prader-Willi Syndrome Association of Victoria (VIC) | The Prader-Willie Syndrome Association provides help, support and information to its members. Pfizer Australia provided funding in support of the 3rd Asia Pacific Prader-Willi Syndrome Conference. | 10000 | 10000 |
| 2016 | Pfizer | Pulmonary Hypertension Association Australia | Grant for the support for the development of a new information and support website | 10000 | 10000 |
| 2016 | Pfizer | Rare Cancers Australia | Rare Cancers Australia is a charity purposed to improve awareness, support and treatment of Australians with rare and less common cancers. Pfizer Australia provided funding to support the publication of the Just a Little More Time report ($25,000) Sick or | 57500 | 57500 |
| 2017 | Pfizer | Arthritis Foundation of Australia | Arthritis Australia is the National organisation representing and supporting state based, service oriented affiliates. Along with Janssen-Cilag, Roche, Abbvie, Lilly and Astra Zeneca, Pfizer Australia sponsored an Industry Community Chest. The main project supported by this funding in 2017 was a study into the impact of Rheumatology Nurses in clinical practice. Pfizer's contribution was $20,000. Arthritis Foundation Juvenile Inflammatory Arthritis (JIA) Clinical Scholarship - a jointly industry funded (Jannsen, Roche, Abbvie & Pfizer) clinical position for a much needed Paediatric Rheumatologist. Recipient selected and grant administered by Arthritis Australia. Pfizer's contribution was $30.000. | 50000 | 50000 |
| 2017 | Pfizer | Arthritis Foundation of Western Australia (WA) | Arthritis Foundation Western Australia is a state based group of Arthritis Australia. A small educational grant of $3000 was provided to support local awareness and support programs in Western Australia. | 3000 | 3000 |
| 2017 | Pfizer | Arthritis Queensland (QLD) | Arthritis Foundation Queensland is a state based group of Arthritis Australia. A small educational grant of $750 was provided to support local education in Queensland. | 750 | 750 |
| 2017 | Pfizer | Australian Crohn's and Colitis Association | Peak body representing the interests of people with Irritable Bowel disease, Crohns & Colitis. Pfizer supported community education. | 10000 | 10000 |
| 2017 | Pfizer | Australian Patients Association | A patient group representing the rights and needs of all Australian patients especially those engaged in our health care system. Pfizer supported an award program recognising outstanding health service delivery in Australia. | 30000 | 30000 |
| 2017 | Pfizer | Australian Pituitary Foundation | The Australian Pituitary Foundation's mission is to provide support to those who have experienced pituitary gland conditions. They promote awareness and disseminate information among the medical community, the public, and pituitary patients and their families. Pfizer Australia was a corporate sponsor of the Australian Pituitary Foundation in 2017 supporting key programs and initiatives including patient and GP/health provider education seminars , the quarterly newsletter and an online resources portal. | 15000 | 15000 |
| 2017 | Pfizer | Breast Cancer Network Australia | Breast Cancer Network Australia are a peak body supporting the needs of women, men and families coping with a breast cancer diagnosis through provision of information, support groups and a support phone line. Pfizer was asked to support one of their major community fundraising activities - The Pink Lady Luncheon, held in October 2017. | 1500 | 1500 |
| 2017 | Pfizer | Chronic Pain Association of Australia | Chronic Pain Australia works towards de-stigmatising chronic pain by providing high quality user-friendly research-based information and support for patients and carers. Pfizer Australia provided funding to support National Pain Week in July 2017. | 35000 | 35000 |
| 2017 | Pfizer | Dragon Claw Charity | A new organisation set up to assist patients with rheumatic disease with self care navigation and peer support. Pfizer provided $10,000 funding to further develop their communication and service offering to members. | 10000 | 10000 |
| 2017 | Pfizer | Meningitis Centre | Meningitis Centre Australia strives to eliminate meningitis in Australia. It has successfully lobbied for vaccines and produced materials for educating the community across Australia to be aware of the signs and symptoms. It also provides support for families affected by the disease. Pfizer provided a sponsorship to support the development of education programs, patient support and vaccination awareness. | 75000 | 75000 |
| 2017 | Pfizer | Meningococcal Australia | Development of a series of meningococcal disease and immunisation awareness videos | 50000 | 50000 |
| 2017 | Pfizer | Multiple Heath Consumer Organisations | Pfizer Australia employees are provided with up to four days of volunteer leave per year and are encouraged to serve their community by volunteering for a registered charity of their choice. Approximately 1000 hours volunteering was attended and an estimated $40,000 in colleague donations to charities. Pfizer Australia Donated $40,000 of corporate funds to The Smith Family our Charity of Choice and also $15,000 worth of community collaboration grants as determined by colleagues. | 0 | 0 |
| 2017 | Pfizer | National Heart Foundation Of Australia | Sponsorship of an educational conference for consumers and health care professionals. | 3000 | 3000 |
| 2017 | Pfizer | National Stroke Foundation | Charitable donation during Stroke awareness week to assist with programs of early detection, prevention and support for people at risk of and with stroke. | 1000 | 1000 |
| 2017 | Pfizer | Osteoporosis Australia | Osteoporosis Australia (OA) provides osteoporosis information and health promotion and patient support services to the community and health professionals. Pfizer Australia provided sponsorship for a Cause Related Marketing contract for our Consumer Health (OTC) Calcium Supplement - Caltrate. | 73000 | 73000 |
| 2017 | Pfizer | Parkinson's Victoria (VIC) | Sponsorship of health care professional conference on Parkinson's disease | 1000 | 1000 |
| 2017 | Pfizer | Pulmonary Hypertension Association Australia | Grant for the support for the development of patient support services. | 5000 | 5000 |
| 2017 | Pfizer | Rare Cancers Australia | Rare Cancers Australia is a charity purposed to improve awareness, support and treatment of Australians with rare and less common cancers. Sick or Treat Rare Cancers awareness and fundraising campaign and events ($25,000) | 25000 | 25000 |
| 2018 | Pfizer | Arthritis Foundation of Australia | Arthritis Australia is the National organisation representing and supporting state based, service oriented affiliates. Along with other MA Member companies, Pfizer supported the development phase of an interactive, user intelligent information and support website called "RASP". This was a $40,000 investment in 2018. Arthritis Foundation Juvenile Inflammatory Arthritis (JIA) Clinical Scholarship - a jointly industry funded (Jannsen, Roche, Abbvie & Pfizer) clinical position for a much needed Paediatric Rheumatologist. Recipient selected and grant administered by Arthritis Australia. Pfizer's contribution in 2018 was $30.000. | 70000 | 70000 |
| 2018 | Pfizer | Arthritis Foundation of South Australia (SA) | State Based Arthritis Patient Support organisation associated with Arthritis Australia. This educational grant supported their annual patient conference. | 1500 | 1500 |
| 2018 | Pfizer | Australian Crohn's and Colitis Association | Peak body representing the interests of people with Irritable Bowel disease, Crohn's & Colitis. Pfizer supported development of community education material, patient support groups and patient phone line and information services. | 50000 | 50000 |
| 2018 | Pfizer | Australian Patients Association | A patient group representing the rights and needs of all Australian patients especially those engaged in our health care system. Pfizer supported an award program recognising outstanding health service delivery in Australia. The sponsorship was for 1 table at the awards dinner and naming rights to "Best Patient Group Awareness Program" award. | 10000 | 10000 |
| 2018 | Pfizer | Australian Pituitary Foundation | The Australian Pituitary Foundation's mission is to provide support to those who have experienced pituitary gland conditions. They promote awareness and disseminate information among the medical community, the public, and pituitary patients and their families. Pfizer Australia was a corporate sponsor of the Australian Pituitary Foundation in 2018 supporting key programs and initiatives including patient and GP/health provider education seminars , the quarterly newsletter and an online resources portal. | 10000 | 10000 |
| 2018 | Pfizer | Breast Cancer Network Australia | Breast Cancer Network Australia is a peak body supporting the needs of women, men and families coping with a breast cancer diagnosis through provision of information, support groups and a support phone line. Pfizer was asked to support one of their major community fundraising activities - The Pink Lady Luncheon, held in Sydney October 2018. | 3272 | 3272 |
| 2018 | Pfizer | Chronic Pain Association of Australia | Chronic Pain Australia works towards de-stigmatising chronic pain by providing high quality user-friendly research-based information and support for patients and carers. Pfizer Australia provided funding to support National Pain Week in July 2018 which included community service announcements, patient education seminars and social media awareness campaign. | 31000 | 31000 |
| 2018 | Pfizer | Diabetes Australia - Tasmania (TAS) | State Based Support organisation for people with diabetes. Pfizer supported HCP & Patient Education | 2000 | 2000 |
| 2018 | Pfizer | Dragon Claw Charity | Patient group supporting patients with rheumatic disease with self care navigation and peer support. Pfizer provided $10,000 in 2018 to further enhance their website, develop their supporter database funding to further develop their communication and service offering to members. | 10000 | 10000 |
| 2018 | Pfizer | Friedreich Ataxia Research Association | Fredericks Ataxia Research Alliance, supporting this rare genetic disease community primarily with research investments for a cure and patient and carer support. Pfizer supported their fundraising efforts by sponsoring a fundraising dinner event. | 2000 | 2000 |
| 2018 | Pfizer | Glaucoma Australia | Peak body advancing awareness, population prevention and patient support. This grant was to fund community awareness, early diagnosis and referral pathways. | 10000 | 10000 |
| 2018 | Pfizer | Global Healthy Living Foundation | Global Healthy Living Foundation advocates for and supports patients around the world across a number of health conditions including arthritis and other inflammatory and immunological conditions. Their leadership is set up in USA. They have a new Australian chapter to this organisation. This grant in 2018 was to facilitate Australian support groups and localised information and support resources. | 10000 | 10000 |
| 2018 | Pfizer | Haemophilia Foundation Australia | Patient Support for this rare condition. This grant supported the running of specialised kids camps and a youth support grant program to advance social and educational outcomes for young people with haemophilia. | 25000 | 25000 |
| 2018 | Pfizer | Leukaemia Foundation Of Australia | Peak body representing the interests of people with blood based cancers. These funds supported the development of information and support resources for patients and carers. | 10000 | 10000 |
| 2018 | Pfizer | McGrath Foundation | Provision of specialised Breast Cancer Nurses in the Australian Health System. Pfizer extended funding of a Metastatic Breast Care Nurse position. | 10000 | 10000 |
| 2018 | Pfizer | Meningitis Centre | Meningitis Centre Australia strives to eliminate meningitis in Australia. It has successfully produced materials for educating the community across Australia to be aware of the signs and symptoms. It also provides support for families affected by the disease. Pfizer provided a sponsorship to support the development of education programs, patient support and vaccination awareness. | 70000 | 70000 |
| 2018 | Pfizer | Multiple Heath Consumer Organisations | Pfizer Australia employees are provided with up to four days of volunteer leave per year and are encouraged to serve their community by volunteering for a registered charity of their choice. Approximately 4500 hours volunteering was attended and an estimated $15,000 in colleague donations to charities. Pfizer Australia Donated $40,000 of corporate funds to The Smith Family our Charity of Choice and also $20,000 worth of community collaboration grants for charities as determined by colleagues. We supported the Starlight Foundation through $100,000. | Pfizer Australia employees' time and donations provided to the community and charities. | 175000 |
| 2018 | Pfizer | National Heart Foundation Of Australia | NHF is the peak body supporting education, awareness, prevention and support for heart disease patients in Australia. Pfizer donated funds as part of a colleague awareness initiative and matched some funds raised by colleagues for this cause. | 700 | 700 |
| 2018 | Pfizer | Osteoporosis Australia | Osteoporosis Australia (OA) provides osteoporosis information and health promotion and patient support services to the community and health professionals. Pfizer Australia provided sponsorship for a Cause Related Marketing contract for our Consumer Health (OTC) Calcium Supplement - Caltrate. | 73000 | 73000 |
| 2018 | Pfizer | Parkinson's Victoria (VIC) | Sponsorship of health care professional conference on Parkinson's disease - focus on latest research | 2000 | 2000 |
| 2018 | Pfizer | Patient Voice Initiative | PVI is an initiative of a collective group of patient organisations seeking to enhance patient and patient group understanding of the Health Technology Assessment Process through the PBAC in Australia. They educate patients and patient groups to enhance the input and impact of consumer consultation in the HTA process, ultimately to enhance medicine access in Australia. Pfizer, along with other MA member companies supported a series of regional patient workshops and the production of education materials. | 10000 | 10000 |
| 2018 | Pfizer | Prader Willi Syndrome Association | PWSA is an organisation representing the interests of and supporting patients with Prader Willi Syndrome, a rare genetic condition. These grant funds supported their education materials and awareness and support events throughout Australia. | 7500 | 7500 |
| 2018 | Pfizer | Rare Cancers Australia | Rare Cancers Australia is a charity purposed to improve awareness, support and treatment of Australians with rare and less common cancers. Sick or Treat Rare Cancers awareness and fundraising campaign and events ($25,000) RCA acted as secretariat and funding source for CDA ( Cancer Drugs Alliance - an alliance of academics, clinicians and patient groups seeking to positively change access to innovative medicines in Australia) Pfizer, along with other MA member companies funded this body of work to support admin of this group and also the data collection and formulation of a report on Australians current access to innovative medicines, to identify gaps and opportunities to improve our systems. ($40,000) | 25000 | 25000 |
| 2018 | Pfizer | Save Our Sons | This charity supports research, education and support for people impacted by Duchenne Muscular Dystrophy. This grant was to support their fundraising efforts by sponsoring a gala dinner fundraiser. | 10000 | 10000 |
| 2019 | Pfizer | Arthritis Foundation of Australia | Arthritis Australia is the National organisation representing and supporting state based, service oriented affiliates. Along with other MA Member companies, Pfizer supported the further development of an interactive website that provides individualised user information website called "RASP". | 40000 | 40000 |
| 2019 | Pfizer | Arthritis Queensland (QLD) | Queensland based Arthritis Patient Support organisation associated with Arthritis Australia. This educational grant supported an education meeting, room hire and catering for patient education meeting. | 681.82 | 681.82 |
| 2019 | Pfizer | Australian Crohn's and Colitis Association | Peak body representing the interests of people with Irritable Bowel disease, Crohn's & Colitis. Pfizer supported development of community education material, patient support groups and patient phone line and information services including: 1.Chrons' & Colitis HUB, digital APP. This platform provides the most comprehensive collection of IBD information that is targeted at the general public as well as IBD and allied health professionals. All curated and new content with a medical focus is reviewed by the CCA Scientific and Medical Advisory Committee to ensure accuracy 2.Patient Education Forums, film, editing and uploading. Traditional forums filmed by a professional videographer to be uploaded later to our website and other social media channels. This allows access to forums for people living in regional areas or too sick to attend a forum 3.Volunteer Support Groups and phone line - includes volunteer training and promotional materials to promote the services nationally Support in 2019 for a two year period (2019 and 2020). Sponsorship also of fundraising events in Sydney and Brisbane - Silver Linings Luncheons | 106780 | 106780 |
| 2019 | Pfizer | Australian Patients Association | A patient group representing the rights and needs of all Australian patients especially those engaged in our health care system. Pfizer supported an award program recognising outstanding health service delivery in Australia. The sponsorship was for 1 table at the awards dinner and naming rights to "Best Patient Group Awareness Program" award. | 10000 | 10000 |
| 2019 | Pfizer | Australian Pituitary Foundation | The Australian Pituitary Foundation's mission is to provide support to those who have experienced pituitary gland conditions. They promote awareness and disseminate information among the medical community, the public, and pituitary patients and their families. Pfizer Australia was a corporate sponsor of the Australian Pituitary Foundation in 2019 supporting key programs and initiatives including patient and GP/health provider education seminars , the quarterly newsletter and an online resources portal. | 27200 | 27200 |
| 2019 | Pfizer | Brain Foundation | Headache Australia is a group held within The Brain Foundation and is a peak body representing the interests and supports to patients with Chronic migraine and headache conditions. Pfizer provided a donation to this organisation to support their work. | 1000 | 1000 |
| 2019 | Pfizer | Breast Cancer Network Australia | Breast Cancer Network Australia is a peak body supporting the needs of women, men and families coping with a breast cancer diagnosis through provision of information, support groups and a support phone line. Pfizer was asked to support one of their major community fundraising activities - The Pink Party Gala, held in Sydney October 2019. | 3272 | 3272 |
| 2019 | Pfizer | Centre for Community - Driven Research | CCDR is an independant community research organisation representing the interests of a patients by providing qualitative and quantitaive patient evidence into health policy decision making. They also skill and equip other patinet groups and collaborate with them on joint projects to shape a better health system. Pfizer sponsored the logistics and conference costs for 2 patient group workshop sessions at their annual Australian Patient Organisation Network Meeting in 2019. One workshop was on Musculoskeletal Health and the other in Cardiovascular Health. | 20000 | 20000 |
| 2019 | Pfizer | Chronic Pain Association of Australia | Chronic Pain Australia works towards de-stigmatising chronic pain by providing high quality user-friendly research-based information and support for patients and carers. Pfizer Australia provided funding to support National Pain Week in July 2019 which included community service announcements, patient education seminars and social media awareness campaign. | 25000 | 25000 |
| 2019 | Pfizer | Diabetes Australia - Tasmania (TAS) | Tasmanian Based Support organisation for people with diabetes. Pfizer supported HCP & Patient Education | 2000 | 2000 |
| 2019 | Pfizer | Dragon Claw Charity | Patient group supporting patients with rheumatic disease with self care navigation and peer support. Pfizer provided $10,000 in 2019 to further enhance their member recruitment and communications including a refresh of their website and update of information material. | 10000 | 10000 |
| 2019 | Pfizer | Friedreich Ataxia Research Association | Fredericks Ataxia Research Alliance, supporting this rare genetic disease community primarily with research investments for a cure and patient and carer support. Pfizer supported their fundraising efforts by sponsoring a fundraising dinner events including gala dinners and bike ride event, support over two years (2019 and 2020) and sponsorship of for Lend Us Some Muscle awareness and communications campaign 2019, plus sponsorship sponsorship of FA patient Forums. | 18636 | 18636 |
| 2019 | Pfizer | Glaucoma Australia | Peak body advancing awareness, population prevention and patient support. This grant was to fund community awareness, early diagnosis and referral pathways. | 3465 | 3465 |
| 2019 | Pfizer | Global Healthy Living Foundation | Global Healthy Living Foundation advocates for and supports patients around the world across a number of health conditions including arthritis and other inflammatory and immunological conditions. Their leadership is set up in USA. They have a new Australian chapter to this organisation. This grant in 2019 was to facilitate Australian support groups and localised information and support resources. | 10000 | 10000 |
| 2019 | Pfizer | Haemophilia Foundation Australia | Patient Support for this rare condition. This grant supported the running of specialised kids camps and a youth support grant program to advance social and educational outcomes for young people with haemophilia; plus disease awareness campaigns and patient support programs. | 31500 | 31500 |
| 2019 | Pfizer | Leukaemia Foundation Of Australia | Peak body representing the interests of people with blood based cancers. These funds supported the development of information and support resources for patients and carers. | 10000 | 10000 |
| 2019 | Pfizer | Lymphoma Australia | Peak body representing the specific interests of patients with Lymphoma. Pfizer offers small grants that colleagues can competitively pitch for funds to go to a charity they are close to. In 2019, one of these community grants was successfully attributed to Lymphoma Australia. | 5000 | 5000 |
| 2019 | Pfizer | Meningitis Centre | Meningitis Centre Australia strives to eliminate meningitis in Australia. It has successfully produced materials for educating the community across Australia to be aware of the signs and symptoms of meningitis. It also provides support for families affected by the disease. Pfizer provided a multi year sponsorship to support the development of education programs, patient support and vaccination awareness. 3 year sponsorship support program. | 90000 | 90000 |
| 2019 | Pfizer | Multiple Heath Consumer Organisations | Pfizer Australia employees are provided with up to four days of volunteer leave per year and are encouraged to serve their community by volunteering for a registered charity of their choice. Approximately 5000 hours volunteering was attended and an estimated $10,000 in colleague donations to charities. Pfizer Australia Donated $55,000 of corporate funds to The Smith Family our Charity of Choice and also $20,000 worth of community collaboration grants for charities as determined by colleagues. We supported the Starlight Foundation through $100,000 commercial sponsorship. | Pfizer Australia employees' time and donations provided to the community and charities. | 0 |
| 2019 | Pfizer | National Stroke Foundation | Funding of the update and reprint of an Atrial Fibrillation information booklet Pfizer co created with Stroke Foundation in 2014 | 10500 | 10500 |
| 2019 | Pfizer | Parkinson's Victoria (VIC) | Parkinson's Victoria is a State based organisation, supporting patients and families impacted by Parkinsons disease. An educational grant was provided to supply education to patients who are on infusion therapy. | 2500 | 2500 |
| 2019 | Pfizer | Patient Voice Initiative | PVI is an initiative of a collective group of patient organisations seeking to enhance patient and patient group understanding of the Health Technology Assessment Process through the PBAC in Australia. They educate patients and patient groups to enhance the input and impact of consumer consultation in the HTA process, ultimately to enhance medicine access in Australia. Pfizer, along with other MA member companies supported a series of regional patient workshops and the production of education materials including a website with search engine optimisation and advertising to help people find this information. | 10000 | 10000 |
| 2019 | Pfizer | Rare Voices Australia | Peak body representing the rare diseases patient population in Australia, mentoring and supporting other small groups and representing the plight of groups and individuals at the National Level. Main focus has been lobbying for a National Action Plan on Rare Diseases and government funding to create and execute the plan. Pfizer supported the Round Table of Companies ($30,000 over 2 years) and the National Rare Diseases Summit held in February 2019 $20,000, and the patient group mentoring program plus the Fair 4 Rare Community awareness campaign $23,000. In addition, charitable donations of $3,258 were made to contribute to fundraising efforts. | 76258 | 76258 |
| 2019 | Pfizer | Save Our Sons | This charity supports research, education and support for people impacted by Duchenne Muscular Dystrophy. This grant was to support their fundraising efforts by sponsoring a gala dinner fundraiser. | 2500 | 2500 |
| 2020 | Pfizer | Arthritis Foundation of Australia | Arthritis Australia is the National organisation representing and supporting state based, service oriented affiliates. Along with other MA Member companies, Pfizer supported specific advertising campaign directed towards patients with Arthritis, to encourage them to see their doctor during the COVID isolation periods. | 25000 | 25000 |
| 2020 | Pfizer | Australian Patients Association | A patient group representing the rights and needs of all Australian patients especially those engaged in our health care system via hospitalisation. Pfizer supported a COVID specific grant to enable continuity of support for people during a time where event fundraising was not permitted due to COVID restrictions. Grant was used for optimising digital communications materials including website updates, direct mail campaigns and advertising to increase awareness of phone and information support services. | 10000 | 10000 |
| 2020 | Pfizer | Centre for Community - Driven Research | CCDR is an independent community research organisation representing the interests of patients by providing qualitative and quantitative patient evidence into health policy decision making. They also skill and equip other patient groups and collaborate with them on joint projects to shape a better health system. Pfizer sponsored the APON Network during the COVID Period for a series of sessions with their membership to facilitate COVID related discussions, barriers and opportunities. | 10000 | 10000 |
| 2020 | Pfizer | Dragon Claw Charity | Patient group supporting patients with rheumatic disease with self care navigation and peer support. Pfizer provided $10,000 in 2020 to further enhance their member recruitment and communications including a refresh of their website and update of information material. | 20000 | 20000 |
| 2020 | Pfizer | Eczema Support Australia | A grass roots patient organisation based in Queensland with a National remit for advocacy and support for patients and families dealing with atopic dermatitis. These funds were directed towards updating information resources, schools and carer educational program materials and roll out as well as online and phone support groups and services. | 28820 | 28820 |
| 2020 | Pfizer | Friedreich Ataxia Research Association | Fredreich's Ataxia Research Australia represents the interests of people with this rare disease. Raising money for research is their primary strategy. Pfizer supported fundraising through the purchase of T Shirts and posted social media messages to raise awareness | 1748 | 1748 |
| 2020 | Pfizer | Global Healthy Living Foundation | Global Healthy Living Foundation advocates for and supports patients around the world across a number of health conditions including arthritis and other inflammatory and immunological conditions. This grant in 2020 was to facilitate Australian support groups and localised information and support resources, including customised communications about COVID19 for immunosuppressed individuals. | 25000 | 25000 |
| 2020 | Pfizer | Haemophilia Foundation Australia | This was for sponsorship of the annual Haemophilia Foundation patient conference ($33,000 - Gold Sponsor) and an educational grant to support a digital awareness campaign ($20,000) | 53000 | 53000 |
| 2020 | Pfizer | Huntington's New South Wales (NSW) & ACT (ACT) | This was a Pfizer CARES, CSR Program, Community Collaboration Grant. These grants offer a pool of Pfizer funds to be competitively awarded to charities our colleagues are personally connected with. These are unsolicited, small grants. Funding was directed towards support services. | 2000 | 2000 |
| 2020 | Pfizer | Leukaemia Foundation Of Australia | The Leukaemia Foundation of Australia is a peak body representing the interests of people with blood based cancers. These funds supported the accomodation services for patients being treated away from home. | 20000 | 20000 |
| 2020 | Pfizer | McGrath Foundation | Annual support for Metastatic Breast Cancer Nurse Program - Northern Sydney Region | 140000 | 140000 |
| 2020 | Pfizer | Multiple Heath Consumer Organisations | Pfizer Australia employees are provided with up to four days of volunteer leave per year and are encouraged to serve their community by volunteering for a registered charity of their choice. Approximately 5000 hours volunteering was attended and an estimated $30,000 in colleague donations to charities including Red Cross for Bushfire Relief Efforts. Pfizer Australia Donated $60,000 of corporate funds to The Smith Family our Charity of Choice and also $25,000 worth of community collaboration grants for charities as determined by colleagues. | Pfizer Australia employees' time and donations provided to the community and charities. | 0 |
| 2020 | Pfizer | Musculoskeletal Australia | Victorian based, National reach support organisation for people with muscle and skeletal conditions. Pfizer supported a patient webinar series and development of digital educational materials and outreach programs during COVID. | 25000 | 25000 |
| 2020 | Pfizer | Parkinson's Victoria (VIC) | Parkinson's Victoria is a State based organisation, supporting patients and families impacted by Parkinson's disease. An educational grant was provided to supply education to patients who are on infusion therapy. | 2000 | 2000 |
| 2020 | Pfizer | Patient Voice Initiative | PVI is an initiative of a collective group of patient organisations seeking to enhance patient and patient group understanding of the Health Technology Assessment Process through the PBAC in Australia. They educate patients and patient groups to enhance the input and impact of consumer consultation in the HTA process, ultimately to enhance medicine access in Australia. Pfizer, along with other MA member companies supported a series of regional patient workshops and the production of education materials including a website with search engine optimisation and advertising to help people find this information. | 7500 | 7500 |
| 2020 | Pfizer | Rare Cancers Australia | Rare Cancers Australia is a charity purposed to improve awareness, support and treatment of Australians with rare and less common cancers. They also founded and facilitate the National Oncology Alliance (NOA), which is a multi stakeholder advocacy initiative to shape cancer care in Australia. Pfizer supported patient engagement and support initiatives including patient support phone and health navigator services for $25,000 and an additional grant appeal for $10,000 to support COVID specific initiatives and online resource development. Pfizer, along with other member companies supported NOA with a membership fee of $25,000 | 60000 | 60000 |
| 2020 | Pfizer | Rare Voices Australia | Rare Voices Australia is a peak body representing the rare diseases patient population in Australia, mentoring and supporting other small groups and representing the plight of groups and individuals at the National Level. Their main focus has been lobbying for implementation of the National Action Plan on Rare Diseases and government funding to further advance this. Pfizer supported the Round Table of Companies ($15,000) and $15,000 for a patient group Mentor Program and $8,000 for the Parliamentary Awareness Event rare diseases day. | 38000 | 38000 |
| 2020 | Pfizer | Save Our Sons | This charity supports research, education and support for people impacted by Duchenne Muscular Dystrophy (DMD). Pfizer sponsored the annual DMD Patient and Professional Conference. | 6000 | 6000 |
| 2013 | Roche | Arthritis Foundation of Australia | Financial support for redevelopment of arthritis booklet | 3000 | 3000 |
| 2013 | Roche | Arthritis Foundation of Australia | Financial support for research project examining the disability impact of arthritis | 20000 | 20000 |
| 2013 | Roche | Arthritis Foundation of Australia | Indirect financial support for travel, accommodation and meeting logistics for rheumatoid arthritis education meeting | Per delegate travel, accommodation and meeting costs equivalent to $32,000 | 32000 |
| 2013 | Roche | Arthritis Foundation of Australia | Financial support for the Ken Muirden Award fellowship to undertake clinical or research training. Jointly funded with the Australian Rheumatology Association | 50000 | 50000 |
| 2013 | Roche | Arthritis Queensland (QLD) | Financial support for Health Professional Seminar | 400 | 400 |
| 2013 | Roche | Australian Kookaburra Kids Foundation | Financial support for purchase of a corporate table at a corporate charity lunch | 2500 | 2500 |
| 2013 | Roche | Bowel Cancer Australia | Indirect support for travel, accommodation and meals in association with an educational meeting | Per delegate travel, accommodation and meeting costs equivalent to $2,000 | 2000 |
| 2013 | Roche | Bowel Cancer Australia | Financial support for nurse advisors to implement patient services | 10000 | 10000 |
| 2013 | Roche | Brain Tumour Alliance Australia | Indirect support for travel, accommodation and meals in association with an educational meeting | Per delegate travel, accommodation and meeting costs equivalent to $2,000 | 2000 |
| 2013 | Roche | Brain Tumour Alliance Australia | Financial support for newsletters | 5000 | 5000 |
| 2013 | Roche | Brain Tumour Alliance Australia | Financial support for patient forum | 5000 | 5000 |
| 2013 | Roche | Breast Cancer Network Australia | Financial support for attendance at Pink Lady Luncheon fundraising initiative | 600 | 600 |
| 2013 | Roche | Breast Cancer Network Australia | Indirect support for travel, accommodation and meals in association with an educational meeting | Per delegate travel, accommodation and meeting costs equivalent to $2,000 | 2000 |
| 2013 | Roche | Cancer Council New South Wales (NSW) | Financial support for purchase of a corporate table at a trivia night | 2700 | 2700 |
| 2013 | Roche | Cancer Council Victoria (VIC) | Financial support in lieu of a consultancy payment to a third party | 1000 | 1000 |
| 2013 | Roche | Cancer Council Western Australia (WA) | Financial support for colorectal cancer educational meeting for healthcare professionals in Nov 2013 | 1500 | 1500 |
| 2013 | Roche | Cancer Council Western Australia (WA) | Indirect support for travel, accommodation and meals in association with an educational meeting | Per delegate travel, accommodation and meeting costs equivalent to $2,000 | 2000 |
| 2013 | Roche | Cancer Council Western Australia (WA) | Financial support for colorectal cancer and breast cancer educational meetings for healthcare professionals in March and April 2013 | 3200 | 3200 |
| 2013 | Roche | Cancer Council Western Australia (WA) | Financial support for the WA Clinical Oncology Group ongoing cancer education initiatives for Healthcare Professionals | 3500 | 3500 |
| 2013 | Roche | Carers Australia | Indirect financial support for travel costs to attend activity planning meeting. Travel costs equivalent to $350 | 350 | 350 |
| 2013 | Roche | Carers Australia | Financial support for corporate participation in the 2013 Pollie Pedal awareness and fundraising activity | 20000 | 20000 |
| 2013 | Roche | Cherish Women's Foundation | Financial support for Battle Against Ovarian Cancer fundraising initiative | 500 | 500 |
| 2013 | Roche | Cystic Fibrosis Australia | Financial support for production of 2013 CF Data Registry Report | 20000 | 20000 |
| 2013 | Roche | Dialysis Escape Line Australia | Financial support for temporary dialysis units | 5000 | 5000 |
| 2013 | Roche | Hepatitis Australia | Financial support for Hepatitis Awareness Week and World Hepatitis Day activities | 25000 | 25000 |
| 2013 | Roche | Kidney Health Australia Western Australia (WA) | Financial support for education seminars to patients | 350 | 350 |
| 2013 | Roche | Kidney Kids South Australia (SA) | Financial support for Kidney Kids SA fundraising bike ride | 1500 | 1500 |
| 2013 | Roche | Leukaemia Foundation Of Australia | Financial support for updating a patient booklet and supporting World Lymphoma Awareness Day Activities | 40000 | 40000 |
| 2013 | Roche | Lung Foundation Australia | Indirect support for travel, accommodation and meals in association with an educational meeting | Per delegate travel, accommodation and meeting costs equivalent to $2,000 | 2000 |
| 2013 | Roche | Lung Foundation Australia | Financial support for the Australian Lung Cancer Conference for healthcare professionals | 50000 | 50000 |
| 2013 | Roche | Lung Foundation Australia | Financial support for the Lung Cancer Consultative Group (LCCG), The Australasian Lung Cancer Trials Group (ALTG), the Kylie Johnston Lung Cancer Network (KJLCN) and the Australia and New Zealand Lung Cancer Nurses Network | 55000 | 55000 |
| 2013 | Roche | Lymphoma Australia | Financial support for purchase of a corporate table at the Touch of Lime Gala Dinner fundraising event | 1400 | 1400 |
| 2013 | Roche | Lymphoma Australia | Financial support in lieu of a consultancy payment to a third party | 1500 | 1500 |
| 2013 | Roche | Lymphoma Australia | Indirect support for travel, accommodation and meals in association with an educational meeting. | Per delegate travel, accommodation and meeting costs equivalent to $2,000 | 2000 |
| 2013 | Roche | Lymphoma Australia | Financial support in lieu of a consultancy payment to a third party | 3000 | 3000 |
| 2013 | Roche | Lymphoma Australia | Financial support for a national patient/carer meeting and a clinical trials awareness project | 40000 | 40000 |
| 2013 | Roche | McGrath Foundation | Financial support for attendance at annual High Tea fundraising event | 2700 | 2700 |
| 2013 | Roche | Melanoma Institute Australia | Financial support for the Parliament Melanoma March awareness event | 5000 | 5000 |
| 2013 | Roche | Melanoma Institute Australia | Financial support for the Melanoma March awareness event | 10000 | 10000 |
| 2013 | Roche | Melanoma Patients Australia | Indirect support for travel, accommodation and meals in association with an educational meeting | Per delegate travel, accommodation and meeting costs equivalent to $2,000 | 2000 |
| 2013 | Roche | Melanoma Patients Australia | Financial support for the National Advocacy Training Workshop | 18200 | 18200 |
| 2013 | Roche | Mental Illness Fellowship of Australia | Indirect financial support for travel costs to attend activity planning meeting. Travel costs equivalent to $350 | 350 | 350 |
| 2013 | Roche | Mental Illness Fellowship of Australia | Financial support for the development of patient information sheets | 3700 | 3700 |
| 2013 | Roche | Ovarian Cancer Australia | Financial support for 'Morning Teal' awareness day educational activities | 500 | 500 |
| 2013 | Roche | Ovarian Cancer Australia | Indirect support for travel, accommodation and meals in association with an educational meeting. Per delegate travel, accommodation and meeting costs equivalent to $2,000 | Per delegate travel, accommodation and meeting costs equivalent to $2,000 | 2000 |
| 2013 | Roche | Rare Cancers Australia | Financial support for the Rare Cancers Report Launch and a healthcare professional survey on rare cancers | 15000 | 15000 |
| 2013 | Roche | Sunflower Foundation Australia | Financial support for the Sydney Bridgewalk for Mental Wellness and Wellness Festival | 10000 | 10000 |
| 2013 | Roche | Sydney Breast Cancer Foundation (Chris O'Brien Lifehouse, Royal Prince Alfred Hospital) | Financial support for purchase of a corporate table at the Annual Ladies Long Lunch fundraising event | 1200 | 1200 |
| 2014 | Roche | Arthritis Foundation of Australia | Support for Arthritis Australia representatives to attend a medical education event (March 2014) $18,500 (equivalent value) Indirect financial support to cover registration, meals, and travel for 9 representatives, and meeting room facilities for 15 people | $18,500 (equivalent value) Indirect financial support to cover registration, meals, and travel for 9 representatives, and meeting room facilities for 15 people at a medical education event (March 2014). | 18500 |
| 2014 | Roche | Arthritis Foundation of Australia | Arthritis Australia, Medicines Australia Community Chest Program (2014-2015). Support for 2015 program of activities undertaken by Arthritis Australia, including a research project investigating an economic evaluation of implementing the Time to Move Stra | 20000 | 20000 |
| 2014 | Roche | Arthritis Foundation of Australia | Financial support for the 2015 Ken Muirden Award fellowship which supports clinical or research training. Jointly funded with the Australian Rheumatology Association. | 50000 | 50000 |
| 2014 | Roche | Arthritis Foundation of South Australia (SA) | Financial support for the Arthritis South Australia Health Professional conference 2015. | 1500 | 1500 |
| 2014 | Roche | Arthritis Foundation of South Australia (SA) | Arthritis South Australia Clinical Update on Rheumatoid Arthritis Meeting. Medical education event sponsorship to enhance medical knowledge and the quality use of medicines providing a platform to increase awareness and education for General Practitioners | 1500 | 1500 |
| 2014 | Roche | Bowel Cancer Australia | Support Bowel Cancer Australia attendance at a medical educational event (February 2014). Indirect financial support for travel and accommodation to facilitate attendance at a medical education event (February 2014). Indirect financial support for travel | $2,000 (equivalent value) Indirect financial support for travel and accommodation to facilitate attendance at a medical education event (February 2014). | 2000 |
| 2014 | Roche | Bowel Cancer Australia | Development of the Bowel Cancer Australia App for patient use on Apple iPhone, Google Play and Samsung Hub android devices. | 25000 | 25000 |
| 2014 | Roche | Breast Cancer Network Australia | Support BCNA attendance at a medical educational event (February 2014). $750 (equivalent value) Indirect financial support for registration to attend medical education event (February 2014). | $750 (equivalent value) Indirect financial support for registration to attend medical education event (February 2014). | 750 |
| 2014 | Roche | Cancer Australia | Attendance at Cancer Australia's Pink Ribbon Breakfast 2014. To benefit women with breast cancer by bringing together stakeholders to mark Australia’s Breast Cancer Awareness Month and raise valuable funds for necessary support and research (October 2014) | 5500 | 5500 |
| 2014 | Roche | Cancer Council Western Australia (WA) | Support Western Australia Clinical Oncology Group attendance at a medical educational event (February 2014). Indirect financial support for travel, accommodation and registration at a medical education event (February 2014). | $2,000 (equivalent value) Indirect financial support for travel, accommodation and registration at a medical education event (February 2014). | 2000 |
| 2014 | Roche | Cancer Council Western Australia (WA) | To support the 2014 Western Australia Cancer Education meeting series coordinated by the WA Clinical Oncology Group and Cancer Council Western Australia. Funding covered cost of the meetings series throughout 2014. | 13000 | 13000 |
| 2014 | Roche | Canspeak | Support Canspeak attendance at a medical educational event (February 2014). Indirect financial support for travel and accommodation to facilitate attendance at a medical education event (February 2014). | $2,000 (equivalent value) Indirect financial support for travel and accommodation to facilitate attendance at a medical education event (February 2014). | 2000 |
| 2014 | Roche | Canspeak | Health Consumer Advocacy 2014 workshop. Support for running the workshop in partnership with several pharmaceutical companies to facilitate improved advocacy skills amongst patient organisations from several disease areas (August 2014). | 15000 | 15000 |
| 2014 | Roche | Cure Our Kids | Support for the publication and printing of the 2015 Oncology Diary for children. To enable children with cancer and their families keep a record of their disease and treatment in a diary. | 3000 | 3000 |
| 2014 | Roche | Cystic Fibrosis Australia | Cystic Fibrosis Australia Quality Improvement Programs. To support and enhance medical knowledge or the quality use of medicines by researching and promoting improvements in clinical care and enhancing clinical outcomes for individuals with cystic fibrosi | 20000 | 20000 |
| 2014 | Roche | Hepatitis Australia | Support for the Love Your Liver Project, including World Hepatitis Day and other awareness raising and educational activities. | 25000 | 25000 |
| 2014 | Roche | Hepatitis Queensland (QLD) | Donation to Hepatitis Queensland made on request of a Hepatitis patient who has recently dedicated his time to sharing his experiences and his treatment journey with Roche employees. | 250 | 250 |
| 2014 | Roche | Kidney Health Australia | idney Check Australia Taskforce, Heath Professional Education Programme 2015. Support Chronic Kidney Disease (CKD) management in general practice, specifically for development launch, promotion and ongoing maintenance of an app version of the ‘CKD Managem | 7000 | 7000 |
| 2014 | Roche | Leukaemia Foundation Of Australia | Support Leukaemia Foundation attendance at a medical educational event (February 2014). Indirect financial support for travel and accomodation to facilitate attendance at a medical education event (February 2014). | $2000 (equivalent value) Indirect financial support for travel and accomodation to facilitate attendance at a medical education event (February 2014). | 2000 |
| 2014 | Roche | Leukaemia Foundation Of Australia | Congress support for Leukaemia Foundation to attend American Society of Haematology Meeting (December 2014). Indirect financial support for overseas travel and accomodation at a medical education event (December 2014). | $12,000 (equivalent value) Indirect financial support for overseas travel and accomodation at a medical education event (December 2014). | 12000 |
| 2014 | Roche | Liver Foundation | Support for the Liver Foundation West Coast Liver Meeting 2014. Continued support and education for The Liver Foundation of WA and the Hepatology community, both in the city and regional areas. Funding used to support the running of the meeting (May 2014) | 5000 | 5000 |
| 2014 | Roche | Lung Foundation Australia | Support Australian Lung Foundation attendance at a medical educational event (February 2014). Indirect financial support for travel and accomodation to facilitate attendance at medical education event (February 2014). | $2,000 (equivalent value) Indirect financial support for travel and accomodation to facilitate attendance at medical education event (February 2014). | 2000 |
| 2014 | Roche | Lung Foundation Australia | Support for the Australian Lung Cancer Conference (ALCC) 2014. Supporting the Lung Foundation Australia to provide one international keynote speaker with travel, accomodation, registration and honorarium costs (October 2014). | 15000 | 15000 |
| 2014 | Roche | Lung Foundation Australia | Support for Lung Foundation of Australia's national program in 2014. Support for various activities on the national program which is driving improvements in treatment outcomes for patients and working to further educate healthcare professionals in the are | 55500 | 55500 |
| 2014 | Roche | Lymphoma Australia | Support Lymphoma Australia attendance at a medical educational event (February 2014). Indirect financial support for travel and accomodation to facilitate attendance at a medical education event (February 2014). | $2,000 (equivalent value) Indirect financial support for travel and accomodation to facilitate attendance at a medical education event (February 2014). | 2000 |
| 2014 | Roche | Lymphoma Australia | Congress support for Lymphoma Australia to attend American Society of Haematology Meeting (December 2014). Indirect financial support for overseas travel and accommodation at a medical education event (December 2014). | $12,000 (equivalent value) Indirect financial support for overseas travel and accommodation at a medical education event (December 2014). | 12000 |
| 2014 | Roche | McGrath Foundation | Support for the McGrath Foundation “Working together to support secondary Breast cancer patients" health care professional meeting, supporting the work of The McGrath Foundation and to provide education to patients (June 2014). | 25000 | 25000 |
| 2014 | Roche | Mental Illness Fellowship of Australia | To support the development of two patient information sheets being developed through the Mental Illness Fellowship of Australia. Information sheets to be available to patients in GP's offices. | 3700 | 3700 |
| 2014 | Roche | Ovarian Cancer Australia | Donation to Ovarian Cancer Australia to support an awareness- raising event. Indirect financial support for meeting catering and arrangements at an ovarian cancer awareness-raising event. | $200 (equivalent value) Indirect financial support for meeting catering and arrangements at an ovarian cancer awareness-raising event. | 200 |
| 2014 | Roche | Ovarian Cancer Australia | Sponsorship to attend overseas educational meeting. Support for Ovarian Cancer Australia to attend the Ovarian Cancer Patient Workshop in Lisbon, providing an opportunity for patient groups to share experiences and expertise (January 2014). Indirect finan | $10,000 (equivalent value) Indirect financial support for overseas travel, attendance and accomodation at a patient group event (January 2014). | 10000 |
| 2014 | Roche | Ovarian Cancer Australia | Support Ovarian Cancer Australia's symposium for women affected by gynaecological cancers, their partners, family and friends to coincide with the 15th biennial meeting of the International Gynaelogic Cancer Society (November 2014). | 15000 | 15000 |
| 2014 | Roche | Rare Cancers Australia | Support for Corporate Table Sponsorship of Rare Cancers Sick or Treat Charity Ball, to raise awareness of Rare Cancers for the Cancer Medicines Fund (October 2014). | 2200 | 2200 |
| 2014 | Roche | Rare Cancers Australia | Supporting Rare Cancers Australia to develop and promote a policy brief addressing key shortcomings facing Australians with rare and less common cancers. | 20000 | 20000 |
| 2014 | Roche | Save The Children Australia | Donation to Save The Children Australia based on employee fundraising initiatives, to provide vulnerable children with the essential support they need to survive and improving the lives of Australia’s children. | 700 | 700 |
| 2015 | Roche | Arthritis Foundation of Australia | Donation for diseases awareness and patient support activities. | 250 | 250 |
| 2015 | Roche | Arthritis Foundation of Australia | Grant for production of arthritis patient booklet in September 2015. | 3000 | 3000 |
| 2015 | Roche | Arthritis Foundation of Australia | Grant to support the activities of the Medicines Australia Community Chest program. | 20000 | 20000 |
| 2015 | Roche | Arthritis Foundation of Australia | Part contribution towards an overseas training fellowship for one health professional in 2016. | 25000 | 25000 |
| 2015 | Roche | Arthritis Foundation of South Australia (SA) | Sponsorship of the Arthritis South Australia Healthcare Professional National Conference in June 2016. | 1500 | 1500 |
| 2015 | Roche | Arthritis Foundation of Western Australia (WA) | Sponsorship for the Arthritis & Osteoporosis WA Clinical Update on Musculoskeletal Conditions (for healthcare professionals). | 450 | 450 |
| 2015 | Roche | Cancer Council Western Australia (WA) | Sponsorship of the WACOG Colorectal Tumour Collaborative Educational Meeting for healthcare professions in August 2015. | 1500 | 1500 |
| 2015 | Roche | Cystic Fibrosis Australia | Grant for a registry for cystic fibrosis. | 20000 | 20000 |
| 2015 | Roche | Kidney Health Australia | Grant for the Kidney Health Australia Caring for Australasians with Renal Impairment (KHA-CARI) Guidelines. | 10000 | 10000 |
| 2015 | Roche | Leukaemia Foundation Of Australia | Grant for travel to the Lymphoma Coalition Global Summit and the American Society of Haematology (ASH) congress in December 2015. | 10000 | 10000 |
| 2015 | Roche | Leukaemia Foundation Of Australia | Grant for Understanding CLL DVD (Chronic lymphocytic leukaemia), and production and distribution of the Lymphoma News publications. | 25000 | 25000 |
| 2015 | Roche | Lung Foundation Australia | Sponsorship for a rare lung disease short course for healthcare professionals in October 2015 . | 15000 | 15000 |
| 2015 | Roche | Lung Foundation Australia | Grant for the Idiopathic Pulmonary Fibrosis (IPF) Peer Support Program for patients and carers. | 20000 | 20000 |
| 2015 | Roche | Lymphoma Australia | Grant for travel to the Lymphoma Coalition Global Summit and the American Society of Haematology (ASH) congress in December 2015. | 10000 | 10000 |
| 2015 | Roche | Lymphoma Australia | Grant for national education days and a lymphoma nurse education meeting. | 25000 | 25000 |
| 2015 | Roche | McGrath Foundation | Sponsorship for a series of workshops for breast care nurses to facilitate the introduction of a new e-learning platform in Nov-Dec 2015. | 25000 | 25000 |
| 2015 | Roche | Ovarian Cancer Australia | Grants for a series of patient information sessions on ovarian cancer in 2015. | 15000 | 15000 |
| 2015 | Roche | Rare Cancers Australia | In kind support for travel and attendance at the Roche International Experience Exchange for Patient Organisations in March 2015. | 9202 | 9202 |
| 2015 | Roche | Rare Cancers Australia | Grant for the publication and launch of a report on rare cancers, including parliamentary event and national roadshow. | 25000 | 25000 |
| 2015 | Roche | Rare Cancers Australia | Sponsorship for Sick or Treat campaign events through August - December to raise awareness of challenges facing Australians with rare/less common cancers. | 35000 | 35000 |
| 2015 | Roche | Redkite | Grant for the 2016 Oncology Diary distributed to families whose child is receiving treatment at the Children’s Hospital Westmead. | 5000 | 5000 |
| 2016 | Roche | Arthritis Foundation of Australia | Grant for update to arthritis patient booklet | 2630 | 2630 |
| 2016 | Roche | Arthritis Foundation of Australia | Grant to support the activities of the Medicines Australia Community Chest program | 20000 | 20000 |
| 2016 | Roche | Arthritis Foundation of Australia | Grant (part contribution) towards an overseas training fellowship for one health professional in 2017 | 25000 | 25000 |
| 2016 | Roche | Arthritis Foundation of Australia | Grant (part contribution) for Paediatric Rheumatology Scholarships Appeal, for further training of healthcare professionals | 30000 | 30000 |
| 2016 | Roche | Arthritis Foundation of South Australia (SA) | Sponsorship of Arthritis South Australia Health Professional Annual Conference in Jun 2017 | 1500 | 1500 |
| 2016 | Roche | Arthritis Foundation of Western Australia (WA) | Sponsorship of Rheumatology Update for General Practitioners event in Oct 2016 | 500 | 500 |
| 2016 | Roche | Bowel Cancer Australia | Grant for migration and expansion of online education resource, mCRC (metastatic colorectal cancer):CARE | 15000 | 15000 |
| 2016 | Roche | Cancer Council Western Australia (WA) | Sponsorship of WA Clinical Oncology Group neuro-oncology meeting in May 2016 | 1000 | 1000 |
| 2016 | Roche | Cancer Council Western Australia (WA) | Sponsorship of Colorectal Tumor Collaborative Educational Meeting in Sep 2016 | 1364 | 1364 |
| 2016 | Roche | Cancer Council Western Australia (WA) | Sponsorship of Breast Tumour Collaborative Educational Meeting in Oct 2016 | 1500 | 1500 |
| 2016 | Roche | Cancer Council Western Australia (WA) | Sponsorship of WA Clinical Oncology Group Advanced Trainee Program in 2016 | 1500 | 1500 |
| 2016 | Roche | Cancer Council Western Australia (WA) | Sponsorship of three WA Clinical Oncology Group Advanced Trainees Educational Meetings (ATEM) in 2016 | 2000 | 2000 |
| 2016 | Roche | Cystic Fibrosis Australia | Donation to Ann Maree Bosch Career Fellowship | 1000 | 1000 |
| 2016 | Roche | Kidney Health Australia | Grant for Kidney Health Australia Caring for Australasians with Renal Impairment (KHA-CARI) Guidelines | 10000 | 10000 |
| 2016 | Roche | Kidney Health Australia | Grant for indigenous healthcare worker module | 20000 | 20000 |
| 2016 | Roche | Leukaemia Foundation Of Australia | Sponsorship of Northern Territory Haematology Education Forum in Aug 2016 | 2000 | 2000 |
| 2016 | Roche | Lung Foundation Australia | Sponsorship of keynote speaker at Australian Lung Cancer Conference in Aug 2016 | 10000 | 10000 |
| 2016 | Roche | Lung Foundation Australia | Grant for lung cancer patient webinar in Nov 2016 | 10000 | 10000 |
| 2016 | Roche | Lung Foundation Australia | Sponsorship of Australian Lung Cancer Conference in Aug 2016 | 25000 | 25000 |
| 2016 | Roche | Lung Foundation Australia | Sponsorship of International Thoracic Oncology Nursing Forum in Dec 2016 | 26000 | 26000 |
| 2016 | Roche | Lymphoma Australia | Grant for patient booklet 'Know your treatment', which explains treatment options for lymphoma patients | 20000 | 20000 |
| 2016 | Roche | Melanoma Patients Australia | Grant for two consumer Information Forum events in Aug and Nov 2016, discussing treatment paths for patients and the psychosocial element of a melanoma diagnosis | 7500 | 7500 |
| 2016 | Roche | MOVE Muscle, Bone & Joint Health | Grant for development of patient guide to living with musculoskeletal conditions | 5000 | 5000 |
| 2016 | Roche | MS Australia | Sponsorship of (and attendance at) MS Gong Ride fundraising event in Nov 2016 | 3820 | 3820 |
| 2016 | Roche | MS Australia | Grant for "Multiple Sclerosis Nurses Research Project", to research the availabilty of specialist MS nurses in Australia, and determine the unmet need | 30000 | 30000 |
| 2016 | Roche | Ovarian Cancer Australia | Grant for ovarian cancer regular webinar in Dec 2016 | 5000 | 5000 |
| 2016 | Roche | Rare Cancers Australia | Sponsorship of (and attendance at) The Canberra Forum patient advocacy event in Oct 2016 | 638 | 638 |
| 2016 | Roche | Rare Cancers Australia | Sponsorship of (and attendance at) Sick or Treat Ball fundraising event in Oct 2016 | 1400 | 1400 |
| 2016 | Roche | Rare Cancers Australia | Sponsorship of Patient Voice Initiative patient advocacy events | 7500 | 7500 |
| 2016 | Roche | Rare Cancers Australia | Grant for Sick or Treat Program, a community and patient education campaign | 30000 | 30000 |
| 2016 | Roche | Redkite | Grant for Oncology Diary, distributed to families whose child is receiving treatment at the Children's Hospital Westmead | 2800 | 2800 |
| 2017 | Roche | Alzheimer's Australia | In kind support for travel and accommodation at Roche meeting for health consumer organisations, February 2017 | 523 | 523 |
| 2017 | Roche | Arthritis Queensland (QLD) | Sponsorship of Rheumatology Primary Care 2017, an educational seminar for General Practitioners, July 2017 | 750 | 750 |
| 2017 | Roche | Bowel Cancer Australia | In kind support for travel and accommodation at Roche meeting for health consumer organisations, February 2017 | 260 | 260 |
| 2017 | Roche | Cancer Council Western Australia (WA) | Sponsorship of WA Clinical Oncology Group South West Conference 2017 - Innovations in Cancer Care, for healthcare professionals, November 2017 | 1000 | 1000 |
| 2017 | Roche | Cancer Council Western Australia (WA) | Sponsorship of WA Clinical Oncology Group Melanoma Clinical Education Update, a meeting for healthcare professionals, July 2017 | 1000 | 1000 |
| 2017 | Roche | Cancer Council Western Australia (WA) | Sponsorship of WA Clinical Oncology Group Colorectal Tumour Collaborative Education Update, a meeting for healthcare professionals, July 2017 | 1500 | 1500 |
| 2017 | Roche | Cancer Council Western Australia (WA) | Sponsorship of WA Clinical Oncology Group Haematology Education Program for healthcare professionals in 2017: two International Conference Highlights | 5000 | 5000 |
| 2017 | Roche | Cancer Council Western Australia (WA) | Sponsorship of WA Clinical Oncology Group monthly education meetings for healthcare professionals in 2017 (11 meetings) | 14000 | 14000 |
| 2017 | Roche | Cancer Voices New South Wales (NSW) | In kind support for travel and accommodation at Roche meeting for health consumer organisations, February 2017 | 520 | 520 |
| 2017 | Roche | Cystic Fibrosis Australia | In kind support for travel and accommodation at Roche meeting for health consumer organisations, February 2017 | 260 | 260 |
| 2017 | Roche | Cystic Fibrosis Australia | Sponsorship of 12th Australasian Cystic Fibrosis Conference for healthcare professionals and consumers, August 2017 | 5000 | 5000 |
| 2017 | Roche | Cystic Fibrosis Australia | Grant for the ongoing management of the Australian Cystic Fibrosis Data Registry | 20000 | 20000 |
| 2017 | Roche | Diabetes Australia | In kind support for travel and accommodation at Roche meeting for health consumer organisations, February 2017 | 854 | 854 |
| 2017 | Roche | Haemophilia Foundation Australia | In kind support for travel and accommodation at Roche meeting for health consumer organisations, February 2017 | 1210 | 1210 |
| 2017 | Roche | Haemophilia Foundation Australia | In kind support for travel, accommodation and attendance at the Roche International Experience Exchange for Patient Organisations, March 2017 | 7205.69 | 7205.69 |
| 2017 | Roche | Haemophilia Foundation Australia | Grant for a haemophilia awareness campaign for consumers | 20000 | 20000 |
| 2017 | Roche | Haemophilia Foundation Australia | Sponsorship of the Haemophilia and Rare Bleeding Disorders Conference for healthcare professionals and consumers, October 2017 | 25000 | 25000 |
| 2017 | Roche | Kidney Health Australia | Grant for the Kidney Health Australia Caring for Australasians with Renal Impairment Guidelines (KHA-CARI) | 10000 | 10000 |
| 2017 | Roche | Leukaemia Foundation Of Australia | Event preparation for Light The Night fundraising walk eg erection of temporary barriers, staging etc | Volunteering of staff time | 0 |
| 2017 | Roche | Leukaemia Foundation Of Australia | Sponsorship of the Hume Region National Myeloma Day Education Seminar for healthcare professionals, May 2017 | 1800 | 1800 |
| 2017 | Roche | Lymphoma Australia | In kind support for travel and accommodation at Roche meeting for health consumer organisations, February 2017 | 465 | 465 |
| 2017 | Roche | Lymphoma Australia | Grant for a lymphoma patient preference survey | 15000 | 15000 |
| 2017 | Roche | Macular Disease Foundation | In kind support for travel and accommodation at Roche meeting for health consumer organisations, February 2017 | 520 | 520 |
| 2017 | Roche | Macular Disease Foundation | Grant for patient support program, elevating patient voices through a digital storytelling initiative | 10000 | 10000 |
| 2017 | Roche | McGrath Foundation | Donation made on behalf of a speaker at a Roche conference, March 2017 | 1000 | 1000 |
| 2017 | Roche | Melanoma Patients Australia | In kind support for travel and accommodation at Roche meeting for health consumer organisations, February 2017 | 812 | 812 |
| 2017 | Roche | MS Australia | In kind support for accommodation at Roche internal event, July 2017 | 149.32 | 149.32 |
| 2017 | Roche | MS Australia | In kind suport for travel and accommodation at Roche meeting for health consumer organisations, February 2017 | 509.81 | 509.81 |
| 2017 | Roche | MS Australia | Grant for continuation of the MS Specialist Nurses (MSSN) Research Project, to explore the availabilty of specialist MS nurses in Australia, and determine the | 20000 | 20000 |
| 2017 | Roche | Ovarian Cancer Australia | In kind support for travel and accommodation at Roche meeting for health consumer organisations, February 2017 | 546.93 | 546.93 |
| 2017 | Roche | Rare Cancers Australia | In kind support for travel and accommodation at Roche meeting for health consumer organisations, February 2017 | 260 | 260 |
| 2017 | Roche | Rare Cancers Australia | Sponsorship of (and attendance at) CanForum 2017 event, August 2017 | 682 | 682 |
| 2017 | Roche | Rare Cancers Australia | Donation made on behalf of a speaker at a Roche meeting, February 2017 | 2000 | 2000 |
| 2017 | Roche | Rare Cancers Australia | Sponsorship of (and attendance at) Sick or Treat Ball fundraising event, October 2017 | 5000 | 5000 |
| 2017 | Roche | Rare Cancers Australia | Grant for various patient projects, including CanForum, for healthcare professionals and consumers (August 2017), a dinner for Members of | 50000 | 50000 |
| 2018 | Roche | Cystic Fibrosis Australia | In kind support for travel and accommodation to attend a political meeting program, Nov 2018 | 1807 | 1807 |
| 2018 | Roche | Cystic Fibrosis Australia | Sponsorship of stage two of development of a mobile app for people living with cystic fibrosis, designed to support and monitor day to day management of their CF | 15000 | 15000 |
| 2018 | Roche | Cystic Fibrosis Australia | Grant for a variety of patient advocacy initiatives, such as: a mentalhealth trial for patients, their families and support networks, research into the health outcomes for indigenous Australians with CF, research into CF siblings | 20000 | 20000 |
| 2018 | Roche | Haemophilia Foundation Australia | In kind support for travel to attend a political meeting program, Nov 2018 | 1264 | 1264 |
| 2018 | Roche | Haemophilia Foundation Australia | Grant for education for haemophilia physiotherapists. (Grant provided as per agreement in 2018; educational activity to take place in 2019) | 1500 | 1500 |
| 2018 | Roche | Haemophilia Foundation Australia | Donation in lieu of payment to patients for participating in communications activity | 2500 | 2500 |
| 2018 | Roche | Haemophilia Foundation Queensland (QLD) | Donation in lieu of payment to patient for participating in communications activity | 500 | 500 |
| 2018 | Roche | Kidney Health Australia | Grant for the Kidney Health Australia Caring for Australasians with Renal Impairment Guidelines (KHA-CARI) | 10000 | 10000 |
| 2018 | Roche | Leukaemia Foundation Of Australia | Donation in lieu of payment to patient for participating in communications activity | 500 | 500 |
| 2018 | Roche | Lymphoma Australia | Grant for establishment of a national lymphoma patient database | 15000 | 15000 |
| 2018 | Roche | Melanoma Patients Australia | Grant for updates to patient website and other patient resources | 15000 | 15000 |
| 2018 | Roche | MS Australia | Donation in recognition of participation in communications activity | 500 | 500 |
| 2018 | Roche | MS Society South Australia (SA) & Northern Territory (NT) | Grant for World MS Day Education Forum for patients, May 2018 | 1000 | 1000 |
| 2018 | Roche | Ovarian Cancer Australia | In kind support for travel and accommodation to attend a political meeting program, Nov 2018 | 1483 | 1483 |
| 2018 | Roche | Ovarian Cancer Australia | Grant for updates and improvements to patient website | 10000 | 10000 |
| 2018 | Roche | Rare Cancers Australia | Sponsorship and attendance of 10 people at fundraising ball, Oct 2018 | 5000 | 5000 |
| 2018 | Roche | Rare Cancers Australia | Grant for CanForum event for healthcare professionals and consumers (Sep 2018), and a series of three dinners for Members of Parliament (beginning Nov 2018 and continuing into 2019) | 35000 | 35000 |
| 2018 | Roche | Rare Cancers Australia | Grant for foundation activities of the National Oncology Alliance (NOA). The intention of NOA is to build a highly collaborative alliance that allows key stakeholders to speak on policy matters with a united voice | 40000 | 40000 |
| 2019 | Roche | Arthritis Foundation of Australia | In kind support of travel, accommodation and attendance at Canberra Health Summit, a meeting of patient advocacy groups facilitated by Roche. Jul 2019 | 626 | 626 |
| 2019 | Roche | Arthritis Foundation of Australia | Grant for development of Giant Cell Arteritis patient resources | 36500 | 36500 |
| 2019 | Roche | Australian Huntington's Disease Association New South Wales (NSW) | In kind support of travel, accommodation and attendance at Canberra Health Summit, a meeting of patient advocacy groups facilitated by Roche. Jul 2019 | 558 | 558 |
| 2019 | Roche | Bowel Cancer Australia | In kind support of travel, accommodation and attendance at Canberra Health Summit, a meeting of patient advocacy groups facilitated by Roche. Jul 2019 | 558 | 558 |
| 2019 | Roche | Braver Stronger Smarter | Donation in lieu of payment to a patient for participating in a communications activity | 500 | 500 |
| 2019 | Roche | Cancer Voices Australia | In kind support of travel, accommodation and attendance at Canberra Health Summit, a meeting of patient advocacy groups facilitated by Roche. Jul 2019 | 859 | 859 |
| 2019 | Roche | CanSpeak | In kind support of travel, accommodation and attendance at Canberra Health Summit, a meeting of patient advocacy groups facilitated by Roche. Jul 2019 | 589 | 589 |
| 2019 | Roche | Climate and Health Alliance | Donation in lieu of payment to a patient for participating in a communications activity | 500 | 500 |
| 2019 | Roche | Cystic Fibrosis Australia | In kind support of accommodation and registration for 2019 Post Budget Health Briefing in Canberra. Apr 2019 | 412 | 412 |
| 2019 | Roche | Cystic Fibrosis Australia | Donation in lieu of payment to a patient for participating in a communications activity | 500 | 500 |
| 2019 | Roche | Cystic Fibrosis Australia | In kind support of travel, accommodation and attendance at Canberra Health Summit, a meeting of patient advocacy groups facilitated by Roche. Jul 2019 | 839 | 839 |
| 2019 | Roche | Cystic Fibrosis Australia | In kind support of travel to attend steering committee meeting for Canberra Health Summit. Dec 2019 | 1124 | 1124 |
| 2019 | Roche | Cystic Fibrosis Australia | In kind support of 400 nebulisers, for distribution to patients | 20000 | 20000 |
| 2019 | Roche | Cystic Fibrosis Australia | Donation of corporate meeting space. June 2019 | Donation of corporate meeting space | 0 |
| 2019 | Roche | Dementia Australia | In kind support of travel, accommodation and attendance at Canberra Health Summit, a meeting of patient advocacy groups facilitated by Roche. Jul 2019 | 644 | 644 |
| 2019 | Roche | Diabetes Australia | In kind support of travel, accommodation and attendance at Canberra Health Summit, a meeting of patient advocacy groups facilitated by Roche. Jul 2019 | 801 | 801 |
| 2019 | Roche | Epilepsy Queensland (QLD) | Donation in lieu of payment to a patient for participating in a communications activity | 500 | 500 |
| 2019 | Roche | Haemophilia Foundation Australia | In kind support of registration for 2019 Post Budget Health Briefing in Canberra. Apr 2019 | 120 | 120 |
| 2019 | Roche | Haemophilia Foundation Australia | Donation in lieu of payment to a patient for participating in a communications activity | 500 | 500 |
| 2019 | Roche | Haemophilia Foundation Australia | In kind support of travel, accommodation and attendance at Canberra Health Summit, a meeting of patient advocacy groups facilitated by Roche. Jul 2019 | 2014 | 2014 |
| 2019 | Roche | Haemophilia Foundation Australia | Grant for patient advocacy activities | 35000 | 35000 |
| 2019 | Roche | Kidney Health Australia | In kind support of travel, accommodation and attendance at Canberra Health Summit, a meeting of patient advocacy groups facilitated by Roche. Jul 2019 | 708 | 708 |
| 2019 | Roche | Kidney Health Australia | Grant for the Kidney Health Australia Caring for Australasians with Renal Impairment Guidelines (KHA-CARI) | 10000 | 10000 |
| 2019 | Roche | Leukaemia Foundation Of Australia | In kind support of travel, accommodation and attendance at Canberra Health Summit, a meeting of patient advocacy groups facilitated by Roche. Jul 2019 | 239 | 239 |
| 2019 | Roche | Leukaemia Foundation Of Australia | Grant for implementation of new digital content management system | 20000 | 20000 |
| 2019 | Roche | Lymphoma Australia | In kind support of registration for 2019 Post Budget Health Briefing in Canberra. Apr 2019 | 120 | 120 |
| 2019 | Roche | Lymphoma Australia | Donation made in support of a patient fundraising campaign | 300 | 300 |
| 2019 | Roche | Lymphoma Australia | In kind support of travel, accommodation and attendance at Canberra Health Summit, a meeting of patient advocacy groups facilitated by Roche. Jul 2019 | 788 | 788 |
| 2019 | Roche | Lymphoma Australia | In kind support of travel, accommodation and ground transportation to attend steering committee meeting for Canberra Health Summit. Nov 2019 | 1506 | 1506 |
| 2019 | Roche | Lymphoma Australia | Grant for development of a patient driven database to better understand patient needs and priority areas | 20000 | 20000 |
| 2019 | Roche | Melanoma Patients Australia | In kind support of travel, accommodation and attendance at Canberra Health Summit, a meeting of patient advocacy groups facilitated by Roche. Jul 2019 | 865 | 865 |
| 2019 | Roche | MS Australia | Donation in lieu of payment to a patient for participating in a communications activity | 500 | 500 |
| 2019 | Roche | MS Australia | In kind support of travel, accommodation and registration for 2019 Post Budget Health Briefing in Canberra. Apr 2019 | 857 | 857 |
| 2019 | Roche | MS Australia | In kind support of travel, accommodation and attendance at Canberra Health Summit, a meeting of patient advocacy groups facilitated by Roche. Jul 2019 | 1052 | 1052 |
| 2019 | Roche | MS Australia | In kind support of travel to attend steering committee meeting for Canberra Health Summit. Dec 2019 | 1524 | 1524 |
| 2020 | Roche | Australian Crohn's and Colitis Association | Sponsorship of project to distribute toilet paper to people living with IBD | 15000 | 15000 |
| 2020 | Roche | Cerebral Palsy Alliance | Purchase of commercial services from mailhouse division (Jan and Mar 2020) | 8231 | 8231 |
| 2020 | Roche | Cystic Fibrosis Australia | Grant for research priority setting and research roadmap | 20000 | 20000 |
| 2020 | Roche | Cystic Fibrosis Australia | Grant for the establishment of the Australian Patients Advocacy Alliance (APAA) and related activities. The APAA will provide a coordinated and cohesive | 76430 | 76430 |
| 2020 | Roche | Haemophilia Foundation Australia | Grant for digital communication tools | 30000 | 30000 |
| 2020 | Roche | Huntington's New South Wales (NSW) & ACT (ACT) | Grant for national Huntington’s on-demand education program | 30000 | 30000 |
| 2020 | Roche | Huntington's Victoria (VIC) | In-kind (non-financial support) of production (by emotivate) of a video for the Huntingtons Victoria 'Public' Conference (non-financial donation) | In kind | 0 |
| 2020 | Roche | KARI Foundation | Donation of 41 children's bicycles | In kind | 0 |
| 2020 | Roche | Kidney Health Australia | Purchase of patient booklets | 2850 | 2850 |
| 2020 | Roche | Kidney Health Australia | Grant for materials for early detection campaign | 15000 | 15000 |
| 2020 | Roche | Leukaemia Foundation Of Australia | Grant for the consumer advocates support program | 25000 | 25000 |
| 2020 | Roche | Lymphoma Australia | Lymphoma Australia Blood Breakfast | 2000 | 2000 |
| 2020 | Roche | Lymphoma Australia | Lymphoma Care Nurse Orientation | 2000 | 2000 |
| 2020 | Roche | Lymphoma Australia | Grant for development of training modules for lymphoma nurses | 28500 | 28500 |
| 2020 | Roche | McGrath Foundation | Sponsorship of Metastatic Workshop | 1905 | 1905 |
| 2020 | Roche | Melanoma Patients Australia | Grant for the development and printing of patient resources | 15000 | 15000 |
| 2020 | Roche | Ovarian Cancer Australia | Grant for ovarian cancer support group | 7783 | 7783 |
| 2020 | Roche | Ovarian Cancer Australia | Grant for patient webinar | 12950 | 12950 |
| 2020 | Roche | Rare Cancers Australia | Grant for development of a patient engagement platform and support of National Oncology Alliance Genomic Testing Blueprint and foundation of a | 60000 | 60000 |
| 2020 | Roche | Rare Find Foundation | Grant for development of patient materials | 7500 | 7500 |
| 2020 | Roche | Rare Voices Australia | Sponsorship of parliamentary event. Feb 2020 | 8000 | 8000 |
| 2020 | Roche | Rare Voices Australia | Grant for mentorship and education program | 15000 | 15000 |
| 2020 | Roche | Rare Voices Australia | Sponsorship of Round Table of Companies program, 4 meetings per year | 15000 | 15000 |
| 2013 | Sanofi | Australian Pompe Association | Sponsorship of Australian Pompe Association Patient Meeting with International Speaker | 1135.00 including Audio Visual 50.00, Room Hire 172.00, Honorarium 835.00 | 1135 |
| 2013 | Sanofi | Australian Pompe Association | Sponsorship of Australian Pompe Association Patient Meeting with International Speaker | 1,435.00 including Audio Visual 150.00, Room Hire 450.00, Honorarium for International Speaker 835.00 | 1435 |
| 2013 | Sanofi | Australian Pompe Association | Sponsorship of Australian Pompe Association Patient Meeting with International Speaker | 1,539.55 including Room Hire 704.55, Honorarium for International Speaker 835.00 | 1539.55 |
| 2013 | Sanofi | Australian Pompe Association | Support provided to cover day to day running costs to enable the association to pursue its stated objectives | Grant 15333.00 | 15333 |
| 2013 | Sanofi | Australian Pompe Association | Third party support for public relations awareness activities | Grant 45036.00 | 45036 |
| 2013 | Sanofi | Australian Pompe Association | Third party support for public relations awareness activities | Grant 49888.00 | 49888 |
| 2013 | Sanofi | Australian Pompe Association | Third party support for public relations awareness activities | Grant 49940.00 | 49940 |
| 2013 | Sanofi | Australian Thyroid Foundation | Support provided to cover day to day running costs to enable the association to pursue its stated objectives | Grant 10,000.00 | 10000 |
| 2013 | Sanofi | Connery Communications | Support for the establishment of the Joyful Dysfunction website | Grant 5000.00 | 5000 |
| 2013 | Sanofi | Diabetes Australia | Support to enable the patient group to puruse its stated objectives - Diabetes Australia International Affairs Activity | Sponsorship 15600.00 | 15600 |
| 2013 | Sanofi | Diabetes Australia | Support to enable the patient group to pursue its stated objectives - Parliamentary Champions Diabetes Forum | Grant 30000.00 | 30000 |
| 2013 | Sanofi | Diabetes Western Australia (WA) | Support for Diabetes Education Forum for Healthcare Professionals | Sponsorship 200.00 | 200 |
| 2013 | Sanofi | Fabry Support Group Australia | Support provided to cover day to day running costs to enable the association to pursue its stated objectives | Grant 22275.00 | 22275 |
| 2013 | Sanofi | Lymphoma Australia | Support for National Patient/Carer Education materials allowing patients to access to the updated treatment information and development of future support structures for the lymphoma community | Sponsorship 30000.00 | 30000 |
| 2013 | Sanofi | Lysosomal Diseases New Zealand | Grant to Lysosomal Storage Diseases New Zealand | Grant 15000.00 | 15000 |
| 2013 | Sanofi | MPS Australia | Support provided to cover day to day running costs to enable the association to pursue its stated objectives | Grant 15000.00 | 15000 |
| 2013 | Sanofi | MPS Australia | Support towards the Patient Group's meeting(s)/seminar(s) - Family Conference | Sponsorship 20000.00 | 20000 |
| 2013 | Sanofi | MPS Australia | Third party support for publication of a mucopolysaccharide disease awareness story booklet for children | Grant 35000 | 35000 |
| 2013 | Sanofi | MS Australia | Support for Multiple Sclerosis Education Forum for Healthcare Professionals | 695.10 including Food and beverage 295.10, Honorarium for speaker 400.00 | 695.1 |
| 2013 | Sanofi | MS Australia | Support for Multiple Sclerosis Education Forum for Healthcare Professionals | Food & Beverage 814.00 | 814 |
| 2013 | Sanofi | MS Australia | Support to enable the patient group to pursue its stated objectives for MS patients | Sponsorship 120,000 | 120000 |
| 2013 | Sanofi | MSWA | Sponsorship of a Multiple Sclerosis Education Meeting for Healthcare Professionals | Food & Beverage 114.30 | 114.3 |
| 2013 | Sanofi | Osteoporosis Australia | We provided support towards the patient group's meeting(s)/seminar(s) - Seminar at Melbourne GPCE meeting | Sponsorship 2500.00 | 2500 |
| 2013 | Sanofi | Osteoporosis Australia | We provided support towards the patient group's meeting(s)/seminar(s) - Australia Parliamentary Breakfast and Burden of Disease Report launch | Sponsorship 7500.00 | 7500 |
| 2013 | Sanofi | Rare Voices Australia | Support to enable the patient group to pursue its stated objectives - Parliamentary Lunch to raise awareness of rare diseases in Australia and the need for a national rare disease plan. | Sponsorship 8000.00 | 8000 |
| 2013 | Sanofi | Rare Voices Australia | Support to educate and raise disease awareness as a national health priority and to advocate for the establishment of a national rare disease registry | Grant 35000.00 | 35000 |
| 2013 | Sanofi | Smile Foundation | Support for Rare Disease Day activities | Sponsorship 3000.00 | 3000 |
| 2013 | Sanofi | Smile Foundation | Support to enable the association to pursue its stated objectives by raising awareness and support for Rare Disease policy | Sponsorship 25,000 | 25000 |
| 2014 | Sanofi | Australian Pompe Association | Support towards the patient group's meeting(s)/seminar(s) | Grant 35000 | 35000 |
| 2014 | Sanofi | Australian Pompe Association | Third party support for public relations awareness activities | Grant 46300 | 46300 |
| 2014 | Sanofi | Australian Pompe Association | Third party support for public relations awareness activities | Grant 48736 | 48736 |
| 2014 | Sanofi | Australian Pompe Association | Third party support for public relations awareness activities | Grant 49960 | 49960 |
| 2014 | Sanofi | Australian Thyroid Foundation | Support towards the patient group's meeting(s)/seminar(s) | Grant 10419 | 10419 |
| 2014 | Sanofi | Diabetes Australia | Support to enable the patient group to pursue its stated objectives | Sponsorship 5580 | 5580 |
| 2014 | Sanofi | Diabetes Australia | Support for patient-care related projects | Sponsorship 112500 | 112500 |
| 2014 | Sanofi | Fabry Support Group Australia | Support for a patient-care related project - Disease Awareness Events for Patients | Sponsorship 10000 | 10000 |
| 2014 | Sanofi | Fabry Support Group Australia | Support for a patient-care related project and disease awareness activities | Grant 20000 | 20000 |
| 2014 | Sanofi | Lymphoma Australia | Support for a patient-care related project | Grant 20000 | 20000 |
| 2014 | Sanofi | MPS Australia | Third party support towards the patient group's meeting(s)/seminar(s) - MPS Patient Conference | Sponsorship 7500 | 7500 |
| 2014 | Sanofi | MPS Australia | Indirect support for a patient-care related project - Katie the Courageous Storybook for Children | Grant 15000 | 15000 |
| 2014 | Sanofi | MS Australia | Contracted Services/ Fees for Service | Fees for Service 1100 | 1100 |
| 2014 | Sanofi | MS Australia | Support towards the patient group's meeting(s)/seminar(s) | Sponsorship 5000 | 5000 |
| 2014 | Sanofi | MS Australia | Indirect support towards the patient group's meeting(s)/seminar(s) | Sponsorship 5756 | 5756 |
| 2014 | Sanofi | MS Australia | Support to enable the patient group to pursue its stated objectives | Donation 10000 | 10000 |
| 2014 | Sanofi | MS Australia | Support for patient-care related projects | Grant 60000 | 60000 |
| 2014 | Sanofi | MS Research Australia | Support towards the patient group's meeting(s)/seminar(s) | Sponsorship 1500 | 1500 |
| 2014 | Sanofi | MS Research Australia | Support for patient-care related projects | Grant 65500 | 65500 |
| 2014 | Sanofi | Osteoarthritis Australia | Support towards the patient group's meeting(s)/seminar(s) - GP Education | Sponsorship 2500 | 2500 |
| 2014 | Sanofi | Osteoarthritis Australia | Support towards the patient group's meeting(s)/seminar(s) - Australian Parliamentary Breakfast | Sponsorship 7500 | 7500 |
| 2014 | Sanofi | Rare Voices Australia | Travel support towards the patient group's meeting(s)/seminar(s) | Grant 1400 | 1400 |
| 2014 | Sanofi | Rare Voices Australia | Support to enable the patient group to pursue its stated objectives - National Rare Diseases Plan | Grant 35000 | 35000 |
| 2015 | Sanofi | Australian Atherosclerosis Society | Funding to engage a PR company to drive awareness of the need to screen and treat familial hypercholesterolaemia in the community. | Grant 8800 | 8800 |
| 2015 | Sanofi | Australian Pompe Association | We provided support towards the patient group's meeting(s)/seminar(s) - APA Family and Member Conference | Grant 15000 | 15000 |
| 2015 | Sanofi | Australian Pompe Association | We provided support for a project (International Pompe Day and running costs of organisation) | Grant 19900 | 19900 |
| 2015 | Sanofi | Australian Pompe Association | Third - party support provided by Ogilvy PR Health to assist Australian Pompe Association PR activities from January - April 2015 (Q1) | Grant 50000 | 50000 |
| 2015 | Sanofi | Australian Pompe Association | Third - party support provided by Ogilvy PR Health to assist Australian Pompe Association PR activities from April - June 2015 (Q2) | Grant 52223 | 52223 |
| 2015 | Sanofi | Diabetes New South Wales (NSW) | We provided support to establish and deploy a patient-care self management program for the Western Sydney Diabetes Initiative over a 2 year period period. | 100000 | 100000 |
| 2015 | Sanofi | Diabetes Victoria (VIC) | We provided support towards attendance at patient group's meeting(s)/seminar(s) by Nurses from Cairns Diabetes Services | Grant 1000 | 1000 |
| 2015 | Sanofi | Diabetes Victoria (VIC) | We provided support towards the patient group's Diabetes Australia Consumer Expo | Grant 5000 | 5000 |
| 2015 | Sanofi | Fabry Australia | We provided support for a project (Communication with families information pack) | Grant 10000 | 10000 |
| 2015 | Sanofi | Fabry Australia | We provided support towards the patient group's meeting(s)/seminar(s) | Grant 20000 | 20000 |
| 2015 | Sanofi | Genetic Alliance Australia | We provided support for a project (Sponsorship of Dinner Event for Genetic Disorders Awareness Week) | Grant 3500 | 3500 |
| 2015 | Sanofi | Genetic Support Network Victoria (GSNV) | We provided support for a publication of Rare Diseases Day Activities | Grant 2000 | 2000 |
| 2015 | Sanofi | Lymphoma Australia | We provided support towards the patient group's meeting(s)/seminar(s) - Hospital Education Days for patients, carers and healthcare professionals | Grant 20000 | 20000 |
| 2015 | Sanofi | MPS Australia | We provided support for a project (David Moran Book on living with MPS) | Grant 16000 | 16000 |
| 2015 | Sanofi | MPS Australia | Support of the MPS Society Australia National Patient Conference | Grant 30000 | 30000 |
| 2015 | Sanofi | MS Australia | We provided support for a project (National Advocacy Programme) | Grant 5000 | 5000 |
| 2015 | Sanofi | MS Australia | We provided support for the MS Awareness Campaign Video | Grant 14500 | 14500 |
| 2015 | Sanofi | MS Australia | We provided support for a patient-care related project called MS Australia Digital Wellness Hub | Grant 65000 | 65000 |
| 2015 | Sanofi | MS Australia | We provided support for a patient-care related project called MS Australia Digital Wellness Hub | Grant 68000 | 68000 |
| 2015 | Sanofi | MS Research Australia | We provided support for a project Kiss MS Goodbye initiative | Grant 60000 | 60000 |
| 2015 | Sanofi | MS Society South Australia (SA) & Northern Territory (NT) | We provided support for the Good Start Project for Multiple Sclerosis | Grant 25000 | 25000 |
| 2015 | Sanofi | MSWA | We provided support for the Good Start Project for Multiple Sclerosis | Grant 25000 | 25000 |
| 2015 | Sanofi | Rare Voices Australia | Support of the Rare Voices Australia Rare Disease Summit. The summit aimed at exploring and improving rare disease management as a comprehensive approach in line with recommendations for a National strategy. | Grant 15000 | 15000 |
| 2015 | Sanofi | Rare Voices Australia | We provided support for a project - Rare Voices The Forgotten Ones Exhibition | Grant 15000 | 15000 |
| 2015 | Sanofi | Rare Voices Australia | Membership fee to Rare Voices Australia and Pharmaceutical Industry Round Table meetings. Membership allowed two representatives from Sanofi to attend 4 quarterly Rare Voice Australia and Pharmaceutical Industry Routable Table Meetings per year. | Grant 15000 | 15000 |
| 2016 | Sanofi | Arthritis Foundation of Australia | Sanofi provided funding for Arthritis Australia to conduct research into the scope, activities and value of rheumatology nurses in Australia | 20000 | 20000 |
| 2016 | Sanofi | Asthma Australia | Sanofi provided funding for the development of a Fact Card for patients and pharmacists to inform patients living with asthma or at risk of asthma about the risk of influenza. Sanofi was not involved with the content development. | 17000 | 17000 |
| 2016 | Sanofi | Australian Pompe Association | Sanofi provided sponsorship to support the Australian Pompe's Association Patient and Family conference in Sydney. | 30000 | 30000 |
| 2016 | Sanofi | Australian Pompe Association | Sanofi provided funding support for the Australian Pompe Association to revamp its website in order to provide more relevant and updated information for patients with Pompe's disease. | 30000 | 30000 |
| 2016 | Sanofi | Diabetes Australia | Sanofi Pasteur provided funding to support an influenza awareness project for diabetes patients. | 17300 | 17300 |
| 2016 | Sanofi | Diabetes Australia | Platinum partnership with Diabetes Australia . Within the partnership, Sanofi supports Diabetes Australia's activities across education, increased awareness and better patient support. | 150000 | 150000 |
| 2016 | Sanofi | Fabry Australia | Sanofi provided sponsorship to support the Fabry Australia Patient Conference in Melbourne and educational interstate meetings | 20000 | 20000 |
| 2016 | Sanofi | Genetic Alliance Australia | Sanofi provided sponsorship to support the launch event for Genetic Disorder Awareness week at Parliament House NSW. | 10000 | 10000 |
| 2016 | Sanofi | Lung Foundation Australia | Sanofi provided sponsorship to support the Lung Foundation's Just One Breath Gala Dinner | 9000 | 9000 |
| 2016 | Sanofi | MPS Australia | Sanofi provided travel support (flights and accommodation) for two MPS Society members to attend the International MPS and Related Disease Network conference in Bonn, Germany. The conference aimed to educate attendees about the latest developments in rese | 10000 | 10000 |
| 2016 | Sanofi | MS Australia | Support of MS Australia's Health and Wellness Hub initiative to provide MS patients with advice on how to optimise their health and wellbeing. Sanofi was not involved with the content development. | 50230 | 50230 |
| 2016 | Sanofi | MS Society South Australia (SA) & Northern Territory (NT) | Funding for the MS Society Goodstart Programme which aims to provide nurse support to multiple sclerosis patients receiving infusion | 20000 | 20000 |
| 2016 | Sanofi | MS Society South Australia (SA) & Northern Territory (NT) | Sanofi provided continued funding for the MS Society Goodstart Programme which aims to provide nurse support to multiple sclerosis patients receiving infusion | 20000 | 20000 |
| 2016 | Sanofi | Multiple Sclerosis | Sanofi made a donation to support the annual MS Sydney to the Gong community bike ride fundraiser. | 30000 | 30000 |
| 2016 | Sanofi | Rare Cancers Australia | Sanofi provided sponsorship to support the Rare Cancers conference in Canberra at Old Parliament House | 4000 | 4000 |
| 2016 | Sanofi | Rare Voices Australia | Sanofi provided funding assistance for Rare Voices Australia to establish a National Rare Disease Plan working group and map out the implementation strategy to adopt a National Rare Disease Plan. | 15000 | 15000 |
| 2016 | Sanofi | Rare Voices Australia | Membership fee to Rare Voices Australia and Pharmaceutical Industry Round Table meetings. Membership allowed two representatives from Sanofi to attend 4 quarterly Rare Voice Australia and Pharmaceutical Industry Roundtable Table Meetings per year. | 15000 | 15000 |
| 2017 | Sanofi | Arthritis Foundation of Western Australia (WA) | Independent support of Arthritis WA's patient educational seminar entitled "Osteoarthritis of the Knee". | 2000 | 2000 |
| 2017 | Sanofi | Australian Pompe Association | Sanofi provided financial support for the organisation to create disease awareness videos with patients and their carers. Sanofi was not involved with the content development. | 39490 | 39490 |
| 2017 | Sanofi | Diabetes Australia | National partnership with Diabetes Australia. Through the partnership, Sanofi supports Diabetes Australia's activities across education, increased awareness and better patient support. | 140000 | 140000 |
| 2017 | Sanofi | Fabry Australia | Sanofi provided financial assistance for a member of the organisation to attend the 2017 World Orphan Drug Conference. | 2000 | 2000 |
| 2017 | Sanofi | Fabry Australia | Contribution towards the cost of Fabry Australia running a patient retreat weekend in Victoria for Fabry sufferers and their care/support people. Sanofi was not involved with the event organising. | 10000 | 10000 |
| 2017 | Sanofi | Genetic Alliance Australia | Sanofi provided sponsorship to support the launch event for Genetic Disorder Awareness week at Parliament House NSW. | 25000 | 25000 |
| 2017 | Sanofi | MPS Australia | Sanofi provided independent financial sponsorship to support the MPS Bi-annual Patient and Carer Conference. The objective of the event is to provide the patient and carer community with information to support their disease management. | 30000 | 30000 |
| 2017 | Sanofi | MS Australia | Support of MS Australia's Health and Wellness Hub initiative to provide MS patients with advice on how to optimise their health and wellbeing. Sanofi was not involved with the content development. | 20000 | 20000 |
| 2017 | Sanofi | MS Australia | Sanofi provided independent financial assistance for a research project on the current status of MS specialist nursing in Australia and identify the optimal model of MS nursing support for patients. | 20000 | 20000 |
| 2017 | Sanofi | MS Australia | Sanofi provided independent funding to support an innovative digital educational campaign aimed at providing assistance and guidance to young Australians living with MS. Sanofi was not involved with the content development. | 30000 | 30000 |
| 2017 | Sanofi | Rare Voices Australia | Sanofi provided support for the "Building Capacity of the Gaucher Community" project. This support enabled Rare Voices Australia to mentor and support Gaucher Association of Australia (GAA) to achieve its goals and objectives. | 10000 | 10000 |
| 2017 | Sanofi | Rare Voices Australia | Sanofi provided support towards Rare Voices' Mentorship and Education Program. This program is designed to help assist and upskill small and young rare disease patient groups. | 15000 | 15000 |
| 2017 | Sanofi | Steve Waugh Foundation | Sanofi provided a donation to help raise funds for the Foundation's 'Captain's Ride' fundraiser aimed at supporting children living with rare diseases. | 2500 | 2500 |
| 2018 | Sanofi | Allergy & Anaphylaxis Australia | Supported patient organisation who aims to improve the quality of life of those living with allergic disease including atopic dermatitis and asthma. | 30000 | 30000 |
| 2018 | Sanofi | Australian Pompe Association | Sponsorship support for a patient round table discussion forum with an overseas key opinion leader on Pompe Disease. | 2000 | 2000 |
| 2018 | Sanofi | Australian Pompe Association | Support to develop materials to raise awareness of the need for Newborn Screening for Infantile Pompe Disease | 15557.25 | 15557.25 |
| 2018 | Sanofi | Australian Pompe Association | Sponsorship support for the APA Family Conference takes place every 2nd year and brings together patients and their families from across Australia | 30000 | 30000 |
| 2018 | Sanofi | Diabetes Australia | National strategic partnership with Diabetes Australia. Diabetes Australia and Sanofi partner to deliver more powerful diabetes advocacy, and education programs for people living with diabetes, healthcare professionals and the wider community. | 125000 | 125000 |
| 2018 | Sanofi | Eczema Association Of Australasia | Corporate Membership of Eczema Association of Australasia for 2018/19 | 15000 | 15000 |
| 2018 | Sanofi | Fabry Australia | Support for Fabry Australia to develop a series of patient educational videos on Fabry Disease | 15000 | 15000 |
| 2018 | Sanofi | Fabry Australia | Financial sponsorship for the group to run several patient educational events. | 30000 | 30000 |
| 2018 | Sanofi | Gaucher Association of Australia & New Zealand | Sponsorship for a member of the organisation to attend the WORLD Conference in 2019 in Orlando and provide several presentations on Gaucher Disease. | 18393.54 | 18393.54 |
| 2018 | Sanofi | Gaucher Association of Australia & New Zealand | Seed funding support for GAANZ in its mission to advocate for people with Gaucher disease and provide community support. | 40000 | 40000 |
| 2018 | Sanofi | Genetic Alliance Australia | Sponsorship funding for the Genetic Alliance Annual Awareness Event | 13000 | 13000 |
| 2018 | Sanofi | MPS Australia | Sponsorship for activities related to disease awareness for World MPS Day and Rare Disease Day | 44000 | 44000 |
| 2018 | Sanofi | Patient Voice Initiative | Sponsorship of organisation comprised of industry, academia and patient advocacy groups who work amplify the patient voice in and through the HTA system and advocate on the value of medicines. | 12000 | 12000 |
| 2018 | Sanofi | Rare Voices Australia | Sponsorship funding to Rare Voices Australia to run a series of RVA Round table meetings | 15000 | 15000 |
| 2018 | Sanofi | Rare Voices Australia | Sponsorship support for the group's bi-annual conference targeted at Rare Disease patient groups and their supporters. | 20000 | 20000 |
| 2018 | Sanofi | Rare Voices Australia | Financial support for the development of a series of educational patient videos. | 67837 | 67837 |
| 2018 | Sanofi | Rare Voices Australia | Sanofi provided independent financial support for Rare Voices' Fair for Rare campaign. | 85000 | 85000 |
| 2018 | Sanofi | Steve Waugh Foundation | Donation to support the Steve Waugh Foundation's major fundraiser - The Captain's Ride | 20000 | 20000 |
| 2019 | Sanofi | Allergy & Anaphylaxis Australia | Sanofi provided funding to support Allergy and Anaphylaxis Australia (AA&A)'s attendance and participation at ACD and Allergy Show and included creation of associated disease awareness educational materials. | 22820 | 22820 |
| 2019 | Sanofi | Allergy & Anaphylaxis Australia | Funding to support upgrades and development of website, maintenance of National Support Hotline and implementation of and training on patient support database and data management system. Sanofi's support allowed patients and carers to improved and timely access to quality patient support advice and disease information. | 46700 | 46700 |
| 2019 | Sanofi | Australian Pompe Association | Sanofi provided in-kind support for the APA to run a patient meeting with an overseas key opinion leader. Sanofi provided venue, onsite AV support and modest hospitality from an prior Sanofi-organised meeting as part of this support. | Venue, AV support and hospitality. | 0 |
| 2019 | Sanofi | Australian Pompe Association | Support for Disease Awareness activities for Pompe Disease including the creation of an animation to be used at conferences, on website and in social media to highlight in laymans terms the symptoms and impact of Pompe disease | 22874.5 | 22874.5 |
| 2019 | Sanofi | Australian Pompe Association | Funding package for the Australian Pompe Association (APA) for patient support activities throughout the year. This included the purchase of Zoom licences to conduct board meetings, upgrade of IT systems to support. The grant also included support of activities to raise awareness on the need for better access to diagnosis. Genetic testing and newborn screening programs are critical to the effective management of infantile onset Pompe - further awareness and call for action activities via 3rd party were funded as part of the grant. | 23028 | 23028 |
| 2019 | Sanofi | Diabetes Australia | Diabetes Australia and Sanofi National Partnership 2019-2020. This funding went towards supporting several of Diabetes Australia's programs and projects including: Raising diasese awareness and awareness of patient needs, enhancing healthcare professional education, addressing Type 2 Diabetes-related stigma, educating patinets on how to prevent long term complications, research into current health trends with diabetes | 140000 | 140000 |
| 2019 | Sanofi | Diabetes New South Wales (NSW) | Funding for Diabetes NSW/ACT's Living with Insulin online program. The program enabled patients to be confidnt in overcoming bariers to an insulin regimen including how to avoid hyperglycaemia and how to be able to safely administer insulin safely. | 86490 | 86490 |
| 2019 | Sanofi | Diabetes Victoria (VIC) | Funding support for the Diabetes Training Programme for Disability and Aged Care Workers. This is a pilot project that aims to provide practical education for disability and aged care workers to better support clients living with diabetes. | 30000 | 30000 |
| 2019 | Sanofi | Eczema Association Of Australasia | Corporate Membership of Eczema Association of Australasia for 2019/2020 with support going towards projects carried out by EAA for 2019. | 15000 | 15000 |
| 2019 | Sanofi | Eczema Support Australia | Support for an awareness video series to promote "Connection, Understanding, Support" for the eczema and allergy community in Australia. Part of the video series is used to induct psychologists, teachers and other professionals on working with patients with eczema and allergies. Support is also given towards facilitator development to assist with their goal of support patients and carers through local support meetings and contacts. | 18650 | 18650 |
| 2019 | Sanofi | Eczema Support Australia | Support to Eczema Support Australia in their development, launch and delivery of a disease awareness and patient engagement campaig on severe eczema/atopic dermatitis, which aimed to highlight the disease burden on patients and their carers, and share stories from the patient community. | 154000 | 154000 |
| 2019 | Sanofi | Gaucher Association of Australia & New Zealand | Support to Gaucher Association of ANZ (GAANZ) to support their educational and advocacy programs. The support included: continued maintenance and updating of the GAANZ website, continued representation of patients with Gaucher disease at key Rare Disease community events, disease awareness activities surrounding Gaucher Awareness Day | 13000 | 13000 |
| 2019 | Sanofi | Gaucher Association of Australia & New Zealand | Support for Gaucher Association of ANZ to carry out several disease awareness activities in partnership with the Genetic Alliance Australia with Rare Disease Day. Activities undertaken includes a series of patient video stories and digital messages that support the theme "Bridging Social Care and Rare Diseases" | 31320 | 31320 |
| 2019 | Sanofi | Genetic Alliance Australia | Support for the Genetic Alliance Australia's Genetic Disorder Awareness Week 2019 themed 'Genetics and Changing Dynamics'. The funding went towards an event at Parliament House which aimed to highlight to policy makrs the increased need for genetic services and the services needed. | 12000 | 12000 |
| 2019 | Sanofi | Genetic Alliance Australia | Support for Genetic Alliance Australia to carry out several disease awareness activities in partnership with the Gaucher Association of ANZ with Rare Disease Day. Activities undertaken includes a series of patient video stories and digital messages that support the theme "Bridging Social Care and Rare Diseases" | 31320 | 31320 |
| 2019 | Sanofi | Haemophilia Foundation Australia | Sanofi provided the Haemophilia Foundation Australia (HFA) with financial funding to assist HFA develop their digital communication strategy as well as support for HFA to further develop their youth website. | 60000 | 60000 |
| 2019 | Sanofi | JDRF Australia | Funding for the JDRF educational and inspirational 4-part podcast series aimed at juvenile patients with type 1 diabetes. The funding wen towards covering studio cost, presenter honoraria and promotional costs. The podcast aims to showcase the extraordinary feats that people with Type 1 Diabetes are able to acheive as well as highlight developments in research. | 50000 | 50000 |
| 2019 | Sanofi | Lung Foundation Australia | Sanofi sponsored the Lung Foundation annual 'Hope in Every Breath' 2019 Gala Fundraising Dinner which aimed to raise money for research towards Lung Disease. | 3000 | 3000 |
| 2019 | Sanofi | MPS Australia | Sponsorship funding of the 16th Australian MPS and Related Disease Family Conference for patients affected by MPS and their carers. The 2-day conference aimed to deliver patient education as well as allow patients to share their experiences with their community. Sanofi sponsorship contributed towards venue hire, accommodation, event management, speaker costs, AV costs and catering over 2 days. | 40000 | 40000 |
| 2019 | Sanofi | Myeloma Australia | Sponsorship funding of one-day educational event program for patients affected by multiple myeloma and their carers. Sanofi's sponsorship contributed towards venue hire, AV costs and hospitality. | 10000 | 10000 |
| 2019 | Sanofi | Patient Voice Initiative | Sanofi provided funding for the Patient Voice Initiative which aimed to deliver a forum for collaboration and dialogue between patient advocacy groups, not-for-profits, pharmaceutical, HCPs, academia and government. | 12000 | 12000 |
| 2019 | Sanofi | Rare Cancers Australia | Sanofi provided sponsorship funding for Rare Cancers' Halloween Ball which aimed to raise money towards patient support and treatment. Sponsorship included logo recognition and a table for 10 Sanofi employee. | 5000 | 5000 |
| 2019 | Sanofi | Rare Voices Australia | Sanofi provided support to Rare Voices Australia to help enable their 2019 activities and projects including: Parliamentary disease awareness events, Mentorship and Educational Programs, webinar educational events for rare disease leaders and advocates, round table industry forums events with other pharmaceutical and biotechnology companies conducted quarterly | 45000 | 45000 |
| 2019 | Sanofi | Rare Voices Australia | Support for Rare Voices Australia (RVA) to commission and assist the McKell Institute to develop a White Paper on Access to Services to all Australians: a review of services available to people living with rare disease as informed by their research activities. | 90000 | 90000 |
| 2020 | Sanofi | Allergy & Anaphylaxis Australia | Funding support for Allergy & Anaphylaxis Australia to continue to increase their capacity to educate, train and support both patients and the broader allergy community including support of the National Allergy Support Hotline, Food Allergy Week campaign and improved social media capacity. | 50000 | 50000 |
| 2020 | Sanofi | Asthma Australia | Sanofi provided support for Asthma Australia's Regional and Rural Campaign for 1800 Asthma Helpline and Asthma Australia's awareness campaign for National Asthma Week in September 2020. | 40000 | 40000 |
| 2020 | Sanofi | Centre for Community - Driven Research | Sponsorship of the Australian Patient Organisation Network (APON) annual conference which is a meeting of PAGs and other interest groups, meeting with government, policy makers and stakeholders from across the health and HTA systems, building the capacity, knowledge and influence of PAGs. | 10000 | 10000 |
| 2020 | Sanofi | Diabetes Western Australia (WA) | Funding support for Aboriginal community diabetes support and education about Type 2 Diabetes. | 31888 | 31888 |
| 2020 | Sanofi | Eczema Association Of Australasia | Annual funding to Eczema Association to renew Gold Corporate Membership. The funding contributes to EAA's support for patients and members, as well as contribute to ongoing eczema disease awareness campaigns. | 15000 | 15000 |
| 2020 | Sanofi | Eczema Support Australia | Support to enable Eczema Support Australia to be a peak patient organisation representing Australians living with eczema and provide ongoing, practical support to their patient members. | 96850 | 96850 |
| 2020 | Sanofi | Fabry Australia | Funding for a medical writer to support production of a medical report on the key findings from the 2020 Patient Survey. Sanofi was not involved in the development or review of the report. | 11000 | 11000 |
| 2020 | Sanofi | Fabry Australia | Sanofi provided funding for programs to support the education and advocacy efforts of Fabry Australia for the calendar year of 2020 | 30000 | 30000 |
| 2020 | Sanofi | Gaucher Association of Australia & New Zealand | Funding to provide ongoing support for advocacy and eductional programs to support patients with Gaucher Disease | 13000 | 13000 |
| 2020 | Sanofi | Genetic Alliance Australia | Sanofi support their annual campaign raise awareness for global Rare Disease Day 2020 amongst Australians. | 78962.73 | 78962.73 |
| 2020 | Sanofi | Haemophilia Foundation Australia | Sanofi provided funding to support new and innovative digital tools and activities to educate and improve the communication channels for Haemophilia patients across Australia. | 62000 | 62000 |
| 2020 | Sanofi | Her Heart | Funding to support reasearch and publication reports from the Her Heart Foundation. Sanofi was not involved in the development or review of the report. | 39950 | 39950 |
| 2020 | Sanofi | Leukaemia Foundation Of Australia | Support for COVID emergency funding for online patient support for blood cancer community which was traditionally done face-to-face pre-Covid | 5000 | 5000 |
| 2020 | Sanofi | Melanoma & Skin Cancer Advocacy Network | Sanofi provided funding to support the production of a series of podcasts on skin cancer including raising awareness on non-melanona skin cancers. | 20000 | 20000 |
| 2020 | Sanofi | Myeloma Australia | Funding to support flagship publication MyeNews, which provides support, information and disease education to patients, carers and the myeloma community. | 5000 | 5000 |
| 2020 | Sanofi | National Heart Foundation Of Australia | Support Heart Foundation's objective to inform and educate Australians, particularly those living with existing heart conditions, on the need to have their flu vaccination this year. | 20000 | 20000 |
| 2020 | Sanofi | National Heart Foundation Of Australia | CVD + COVID Strategic Research Grant - The purpose of this grant is to improve knowledge and/or treatment of the complications or impact of COVID-19 for people with existing cardiovascular disease | 50000 | 50000 |
| 2020 | Sanofi | Patient Voice Initiative | Sanofi provided funding to support a patient advocacy network to foster collaboration and education with patient advocacy groups across Australia, and other stakeholders including Government, Health Departments and healthcare professionals to raise the voice of patients and their needs. | 12000 | 12000 |
| 2020 | Sanofi | Rare Cancers Australia | Sanofi participated in the 2020 Kosi Challenge fundraiser organised by Rare Cancers to raise funds and awareness for people diagnosed with rare and less common cancers in Australia. | 8817 | 8817 |
| 2020 | Sanofi | Rare Cancers Australia | Funding to support Rare Cancers Australia in development of a report investigating the Societal Impact of Cancer. Sanofi was not involved in the development or review of the report. | 15000 | 15000 |
| 2020 | Sanofi | Rare Voices Australia | Sponsorship of the Rare Voices Australia (RVA)'s Roundtable of Companies - which is open to all biotech and biopharmaceutical companies with an interest in Rare Diseases and medicine policy | 15000 | 15000 |
| 2020 | Sanofi | Syndromes Without A Name (S.W.A.N.) Australia | Sanofi support their annual campaign raise awareness for global Rare Disease Day 2020 amongst Australians. | 78962.73 | 78962.73 |
| 2015 | Seqirus | Australian Pain Society | Support of the Australian Pain society to achieve their national health care practitioner and patient support initiatives. | 10000 | 10000 |
| 2015 | Seqirus | Australian Pain Society | Support of the Australian Pain society to achieve their national health care practitioner and patient support initiatives. | 43636 | 43636 |
| 2015 | Seqirus | Chronic Pain Association of Australia | Sponsorship of National Pain week in July 2015 to support pain education and awareness activities. | 13636 | 13636 |
| 2015 | Seqirus | MS Queensland (QLD) | Support for travel costs associated with patient education. | 438 | 438 |
| 2015 | Seqirus | MS Research Australia | Contribution to cover a year's registration to join the Karma Currency/Good Company giving website. | 300 | 300 |
| 2016 | Seqirus | Australian Pain Relief Association | Three year independent educational research grant for pain research in Australia | 105000 | 105000 |
| 2016 | Seqirus | Painaustralia | Support of the Australian Pain Society to achieve their national health care practitioner and patient support initiatives. | 124000 | 124000 |
| 2017 | Seqirus | Chronic Pain Association of Australia | To support National Pain week and associated activities in order to raise awareness of the debilitating impact of chronic pain on patients lives | 10000 | 10000 |
| 2018 | Seqirus | Painaustralia | Unrestricted grant for the Australian Pain Society supporting a National Pain Strategy round table meeting to be able to develop the National Action Plan for Chronic Pain Management | 47000 | 47000 |
| 2018 | Seqirus | Painaustralia | Unrestricted grant in support of the Australian Pain Society for 2 years to achieve their national health care practitioner and patient support initiatives May-2018 to May-2020 | 120000 | 120000 |
| 2018 | Seqirus | Painaustralia | Unrestricted grant to perform an in depth analysis of the economic burden of pain in Australia | 180000 | 180000 |
| 2013 | Servier Laboratories | Kidney Health Australia | Servier provided an educational grant to support awareness raising of kidney health issues in Australia. This included supporting the costs of a Third Party Digital Consultancy to develop and conduct two webinar programs as well as develop an e- newslette | 25000 | 25000 |
| 2013 | Servier Laboratories | National Heart Foundation Of Australia | Servier is a member of the Heart Foundation Pharmaceutical Roundtable. The Roundtable brings together the Heart Foundation and members of leading pharmaceutical companies with the aim of improving the cardiovascular health of all Australians. In 2013 Serv | 20000 | 20000 |
| 2013 | Shire | Australasian Patient Organisation for Hereditary Angioedema | To support National educational meeting focusing on Hereditary Angioedema Management for HAE Patients and their families/carers. | 11000 | 11000 |
| 2013 | Shire | Australasian Society of Inborn Errors of Metabolism | To support members attendance to the Annual Australasian Society of Inborn Errors of Metabolism's Annual Conference. | 1000 | 1000 |
| 2013 | Shire | Australian Crohn's and Colitis Association | To support development of Health Membership Program to provide Patient support and services available to them. | $20000.00 Volunteering of staff time | 20000 |
| 2013 | Shire | Australian Crohn's and Colitis Association | To support 4 quarterly Crohn's and Colitis Australia "Inside Insights" educational magazine for patients with Inflammatory Bowel Disease. | 44000 | 44000 |
| 2013 | Shire | Fabry Australia | To support educational initiatives throughout Australia including Administrative Support, Strategic Planning Day and Awareness Month for 2013 | 15000 | 15000 |
| 2013 | Shire | Fabry Australia | To support educational initiatives throughout Australia including Administrative Support, Strategic Planning Day and Awareness Month for 2014 | 20000 | 20000 |
| 2013 | Shire | Fabry Australia | To support educational initiatives throughout Australia including Administrative Support, Strategic Planning Day and Awareness Month | 20000 | 20000 |
| 2013 | Shire | HAE Australasia | To support educational round table meeting costs associated with venue hire and hospitality. | 500 | 500 |
| 2013 | Shire | HAE Australasia | To support state/ regional educational meetings focusing on Hereditary Angioedema Management for HAE patients , and their families/carers | 10000 | 10000 |
| 2013 | Shire | Kidney Health Australia | To support the development of Caring for Australasian with Renal Impairment Guidelines. | 20000 | 20000 |
| 2013 | Shire | Lysosomal Diseases New Zealand | To support activities that include Clinical Care and Therapies and ensure all LSD families have the opportunity to up to date information. | 13143 | 13143 |
| 2013 | Shire | Rare Voices Australia | To support educational activities for Parliamentary Day Event. | 8000 | 8000 |
| 2013 | Shire | Rare Voices Australia | To support Rare Voices Australia 2014 activities. Initiatives of RVA to include RVA International Rare Disease Day including Websites, printed Materials and Social Media. | 25000 | 25000 |
| 2013 | Shire | Smile Foundation | To support educational activities for Rare Diseases Day 2013. | 1000 | 1000 |
| 2013 | Shire | Smile Foundation | To support objectives to enhance the quality of Life of Children with Rare Diseases in Family Relief, Case Management Service, Research and Advocacy and Awareness. | 10000 | 10000 |
| 2014 | Shire | ADDults with ADHD | To support the Annual 2014 Patient Conference . The conference provides relevant, up to date and evidence based information for people with Attention Deficit Hyperactivity Disorder. | 5000 | 5000 |
| 2014 | Shire | Australian Crohn's and Colitis Association | Payment for presentation to Shire employees on the Effects of living with Ulcertic Colitis | 500 | 500 |
| 2014 | Shire | Australian Crohn's and Colitis Association | To support a Inflammatory Bowel Disease Awareness Campaign by Crohns and Colitis Australia. | 22727.27 | 22727.27 |
| 2014 | Shire | Australian Crohn's and Colitis Association | To support the 4 quarterly Crohn's and Colitis Australia "Inside Insights" educational magazine for patients with Inflammatory Bowel Disease | 44000 | 44000 |
| 2014 | Shire | HAE Australasia | To support round-table on the Importance of Data Collection in the Identification and Management of Hereditary Angioedema | 454.55 | 454.55 |
| 2014 | Shire | Rare Voices Australia | To support the operation of the Rare Voices Australia (RVA) Industry round-table and sponsorship of RVA Rare Disease Summit 2015. | 30000 | 30000 |
| 2015 | Shire | ADDults with ADHD | To support ADDults with ADHD NSW Inc educational meeting | 4000 | 4000 |
| 2015 | Shire | Australian Crohn's and Colitis Association | To support a Inflammatory Bowel Disease Awareness Campaign by Crohns and Colitis Australia | 5000 | 5000 |
| 2015 | Shire | Australian Crohn's and Colitis Association | To support the quarterly Crohn's and Colitis Australia "Inside Insights" educational magazine for patients with Inflammatory Bowel Disease | 40000 | 40000 |
| 2015 | Shire | Fabry Australia | To support Fabry Support Group Australia's strategic planning meeting and national conference | 15000 | 15000 |
| 2015 | Shire | HAE Australasia | To support HAE Australasia for attendence at indepent conference organised by CPA Australia | 561.82 | 561.82 |
| 2015 | Shire | HAE Australasia | To support HEA Australasia attendee to participate in the Rare Voices Australia Rare Disease Summit | 1500 | 1500 |
| 2015 | Shire | HAE Australasia | To support independent HAE Australasia meeting looking at the Identification and Management of Hereditary Angioedema | 20000 | 20000 |
| 2016 | Shire | Australian Crohn's and Colitis Association | Funding to support Crohn's & Colitis Australia's Awareness month posters distributed in hospitals and through Crohn's & Colitis Australia's networks. | 5000 | 5000 |
| 2016 | Shire | Australian Crohn's and Colitis Association | Funding to support Crohn's and Colitis Australia's 2016 quarterly "Inside Insights" educational magazines for patients with inflammatory bowel disease. | 50000 | 50000 |
| 2016 | Shire | Crohn's Colitis Cure | Funding to support Crohn's & Colitis Cure Inflammatory Bowel Disease (IBD) research consortium meeting. | 2875.67 | 2875.67 |
| 2016 | Shire | Fabry Australia | Funding to support Fabry Australia's annual patient group meeting and educational material for use by patients and their families. | 25000 | 25000 |
| 2016 | Shire | HAE Australasia | Funding to support HAE Australasia in raising community awareness and supporting the organisation's strategy workshop. | 4500 | 4500 |
| 2016 | Shire | HAE Australasia | Funding to support HAE Australasia's workshops on 'How to cope and adapt life with HAE'. | 5000 | 5000 |
| 2016 | Shire | HAE Australasia | Funding to support independent HAE Australasia meetings looking at the identification and management of hereditary angioedema. | 5000 | 5000 |
| 2016 | Shire | Parenteral Nutrition Down Under | Funding to support Parenteral Nutrition Down Under to conduct workshops and patient perspective representations at forums and conferences. | 5000 | 5000 |
| 2016 | Shire | Rare Voices Australia | Funding to support Rare Voices Australia's "Fair for Rare" campaign aimed at raising community awareness of the impact of rare disease. | 13636.36 | 13636.36 |
| 2016 | Shire | Rare Voices Australia | Funding to support Rare Voices Australia to undertake disease awareness and patient education projects throughout 2016. | 27272.73 | 27272.73 |
| 2017 | Shire | ADHD Western Australia (WA) | Funding to support Learning and Attentional Disorders Society of WA (Inc.) (LADS) 2017 seminar programme. | 8590.9 | 8590.9 |
| 2017 | Shire | Australian Crohn's and Colitis Association | Funding to support Crohn's & Colitis Australia for National Crohn's and Colitis Awareness Month - May 2017 and World IBD Day. | 5000 | 5000 |
| 2017 | Shire | Australian Crohn's and Colitis Association | Funding to support Crohn's & Colitis Australia's 2017 quarterly "Inside Insights" educational magazines for patients with Inflammatory Bowel Disease. | 55000 | 55000 |
| 2017 | Shire | Crohn's Colitis Cure | Funding to support Crohn's Colitis Cure in the ongoing development of IBD clinical management software and database to support best patient outcomes. | 20000 | 20000 |
| 2017 | Shire | Fabry Australia | Funding to support a Fabry Australia Inc. representative's attendance at the 14th Annual WORLD Symposium 2018 and 2018 Fabry Support and Information Group (FISG) Conference. | 2000 | 2000 |
| 2017 | Shire | Fabry Australia | Funding to support Fabry Australia Inc. patient education activities including a national patient conference and state based educational meetings. | 25000 | 25000 |
| 2017 | Shire | HAE Australasia | Funding to support HAE Australasia 2017 Patient & Carers Conference. | 10000 | 10000 |
| 2017 | Shire | Murdoch Childrens Research Institute | Funding to support Murdoch Childrens Research Institute's Renal Genetics Symposium 7 - 8 December 2017. | 3000 | 3000 |
| 2017 | Shire | Parenteral Nutrition Down Under | Funding to support Parenteral Nutrition Down Under Inc. in their provision of resources and activities to its members. | 4545.45 | 4545.45 |
| 2017 | Shire | Rare Voices Australia | Funding to support Rare Voices Australia's ongoing Industry Roundtable and mentoring and educational activities for the rare disease community. | 30000 | 30000 |
| 2018 | Shire | ADHD Australia | Funding to support ADHD Australia Limited's 2018 projects: The Voice, ADHD Newsletter; and Re-thinking ADHD, by busting the myths through eveidence-based research. | 30000 | 30000 |
| 2018 | Shire | ADHD Western Australia (WA) | Funding to support Learning and Attentional Disorders Society of WA (Inc.) (LADS) 2018 seminar programme. | 12000 | 12000 |
| 2018 | Shire | AusPIPS | Funding to support AusPIPS Inc.'s initiation of a Working Party for the development of the National Standard Care for people living with Primary Immune Deficiency (PID) in 2018 and 2018 travel costs for AusPIPS Inc. meetings. | 20000 | 20000 |
| 2018 | Shire | Australian Crohn's and Colitis Association | Funding to support Crohn's & Colitis Australia's IBD Awareness Month and World IBD Day. Funding will be used to print posters and fliers for distribution at hospitals and IBD Clinics, community centers and around light up sites for IBD Awareness Month and World IBD Day. | 5000 | 5000 |
| 2018 | Shire | Australian Crohn's and Colitis Association | Funding to support Crohn's & Colitis Australia's 2018 quarterly "Inside Insight" educational magazines for patients with Inflammatory Bowel Disease. | 55000 | 55000 |
| 2018 | Shire | Fabry Australia | Funding to support Fabry Australia's annual patient group meetings in NSW and WA and educational material for use by patients and their families. | 25000 | 25000 |
| 2018 | Shire | Gaucher Association of Australia & New Zealand | Funding to support Gaucher Association of Australia & New Zealand's (GAANZ) website creation, advocacy activities, annual conference activities, creation of patient educational materials, attendance at educational meetings, facilitation of committee meetings and administrative supplies. | 10000 | 10000 |
| 2018 | Shire | HAE Australasia | Funding to support HAE Australasia's patient and carer support, advocacy and education and event sponsorship of the 2019 Patient and Carer conference. | 25000 | 25000 |
| 2018 | Shire | HAE Australasia | Funding to support HAE Australasia's targeted education and community awareness programs. | 26000 | 26000 |
| 2018 | Shire | Haemophilia Foundation Australia | Funding to support Haemophilia Foundation Australia's musculoskeletal (MSK) management Continuing Education Fund which will be used for the costs of local or overseas MSK, sports medicine or orthopaedic experts to deliver presentations at their annual meeting. | 1818.1 | 1818.1 |
| 2018 | Shire | Haemophilia Foundation Australia | Funding for gold sponsorship of Haemophilia Foundation Australia's 19th Australian Conference on Haemophilia, VWD & Rare bleeding disorders. | 33000 | 33000 |
| 2018 | Shire | Haemophilia Foundation Australia | Funding to support the Haemophilia Foundation Australia's 2018 Ageing Project. | 51000 | 51000 |
| 2018 | Shire | Immune Deficiency Foundation Australia | Funding to support the Immune Deficiencies Foundation Australia's Patient and Healthcare Professional Resource Kits. | 30000 | 30000 |
| 2018 | Shire | Rare Voices Australia | Funding for the renewal of company membership to Rare Voices Australia and Pharmaceutical Industry Round Table. | 15000 | 15000 |
| 2018 | Shire | Rare Voices Australia | Funding to support Rare Voices Australia's bi-annual National Rare Disease Summit. | 20000 | 20000 |
| 2019 | Shire | Australian Crohn's and Colitis Association | Funding to support Crohn's & Colitis Australia's membership fees for their patient support programme for Crohn's disease and ulcerative colitis patients. | 368 | 368 |
| 2019 | Shire | Australian Crohn's and Colitis Association | Funding to support Crohn's & Colitis Australia's bronze sponsorship as a print partner for World IBD Day and Crohn's & Colitis Awareness Month in 2019. | 5000 | 5000 |
| 2019 | Shire | Australian Crohn's and Colitis Association | Funding to support Crohn's & Colitis Australia's 2019 quarterly "Inside Insights" printed and digital educational magazines for patients with Inflammatory Bowel Disease. | 55000 | 55000 |
| 2019 | Shire | Fabry Australia | Funding to support Fabry Australia's disease awareness activities, patient educational activities and their 2019 advocacy program. | 20000 | 20000 |
| 2019 | Shire | Gaucher Association of Australia & New Zealand | Funding to support Gaucher Association of Australia & New Zealand's various projects and initiatives in 2019 including the creation of educational material for members, patient advocacy and supporting Gaucher Awareness Day. | 15000 | 15000 |
| 2019 | Shire | Genetic Alliance Australia | Funding to support Genetic Alliance Australia's educational event 'Genetics - Today's Science for Everyday Families' for families with genetic concerns seeking information and resources. | 2350 | 2350 |
| 2019 | Shire | Immune Deficiency Foundation Australia | Funding to support The Immune Deficiency Foundation Australia (IDFA) for awareness, education and advocacy activities, events and initiatives for Primary and Secondary Immune Deficient patients. | 20000 | 20000 |
| 2019 | Shire | Parenteral Nutrition Down Under | Funding to support Parenteral Nutrition Down Under Inc. in their provision of resources and activities for its members. These include ongoing resources, such as printed and digital educational resources for patients, patient surveys and activities such as patient perspective representation at forums and conferences. | 5000 | 5000 |
| 2019 | Shire | Rare Voices Australia | Funding for the renewal of company membership to Rare Voices Australia and Pharmaceutical Industry Round Table. | 15000 | 15000 |
| 2019 | Shire | Rare Voices Australia | Funding to support Rare Voices Australia's 2019 Parliamentary Events which aim to highlight the challenges of rare diseases, opportunities for improvement and to raise the profile and awareness of rare disease. | 15000 | 15000 |
| 2019 | Shire | Rare Voices Australia | Funding to support Rare Voices Australia's ongoing Industry Roundtable in 2019. | 15000 | 15000 |
| 2020 | Shire | Fabry Australia | Funding to support Fabry Australia’s Be Rare. Be YOU. Tattoo campaign through the purchase and use of Be Rare. Be YOU. tattoos. | 1000 | 1000 |
| 2020 | Shire | Fabry Australia | Funding to support Fabry Australia's Fabry Patient Educational virtual meeting and printing of their Factsheet booklet "Understanding Fabry Disease" and other educational materials for Fabry patients. | 25000 | 25000 |
| 2020 | Shire | Gaucher Association of Australia & New Zealand | Funding to support Gaucher Association of Australia & New Zealand in the areas of: - Mask and media costs related to International Gaucher Day; - 2021 Melbourne meeting and a joint Gaucher and Fabry meeting at the ICIEM 2021 Conference; - Educational initiatives and resources - Lexi's Brave Bunny; and - Cancellation fees related to flight bookings for the European Working Group meeting. | 10000 | 10000 |
| 2020 | Shire | HAE Australasia | Funding to support HAE Australasia Ltd's Patient Survey in the areas of: - Software and data analysis; and - Patient Meet Ups for patients and their carers in the areas of travel, accommodation, venue hire, catering and educational resources. | 13500 | 13500 |
| 2020 | Shire | Immune Deficiency Foundation Australia | Funding to support The Immune Deficiency Foundation Australia Ltd (IDFA) in the areas of: - Weekly online support group program and webinar series for members, carers and healthcare professionals; - Establishment of an online platform to deliver member support; and - Production of resources to support online member support initiatives. | 10000 | 10000 |
| 2020 | Shire | Immune Deficiency Foundation Australia | Funding to support The Immune Deficiency Foundation Australia Ltd's (IDFA) development and printing of educational patient resources for raising awareness of the signs and symptoms of primary and secondary immune deficiencies and their management and for the update and rebuild of the IDFA website. | 20000 | 20000 |
| 2020 | Shire | Parenteral Nutrition Down Under | Funding to support Parenteral Nutrition Down Under Inc.'s publication and printing costs of resources for their Home Parenteral Nutrition members. | 5000 | 5000 |
| 2020 | Shire | Rare Voices Australia | Funding to support Rare Voices Australia's Rare Disease Day Parliamentary Events 2020 which aim to highlight the challenges of rare diseases, opportunities for improvement and to raise the profile and awareness of rare disease. | 8000 | 8000 |
| 2020 | Shire | Rare Voices Australia | Funding to support Rare Voices Australia's 2020 Mentorship and Education Project in the areas of travel and accommodation costs only and the development of printed Action Plan implementation one-page summaries for specific stakeholders. This project includes the RVA Speakers Program: Engaging with the Action Plan and Advocacy Mentorship for RVA Partner organisations. | 10000 | 10000 |
| 2020 | Shire | Rare Voices Australia | Funding to support Rare Voices Australia's National Rare Disease Summit 2021. The Summit will bring together all stakeholders, with the focus to build on the Priorities and Actions of the National Strategic Action Plan for Rare Diseases. | 20000 | 20000 |
| 2014 | Takeda | Lymphoma Australia | Support for National Education Day | 15000 | 15000 |
| 2015 | Takeda | Leukaemia Foundation Of Australia | Sponsorship of the Leukaemia Foundation Newsletter | 17000 | 17000 |
| 2015 | Takeda | Lymphoma Australia | Support for National Education Days | 13636.36 | 13636.36 |
| 2016 | Takeda | Australian Crohn's and Colitis Association | Sponsorship of flyers - distributed to CCA members, hospitals, support groups, volunteers, commnunity centres and social media posts, throughout May 2016 | 7500 | 7500 |
| 2016 | Takeda | Australian Crohn's and Colitis Association | Phone Helpline Specialised 1800 Helpline offering information, counselling and support nationally for all people living with IBD. With over 4,000 calls made through the service each year, the telephone helpline provides immediate guidance and support to p | 25000 | 25000 |
| 2016 | Takeda | Gut Foundation | IBD Day Support for the program for the Australian IBD Day - 19 May 2016. This included: Social media strategy development and execution Media release develoment and distribution Online Content collateral, photos, videos, graphic design Sponsorship of the | 5000 | 5000 |
| 2017 | Takeda | Australian Crohn's and Colitis Association | Online Research Update Series and Guide to IBD Brochure | 35000 | 35000 |
| 2017 | Takeda | Myeloma Australia | Sponsorship of MSAG Myeloma Education Workshop September 2017 | 5000 | 5000 |
| 2017 | Takeda | Rare Cancers Australia | Sick or Treat Ball table sponsorship | 2273 | 2273 |
| 2018 | Takeda | Australian Crohn's and Colitis Association | IBD Quality of Care Program - The Patient Experience (Stage 2) - Quantitative National Survey | 50000 | 50000 |
| 2018 | Takeda | Australian Crohn's and Colitis Association | National IBD helpline and Online Research Video updates | 50000 | 50000 |
| 2018 | Takeda | Rare Cancers Australia | Halloween Charity Ball table sponsorship | 2500 | 2500 |
| 2019 | Takeda | Australian Crohn's and Colitis Association | Funding to support Crohn's & Colitis Australia's "My IBD Care" hardcopy booklet and e-book version for members, others living with IBD and distribution at IBD forums and events and the printing and distribution of the Crohn's and Colitis membership brochure. | 40000 | 40000 |
| 2019 | Takeda | Australian Crohn's and Colitis Association | Funding to support Crohn's & Colitis Australia's National IBD Helpline for people living with IBD and updates of online research video interviews with specialists, researchers and academics for members. | 50000 | 50000 |
| 2019 | Takeda | Lung Foundation Australia | Funding to support Lung Foundation Australia's Hope in Every Breath Ball through a table sponsorship. | 3000 | 3000 |
| 2019 | Takeda | Rare Cancers Australia | Funding to support Rare Cancers Australia's Halloween Charity Ball through a table sponsorship. | 10000 | 10000 |
| 2020 | Takeda | ADHD Australia | Funding to support ADHD Australia Ltd's Better Futures Initiative and Better Futures Symposium in the areas of: - Initial research to understand key challenges facing patients prior to online symposium; - Technology costs for webcast of online symposium; - Event room/studio hire for online symposium; - Promotion of the online symposium; and - Preparation of post symposium analysis and funding. | 50000 | 50000 |
| 2020 | Takeda | Australian Crohn's and Colitis Association | Funding to support Crohn's & Colitis Australia's 2020 quarterly "Inside Insights" printed and digital educational magazines for patients with Inflammatory Bowel Disease. | 45000 | 45000 |
| 2020 | Takeda | Australian Crohn's and Colitis Association | Funding to support Crohn's and Colitis Australia's initiatives in the areas of: - A national IBD Helpline for people living with IBD; - Identifying Australian priorities for Inflammatory Bowel Disease research; - A guide to IBD brochure for health professionals and the Crohn’s and Colitis community; and - A silver sponsor for Crohn's and Colitis Awareness month. | 65000 | 65000 |
| 2020 | Takeda | Fabry Australia | Funding to support Fabry Australia's "Fabry Disease Guideline Review Project". The goal of this project is to engage with Fabry Australia and recent survey data findings and to inform a new set of criteria to be shared and peer reviewed as current guidelines for Fabry disease treatments do not meet requirements. Funding will support the engagement of a project manager and medical writer. | 11000 | 11000 |
| 2020 | Takeda | Patient Voice Initiative | Funding to support Patient Voice Initiative Incorporated's "Sponsors Roundtable" virtual event through a silver corporate sponsorship. | 7500 | 7500 |
| 2013 | UCB | Epilepsy Association of South Australia (SA) and Northern Territory (NT) | Funds donated to support the Youth Leadership Epilepsy Camp | 2101 | 2101 |
| 2013 | UCB | Epilepsy Association of South Australia (SA) and Northern Territory (NT) | Funds donated to support the creation of an Epilepsy awareness book called the "Trigger Book" | 5000 | 5000 |
| 2013 | UCB | Epilepsy Foundation | Funds donated to support the Longitudinal Research Wave and Annual Epilepsy Society dinner | 27500 | 27500 |
| 2013 | UCB | Parkinson's Victoria (VIC) | Funds donated to support the 'walk in the park' for Parkinson's Disease | 909.09 | 909.09 |
| 2014 | UCB | Arthritis Foundation of Australia | Funds donated to support the Arthritis foundation booklet for back pain | 24250 | 24250 |
| 2014 | UCB | Arthritis Foundation of Australia | Funds donated to the Arthritis Australia to support fellowship grant and research program | 65000 | 65000 |
| 2014 | UCB | Arthritis Foundation of Western Australia (WA) | Funds donated to support the unity 'walk in the park' for Parkinson's Disease | 345 | 345 |
| 2014 | UCB | Epilepsy Association of South Australia (SA) and Northern Territory (NT) | Funds donated to the Epilepsy Centre South Australia and Northern Teritory to support the SYNERGY Transition project | 3000 | 3000 |
| 2014 | UCB | Epilepsy Association of South Australia (SA) and Northern Territory (NT) | Funds donated to the Epilepsy Centre South Australia and Northern Teritory to support the SUMMIT1625 project | 15000 | 15000 |
| 2014 | UCB | Epilepsy Australia | Support of the medication adherance survey and report | non financial support | 0 |
| 2014 | UCB | Epilepsy Australia | Funds donated to support the Epilepsy Australia website upgrade | 19200 | 19200 |
| 2014 | UCB | Epilepsy Foundation | Funds donated to support the Epilepsy Foundation Australian and New Zealand Dravet Syndrome Family Conference | 2000 | 2000 |
| 2014 | UCB | Epilepsy Foundation | Funds donated to support the Epilepsy Foundation Purple Day | 10000 | 10000 |
| 2014 | UCB | Epilepsy Foundation | Funds donated to support the Epilepsy Foundation website upgrade | 15000 | 15000 |
| 2014 | UCB | Epilepsy Foundation | Funds donated to support the Epilepsy Foundation research register project | 15000 | 15000 |
| 2014 | UCB | Epilepsy Foundation | Funds donated to the Epilepsy Foundation to support the Longitudinal Research into the Impact of Epilepsy in the community | 20000 | 20000 |
| 2014 | UCB | Epilepsy Foundation | Funds donated to the Epilepsy foundation to support the smart schools program | 22100 | 22100 |
| 2014 | UCB | Epilepsy Queensland (QLD) | Support of the medication adherance survey and report | non financial support | 0 |
| 2014 | UCB | Epilepsy Queensland (QLD) | Funds donated to support the Queensland Epilepsy Symposium | 4000 | 4000 |
| 2014 | UCB | Parkinson's New South Wales (NSW) | Funds donated to support the unity 'walk in the park' for Parkinson's Disease | 3000 | 3000 |
| 2014 | UCB | Parkinson's Queensland (QLD) | Funds donated to support the 'walk in the park' for Parkinson's Disease | 1500 | 1500 |
| 2014 | UCB | Parkinson's South Australia (SA) | Funds donated to support the 'walk in the park' for Parkinson's Disease | 1000 | 1000 |
| 2014 | UCB | Parkinson's Victoria (VIC) | Funds donated to support the 'walk in the park' for Parkinson's Disease | 2500 | 2500 |
| 2014 | UCB | Parkinson's Western Australia (WA) | Funds donated to support the 'walk in the park' for Parkinson's Disease | 1000 | 1000 |
| 2015 | UCB | Arthritis Foundation of Australia | Funds donated to the Arthritis Australia to support the printing of consumer booklets | 20000 | 20000 |
| 2015 | UCB | Arthritis Foundation of Australia | Funds donated to the Arthritis Australia to support fellowship grant and research program | 50000 | 50000 |
| 2015 | UCB | Arthritis Foundation of Western Australia (WA) | Funds donated to support an educational seminar for Musculosketal Conditions | 450 | 450 |
| 2015 | UCB | Arthritis Queensland (QLD) | Funds donated to support their annual health professional seminar | 550 | 550 |
| 2015 | UCB | Arthritis Queensland (QLD) | Funds donated to support an educational seminar to healthcare professionals | 750 | 750 |
| 2015 | UCB | Epilepsy Foundation | non financial support to host meeting to better understand the unmet need of patients with epilepsy | 0 | 0 |
| 2015 | UCB | Epilepsy Foundation | Funds donated to support the Epilepsy foundation annual meeting | 6000 | 6000 |
| 2015 | UCB | Epilepsy Foundation | Funds donated to support the Australian Epilepsy Research Register Expansion project | 10000 | 10000 |
| 2015 | UCB | Epilepsy Foundation | Funds donated to support the Patient story project | 18000 | 18000 |
| 2015 | UCB | Epilepsy Queensland (QLD) | Funds donated to support the Queensland Epilepsy "Out of the box" Symposium | 5572 | 5572 |
| 2015 | UCB | Parkinson's New South Wales (NSW) | Funds donated to support the unity 'walk in the park' for Parkinson's Disease | 3000 | 3000 |
| 2015 | UCB | Parkinson's New South Wales (NSW) | Funds donated to Reprint the 'DASH information booklet' for Parkinson Disease patients | 7035 | 7035 |
| 2015 | UCB | Parkinson's Queensland (QLD) | Funds donated to support the Parkinson’s Queensland Seminar | 1500 | 1500 |
| 2015 | UCB | Parkinson's Queensland (QLD) | Funds donated to support the 'walk in the park' for Parkinson's Disease in Queensland | 1500 | 1500 |
| 2015 | UCB | Parkinson's Victoria (VIC) | Funds donated to support the 'walk in the park' for Parkinson's Disease in Victoria | 3500 | 3500 |
| 2015 | UCB | Parkinson's Western Australia (WA) | Funds donated to support the 'walk in the park' for Parkinson's Disease in Western Australia | 1000 | 1000 |
| 2016 | UCB | Arthritis Foundation of Australia | Funds to support the reprint of consumer booklets for distribution | 28918 | 28918 |
| 2016 | UCB | Arthritis Queensland (QLD) | Funds to support the Arthritis Queensland health professionals seminar | 600 | 600 |
| 2016 | UCB | Arthritis Queensland (QLD) | Funds to support consumer resources information packs for newly diagnosed patients | 5000 | 5000 |
| 2016 | UCB | Epilepsy Action Australia | Funds to support the MyEpilepsy Key project | 25000 | 25000 |
| 2016 | UCB | Epilepsy Action Australia | Funds to support the Medikids Explainz Epilepsy project | 30000 | 30000 |
| 2016 | UCB | Epilepsy Action Australia, Epilepsy Foundation, Epilepsy Australia | Collaboration by circulating the details of a live streaming to people with epilepsy, families and carers | non-financial support of an opportunity for people living with epilepsy, families and carers to listen to an international neurologist, speak on the topic of Quality of Life and Epilepsy through a live streaming oline presentation | 0 |
| 2016 | UCB | Epilepsy Assocation of Western Australia (WA) | Collaboration in organising a patient value table to enhance the undersadning o fthe patients experience with Parkinson Disease in New South Wales | non-financial support of patient meeting to gather feedback from patients experiences | 0 |
| 2016 | UCB | Epilepsy Foundation | Funds to support the Epilepsy foundation annual meeting | 6000 | 6000 |
| 2016 | UCB | Epilepsy Foundation | Funds to support the NDIS pre planning resources project | 15000 | 15000 |
| 2016 | UCB | Epilepsy Foundation | Funds to support the expansion of the epilepsy research register | 15000 | 15000 |
| 2016 | UCB | Epilepsy Foundation | Funds to support the Australian epilepsy longitudinal study (AELS) Wave 4 | 20000 | 20000 |
| 2016 | UCB | Epilepsy Foundation | Funds to support the Epilepsy foundation smart schools program - 'extending the reach' | 100000 | 100000 |
| 2016 | UCB | Epilepsy Queensland (QLD) | Funds to support the Queensland Epilepsy "Out of the box" Symposium | 6090 | 6090 |
| 2016 | UCB | Parkinson's New South Wales (NSW) | Collaboration in organising a patient value table to enhance the undersadning o fthe patients experience with Parkinson Disease in New South Wales | non-financial support of patient meeting to gather feedback from patients experiences | 0 |
| 2016 | UCB | Parkinson's New South Wales (NSW) | Funds to support the Annual Unity Walk & Run for Parkinson Disease patients in New South Wales | 3000 | 3000 |
| 2016 | UCB | Parkinson's Victoria (VIC) | Collaboration in a Parkinson's Disease Patient Education Meeting | 448.18 | 448.18 |
| 2016 | UCB | Parkinson's Victoria (VIC) | Funds to support the Living Well - Health Care Professionals Seminar | 1500 | 1500 |
| 2016 | UCB | Parkinson's Victoria (VIC) | Funds to support the InSearch Parkinson's Research Series | 2500 | 2500 |
| 2016 | UCB | Parkinson's Victoria (VIC) | Funds to support the 'walk in the park' for Parkinson's Disease in Victoria | 3500 | 3500 |
| 2016 | UCB | Parkinson's Western Australia (WA) | Funds to support the 'walk in the park' for Parkinson's Disease in Western Australia | 1000 | 1000 |
| 2017 | UCB | Arthritis Foundation of Australia | Funds to support training of 10 new paediatric rheumatologists to support Australian Paediatric Rheumatology Group | 1000 | 1000 |
| 2017 | UCB | Arthritis Foundation of Australia | Funds to support a project to review, update, print consumer resources for distribution | 25350 | 25350 |
| 2017 | UCB | Epilepsy ACT, Epilepsy Action, Epilepsy Association of Tasmania, Epilepsy Association of Western Australia (WA), Epilepsy Australia, Epilespy Centre South Australia (SA) and Northern Territory (NT), Epilepsy Foundation, Epilepsy Queensland (QLD) | Fund to support for patient education seminars throughout 2017 | 10000 | 10000 |
| 2017 | UCB | Epilepsy Centre | Funds to support the building youth workshop | 1000 | 1000 |
| 2017 | UCB | Epilepsy Foundation | Funds to support the Genetic Epilepsy Family Conference | 2000 | 2000 |
| 2017 | UCB | Epilepsy Foundation | Funds to support the epilepsy Foundation Patient Day | 4840 | 4840 |
| 2017 | UCB | Epilepsy Foundation | Funds to support of the Trek for Epilepsy | 5000 | 5000 |
| 2017 | UCB | Epilepsy Foundation | Funding to support the Annual Dinner | 6000 | 6000 |
| 2017 | UCB | Epilepsy Foundation | Funds to support the Epilepsy foundation smart schools program media launch | 7000 | 7000 |
| 2017 | UCB | Epilepsy Foundation | Funds to support the IEC Barcelon 2017 Project | 10805 | 10805 |
| 2017 | UCB | Epilepsy Foundation | Funds to support the Australian epilepsy longitudinal study (AELS) Wave 4 | 20000 | 20000 |
| 2017 | UCB | Epilepsy Foundation | Funds to support the Praxhub Group- providing medical practitioners with access to resources | 48500 | 48500 |
| 2017 | UCB | Epilepsy Foundation, Epilepsy Action & Epilepsy Australia | Non- financial support - Collaboration by conducting a survey for adult and paediatric patients with Epilepsy | 0 | 0 |
| 2017 | UCB | Epilepsy Support Centre West | Funds to support the Epilepsy educational day | 1400 | 1400 |
| 2017 | UCB | Epilpesy Foundation | Funds to support the 'Tackling Epilepsy in Later years 'program for the production of educational resources | 5000 | 5000 |
| 2017 | UCB | Global Healthy Living Foundation | Funds to support the development and implementof vital patient-centered activites for Australian patient's and caregiver's community | 10000 | 10000 |
| 2017 | UCB | Orange Neurology Centre | Funds to support three patient support group meetings | 1700 | 1700 |
| 2017 | UCB | Parkinson's New South Wales (NSW) | Funds to support the 10th Annual Unity Walk & Run for Parkinson Disease patients in New South Wales | 3000 | 3000 |
| 2017 | UCB | Parkinson's New South Wales (NSW) | Funds to support the regional educational seminars | 5000 | 5000 |
| 2017 | UCB | Parkinson's Queensland (QLD) | Funds to support the 'A walk in the park' in Queensland | 2750 | 2750 |
| 2017 | UCB | Parkinson's South Australia (SA) | Funds to support the 'A walk in the park' in South Australia | 1500 | 1500 |
| 2017 | UCB | Parkinson's Support Group Wagga Wagga | Funds to support the Parkinsons education day | 1300 | 1300 |
| 2017 | UCB | Parkinson's Victoria (VIC) | Funds to support for the 'A walk in the park' in Victoria | 3500 | 3500 |
| 2017 | UCB | Parkinson's Victoria (VIC) | Funds to support the Parkinsons' Research Series: Insearch | 5000 | 5000 |
| 2017 | UCB | Parkinson's Victoria (VIC) | Funds to support the National PD Nurses meeting | 40200 | 40200 |
| 2017 | UCB | Parkinson's Western Australia (WA) | Funds to support for the 'A walk in the park' in Western Australia | 1100 | 1100 |
| 2018 | UCB | Arthritis Foundation of Australia | Financial support for the project 'patient journey, A patient panel with Arthritis Australia' national reference group to understand each patient's journey and experience of life with their condition. | 4025 | 4025 |
| 2018 | UCB | Arthritis Foundation of Australia | Financial Support for developing and reviewing the colour booklet for consumers with arthritis. This resource is designed to discuss the factors involved when considering family planning, pregnancy and early stages of parenting for both men and women with arthritis. | 15600 | 15600 |
| 2018 | UCB | Arthritis Foundation of Australia | Financial Support for a project to review, update and print consumer booklets for distribution to callers of the National Arthritis Helpline and at a consumer health professional educational seminar. | 25350 | 25350 |
| 2018 | UCB | Arthritis Foundation of Western Australia (WA) | Financial support to develop consumer reference handbooks for people living with Ankylosing Spondylitis and Psoriatic Arthritis | 5000 | 5000 |
| 2018 | UCB | Arthritis Queensland (QLD), Australian Rheumatology Association Queensland (ARAQ) | Financial Support of the Arthritis Queensland Seminar for healthcare professionals | 750 | 750 |
| 2018 | UCB | Epilepsy Action Australia | Financial support was provided to the Chief Executive Officer Carol Ireland from Epilepsy Action to attend and speak to UCB Directors on collaborations with Patient Organisations. | 500 | 500 |
| 2018 | UCB | Epilepsy Action Australia | Financial support for the production of two animated educational first aid for seizure digital videos for children and adults that would be distributed onto the foundation website to assist the community on first aid seizures. | 10000 | 10000 |
| 2018 | UCB | Epilepsy Assocation of Western Australia (WA) | Financial support provided to the patient organisation to conduct 10 seminars in 2018 covering topics on epilepsy and employment, driving, wellbeing, medication compliance, aid and equipment, new diagnosis, dementia for patients to Healthcare Professionals in Western Australia | 10000 | 10000 |
| 2018 | UCB | Epilepsy Centre, Epilepsy Association of South Australia (SA) and the Northern Territory (NT) | The Epilepsy Centre, Epilepsy Association of South Australia and the Northern Territory is a non-for-profit patient organisation committed to supporting the Epilepsy community. The Financial support provided for the 'Epilepsy Youth and Young Adults Camp' workshops to support youths living with epilepsy. | 1500 | 1500 |
| 2018 | UCB | Epilepsy Foundation | Financial support for the 'Epilepsy Walk 2018'. The event aims to raise both awareness and funds to support research and development for the foundation to benefit epilepsy patients. | 2500 | 2500 |
| 2018 | UCB | Epilepsy Foundation | Financial support provided to the patient organisation for the Webinar Epilepsy and Schools to educate children and their peers to improved epilepsy awareness. | 5000 | 5000 |
| 2018 | UCB | Epilepsy Foundation | Support provided to the Epilepsy Foundation for the Genetic Epilepsy Family Conference. The conference enabled people to learn more on the latest research in genetic epilepsy and attend workshops designed for parents and carers to help manage children and adolescents with genetic epilepsy. | 5000 | 5000 |
| 2018 | UCB | Epilepsy Foundation | The Epilepsy foundation in an non-profit organisation dedicated to supporting epilepsy patients and their families. The funds assisted the annual epilepsy foundation dinner for clients and people who support and partner the work of the Epilepsy Foundation. | 6000 | 6000 |
| 2018 | UCB | Epilepsy Foundation | Support provided to the Epilepsy Foundation project 'People living with epilepsy and caregiver webinar series'. The support allowed a series of four webinars for people living with epilepsy and caregivers to better understand the psycho-social impact of epilepsy. | 20000 | 20000 |
| 2018 | UCB | Epilepsy Foundation | Support provided to the Epilepsy Foundation for the webinars 'Updated Epilepsy training for disability sector- Know Me, Support Me'. The development of evidence based online resources provided information, practical tools, resources and education for people with disabilities. | 30000 | 30000 |
| 2018 | UCB | Epilepsy Foundation | Financial support for the Online resource project Epilepsy training for the aged care sector - Epilepsy in later years 'Understand Me, Support Me' developed an education and training package for the aged care sector which builds the capacity of aged care workers and carers to better understand epilepsy and seizures and its impact on the older person, to improve service practice and person centred outcomes. | 30000 | 30000 |
| 2018 | UCB | Epilepsy Queensland (QLD) | Epilepsy Queensland is a patient organisation committed to providing information to families and individuals with epilepsy across Queensland, the support provided for the Annual Symposium 'thinking outside the box' in Brisbane, for medical specialists, GP's , Allied health professionals, health professionals, medical students and people with epilepsy and their families to raise awareness of epilepsy. | 6550 | 6550 |
| 2018 | UCB | Parkinson's New South Wales (NSW) | Parkinson's New South Wales Inc is a not-for-profit organisation that provides support and information to people living with Parkinson's Disease, their families and healthcare professionals. The financial support was provided for the Educational Seminars in 2018, which aims to provide education on treatment options and latest research developments. | 8000 | 8000 |
| 2018 | UCB | Parkinson's Queensland (QLD) | Parkinson's Queensland is a not-for-profit organisation that provides support and information to people living with Parkinson's Disease and their families in Queensland. The financial support provided for the education meeting 'Newly diagnosed forum' to raise awareness of Parkinson's Disease and help engage healthcare professionals and researchers within the communities across Queensland. | 1000 | 1000 |
| 2018 | UCB | Parkinson's South Australia (SA) | Parkinson's South Australia is a not-for-profit organisation that provides support and information to people living with Parkinson's Disease their families and healthcare professionals. Financial support was provided to assist the annual "A walk in the park" event. | 1800 | 1800 |
| 2018 | UCB | Parkinson's South Australia (SA) | Parkinson's South Australia is a not-for-profit organisation that provides support and information to people living with Parkinson's, families and healthcare professionals in South Australia. Financial Support was provided to assist the 2018 Conference with various topics on Parkinson's Disease. | 2000 | 2000 |
| 2018 | UCB | Parkinson's Victoria (VIC) | Parkinson's Victoria is a not- for -profit organisation thatprovides support and information to people living with Parkinson's Disease, their families and Healthcare Professionals, support was provided for the Parkinson's Victoria event 'Australian National Movement Disorder Nurse Meeting 2018'. The meeting aimed at nurse specialists to offer focused education to meet their specific professional development needs. | 47000 | 47000 |
| 2018 | UCB | Parkinson's Victoria (VIC) | Parkinson's Victoria is a not-for-profit organisation that provides support and information to people living with Parkinson's Disease, their families and healthcare professionals. Financial support was provided to assist the annual "A walk in the park" event. | 3000 | 3000 |
| 2018 | UCB | Parkinson's Western Australia (WA) | Parkinson's Western Australia Inc is a not-for-profit organisation that provides support and information to people living with Parkinson's Disease, their families and Healthcare Professionals. Financial Support was provided to assist the annual " A walk in the park" event. | 1000 | 1000 |
| 2018 | UCB | Parkinson's Western Australia (WA) | Parkinson's Western Australia Inc is a not-profit- profit organisation that provides support and information to people living with Parkinson's Disease, their families and Healthcare Professionals. Financial support provided for the General Practitioner Seminar Series for South Western Australia on the topic 'G.P. Information Seminar Management of Advanced Parkinson's'. | 3500 | 3500 |
| 2019 | UCB | Arthritis Foundation of Australia | Financial support for printing of colour booklets for consumers with Arthritis. These booklets contain resources which discuss factors to consider for family planning, pregnancy, and early stages of parenting for both men and women with arthritis. | 5500 | 5500 |
| 2019 | UCB | Arthritis Foundation of Australia | Financial support for a project Rheumatoid Arthritis Support Program (RASP). RASP provided delivery of information to patients living with Rheumatoid arthritis to support them with their care. | 70000 | 70000 |
| 2019 | UCB | Arthritis Queensland (QLD), Australian Rheumatology Association Queensland (ARAQ) | Financial support of the Arthritis Queensland Seminar for healthcare professionals to offer focused education to meet their specific professional development needs. | 750 | 750 |
| 2019 | UCB | Chronic Illness Alliance | Support towards the attendance of Christine Walker, Executive officer to ESA Congress to present a scientific poster 'Association between geographical remoteness and epilepsy disease management: A survey of adult and paediatric epilepsy patients in Australia' in Sydney | 1150.26 | 1150.26 |
| 2019 | UCB | Epilepsy Action Australia | Financial support for the Epilepsy Awareness and Educational day held at Gosford Hospital in New South Wales, Australia. | 600 | 600 |
| 2019 | UCB | Epilepsy Action Australia | Financial support for the production of two animated educational first aid for seizure digital videos for children and adults that would be distributed onto the foundation website to assist the community on first aid seizures translated in Japanese. | 3500 | 3500 |
| 2019 | UCB | Epilepsy Action Australia | Financial support for the production of a SUDEP and Seizure Safety Checklist Project. | 33500 | 33500 |
| 2019 | UCB | Epilepsy Assocation of Western Australia (WA) | Financial support provided to the patient organisation to conduct 3 seminars/webinars in 2019 covering topics on epilepsy and employment, driving, wellbeing, medication compliance, aid and equipment, new diagnosis, dementia for patients to Healthcare Professionals in Western Australia | 10000 | 10000 |
| 2019 | UCB | Epilepsy Foundation | Financial support for the 'Epilepsy Walk 2019'. The event aims to raise both awareness and funds to support research and development for the foundation to benefit epilepsy patients. | 5000 | 5000 |
| 2019 | UCB | Epilepsy Foundation | The Epilepsy foundation in an non-profit organisation dedicated to supporting epilepsy patients and their families. The funds assisted the annual epilepsy foundation dinner for clients and people who support and partner the work of the Epilepsy Foundation. | 6000 | 6000 |
| 2019 | UCB | Epilepsy Foundation | Financial support provided to the Australian Epilepsy Research Register (AERR) and Longitudinal Study (AELS) Project. The register encourages people with epilepsy, their families and caregivers to participate in research that will increase understanding about epilepsy and the impact on people's lives. The support provided production of two papers for peer journals, promoting the AERR and prepared questions for the next wave of the study 2019/2020. | 20000 | 20000 |
| 2019 | UCB | Epilepsy Foundation | Financial support provided to the Epilepsy Foundation project, Epilepsy Management Plan an Online System (web application). The support provided to the Epilepsy Foundation developed an online Epilepsy Management plan (EMP) and Epilepsy Emergency Management plan (EEMP) production and management system (web application) for people living with epilepsy and those who support them. | 30000 | 30000 |
| 2019 | UCB | Epilepsy Queensland (QLD) | Epilepsy Queensland is a patient organisation committed to providing information to families and individuals with epilepsy across Queensland, the support provided for the Annual Symposium 'thinking outside the box' in Brisbane, for medical specialists, GP's , Allied health professionals, health professionals, medical students and people with epilepsy and their families to raise awareness of epilepsy. | 6550 | 6550 |
| 2019 | UCB | Musculoskeletal Australia | Financial support for a webinar on the diagnosis and management of psoriatic arthritis for consumers of Musculoskeletal Australia. | 3000 | 3000 |
| 2019 | UCB | Parkinson's New South Wales (NSW) | Parkinson's New South Wales Inc is a not-for-profit organisation that provides support and information to people living with Parkinson's Disease, their families and healthcare professionals. The financial support was provided for a GP Educational Seminar in 2019 held in Port Macquarie, which provided education on treatment options and latest research | 900 | 900 |
| 2019 | UCB | Parkinson's New South Wales (NSW) | Parkinson's New South Wales Inc is a not-for-profit organisation that provides support and information to people living with Parkinson's Disease, their families and healthcare professionals. The financial support was provided for the Educational Seminars in 2019, which aims to provide education on treatment options and latest research developments. | 2500 | 2500 |
| 2019 | UCB | Parkinson's South Australia (SA) | Parkinson's South Australia is a not-for-profit organisation that provides support and information to people living with Parkinson's, families and healthcare professionals in South Australia. Financial support was provided to assist the 2019 Conference with various topics on Parkinson's Disease and financial support provided to the annual "A walk in the park" | 5000 | 5000 |
| 2019 | UCB | Parkinson's Victoria (VIC) | Parkinson's Victoria is a not-for-profit organisation that provides support and information to people living with Parkinson's Disease, their families and healthcare professionals. Financial support was provided to assist the annual "A walk in the park" event. | 3000 | 3000 |
| 2019 | UCB | Parkinson's Victoria (VIC) | Parkinson's Victoria is a not- for -profit organisation that provides support and information to people living with Parkinson's Disease, their families and Healthcare Professionals, support was provided for the Parkinson's Victoria event 'Smart Health Event'. The meeting aimed at healthcare professionals to offer focused education to meet their specific professional development needs | 4000 | 4000 |
| 2019 | UCB | Parkinson's Western Australia (WA) | Parkinson's Western Australia Inc is a not-for-profit organisation that provides support and information to people living with Parkinson's Disease, their families and Healthcare Professionals. Financial support was provided to assist the annual "A walk in the park" event. | 1000 | 1000 |
| 2020 | UCB | Arthritis Foundation of Australia | Financial support for the Arthritis Australia PsA Patient support program MyAS Website development project. | 30000 | 30000 |
| 2020 | UCB | Arthritis Foundation of Australia | Financial support for the Arthritis Australia PsA Patient support program MyPsA Website development project. | 30000 | 30000 |
| 2020 | UCB | Epilepsy Action Australia | Financial support for the Better consult project development. The benefit to the patient will be more time to think through symptoms so as to be better prepared for the consultation, resulting in enhanced interaction between patient and their healthcare professional. | 30000 | 30000 |
| 2020 | UCB | Epilepsy Assocation of Western Australia (WA) | Financial support provided to the patient organisation to rebuild the website and two webinar/recorded seminars in 2020. | 12500 | 12500 |
| 2020 | UCB | Epilepsy Australian Capital Territory (ACT), Epilepsy Action, Epilepsy Association of Tasmania (TAS), Epilepsy Association of Western Australia (WA), Epilepsy Australia, Epilespy Centre Southern Australia (SA) and Northern Territory (NT), Epilepsy Foundation, Epilepsy Queensland (QLD) | UCB Australia worked collaboratively to launch a disease awareness PR campaign called ‘Look for Epilepsy’. The objective was to help raise public awareness about the associated stigma and how epilepsy impacts the lives of patients every day. | 0 | 0 |
| 2020 | UCB | Epilepsy Foundation | Financial support for the 'Virtual walk for Epilepsy'. The event aims to raise both awareness and funds to support research and development for the foundation to benefit epilepsy patients. | 5000 | 5000 |
| 2020 | UCB | Epilepsy Foundation | Financial support provided to the Australian Epilepsy Research Register (AERR)and Longitudinal Study (AELS) Project. The register encourages people with epilepsy, their families and caregivers to participate in research that will increase understanding about epilepsy and the impact on people's lives. The support procided funding to analyse and report on the data from Wave 5. | 20000 | 20000 |
| 2020 | UCB | Global Healthy Living Foundation | Global Healthy Living Foundation Pty Ltd (CreakyJoints Australia) a not-forprofitPatient Organisation Support for contribution to allow the organisation to continue its efforts developing and implementing vital patient-centred education, support and advocacy for the Australian patientand caregiver community impacted by the ongoing public health crisis. | 10000 | 10000 |
| 2020 | UCB | Parkinson's Victoria (VIC) | Parkinson's Victoria is a not-for-profit organisation that provides support and information to people living with Parkinson's Disease, their families and healthcare professionals. Financial support was provided to assist virtual 'Walk in the park' event. | 2500 | 2500 |
| 2020 | Vertex Pharmaceuticals | Arthritis Queensland (QLD), Australian Rheumatology Association Queensland (ARAQ) | Charitable Contribution: Circle of Care Cystic Fibrosis Families - Patient information program to support families of babies diagnosed with CF | 34400 | 34400 |
| 2020 | Vertex Pharmaceuticals | Cystic Fibrosis Australia | Sponsorship: Event sponsor and host of Supporter Breakfast at the Marathon Event December 12 2020 | 22000 | 22000 |
| 2020 | Vertex Pharmaceuticals | Cystic Fibrosis Australia | Charitable Contribution: COVID-19 and CF Comorbidities Patient Education Program | 34820 | 34820 |
| 2020 | Vertex Pharmaceuticals | Cystic Fibrosis Community Care | Charitable Contribution: COVID-19 Response Packages (CRP) aims to support people with CF and their families to optimise their health and wellbeing during the pandemic while they are in isolation | 11050 | 11050 |
| 2020 | Vertex Pharmaceuticals | Cystic Fibrosis Queensland (QLD) | Sponsorship: Queensland CF Nurses Conference December 3-4 2020 | 5000 | 5000 |
| 2020 | Vertex Pharmaceuticals | Cystic Fibrosis South Australia (SA) | Sponsorship: South Australian Nurses and Allied Health Cystic Fibrosis (CF) Study Day | 12980 | 12980 |
| 2020 | Vertex Pharmaceuticals | Cystic Fibrosis Western Australia (WA) | Sponsorship of Respiratory Training Program for Nurses and Physiotherapists held on 7-11 September 2020 | 1210 | 1210 |
| 2020 | Vertex Pharmaceuticals | Patient Voice Initiative | Sponsorship: Patient Voice Initiative(PVI) 2020-2021 Patient and Patient Advocacy Group Education Series | 8250 | 8250 |
